TERM LOAN CREDIT AGREEMENT dated as of December 21, 2012 among ROTECH HEALTHCARE INC., THE LENDERS PARTY HERETO and SILVER POINT FINANCE, LLCas Administrative Agent

EXECUTION VERSION

THE LOANS WERE ISSUED WITH "ORIGINAL ISSUE DISCOUNT" WITHIN THE MEANING OF SECTION 1272, ET SEQ. OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. UPON WRITTEN REQUEST, THE BORROWER WILL PROVIDE TO ANY LENDER (1) THE ISSUE PRICE AND CLOSING DATE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE LOANS AND (3) THE ORIGINAL YIELD TO MATURITY OF THE LOANS. SUCH REQUEST SHOULD BE SENT TO THE BORROWER AT Rotech Healthcare Inc., ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, ATTN: CHIEF FINANCIAL OFFICER.

TERM LOAN CREDIT AGREEMENT

dated as of

December 21, 2012

among

ROTECH HEALTHCARE INC.,

THE LENDERS PARTY HERETO

and

SILVER POINT FINANCE, LLC

as Administrative Agent

EXECUTION VERSION

Table of Contents

Page



	ARTICLE I

	Definitions

SECTION 1.01.	Defined Terms	1
SECTION 1.02.	Terms Generally	38
SECTION 1.03.	Pro Forma Calculations	38
SECTION 1.04.	Classification of Loans and Borrowings	39

	ARTICLE II

	Amounts and Terms of Credit

SECTION 2.01.	Term Loan Borrowing Commitments	39
SECTION 2.02.	Minimum Amount of Each Borrowing	39
SECTION 2.03.	Borrowing Procedure	39
SECTION 2.04.	Disbursement of Funds	40
SECTION 2.05.	Evidence of Debt; Repayment of Loans	41
SECTION 2.06.	Conversions and Continuations	41
SECTION 2.07.	Pro Rata Borrowings	42
SECTION 2.08.	Interest	42
SECTION 2.09.	Fees	44
SECTION 2.10.	Optional Prepayment	44
SECTION 2.11.	Mandatory Prepayments.	44
SECTION 2.12.	Reserve Requirements; Change in Circumstances	45
SECTION 2.13.	Change in Legality	46
SECTION 2.14.	Indemnity	46
SECTION 2.15.	Sharing of Setoffs	47
SECTION 2.16.	Payments	47
SECTION 2.17.	Taxes	48
SECTION 2.18.	Assignment of Commitments Under Certain Circumstances; Duty to Mitigate	50

	ARTICLE III

	Representations and Warranties

SECTION 3.01.	Organization; Powers	52
SECTION 3.02.	Authorization	52
SECTION 3.03.	Enforceability	52
SECTION 3.04.	Governmental Approvals	53

Table of Contents

(continued)

Page



SECTION 3.05.	Financial Statements	53
SECTION 3.06.	No Material Adverse Change	53
SECTION 3.07.	Title to Properties; Possession Under Leases	53
SECTION 3.08.	Restricted Subsidiaries	53
SECTION 3.09.	Litigation; Compliance with Laws	53
SECTION 3.10.	Agreements	54
SECTION 3.11.	Federal Reserve Regulations	54
SECTION 3.12.	Investment Company Act	54
SECTION 3.13.	Use of Proceeds	54
SECTION 3.14.	Tax Returns and Payments	54
SECTION 3.15.	No Material Misstatements	54
SECTION 3.16.	Employee Benefit Plans; Compliance with ERISA	55
SECTION 3.17.	Environmental Matters	55
SECTION 3.18.	Insurance	55
SECTION 3.19.	Security Documents	56
SECTION 3.20.	Location of Leased Premises	56
SECTION 3.21.	Labor Matters	56
SECTION 3.22.	Solvency	57
SECTION 3.23.	Sanctioned Persons; OFAC	57
SECTION 3.24.	USA PATRIOT Act	57
SECTION 3.25.	Foreign Corrupt Practices Act	57
SECTION 3.26.	Health Care Matters	57

	ARTICLE IV

	Conditions of Lending

SECTION 4.01.	The Closing Date Term Loans	58
SECTION 4.02.	Delayed Draw Term Loans	60

	ARTICLE V

	Affirmative Covenants

SECTION 5.01.	Existence; Compliance with Laws; Businesses and Properties	61
SECTION 5.02.	Insurance	61
SECTION 5.03.	Obligations and Taxes	62
SECTION 5.04.	Financial Statements, Reports, etc	62
SECTION 5.05.	Litigation and Other Notices	64
SECTION 5.06.	Information Regarding Collateral	64

Table of Contents

(continued)

Page



SECTION 5.07.	Maintaining Records; Access to Properties and Inspections	64
SECTION 5.08.	Use of Proceeds	64
SECTION 5.09.	Employee Benefits	64
SECTION 5.10.	Compliance with Environmental Laws	65
SECTION 5.11.	Preparation of Environmental Reports	65
SECTION 5.12.	Further Assurances	65
SECTION 5.13.	Proceeds of Certain Dispositions	66
SECTION 5.14.	Post Closing Deliverables	66

	ARTICLE VI

	Negative Covenants

SECTION 6.01.	Intentionally Omitted.	66
SECTION 6.02.	Financial Covenants	66
SECTION 6.03.	Limitation on Indebtedness	67
SECTION 6.04.	Limitation on Restricted Payments	69
SECTION 6.05.	Limitation on Restrictions on Distributions from Restricted Subsidiaries	72
SECTION 6.06.	Limitation on Sales of Assets and Subsidiary Stock	73
SECTION 6.07.	Limitation on Affiliate Transactions	75
SECTION 6.08.	Limitation on Line of Business	76
SECTION 6.09.	Limitation on Liens	76
SECTION 6.10.	Limitation on Sale/Leaseback Transactions	77
SECTION 6.11.	When Borrower May Merge or Transfer Assets	77
SECTION 6.12.	Prepayments or Modification of Certain Debt	78

	ARTICLE VII

	Events of Default

SECTION 7.01.	Events of Default	78

	ARTICLE VIII

	The Administrative Agent and the Collateral Agent

	ARTICLE IX

	Miscellaneous
SECTION 9.01.	Notices; Electronic Communications	83

iii

Table of Contents

(continued)

Page



SECTION 9.02.	Survival of Agreement	86
SECTION 9.03.	Binding Effect	86
SECTION 9.04.	Successors and Assigns	86
SECTION 9.05.	Expenses; Indemnity	90
SECTION 9.06.	Right of Setoff	91
SECTION 9.07.	Applicable Law	91
SECTION 9.08.	Waivers; Amendment	92
SECTION 9.09.	Interest Rate Limitation	92
SECTION 9.10.	Entire Agreement	93
SECTION 9.11.	WAIVER OF JURY TRIAL	93
SECTION 9.12.	Severability	93
SECTION 9.13.	Counterparts	93
SECTION 9.14.	Headings	94
SECTION 9.15.	Jurisdiction; Consent to Service of Process	94
SECTION 9.16.	Confidentiality	94
SECTION 9.17.	Lender Action	95
SECTION 9.18.	USA PATRIOT Act Notice	95
SECTION 9.19.	Application of Proceeds	95

SCHEDULES


Schedule 1.01(a)	- Subsidiary Guarantors


Schedule 2.01	- Lenders and Commitments


Schedule 3.08	- Restricted Subsidiaries***


Schedule 3.09	- Litigation


Schedule 3.17	- Environmental Matters


Schedule 3.18	- Insurance***


Schedule 3.19(a)	- UCC Filing Offices


Schedule 3.20	- Leased Real Property


Schedule 4.01(d)	- Local Counsel


Schedule 6.03(b)(v)	- Indebtedness

EXHIBITS


Exhibit A	- Form of Administrative Questionnaire


Exhibit B	- Form of Assignment and Acceptance


Exhibit C-1	- Form of Closing Date Borrowing Request


Exhibit C-2	- Form of Delayed Draw Borrowing Request


Exhibit D	- Form of Collateral Agreement


Exhibit E	- Form of Guarantee Agreement

Table of Contents

(continued)

Page


Exhibit F-1	- Form of Opinion of ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇ LLP


Exhibit F-2	- Form of Local Counsel Opinion (Colorado)


Exhibit F-3	- Form of Local Counsel Opinion (Florida)


Exhibit G	- Form of Compliance Certificate


Exhibit H	- Proposed Amendments to Senior Secured Notes Indenture***

*** Certain information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

TERM LOAN CREDIT AGREEMENT, dated as of December 21, 2012 among ROTECH HEALTHCARE INC., a Delaware corporation (the “Borrower”), the Lenders (as defined in Article I) and SILVER POINT FINANCE, LLC, as administrative agent (in such capacity, together with its successors and assigns, the “Administrative Agent”) for the Secured Parties (as defined in Article I).

The Borrower has requested the Lenders to extend credit to the Borrower, in the form of term Loans, in an aggregate principal amount of up to $25,000,000, $1,500,000 of which will be available on a delayed draw basis. The proceeds of the Loans are to be used solely for the repayment of the Borrower’s existing revolving credit facility, for the general corporate purposes of the Borrower and the Subsidiaries and the payment of fees and transaction costs in connection with the incurrence of the Loans.

The Lenders are willing to extend the Loans to the Borrower on the terms and subject to the conditions set forth herein. Accordingly, the parties hereto agree as follows:

ARTICLE 1

Definitions

SECTION 1.01. Defined Terms. As used in this Agreement, the following terms shall have the meanings specified below:

“ABR” shall mean, for any day, a fluctuating rate per annum equal to the highest of (a) the Federal Funds Effective Rate plus 1/2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by JPMorgan Chase as its “prime rate”, and (c) the LIBOR Rate at such time determined for a one-month Interest Period plus 1%. The “prime rate” is a rate set by JPMorgan Chase based upon various factors including JPMorgan Chase’s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate. Any change in such prime rate announced by JPMorgan Chase shall take effect at the opening of business on the day specified in the public announcement of such change.

“ABR Loan” shall mean each Loan bearing interest at the rate provided in Section 2.08(a).

“Administrative Agent” shall have the meaning assigned to such term in the introductory statement to this Agreement.

“Administrative Agent Fee” shall have the meaning assigned to such term in the Fee Letter.

“Administrative Questionnaire” shall mean an Administrative Questionnaire in the form of Exhibit A, or such other form as may be supplied from time to time by the Administrative Agent.

“Affiliate” shall mean, when used with respect to a specified person, another person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the person specified.

us\smolyju\8802494.13

“Agreement” shall mean this Term Loan Credit Agreement, as the same may be amended, restated, supplemented or otherwise modified from time to time.

“Applicable ABR Margin” shall mean at any date, with respect to all ABR Loans, 9.00% per annum.

“Applicable LIBOR Margin” shall mean at any date, with respect to all LIBOR Loans, 10.00% per annum.

“Applicable Senior Indebtedness” shall mean

(1) in respect of any asset that is the subject of an Asset Disposition at a time when such asset is included in the Collateral, other Senior Indebtedness that is secured at such time by a Permitted Collateral Lien on such asset;

(2) in respect of any asset that is the subject of an Asset Disposition at a time when such asset is owned, directly or indirectly, by a Restricted Subsidiary that is not a Subsidiary Guarantor but the Equity Interests of which is included in the Collateral, other Senior Indebtedness that is secured at such time by a Permitted Collateral Lien on such Equity Interests; or

(3) in respect of any other asset (including any asset previously constituting Collateral that has been released from the Liens securing the Obligations), other Senior Indebtedness that is not a Subordinated Obligation.

“Asset Disposition” shall mean any sale, lease, transfer or other disposition (or series of related sales, leases, transfers or dispositions) by the Borrower or any Restricted Subsidiary, including any disposition by means of a merger, consolidation or similar transaction (each referred to for the purposes hereof as a “Disposition”), of:


(1)	any Equity Interests of a Restricted Subsidiary (other than directors’ (or similar persons’) qualifying shares or shares required by applicable law to be held by a Person other than the Borrower or a Restricted Subsidiary);


(2)	all or substantially all the assets of any division or line of business of the Borrower or any Restricted Subsidiary; or


(3)	any other assets of the Borrower or any Restricted Subsidiary outside of the ordinary course of business of the Borrower or such Restricted Subsidiary;

other than, in the case of clauses (1), (2) and (3) above,


(A)	a Disposition by a Restricted Subsidiary to the Borrower or by the Borrower or a Restricted Subsidiary to a Restricted Subsidiary;


(B)	for purposes of Section 6.06 only, (x) a Disposition that constitutes a Restricted Payment (or would constitute a Restricted Payment but for the exclusions from the definition thereof) and that is not

us\smolyju\8802494.13

prohibited by Section 6.04 and (y) a disposition of all or substantially all the assets of the Borrower in accordance with Section 6.11;


(C)	Dispositions of assets in any single fiscal year with an aggregate Fair Market Value not exceeding $10,000,000;


(D)	a Disposition of cash or Cash Equivalents;

(E)

the Disposition of (x) equipment, inventory (including raw materials, work-in-progress and finished goods), accounts receivable or other assets or rights in the ordinary course of business, and (y) any excess, obsolete, damaged, worn-out or surplus assets no longer used or useful in the conduct of business as then being conducted; provided that the total Fair Market Value of dispositions pursuant to this clause (E)(y) shall not exceed $10,000,000 in any fiscal year of the Borrower;


(F)	the creation of a Lien (but not the sale or other Disposition of the property subject to such Lien); and


(G)	foreclosures on assets not constituting Collateral.

“Asset Sale Prepayment Event” shall mean any Asset Disposition of the Borrower or any of its Restricted Subsidiaries.

“Assignment and Acceptance” shall mean an assignment and acceptance entered into by a Lender and an assignee, and accepted by the Administrative Agent, in the form of Exhibit B or such other form as shall be approved by the Administrative Agent.

“Attributable Debt” in respect of a Sale/Leaseback Transaction means, as at the time of determination, the present value of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale/Leaseback Transaction (including any period for which such lease has been extended); provided, however, that if such Sale/Leaseback Transaction results in a Capital Lease Obligation, the amount of Indebtedness represented thereby will be determined in accordance with the definition of “Capital Lease Obligation.” Such present value shall be calculated using a discount rate equal to the rate of interest implicit in such transaction determined in accordance with GAAP (or, in the absence thereof, the original yield to maturity of the Closing Date Term Loans).

“Average Life” shall mean, as of the date of determination, with respect to any Indebtedness, the quotient obtained by dividing:


(1)	the sum of the products of the number of years from the date of determination to the date of each successive scheduled principal payment of or redemption or similar payment with respect to such Indebtedness multiplied by the amount of such payment by

us\smolyju\8802494.13


(2)	the sum of all such payments.

“Board” shall mean the Board of Governors of the Federal Reserve System of the United States of America.

“Board of Directors” shall mean, as to any Person, the board of directors, board of managers or other similar body or Person performing a similar function or any duly authorized committee thereof.

“Borrower” shall have the meaning assigned to such term in the introductory statement to this Agreement.

“Borrower Materials” shall have the meaning assigned to such term in Section 9.01.

“Borrowing” shall mean Loans of the same Type made, converted or continued on the same date and, in the case of LIBOR Loans, as to which a single Interest Period is in effect.

“Borrowing Request” shall mean a request by the Borrower in accordance with the terms of Section 2.03 and substantially in the form of (a) in the case of a Closing Date Term Loan, Exhibit C-1 and (b) in the case of a Delayed Draw Term Loan, Exhibit C-2 (or, in either case, such other form as shall be approved by the Administrative Agent).

“Breakage Event” shall have the meaning assigned to such term in Section 2.14.

“Business Day” shall mean any day other than a Saturday, Sunday or day on which banks in New York City are authorized or required by law to close; provided, however, that when used in connection with a LIBOR Loan, the term “Business Day” shall also exclude any day on which banks are not open for dealings in Dollar deposits in the London interbank market.

“Capital Expenditures” shall mean, for any period, the aggregate cash expenditures of the Borrower and its Restricted Subsidiaries during such period on account of property, plant, equipment or similar fixed assets that, in conformity with GAAP, are required to be reflected as such on the cash flow statement of the Borrower.

“Capital Lease Obligations” of any person shall mean the obligations of such person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP.

“Capital Stock” shall mean:

(1) in the case of a corporation, corporate stock;

(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock;

us\smolyju\8802494.13

(3) in the case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and

(4) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person.

“Cash Equivalents” shall mean (a) direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America), in each case maturing within one year from the date of issuance thereof, (b) investments in commercial paper maturing within 270 days from the date of issuance thereof and having, at such date of acquisition, the highest credit rating obtainable from S&P or from ▇▇▇▇▇’▇, (c) investments in certificates of deposit, banker’s acceptances and time deposits maturing within one year from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, the Administrative Agent or any domestic office of any commercial bank organized under the laws of the United States of America or any State thereof that has a combined capital and surplus and undivided profits of not less than $500,000,000 and that issues (or the parent of which issues) commercial paper rated at least “Prime-1” (or the then equivalent grade) by ▇▇▇▇▇’▇ or “A-1” (or the then equivalent grade) by S&P, (d) fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (a) above and entered into with a financial institution satisfying the criteria of clause (c) above, and (e) investments in “money market funds” within the meaning of Rule 2a-7 of the Investment Company Act of 1940, as amended, substantially all of whose assets are invested in investments of the type described in clauses (a) through (d) above.

“Casualty Prepayment Event” shall mean, with respect to any Collateral or other property or assets of the Borrower or its Restricted Subsidiaries, any loss of or damage to, or any condemnation or other taking by a Governmental Authority of property for which such Collateral or other property or assets for which the Borrower or any of its Restricted Subsidiaries receives insurance proceeds, or proceeds of a condemnation award or other compensation.

“CHAMPUS” shall mean, collectively, the Civilian Health and Medical Program of the Uniformed Services, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, which is now known as TRICARE, financed and administered by the United States Departments of Defense, Health and Human Services and Transportation, and all laws, rules, regulations, manuals, orders, guidelines or requirements pertaining to such program including (a) all Federal statutes (whether set forth in 10 U.S.C. §§1071-1107 or elsewhere) affecting such program; and (b) all rules, regulations (including 32 C.F.R. §§199.1-199.22), manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“CHAMPVA” shall mean, collectively, the Civilian Health and Medical Program of the Department of Veteran Affairs, a program of medical benefits covering retirees and dependents of former members of the armed services administered by the United States Department of Veteran

us\smolyju\8802494.13

Affairs, and all laws, rules, regulations, manuals, orders, guidelines or requirements pertaining to such program including (a) all Federal statutes (whether set forth in 38 U.S.C. §1713 or elsewhere) affecting such program; (b) to the extent applicable to CHAMPVA, the CHAMPUS regulations; and (c) all rules, regulations (including 38 C.F.R. §§17.270-17.278), manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“Change in Control” shall mean the occurrence of any of the following events:

(1)

the Borrower becomes aware that any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) is or becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of the Voting Stock of the Borrower; provided, however, that for purposes of this clause (1) such other Person shall be deemed to have “beneficial ownership” of any Voting Stock of a Person held by any other Person (the “parent entity”), if such other Person is the beneficial owner (as defined above in this clause (1)), directly or indirectly, of more than 50% of the total voting power of the Voting Stock of such parent entity;


(2)	the adoption of a plan relating to the liquidation or dissolution of the Borrower; or

(3)

the merger or consolidation of the Borrower with or into another Person or the merger of another Person with or into the Borrower, or the sale of all or substantially all the assets of the Borrower (determined on a consolidated basis) to another Person other than a transaction following which, in the case of a merger or consolidation transaction, holders of securities that represented 100% of the Voting Stock of the Borrower immediately prior to such transaction (or other securities into which such securities are converted as part of such merger or consolidation transaction) own directly or indirectly at least a majority of the voting power of the Voting Stock of the surviving Person in such merger or consolidation transaction immediately after such transaction.

“Change in Law” shall mean (a) the adoption of any law, rule or regulation after the Closing Date, (b) any change in any law, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the Closing Date or (c) compliance by any Lender (or, for purposes of Section 2.12, by any lending office of such Lender or by such Lender’s holding company, if any) with any request, guideline or directive of any Governmental Authority made or issued after the Closing Date.

“Charges” shall have the meaning assigned to such term in Section 9.09.

“Closing Date” shall mean December 21, 2012.

us\smolyju\8802494.13

“Closing Date Term Loan” shall have the meaning provided in Section 2.01(a).

“Closing Fee” shall have the meaning assigned to such term in the Fee Letter.

“Closing Date Term Loan Commitment” shall mean, with respect to each Lender, the obligations of such Lender, if any, to make a Closing Date Term Loan hereunder in an aggregate principal amount not to exceed the amount set forth opposite such Lender’s name on Schedule 2.01, or in the Assignment and Acceptance pursuant to which such Lender assumed its commitment, as applicable, as the same may be reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04 or as otherwise modified pursuant to the terms hereof.

“Code” shall mean the Internal Revenue Code of 1986, as amended from time to time.

“Collateral” shall mean all the “Collateral” as defined in any Security Document.

“Collateral Agent” shall mean The Bank of New York Mellon Trust Company, N.A., in its capacity as collateral agent for the Secured Parties, together with its successors and assigns.

“Collateral Agreement” shall mean the Collateral Agreement dated as of October 6, 2010, as amended and restated as of March 17, 2011, as further amended and restated substantially in the form of Exhibit D, among the Borrower, the Subsidiaries party thereto and the Collateral Agent for the benefit of the Secured Parties.

“Commitment” shall mean a Closing Date Term Loan Commitment and/or a Delayed Draw Term Loan Commitment, as applicable.

“Communications” shall have the meaning assigned to such term in Section 9.01.

“Consolidated Coverage Ratio” as of any date of determination shall mean the ratio of (x) the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters ending at least 45 days prior to the date of such determination to (y) Consolidated Interest Expense for such four fiscal quarters; provided, however, that:

(1)

if the Borrower or any Restricted Subsidiary has Incurred any Indebtedness since the beginning of such period that remains outstanding or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio is an Incurrence of Indebtedness, or both, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving effect on a pro forma basis to such Indebtedness as if such Indebtedness had been Incurred (and the proceeds thereof applied) on the first day of such period;

(2)

if the Borrower or any Restricted Subsidiary has repaid, repurchased, defeased or otherwise discharged any Indebtedness since the beginning of such period or if any Indebtedness is to be repaid, repurchased, defeased or otherwise discharged (in each case other than Indebtedness Incurred under any revolving credit facility unless such Indebtedness has been permanently repaid and has not been replaced) on the date of the transaction giving rise

us\smolyju\8802494.13

to the need to calculate the Consolidated Coverage Ratio, EBITDA and Consolidated Interest Expense for such period shall be calculated on a pro forma basis as if such discharge had occurred on the first day of such period and as if the Borrower or such Restricted Subsidiary had not earned the interest income actually earned during such period in respect of cash or Cash Equivalents used to repay, repurchase, defease or otherwise discharge such Indebtedness;

(3)

if since the beginning of such period the Borrower or any Restricted Subsidiary shall have made any Asset Disposition, EBITDA for such period shall be reduced by an amount equal to EBITDA (if positive) directly attributable to the assets which are the subject of such Asset Disposition for such period, or increased by an amount equal to EBITDA (if negative), directly attributable thereto for such period, and Consolidated Interest Expense for such period shall be reduced by an amount equal to the Consolidated Interest Expense directly attributable to any Indebtedness of the Borrower or any Restricted Subsidiary repaid, repurchased, defeased or otherwise discharged with respect to the Borrower and its continuing Restricted Subsidiaries in connection with such Asset Disposition for such period (or, if the Equity Interests of any Restricted Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of such Restricted Subsidiary to the extent the Borrower and its continuing Restricted Subsidiaries are no longer liable for such Indebtedness after such sale);

(4)

if, since the beginning of such period, the Borrower or any Restricted Subsidiary (by merger or otherwise) shall have made an Investment in any Restricted Subsidiary (or any Person which becomes a Restricted Subsidiary) or an acquisition of assets, including any acquisition of assets occurring in connection with a transaction requiring a calculation to be made hereunder, which constitutes all or substantially all of an operating unit of a business, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or an acquisition permitted under this Agreement had occurred on the first day of such period; and

(5)

if since the beginning of such period any Person (that subsequently became a Restricted Subsidiary or was merged with or into the Borrower or any Restricted Subsidiary since the beginning of such period) shall have made any Asset Disposition, any Investment or acquisition of assets that would have required an adjustment pursuant to clause (3) or (4) above if made by the Borrower or a Restricted Subsidiary during such period, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving pro forma effect thereto as if such Asset Disposition, Investment or acquisition had occurred on the first day of such period.

us\smolyju\8802494.13

For purposes of this definition, whenever pro forma effect is to be given to any of the transactions referred to in clauses (1) through (5) above, the amount of income or earnings relating to such transaction and the amount of Consolidated Interest Expense associated with any Indebtedness Incurred in connection therewith, the pro forma calculations shall be (x) determined in good faith by a responsible financial or accounting Officer of the Borrower and set forth in an Officers’ Certificate (and may include, without limitation, cost savings and operating expense reductions (A) that have resulted from specified actions that have been taken or (B) in connection only with any acquisition, resulting from specified actions that are reasonably expected to be taken within twelve months of such acquisition and that are reasonably expected to be realized within twelve months from the date such actions are taken and, in each case, that are based upon identifiable and factually supportable data) or (y) determined in accordance with Regulation S-X (which cost savings and operating expense reductions shall be calculated on a pro forma basis as though such cost savings and operating expense reductions had been realized on the first day of the applicable period). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any interest rate agreement applicable to such Indebtedness if such interest rate agreement has a remaining term in excess of 12 months). If any Indebtedness is incurred under a revolving credit facility and is being given pro forma effect, the interest on such Indebtedness shall be calculated based on the average daily balance of such Indebtedness for the four fiscal quarters subject to the pro forma calculation to the extent that such Indebtedness was incurred solely for working capital purposes.

“Consolidated Interest Expense” shall mean, for any period, the sum of (i) the interest expense (including that attributable to capital leases in accordance with GAAP), net of interest income of the Borrower and its Restricted Subsidiaries on a consolidated basis in accordance with GAAP with respect to all outstanding Indebtedness of the Borrower and its Restricted Subsidiaries, including all commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptance financing and net costs under Hedge Agreements, and (ii) any payments made during such period in respect of obligations referred to in clause (b) below relating to funded Indebtedness that were amortized or accrued in a previous period (other than any such obligations resulting from the discounting of Indebtedness in connection with the application of purchase accounting in connection with any acquisition), but excluding, however, (a) the accretion or accrual of discounted liabilities during such period and (b) all non-recurring interest expense consisting of liquidated damages for failure to timely comply with registration rights obligations and financing fees, all as calculated on a consolidated basis in accordance with GAAP and excluding, for the avoidance of doubt, any interest in respect of items excluded from Indebtedness in the proviso to the definition thereof, provided that (x) except as provided in clause (y) below, there shall be excluded from Consolidated Interest Expense for any period the interest expense (or interest income) of all Unrestricted Subsidiaries for such period to the extent otherwise included in Consolidated Interest Expense, (y) there shall be included in determining Consolidated Interest Expense for any period the interest expense (or income) of any acquired entity or business acquired in an acquisition permitted hereunder since the beginning of such period and of any converted Restricted Subsidiary since the beginning of such period, in each case based on the interest expense (or income) of such acquired entity or business or converted Restricted Subsidiary for such period (including the portion thereof occurring prior to such acquisition or conversion) assuming any Indebtedness incurred or

us\smolyju\8802494.13

repaid in connection with any such acquisition or conversion had been incurred or prepaid on the first day of such period, and (z) there shall be excluded from determining Consolidated Interest Expense for any period the interest expense (or income) of any entity or business disposed of in an Asset Disposition since the beginning of such period, based on the interest expense (or income) relating to any Indebtedness relieved, retired or repaid in connection with any such disposition of such entity or business disposed of for such period (including the portion thereof occurring prior to such disposal) assuming such debt relieved, retired or repaid in connection with such disposition had been relieved, retired or repaid on the first day of such period.

“Consolidated Net Income” shall mean, for any period, the aggregate of the Net Income of the Borrower and its Restricted Subsidiaries for such period, on a consolidated basis determined in accordance with GAAP; provided, however, that there shall not be included in such Consolidated Net Income:


(1)	extraordinary, unusual or non-recurring gains or losses;


(2)	the cumulative effect of any change in accounting principles during such period; and


(3)	any net after-tax gain (or loss) attributable to the early retirement or conversion of Indebtedness,

in each case, for such period. Notwithstanding the foregoing, for the purposes of Section 6.04 only, there shall be excluded from Consolidated Net Income any repurchases, repayments or redemptions of Investments, proceeds realized on the sale of Investments or return of capital to the Borrower or a Restricted Subsidiary to the extent such repurchases, repayments, redemptions, proceeds or returns increase the amount of Restricted Payments permitted under Section 6.04 (a)(iv)(D).

“Control” shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a person, whether through the ownership of voting securities, by contract or otherwise, and the terms “Controlling” and “Controlled” shall have meanings correlative thereto.

“Currency Agreement” shall mean any foreign exchange contract, currency swap agreement or other similar agreement with respect to currency values.

“Debt Incurrence Prepayment Event” shall mean any issuance or incurrence by the Borrower or any of its Restricted Subsidiaries of any Indebtedness (but excluding any Indebtedness permitted to be issued or incurred under Section 6.03).

“Debtor Relief Law” shall mean Title 11 of United States Code, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, examinership or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.

us\smolyju\8802494.13

“Default” shall mean any event or condition which upon notice, lapse of time or both would constitute an Event of Default.

“Default Rate” shall mean an interest rate equal to (i) the ABR Rate plus (ii) the Applicable ABR Margin plus (iii) 3% per annum; provided, however, that with respect to a LIBOR Loan, the Default Rate shall be an interest rate equal to the interest rate (including any Applicable LIBOR Rate) otherwise applicable to such Loan plus 3% per annum.

“Delayed Draw Availability Period” shall mean the period from (i) the date that is five (5) Business Days after the date on which the Indenture Amendment has become effective in accordance with its terms through and including (ii) the date that is fifteen (15) Business Days after the date on which the Indenture Amendment has become effective in accordance with its terms; provided that the Delayed Draw Availability Period shall automatically terminate immediately on the earlier of January 1, 2014 and the date, if any, the Delayed Draw Term Loans are funded hereunder.

“Delayed Draw Term Loan” shall have the meaning specified in Section 2.01(b).

“Delayed Draw Term Loan Commitment” shall mean, with respect to each Lender, the obligation of such Lender, if any, to make a Delayed Draw Term Loan hereunder in an aggregate principal amount not to exceed the amount set forth opposite such Lender’s name on Schedule 2.01, or in the Assignment and Acceptance pursuant to which such Lender assumes its commitment, as applicable, as the same may be reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04 or as otherwise modified pursuant to the terms hereof. The aggregate amount of the Delayed Draw Term Loan Commitment as of the Closing Date is $1,500,000.

“Delayed Draw Ticking Fee” shall have the meaning assigned to such term in the Fee Letter.

“Designated Non-cash Consideration” shall mean the Fair Market Value of non-cash consideration received by the Borrower or a Restricted Subsidiary in connection with an Asset Disposition that is so designated as Designated Non-cash Consideration pursuant to an Officers’ Certificate setting forth the basis of such valuation, executed by the principal financial officer of the Borrower, less the amount of Cash Equivalents received in connection with a subsequent sale of, or collection on, such Designated Non-cash Consideration.

“Disqualified Stock” shall mean, with respect to any Person, any Equity Interest which by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable at the option of the holder) or upon the happening of any event:


(1)	matures or is mandatorily redeemable (other than redeemable only for Equity Interests of such Person which is not itself Disqualified Stock) pursuant to a sinking fund obligation or otherwise;


(2)	is convertible or exchangeable at the option of the holder for Indebtedness or Disqualified Stock; or

us\smolyju\8802494.13


(3)	is mandatorily redeemable or must be purchased upon the occurrence of certain events or otherwise, in whole or in part;

in each case on or prior to the date 91 days after the maturity of the Loans.

“Dollars” or “$” shall mean lawful money of the United States of America.

“Domestic Subsidiaries” shall mean all Subsidiaries incorporated or organized under the laws of the United States of America, any State thereof or the District of Columbia.

“Early Termination Fee” shall mean, (1) in connection with each voluntary and mandatory prepayment of the principal amount of the Loans, an amount equal to (a) if such prepayment occurs at any time from Closing Date through and including December 31, 2013, 6% (or, in the case of any prepayment in connection with a Change in Control, 4.5%) of the principal amount of the Loans prepaid or (b) from January 1, 2014 through and including December 31, 2014, 3% of the principal amount of the Loans prepaid and (2) in connection with any termination of the Delayed Draw Term Loan Commitment after 5 p.m. (New York City time) on March 31, 2013, without the funding of the Delayed Draw Term Loan Commitment (including as a result of the termination of the Delayed Draw Availability Period ), an amount equal to Early Termination Fee that would have been payable if the full Delayed Draw Term Loan had been funded as of the date of such termination and then prepaid as provided in clause (1) above.

“EBITDA” shall mean, for any period, the sum of Consolidated Net Income, plus the following to the extent deducted in calculating such Consolidated Net Income (without duplication):


(1)	all income tax expense of the Borrower and its consolidated Restricted Subsidiaries; plus


(2)	Consolidated Interest Expense; plus


(3)	depreciation and amortization expense of the Borrower and its consolidated Restricted Subsidiaries (excluding amortization expense attributable to a prepaid item that was paid in cash in a prior period); plus

(4)

the amount of net cost savings and operating expense reductions (which cost savings and operating expense reductions in each case shall be added to EBITDA until fully realized and calculated on a pro forma basis as though such cost savings and operating expense reductions had been realized on the first day of such period) (x) (A) that have resulted from specified actions that have been taken or (B) in connection only with any acquisition that is reasonably expected to result from specified actions that are reasonably expected to be taken within twelve months of such acquisition and that are reasonably expected to be realized by the Borrower within the twelve month period following the date such actions are taken (in each case determined in good faith by a responsible financial or accounting Officer of the Borrower and set forth in an Officers’ Certificate); provided that, in each case such cost

us\smolyju\8802494.13

savings and operating expense reductions are reasonably identifiable and factually supportable or (y) determined in accordance with Regulation S-X (which adjustments in each case may be incremental to, but without duplication of, pro forma adjustments made pursuant to the second paragraph of the definition of “Consolidated Coverage Ratio”); plus


(5)	non-cash charges relating to equity compensation; plus


(6)	any non-cash impairment charges or write-off or write-down relating to goodwill or intangible assets; plus


(7)	any gain (or loss) realized upon the sale or other disposition of any assets of the Borrower, its consolidated Subsidiaries or any other Person (including pursuant to any sale-and-leaseback arrangement) which are not sold or otherwise disposed of in the ordinary course of business and any gain (or loss) realized upon the sale or other disposition of any Equity Interests of any Person; plus

(8)

all other non-cash charges of the Borrower and its consolidated Restricted Subsidiaries, including any non-cash charges arising from any interest rate agreement or with respect to the issuance, exercise, cancellation or appreciation of options and other grants in connection with Equity Interests, but excluding, in each case, any such non-cash charge to the extent that it represents an accrual of or reserve for cash expenditures in any future period, less (without duplication) all non-cash items of income of the Borrower and its Restricted Subsidiaries (other than accruals of revenue by the Borrower and its Restricted Subsidiaries in the ordinary course of business);

in each case determined on a consolidated basis in accordance with GAAP for such period. Notwithstanding the foregoing, the provision for taxes based on the income or profits of, and the depreciation and amortization and non-cash charges of, a Restricted Subsidiary shall be added to Consolidated Net Income to compute EBITDA only to the extent (and in the same proportion, including by reason of minority interests) that the Net Income of such Restricted Subsidiary was included in calculating Consolidated Net Income and only if a corresponding amount would be permitted at the date of determination to be dividend to the Borrower by such Restricted Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to such Restricted Subsidiary or its stockholders.

“Eligible Assignee” shall mean any commercial bank, insurance company, investment or mutual fund or other entity (but not any natural person) that is an “accredited investor” (as defined in Regulation D under the Securities Act of 1933, as amended) that extends credit or invests in bank loans as one of its businesses; provided that neither (i) the Borrower nor any of its Affiliates nor (ii) any person separately identified in writing on the Closing Date by the Borrower to the Administrative Agent nor any of such person’s Affiliates shall be an Eligible Assignee.

us\smolyju\8802494.13

“Environmental Laws” shall mean all former, current and future Federal, state, local and foreign laws (including common law), treaties, regulations, rules, ordinances, codes, decrees, judgments, directives, orders (including consent orders) and agreements, in each case, relating to protection of the environment, natural resources, human health and safety or the presence, Release of, or exposure to, Hazardous Materials, or the generation, manufacture, processing, distribution, use, treatment, storage, transport, recycling or handling of, or the arrangement for such activities with respect to, Hazardous Materials.

“Environmental Liability” shall mean all liabilities, obligations, damages, losses, claims, actions, suits, judgments, orders, fines, penalties, fees, expenses and costs (including administrative oversight costs, natural resource damages and remediation costs), whether contingent or otherwise, arising out of or relating to (a) compliance or non‑compliance with any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release of any Hazardous Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.

“Equity Interests” shall mean Capital Stock and all warrants, options or other rights to acquire Capital Stock, but excluding any debt security that is convertible into, or exchangeable for, Capital Stock.

“Equity Issuance Prepayment Event” shall mean any issuance of Capital Stock by the Borrower (other than pursuant to a registration statement on Form S-8 (or any successor form)).

“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time.

“ERISA Affiliate” shall mean any trade or business (whether or not incorporated) that, together with the Borrower, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.

“ERISA Event” shall mean (a) any “reportable event”, as defined in Section 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) any failure by any Plan to satisfy the minimum funding standard (within the meaning of Section 412 of the Code or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA, of an application for a waiver of the minimum funding standard with respect to any Plan, (d) a determination that any Plan is, or is expected to be, in “at-risk” status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code), (e) the incurrence by the Borrower or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Borrower or any of its ERISA Affiliates from any Plan or Multiemployer Plan, (f) the receipt by the Borrower or any of its ERISA Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (g) the receipt by the Borrower or any of its ERISA Affiliates of any notice, or the receipt by any Multiemployer Plan from the Borrower or any

us\smolyju\8802494.13

of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA or in endangered or critical status, within the meaning of Section 305 of ERISA, (h) the occurrence of a “prohibited transaction” with respect to which the Borrower or any of the Subsidiaries is a “disqualified person” (within the meaning of Section 4975 of the Code) or with respect to which the Borrower or any such Subsidiary could otherwise be liable or (i) any other event or condition with respect to a Plan or Multiemployer Plan that could result in liability of the Borrower or any Subsidiary.

“Events of Default” shall have the meaning assigned to such term in Article VII.

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, as in effect on the date hereof.

“Excluded Taxes” shall mean, with respect to the Administrative Agent, any Lender or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder, (a) income or franchise taxes imposed on (or measured by) its net income or net profits (and, in each case, franchise taxes imposed in lieu thereof) by the United States of America, or by the jurisdiction under the laws of which such recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, or in which it is otherwise deemed to be engaged in business (other than in connection with such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned any interest in any Loan or Loan Document), (b) any branch profits taxes imposed by the United States of America or any similar tax imposed by any other jurisdiction described in clause (a) above and (c) in the case of a Lender (other than an assignee pursuant to a request by the Borrower under Section 2.18(a)) or participant, any withholding tax (including FATCA) that is imposed on amounts payable to such Lender or participant pursuant to any law enacted at the time such Lender becomes a party to this Agreement (or designates a new lending office) or such participant acquires its participation or is attributable to such Lender’s or participant’s failure to comply with Sections 2.17(e) and 2.17(f), except to the extent that such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment) or sale of the participation, to receive additional amounts from the Borrower with respect to such withholding tax pursuant to Section 2.17(a).

“Existing Notes” shall mean the Senior Secured Notes and the Junior Secured Notes.

“Fair Market Value” shall mean, with respect to any asset or property, the price which could be negotiated in an arm’s length, free market transaction, for cash, between a willing seller and a willing and able buyer, neither of whom is under undue pressure or compulsion to complete the transaction. Fair Market Value will be determined in good faith by the Board of Directors of the Borrower, whose determination shall be conclusive and evidenced by a resolution of such Board of Directors of the Borrower; provided, however, that for purposes of Section 6.04(a)(iv)(B), if the Fair Market Value of the property or assets in question is so determined to be in excess of $5,000,000, such determination must be confirmed by an Independent Qualified Party. For purposes of determining the Fair Market Value of Capital Stock, the value of the Capital Stock of a Person shall

us\smolyju\8802494.13

be based upon such Person’s property and assets, exclusive of goodwill or any similar intangible asset.

“FATCA” shall mean Sections 1471 through 1474 of the Code, as of the date of this Agreement, and any current or future regulations thereunder or official interpretations thereof.

“Federal and/or State Healthcare Programs” shall mean one or more of the Medicare, TRICARE, CHAMPUS, CHAMPVA, and black lung disease programs and any other health care plan or program that provides health benefits, whether directly, through insurance or otherwise, which is funded directly, in whole or in part, by the United States government, other than the federal employee health benefits program and any program receiving funds under Titles V, XVII (including Medicare), XIX (including Medicaid), and XX of the Social Security Act or from an allotment to a state under such title or a state child health plan approved under Title XXI of the Social Security Act.

“Federal Funds Effective Rate” shall mean, for any day, the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.

“Fee Letter” shall mean that certain letter agreement dated December 21, 2012, executed by the Borrower and the Administrative Agent.

“Financial Officer” of any Person shall mean the chief financial officer, principal accounting officer, treasurer or controller of such Person.

“Fixed Charge Ratio” shall mean, on any date of determination, the ratio of (a) EBITDA for the period of four consecutive fiscal quarters ended on such date to (b) Fixed Charges for such four fiscal quarter period, in each case calculated on the pro forma basis.

“Fixed Charges” shall mean, for the four fiscal quarter period ending on the last day of any fiscal quarter, the sum of (a) the cash paid component of Consolidated Interest Expense for such period, plus (b) scheduled payments of principal on Indebtedness of the Borrower or its Restricted Subsidiaries during such period, plus (c) unfinanced Capital Expenditures paid by the Borrower and its Restricted Subsidiaries on a consolidated basis during such period.

“Foreign Lender” shall mean any Lender that is organized under the laws of a jurisdiction other than that in which the Borrower is located. For purposes of this definition, the United States of America, each State thereof and the District of Columbia shall be deemed to constitute a single jurisdiction.

“GAAP” shall mean United States generally accepted accounting principles applied on a consistent basis.

us\smolyju\8802494.13

“Governmental Authority” shall mean any Federal, state, local or foreign court or governmental agency, authority, instrumentality or regulatory body.

“Granting Lender” shall have the meaning assigned to such term in Section 9.04(i).

“Guarantee” of or by any person shall mean any obligation, contingent or otherwise, of such person guaranteeing or having the economic effect of guaranteeing any Indebtedness of any other person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of such person, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment of such Indebtedness or (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness; provided, however, that the term “Guarantee” shall not include endorsements for collection or deposit in the ordinary course of business.

“Guarantee Agreement” shall mean the Guarantee Agreement, substantially in the form of Exhibit E, among the Subsidiaries party thereto and the Administrative Agent for the benefit of the Secured Parties.

“Hazardous Materials” shall mean (a) any petroleum products or byproducts and all other hydrocarbons, coal ash, radon gas, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, chlorofluorocarbons and all other ozone-depleting substances and (b) any chemical, material, substance or waste that is prohibited, limited or regulated by or pursuant to any Environmental Law.

“Healthcare Laws” shall mean all applicable statutes, laws, ordinances, rules, regulations and orders of any Governmental Authority with respect to the regulation of patient health care and the submission of claims for reimbursement including: (1) federal fraud and abuse laws and regulations, including the federal patient referral law, 42 U.S.C. §1395nn, commonly known as “▇▇▇▇▇ II”, the federal anti-kickback law, 42 U.S.C. §1320a-7b, the federal civil monetary penalty statute, 42 U.S.C. §1320a-7a, federal laws regarding the submission of false claims, false billing, false coding and similar state laws and regulations; (2) federal and state laws applicable to reimbursement and reassignment; (3) HIPAA; (4) federal statutes and regulations affecting the health insurance program for the aged and disabled established by Title XVIII of the Social Security Act and any statutes succeeding thereto; (5) statutes affecting the TRICARE, CHAMPUS, CHAMPVA, and black lung disease programs and any other health care program financed with United States government funds; (6) all federal statutes and regulations affecting the medical assistance program established by Titles V, XIX, XX, and XXI of the Social Security Act and any statutes succeeding thereto, and all state statutes and plans for medical assistance enacted in connection with the federal statutes and regulations; and (7) any other federal or state law or regulation governing health care.

us\smolyju\8802494.13

“Hedging Agreement” shall mean any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.

“Hedging Obligations” shall mean, with respect to any specified Person, the obligations of such Person pursuant to (i) any Hedging Agreement, or (ii) other derivative agreements or arrangements designed to protect such Person against fluctuations in currency exchange rates, commodity prices or raw materials, but excluding purchase and supply agreements.

“HIPAA” shall mean, collectively, (1) the administrative simplification provisions of the Health Insurance Portability and Accountability Act of 1996, and (2) the Health Information Technology for Economic and Clinical Health Act, as incorporated in Title XIII, Subtitle D of the American Recovery and Reinvestment Act of 2009, ▇▇▇.▇.▇▇. 111-5, and its implementing regulations and guidance issued by the Secretary of the Department of Health and Human Services (the “HITECH Act”), as the same may be amended, modified or supplemented from time to time, and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder.

“Incur” shall mean issue, assume, Guarantee, incur or otherwise become liable for; provided, however, that any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the time it becomes a Restricted Subsidiary. The term “Incurrence” when used as a noun shall have a correlative meaning. Solely for purposes of determining compliance with Section 6.03:


(1)	amortization of debt discount or the accretion of principal with respect to a non-interest bearing or other discount security;


(2)	the payment of regularly scheduled interest in the form of additional Indebtedness of the same instrument or the payment of regularly scheduled dividends on Equity Interests in the form of additional Equity Interests of the same class and with the same terms; and


(3)	the obligation to pay a premium in respect of Indebtedness arising in connection with the issuance of a notice of redemption or the making of a mandatory offer to purchase such Indebtedness will be deemed not to be an Incurrence of Indebtedness.

“Indebtedness” shall mean, with respect to any Person on any date of determination (without duplication):


(1)	the principal in respect of (A) indebtedness of such Person for money borrowed and (B) indebtedness evidenced by notes, debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable, including, in each case, any premium on such indebtedness to the extent such premium has become due and payable;

us\smolyju\8802494.13


(2)	all Capital Lease Obligations of such Person and all Attributable Debt in respect of Sale/Leaseback Transactions entered into by such Person;


(3)	all obligations of such Person issued or assumed as the deferred purchase price of property, all conditional sale obligations of such Person and all obligations of such Person under any title retention agreement (but excluding any accounts payable or other liability to trade creditors arising in the ordinary course of business);

(4)

all obligations of such Person for the reimbursement of any obligor on any letter of credit, surety bond, bankers’ acceptance or similar credit transaction (other than obligations with respect to letters of credit or surety bonds securing obligations (but excluding obligations described in clauses (1) through (3) above) entered into in the ordinary course of business of such Person to the extent such letters of credit or surety bonds are not drawn upon or, if and to the extent drawn upon, such drawing is reimbursed no later than the tenth Business Day following payment on the letter of credit or surety bond);


(5)	the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any Disqualified Stock of such Person or, with respect to any Preferred Stock of any Subsidiary of such Person, the principal amount of such Preferred Stock to be determined in accordance with this Agreement (but excluding, in each case, any accrued dividends);


(6)	all obligations of the type referred to in clauses (1) through (5) above of other Persons and all dividends of other Persons for the payment of which, in either case, such Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise, including by means of any Guarantee;


(7)	all obligations of the type referred to in clauses (1) through (6) above of other Persons secured by any Lien on any property or asset of such Person (whether or not such obligation is assumed by such Person), the amount of such obligation being deemed to be the lesser of the Fair Market Value of such property or assets and the amount of the obligation so secured; and


(8)	to the extent not otherwise included in this definition, Hedging Obligations of such Person.

Notwithstanding the foregoing, in connection with the purchase by the Borrower or any Restricted Subsidiary of any business, the term “Indebtedness” shall exclude post-closing payment adjustments to which the seller may become entitled to the extent such payment is determined by a final closing balance sheet or such payment depends on the performance of such business after the closing; provided, however, that, at the time of closing, the amount of any such payment is not determinable and, to the extent such payment thereafter becomes fixed and determined, the amount is paid within 30 days thereafter.

us\smolyju\8802494.13

The amount of Indebtedness of any Person at any date shall be the outstanding balance at such date of all obligations as described above; provided, however, that in the case of Indebtedness sold at a discount, the amount of such Indebtedness at any time will be the accreted value thereof at such time.

The amount of any Disqualified Stock or Preferred Stock that has a fixed redemption, repayment or repurchase price will be calculated in accordance with the terms of such Disqualified Stock or Preferred Stock as if such Disqualified Stock or Preferred Stock were redeemed, repaid or repurchased on any date on which the amount of such Disqualified Stock is to be determined pursuant to this Agreement; provided, however, that if such Disqualified Stock or Preferred Stock could not be required to be redeemed, repaid or repurchased at the time of such determination, the redemption, repayment or repurchase price will be the book value of such Disqualified Stock or Preferred Stock as reflected in the most recent financial statements of such Person.

“Indemnified Taxes” shall mean Taxes other than Excluded Taxes.

“Indemnitee” shall have the meaning assigned to such term in Section 9.05(b).

“Indenture Amendment” shall mean an Amendment to the Senior Secured Notes Indenture that modifies the terms thereof as set forth on Exhibit H.

“Independent Qualified Party” shall mean an investment banking firm, accounting firm or appraisal firm of national standing; provided, however, that such firm is not an Affiliate of the Borrower.

“Information” shall have the meaning assigned to such term in Section 9.16.

“Intercreditor Agreements” shall mean the Pari Passu Intercreditor Agreement and the Junior Lien Intercreditor Agreement.

“Interest Payment Date” shall mean (a) with respect to any ABR Loan, the last Business Day of each month, and (b) with respect to any LIBOR Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part.

“Interest Period” shall mean, with respect to any LIBOR Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day (or, if there is no numerically corresponding day, on the last day) in the calendar month that is one month thereafter, as the Borrower may elect; provided, however, that (a) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, (b) any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end of such Interest Period and (c) no Interest Period for any Loan shall extend beyond the Maturity Date of such Loan. Interest shall accrue from and including the first day of an Interest Period to but excluding the last day of such Interest Period.

us\smolyju\8802494.13

For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.

“Investment” in any Person shall mean any direct or indirect advance, loan (other than advances to customers in the ordinary course of business that are recorded as accounts receivable on the balance sheet of the lender) or other extensions of credit (including by way of a Guarantee or similar arrangement) or capital contribution to (by means of any transfer of cash or other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Equity Interests, Indebtedness or other similar instruments issued by such Person. If the Borrower or any Restricted Subsidiary issues, sells or otherwise disposes of any Equity Interests of a Person that is a Restricted Subsidiary such that, after giving effect thereto, such Person is no longer a Restricted Subsidiary, any Investment by the Borrower or any Restricted Subsidiary in such Person remaining after giving effect thereto shall be deemed to be a new Investment at such time. The acquisition by the Borrower or any Restricted Subsidiary of a Person that holds an Investment in a third Person shall be deemed not to be an Investment by the Borrower or such Restricted Subsidiary in such third Person at such time unless such Investment was made in contemplation of such acquisition or acquiring that Investment was the primary purpose of such acquisition. Except as otherwise provided for herein, the amount of an Investment shall be its Fair Market Value at the time the Investment is made and without giving effect to subsequent changes in value.

“JPMorgan Chase” shall mean JPMorgan Chase Bank, N.A.

“Junior Lien Intercreditor Agreement” shall mean the Junior Lien Intercreditor Agreement dated as of March 17, 2011, as amended by that certain First Amendment to Junior Lien Intercreditor Agreement, dated as of December 21, 2012, among the Senior Secured Notes Trustee, as first priority representative, the Borrower, the Subsidiaries party thereto and The Bank of New York Mellon Trust Company, N.A., as junior priority representative.

“Junior Secured Notes” shall mean the Borrower’s 10.5% senior second priority secured notes due 2018, issued on March 17, 2011, in an aggregate principal amount of $290,000,000 and any exchange notes issued in exchange therefor, in each case pursuant to the Junior Secured Notes Indenture.

“Junior Secured Notes Documents” shall mean the Junior Secured Notes, the Junior Secured Notes Indenture and all other documents executed and delivered with respect to the Junior Secured Notes or the Junior Secured Notes Indenture.

“Junior Secured Notes Indenture” shall mean the Indenture for the Junior Secured Notes dated as of March 17, 2011, among the Borrower, the Subsidiaries party thereto and The Bank of New York Mellon Trust Company, N.A., as trustee, as amended, supplemented or otherwise modified from time to time in accordance with the terms hereof and thereof.

us\smolyju\8802494.13

“Lenders” shall mean (a) the persons listed on Schedule 2.01 (other than any such person that has ceased to be a party hereto pursuant to an Assignment and Acceptance) and (b) any person that has become a party hereto pursuant to an Assignment and Acceptance.

“LIBOR Loan” shall mean any Loan bearing interest at a rate determined by reference to the LIBOR Rate.

“LIBOR Rate” shall mean:

(a) for any Interest Period with respect to a LIBOR Loan, a rate per annum determined by the Administrative Agent pursuant to the following formula:



LIBOR Rate =	LIBOR ABR
	1.00 – LIBOR Reserve Percentage

where,

“LIBOR ABR” shall mean, for such interest period, the rate per annum equal to (i) the British Bankers Association LIBOR Rate or the successor thereto if the British Bankers Association is no longer making a LIBOR Rate available (“BBA LIBOR”), as published by Reuters (or such other commercially available source providing quotations of BBA LIBOR as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m. (London time) two London Banking Days prior to the commencement of such Interest Period, for Dollar deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period, or (ii) if such rate is not available at such time for any reason, the rate per annum determined by the Administrative Agent to be the rate at which deposits in Dollars for delivery on the first day of such Interest Period in same day funds in the approximate amount of the LIBOR Rate Loan being made, continued or converted and with a term equivalent to such Interest Period would be offered by Bank of America’s London Branch to major banks in the London interbank LIBOR market at their request at approximately 11:00 a.m. (London time) two London Banking Days prior to the commencement of such Interest Period; and

(b) for any interest calculation with respect to an ABR Loan on any date, a rate per annum determined by the Administrative Agent pursuant to the following formula:



LIBOR Rate =	LIBOR ABR
	1.00 – LIBOR Reserve Percentage

where,

“LIBOR ABR” shall mean the rate per annum equal to (i) BBA LIBOR, as published by Reuters (or such other commercially available source providing quotations of BBA LIBOR as may be designated by the Administrative Agent from time to time)

us\smolyju\8802494.13

at approximately 11:00 a.m., (London time) two London Banking Days prior to such date, for Dollar deposits with a term of one month commencing on that day, or (ii) if such rate is not available at such time for any reason, the rate per annum determined by the Administrative Agent to be the rate at which deposits in Dollars for delivery on the date of determination in same day funds in the approximate amount of the ABR Loan being made or maintained and with a term equal to one month would be offered by JPMorgan to major banks in the London interbank eurodollar market at their request at the date and time of determination.

Notwithstanding the foregoing, the LIBOR Rate shall at no time be less than 2.00% per annum.

“LIBOR Reserve Percentage” shall mean, for any day during any Interest Period, the reserve percentage (expressed as a decimal, carried out to five decimal places) in effect on such day, whether or not applicable to any Lender, under regulations issued from time to time by the FRB for determining the maximum reserve requirement (including any emergency, supplemental, marginal or other reserve requirement) with respect to Eurocurrency funding (currently referred to as “Eurocurrency liabilities”). The LIBOR Rate for each outstanding Loan, the interest on which is determined by reference to the LIBOR Rate shall be adjusted automatically as of the effective date of any change in the LIBOR Reserve Percentage.

“Lien” shall mean, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, encumbrance, charge or security interest in or on such asset, (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset and (c) in the case of securities, any purchase option, call or similar right of a third party with respect to such securities.

“Loan Documents” shall mean this Agreement, the Guarantee Agreement, the Security Documents, the promissory notes, if any, executed and delivered pursuant to Section 2.05(e) and any other document executed in connection with the foregoing.

“Loan Parties” shall mean the Borrower and the Subsidiary Guarantors.

“Loans” shall have the meaning specified in Section 2.01(b).

“Margin Stock” shall have the meaning assigned to such term in Regulation U.

“Material Adverse Effect” shall mean (a) a materially adverse effect on the business, assets, liabilities, operations, condition (financial or otherwise), operating results or prospects of the Borrower and the Subsidiaries, taken as a whole, (b) a material impairment of the ability of the Borrower or any other Loan Party to perform any of its obligations under any Loan Document to which it is or will be a party or (c) a material impairment of the rights and remedies of or benefits available to the Lenders under any Loan Document.

us\smolyju\8802494.13

“Material Indebtedness” shall mean Indebtedness (other than the Loans) of the Borrower and its Restricted Subsidiaries in the amount of $10,000,000 or greater.

“Maturity Date” shall mean April 30, 2015.

“Maximum Rate” shall have the meaning assigned to such term in Section 9.09.

“Medicaid” shall mean the medical assistance program established by Title XIX of the Social Security Act (42 U.S.C. Secs. 1396 et seq.) and any statutes succeeding thereto.

“Medicare” shall mean the health insurance program for the aged and disabled established by Title XVIII of the Social Security Act (42 U.S.C. Secs. 1395 et seq.) and any statutes succeeding thereto.

“Minimum Borrowing Amount” shall mean $23,500,000 with respect to Closing Date Term Loans and $1,500,000 with respect to Delayed Draw Term Loans.

“Moody’s” shall mean ▇▇▇▇▇’▇ Investors Service, Inc., or any successor thereto.

“Multiemployer Plan” shall mean a Plan that is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.

“Net Cash Proceeds” shall mean, with respect to any Prepayment Event, (a) the gross cash proceeds (including payments from time to time in respect of installment obligations, if applicable) received by or on behalf of the Borrower or any of the Restricted Subsidiaries in respect of such Prepayment Event or issuance, as the case may be, less (b) the sum of:

(i) the amount, if any, of all taxes paid or estimated to be payable by the Borrower or any of its Restricted Subsidiaries in connection with such Prepayment Event,

(ii) the amount of any reasonable reserve established in accordance with GAAP against any liabilities (other than any taxes deducted pursuant to clause (i) above) (x) associated with the assets that are the subject of such Prepayment Event and (y) retained by the Borrower or any of its Restricted Subsidiaries, provided that the amount of any subsequent reduction of such reserve (other than in connection with a payment in respect of any such liability) shall be deemed to be Net Cash Proceeds of such a Prepayment Event occurring on the date of such reduction;

(iii) in case of any Asset Sale Prepayment Event or Casualty Prepayment Event, the amount of any Indebtedness (including any premium in respect thereof) secured by a Lien on the assets that are the subject of such Prepayment Event to the extent that the instrument creating or evidencing such Indebtedness requires that such Indebtedness be repaid upon consummation of such Prepayment Event;

(iv) in the case of any Asset Sale Prepayment Event, Casualty Prepayment Event or Equity Issuance Prepayment Event, the amount of any proceeds of such Prepayment Event that the Borrower or any Subsidiary has reinvested (or intends to reinvest) within the

us\smolyju\8802494.13

Reinvestment Period in the business of the Borrower or any of the Restricted Subsidiaries, or the amount that is applied within the Reinvestment Period to consummate a transaction permitted under this Agreement, provided that any portion of such proceeds that has not been so reinvested within such Reinvestment Period (with respect to such Prepayment Event, the “Deferred Net Cash Proceeds”) shall (x) be deemed to be Net Cash Proceeds of an Asset Sale Prepayment Event, Casualty Prepayment Event, or Equity Issuance Prepayment Event occurring on the last day of such Reinvestment Period and (y) be applied to the repayment of Loans in accordance with Section 2.11; and

(v) reasonable and customary fees including, but not limited to, attorneys’ fees, accountants’ fees, investment banking fees, brokers’ fees and, with respect to any Equity Issuance Prepayment Event, underwriting discounts and commissions and other customary fees and expenses.

“Net Income” shall mean, with respect to any Person, the net income (loss) of such Person, determined in accordance with GAAP.

“Obligations” shall mean all obligations defined as “Loan Documents Obligations” in the Collateral Agreement together with all other obligations under all other Loan Documents.

“OFAC” shall have the meaning assigned to such term in Section 3.23.

“Officer” shall mean the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, the President, any Vice President, the Treasurer, the General Counsel or the Secretary of the Borrower.

“Officers’ Certificate” shall mean a certificate signed by two Officers of the Borrower.

“Opinion of Counsel” shall mean a written opinion from legal counsel who is acceptable to the Administrative Agent. The counsel may be an employee of or counsel to the Borrower.

“Other Taxes” shall mean any and all present or future stamp, court or documentary, recording or filing Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made under any Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, any Loan Document.

“Pari Passu Intercreditor Agreement” shall mean the Pari Passu Intercreditor Agreement dated as of March 17, 2011, among the Collateral Agent, the Senior Secured Notes Trustee, the Borrower, the Subsidiaries party thereto, the Administrative Agent, as an additional authorized representative, and each additional representative from time to time party thereto.

“PBGC” shall mean the Pension Benefit Guaranty Corporation referred to and defined in ERISA.

“Perfection Certificate” shall mean the Perfection Certificate substantially in the form of Annex X to the Collateral Agreement.

us\smolyju\8802494.13

“Permitted Collateral Liens” shall mean:


(a)	(i) any Lien on the Collateral to secure any of the foregoing (in each case, together with all related Obligations):

(1)

any Indebtedness (A) incurred pursuant to Section 6.03(b)(i) or (B) incurred as L/C Indebtedness pursuant to Section 6.03(b)(ii); provided that the total L/C Indebtedness secured by Liens on assets of the Borrower and its Restricted Subsidiaries under this clause (a)(i)(1) of this definition and under clause (17) of the definition of Permitted Liens shall not exceed $12,000,000 at any one time outstanding;


(2)	the Existing Notes (or any Subsidiary Guarantees thereof) incurred as Permitted Indebtedness pursuant to the provisions described in Section 6.03(b)(iv);


(3)	[reserved]; or


(4)	any Refinancing Indebtedness of Indebtedness described in the foregoing clause (2) or this clause (4),

in each case which are subject to the terms of an Intercreditor Agreement; and

(ii) any Lien on the Collateral that is a statutory Lien arising by operation of law; provided, however, that such Lien either ranks:


(1)	equal to all other Liens on such Collateral securing unsubordinated Indebtedness of the Borrower or the relevant Restricted Subsidiary, if the Lien secures unsubordinated Indebtedness; or

(2) junior to the Liens securing the Loans;

(b) any Permitted Lien described in clauses (1), (2), (3), (4), (5), (6), (7), (8), (9), (11), (12), (13), (16), (17), (18), and (19) of the definition of “Permitted Lien;” provided, however, that such Permitted Lien (other than any Lien described in clauses (2)(B), (3), (4), (8), (9), (11) and (17) of such definition) is not a Lien on any cash, Cash Equivalents or Equity Interests constituting Collateral and held by the Collateral Agent.

“Permitted Investment” shall mean an Investment by the Borrower or any Restricted Subsidiary in:


(1)	the Borrower, a Subsidiary Guarantor or a Person that will, upon the making of such Investment, become a Subsidiary Guarantor; provided, however, that the primary business of such Subsidiary Guarantor is a Related Business;


(2)	another Person if, as a result of such Investment, such other Person, in one transaction or a series of transactions, is merged or consolidated or

us\smolyju\8802494.13

amalgamated with or into, or transfers or conveys all or substantially all its assets to, the Borrower or a Subsidiary Guarantor; provided, however, that such Person’s primary business is a Related Business;


(3)	cash and Cash Equivalents;


(4)	receivables owing to the Borrower or any Restricted Subsidiary if created or acquired in the ordinary course of business and payable or dischargeable in accordance with customary trade terms; provided, however, that such trade terms may include such concessionary trade terms as the Borrower or any such Restricted Subsidiary deems reasonable under the circumstances;


(5)	payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses for accounting purposes and that are made in the ordinary course of business;


(6)	loans or advances to employees made in the ordinary course of business for bona fide business purposes and consistent with past practices of the Borrower or such Restricted Subsidiary; provided that such loans and advances do not exceed $1,000,000 principal amount outstanding at any one time;


(7)	stock, obligations or securities received in settlement of debts created in the ordinary course of business and owing to the Borrower or any Restricted Subsidiary or in satisfaction of judgments;


(8)	any Person to the extent such Investment represents the non-cash portion of the consideration received for (i) an Asset Disposition as permitted pursuant to Section 6.06, or (ii) a disposition of assets not constituting an Asset Disposition;

(9)

any Person where such Investment was acquired by the Borrower or any of the Restricted Subsidiaries (a) in exchange for any other Investment or accounts receivable held by the Borrower or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable or (b) as a result of a foreclosure by the Borrower or any of the Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default;


(10)	any Person to the extent such Investments consist of prepaid expenses, negotiable instruments held for collection and lease, utility and workers’ compensation, performance and other similar deposits made in the ordinary course of business by the Borrower or any Restricted Subsidiary;

us\smolyju\8802494.13


(11)	any Person to the extent such Investments consist of Hedging Obligations otherwise permitted under Section 6.03;

(12)

any Person to the extent such Investment exists on the Closing Date, and any extension, modification or renewal of any such Investments existing on the Closing Date, but only to the extent not involving additional advances, contributions or other Investments of cash or other assets or other increases thereof (other than as a result of the accrual or accretion of interest or original issue discount or the issuance of pay-in-kind securities, in each case, pursuant to the terms of such Investment as in effect on the Closing Date);


(13)	repurchases of Securities;


(14)	guarantees of Indebtedness of the Borrower or any Restricted Subsidiary permitted under Section 6.03; and

(15)

additional Investments, when taken together with all other Investments made pursuant to this clause (15) and outstanding on the date such Investment is made, do not exceed $2,500,000; provided, however, that, in the event of an Investment in any Person that is not a Restricted Subsidiary, such Person shall not use the proceeds of such Investment to purchase, redeem, retire or otherwise acquire for value any Equity Interests of the Borrower.

“Permitted Liens” shall mean, with respect to any Person:

(1)

pledges or deposits by such Person under workers compensation laws, unemployment insurance laws or similar legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits of cash or United States government bonds to secure surety or appeal bonds to which such Person is a party, or deposits as security for contested taxes or import duties or for the payment of rent, in each case Incurred in the ordinary course of business;

(2)

(A) Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ Liens, in each case for sums not yet due or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review and (B) Liens arising solely by virtue of any statutory or common law provision relating to banker’s Liens, rights of set-off or similar rights and remedies as to deposit accounts or other funds maintained with a creditor depository institution; provided, however, that (x) such deposit account is not a dedicated cash collateral account and is not subject to restrictions against access by the Borrower in excess of those set forth by regulations promulgated by the

us\smolyju\8802494.13

Federal Reserve Board and (y) such deposit account is not intended by the Borrower or any Restricted Subsidiary to provide collateral to the depository institution;


(3)	Liens for taxes not yet subject to penalties for non-payment or which are being contested in good faith by appropriate proceedings; provided, however, that any reserve or other appropriate provision as is required in conformity with GAAP has been made therefor;

(4)

Liens or deposits to secure the performance of statutory or regulatory obligations or in favor of issuers of surety, appeal, indemnity or performance bonds, warranty and contractual requirements, other obligations of a like nature or letters of credit issued pursuant to the request of and for the account of such Persons in the ordinary course of its business; provided, however, that such letters of credit, surety bonds or other similar arrangements do not constitute Indebtedness;

(5)

survey exceptions, encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens incidental to the conduct of the business of such Person or to the ownership of its properties which were not Incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or materially impair their use in the operation of the business of such Person;

(6)

Liens securing Indebtedness Incurred to finance the construction, purchase or lease of, or repairs, improvements or additions to, property, plant, equipment or vehicles of such Person (and any Refinancing Indebtedness Incurred to Refinance such Indebtedness); provided, however, that the Lien may not extend to any other property owned by such Person or any of the Restricted Subsidiaries at the time the Lien is Incurred (other than assets and property affixed or appurtenant thereto), and the Indebtedness (other than any interest thereon) secured by the Lien may not be Incurred more than 180 days after the later of the acquisition, completion of construction, repair, improvement, addition or commencement of full operation of the property subject to the Lien and the Indebtedness (other than any interest thereon) secured by the Lien is subject to a cap of $10,000,000;


(7)	Liens existing on the Closing Date;


(8)	Liens on assets, property or Equity Interests of another Person at the time such other Person becomes a Subsidiary of such Person; provided, however, that the Liens may not extend to any other property owned by such Person or any of the Restricted Subsidiaries (other than assets and property affixed or appurtenant thereto);

us\smolyju\8802494.13

(9)

Liens on property or assets at the time such Person or any of its Subsidiaries acquires the property or assets, including any acquisition by means of a merger or consolidation with or into such Person or a Subsidiary of such Person; provided, however, that the Liens may not extend to any other property or assets owned by such Person or any of the Restricted Subsidiaries (other than assets and property affixed or appurtenant thereto);


(10)	Liens securing Indebtedness or other obligations of a Subsidiary of such Person owing to such Person or a Restricted Subsidiary of such Person;


(11)	Liens securing Hedging Obligations so long as such Hedging Obligations are permitted to be Incurred under this Agreement;


(12)	Liens to secure any Refinancing (or successive Refinancings) as a whole, or in part, of any Indebtedness secured by any Lien referred to in the foregoing clause (6), (7), (8) or (9); provided, however, that:


(A)	such new Lien shall be limited to all or part of the same property and assets that secured or, under the written agreements pursuant to which the original Lien arose, could secure the original Lien (plus improvements and accessions to, such property or proceeds or distributions thereof); and

(B)

the Indebtedness secured by such Lien at such time is not increased to any amount greater than the sum of (x) the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (6), (7), (8) or (9) at the time the original Lien became a Permitted Lien and (y) an amount necessary to pay any fees and expenses, including premiums, related to such Refinancing;


(13)	Liens on equipment of the Borrower or any Restricted Subsidiary granted in the ordinary course of business to clients or customers on or about the premises of which such equipment is located;


(14)	Liens in favor of the Borrower or the Subsidiary Guarantors;


(15)	Permitted Collateral Liens, including Liens created under the Security Documents;


(16)	leases, licenses, subleases or sublicenses granted to other Persons in the ordinary course of business and not interfering in any material respect with the business of the Borrower or its Subsidiaries;


(17)	Liens on Cash Equivalents of up to 105% of the face amount of L/C Indebtedness Incurred pursuant to Section 6.03(b)(ii);

us\smolyju\8802494.13


(18)	Liens securing Indebtedness permitted to be Incurred pursuant to Section 6.03(b)(xii); provided that such Liens do not at any time encumber any property or assets other than the property or assets all or a material portion of the cost of which is either financed or reimbursed by such Indebtedness and the proceeds and the products thereof; and


(19)	other Liens securing obligations Incurred in the ordinary course of business which obligations do not exceed $2,500,000 at any one time outstanding.

For purposes of this definition, the term “Indebtedness” shall be deemed to include interest on such Indebtedness.

“Person” shall mean any natural person, corporation, business trust, joint venture, association, company, limited liability company, partnership, Governmental Authority or other entity.

“Plan” shall mean any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA.

“Platform” shall have the meaning assigned to such term in Section 9.01.

“Preferred Stock”, as applied to the Equity Interests of any Person, shall mean Equity Interests of any class or classes (however designated) which is preferred as to the payment of dividends or distributions, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Person, over Equity Interests of any other class of such Person.

“Prepayment Event” shall mean any Asset Sale Prepayment Event, Casualty Prepayment Event, Debt Incurrence Prepayment Event, or Equity Issuance Prepayment Event.

“Pro Rata Percentage” shall mean, for each Lender, the percentage of the Closing Date Term Loan Commitments or the Delayed Draw Term Loan Commitments held by all Lenders represented by such Lender’s Closing Date Term Loan Commitments or Delayed Draw Term Loan Commitments, as applicable or, if the Closing Date Term Loan Commitments or the Delayed Draw Term Loan Commitments have been terminated or have expired, the percentage held by such Lender of the aggregate principal amount of all Closing Date Term Loans or all Delayed Draw Term Loans (if any) then outstanding, as applicable.

“Public Lender” shall have the meaning assigned to such term in Section 9.01.

“Purchase Money Indebtedness” shall mean Indebtedness (1) consisting of the deferred purchase price of property, conditional sale obligations, obligations under any title retention agreement, other purchase money obligations and obligations in respect of industrial revenue bonds or similar Indebtedness, in each case where the maturity of such Indebtedness does not exceed the

us\smolyju\8802494.13

anticipated useful life of the asset being financed and (2) Incurred to finance the acquisition by the Borrower or a Restricted Subsidiary of such asset, including additions and improvements, in the ordinary course of business; provided, however, that any Lien arising in connection with any such Indebtedness shall be limited to the specific asset being financed or, in the case of real property or fixtures, including additions and improvements, the real property on which such asset is attached; provided further, however, that such Indebtedness is Incurred within 180 days after such acquisition of such assets.

“Qualified Equity Interests” of a Person shall mean Capital Stock of such Person other than Disqualified Capital Stock; provided, however, that such Capital Stock shall not be deemed Qualified Equity Interests to the extent sold to a Subsidiary of such Person or financed, directly or indirectly, using funds (1) borrowed from such Person or any Subsidiary of such Person or (2) contributed, extended, guaranteed or advanced by such Person or any Subsidiary of such Person (including, in respect of any employee stock ownership or benefit plan). Unless otherwise specified, Qualified Equity Interests refers to Qualified Equity Interests of the Borrower.

“Refinance” shall mean, in respect of any Indebtedness, to refinance, extend, renew, refund, repay, prepay, purchase, redeem, defease, discharge or retire, or to issue other Indebtedness in exchange or replacement for, such Indebtedness. “Refinanced” and “Refinancing” shall have correlative meanings.

“Refinancing Indebtedness” shall mean Indebtedness that Refinances any Indebtedness of the Borrower or any Restricted Subsidiary existing on the Closing Date or Incurred in compliance with this Agreement, including Indebtedness that Refinances Refinancing Indebtedness; provided, however, that:


(1)	such Refinancing Indebtedness has a stated maturity no earlier than the stated maturity of the Indebtedness being Refinanced; provided further, however, any Refinancing Indebtedness that Refinances Junior Secured Notes, has a stated maturity no earlier than the stated maturity of the Loans;


(2)	such Refinancing Indebtedness has an Average Life at the time such Refinancing Indebtedness is Incurred that is equal to or greater than the Average Life of the Indebtedness being Refinanced; and


(3)	such Refinancing Indebtedness has an aggregate principal amount (or if Incurred with original issue discount, an aggregate issue price) that is equal to or less than the aggregate principal amount (or if Incurred with original issue discount, the aggregate accreted value) then outstanding (plus fees and expenses, including any premium and defeasance costs) under the Indebtedness being Refinanced;

provided further, however, that Refinancing Indebtedness shall not include (A) Indebtedness of a Subsidiary that Refinances Indebtedness of the Borrower or (B) Indebtedness of the Borrower or a Restricted Subsidiary that Refinances Indebtedness of an Unrestricted Subsidiary.

us\smolyju\8802494.13

“Register” shall have the meaning assigned to such term in Section 9.04(d).

“Regulation T” shall mean Regulation T of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.

“Regulation U” shall mean Regulation U of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.

“Regulation X” shall mean Regulation X of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.

“Reinvestment Period” shall mean 270 days following the date of an Asset Sale Prepayment Event or Casualty Prepayment Event.

“Related Business” shall mean any business in which the Borrower or any of the Restricted Subsidiaries was engaged on the Closing Date and any business related, ancillary or complementary to such business.

“Related Fund” shall mean, with respect to any Lender that is a fund or commingled investment vehicle that invests in bank loans, any other fund that invests in bank loans and is managed or advised by the same investment advisor as such Lender or by an Affiliate of such investment advisor.

“Related Parties” shall mean, with respect to any specified person, such person’s Affiliates and the respective directors, trustees, officers, employees, agents and advisors of such person and such person’s Affiliates.

“Release” shall mean any release, spill, emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the environment or within, under, from or upon any building, structure, facility or fixture.

“Required Lenders” shall mean, at any time, Lenders having Loans and unused Commitments representing more than 50% of the sum of all Loans outstanding and unused Commitments at such time.

“Responsible Officer” of any person shall mean any executive officer or Financial Officer of such Person and any other officer or similar official thereof responsible for the administration of the obligations of such person in respect of this Agreement.

“Restricted Payment” with respect to any Person shall mean:

(1)

the declaration or payment of any dividends or any other distributions of any sort in respect of its Equity Interests (including any payment in connection with any merger or consolidation involving such Person) or similar payment to the direct or indirect holders of its Equity Interests (other than (A) dividends or distributions payable solely in its Equity Interests (other than Disqualified Stock), (B) dividends or distributions payable solely to the Borrower or a

us\smolyju\8802494.13

Restricted Subsidiary and (C) pro rata dividends or other distributions made by a Subsidiary that is not a Wholly Owned Subsidiary to minority stockholders (or owners of an equivalent interest in the case of a Subsidiary that is an entity other than a corporation));

(2)

the purchase, repurchase, redemption, defeasance or other acquisition or retirement for value of any Equity Interests of the Borrower held by any Person (other than by a Restricted Subsidiary) or of any Equity Interests of a Restricted Subsidiary held by any Affiliate of the Borrower (other than by a Restricted Subsidiary), including in connection with any merger or consolidation and including the exercise of any option to exchange any Equity Interests (other than into Equity Interests of the Borrower that is not Disqualified Stock);

(3)

the purchase, repurchase, redemption, defeasance or other acquisition or retirement for value, prior to scheduled maturity, scheduled repayment or scheduled sinking fund payment of any Subordinated Obligations of the Borrower or any Subsidiary Guarantor (other than (A) from the Borrower or a Restricted Subsidiary or (B) the purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations (other than the Junior Secured Notes) purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of such purchase, repurchase, redemption, defeasance or other acquisition or retirement); or


(4)	the making of any Investment (other than a Permitted Investment) in any Person.

“Restricted Subsidiary” shall have the meaning assigned to such term in the Senior Secured Notes Indenture as in effect on the Closing Date.

“S&P” shall mean Standard & Poor’s Ratings Service, or any successor thereto.

“Sale/Leaseback Transaction” shall mean an arrangement relating to property owned by the Borrower or a Restricted Subsidiary on the Closing Date or thereafter acquired by the Borrower or a Restricted Subsidiary whereby the Borrower or a Restricted Subsidiary transfers such property to a Person and the Borrower or a Restricted Subsidiary substantially concurrently leases it from such Person.

“Secured Notes” shall mean the Senior Secured Notes and the Junior Secured Notes.

“Secured Parties” shall mean (a) the Administrative Agent, (b) the Collateral Agent, (c) the beneficiary of each indemnification obligation undertaken by any Loan Party under any Loan Document, (d) the Lenders, and (e) the permitted successors and assigns of each of the foregoing.

“Securities Act” shall mean the U.S. Securities Act of 1933, as amended.

us\smolyju\8802494.13

“Security Documents” shall mean the Collateral Agreement, the Intercreditor Agreements and each of the security agreements and other instruments and documents executed and delivered pursuant to any of the foregoing or pursuant to Section 5.12.

“Senior Indebtedness” shall mean with respect to any Person:


(1)	Indebtedness of such Person, whether outstanding on the Closing Date or thereafter Incurred (including, with respect to the Borrower, the Junior Secured Notes); and


(2)	all other obligations of such Person (including interest accruing on or after the filing of any petition in bankruptcy or for reorganization relating to such Person whether or not post-filing interest is allowed in such proceeding) in respect of Indebtedness described in clause (1) above

unless, in the case of clauses (1) and (2), in the instrument creating or evidencing the same or pursuant to which the same is outstanding, it is provided that such Indebtedness is subordinate in right of payment to the Obligations of such Person, as the case may be; provided, however, that Senior Indebtedness shall not include:


(1)	any obligation of such Person to the Borrower or any Subsidiary of the Borrower;


(2)	any liability for Federal, state, local or other taxes owed or owing by such Person;


(3)	any accounts payable or other liability to trade creditors arising in the ordinary course of business (including Guarantees thereof or instruments evidencing such liabilities);


(4)	any Indebtedness of such Person which is subordinate or junior in any respect to any other Indebtedness of such Person;


(5)	that portion of any Indebtedness which at the time of Incurrence is Incurred in violation of this Indenture; or


(6)	any Subordinated Obligations.

“Senior Secured Notes” shall mean the Borrower’s 10.75% senior secured notes due 2015, issued on October 6, 2010, in an aggregate principal amount of $230,000,000, and any exchange notes issued in exchange therefor, in each case pursuant to the Senior Secured Notes Indenture.

“Senior Secured Notes Documents” shall mean the Senior Secured Notes, the Senior Secured Notes Indenture, the Senior Secured Notes Security Documents and all other documents executed and delivered with respect to the Senior Secured Notes or the Senior Secured Note Indenture.

us\smolyju\8802494.13

“Senior Secured Notes Indenture” shall mean the Indenture for the Senior Secured Notes dated as of October 6, 2010, among the Borrower, the Subsidiaries party thereto and the Senior Secured Notes Trustee, as amended, supplemented or otherwise modified from time to time in accordance with the terms hereof and thereof.

“Senior Secured Notes Security Documents” shall mean the “Security Documents” as defined in the Senior Secured Notes Indenture.

“Senior Secured Notes Trustee” shall mean The Bank of New York Mellon Trust Company, N.A. and its successors and assigns acting as trustee under the Senior Secured Notes Indenture.

“Significant Subsidiary” shall mean any Restricted Subsidiary that would be a “Significant Subsidiary” of the Borrower within the meaning of Rule 1‑02 under Regulation S‑X promulgated by the SEC and, for purposes of an Event of Default, any group of Restricted Subsidiaries that combined would be such a Significant Subsidiary.

“SPC” shall have the meaning assigned to such term in Section 9.04(i).

“Subordinated Obligation” shall mean, with respect to a Person, any Indebtedness of such Person (whether outstanding on the Closing Date or thereafter Incurred) which is subordinate or junior in right of payment to the Obligations of such Person, pursuant to a written agreement to that effect. No Indebtedness shall be deemed to be subordinated in right of payment to any other Indebtedness solely by virtue of being unsecured or secured by a lower priority Lien or by virtue of the fact that the holders of such Indebtedness have entered into intercreditor agreements or other arrangements giving one or more of such holders priority over the other holders in the collateral held by them.

“Subsidiary” shall mean any subsidiary of the Borrower.

“subsidiary” shall mean, with respect to any Person (herein referred to as the “parent”), any corporation, partnership, limited liability company, association or other business entity (a) of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general partnership interests are, at the time any determination is being made, owned, Controlled or held, or (b) that is, at the time any determination is made, otherwise Controlled, by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent.

“Subsidiary Guarantor” shall mean each Subsidiary listed on Schedule 1.01(a), and each other Subsidiary that is or becomes a party to the Guarantee Agreement.

“Taxes” shall mean any and all present or future taxes, levies, imposts, duties, deductions, charges or withholdings imposed by any Governmental Authority.

“Total Debt” shall mean, at any time, (a) the total Indebtedness of the Borrower and the Subsidiaries at such time (excluding any contingent liability in respect of any letter of credit) minus (b) unrestricted cash and Cash Equivalents, at such time, in an aggregate amount not to exceed

us\smolyju\8802494.13

$50,000,000, to the extent that any such unrestricted cash is, or any such Cash Equivalents are, maintained in one or more deposit or securities accounts over which the Collateral Agent has a perfected security interest by virtue of satisfying one of the requirements for control specified in Section 9-104 of the New York Uniform Commercial Code.

“Total Leverage Ratio” shall mean, on any date of determination, the ratio of (a) Total Debt on such date to (b) EBITDA for the period of four consecutive fiscal quarters ended on such date.

“Transactions” shall mean, collectively, (a) the execution, delivery and performance by the Loan Parties of the Loan Documents to which they are a party, and, in the case of the Borrower, the making of the Borrowings hereunder, and (b) the payment of related fees and expenses.

“TRICARE” shall mean, collectively, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, financed and administered by the United States Departments of Defense, Health and Human Services and Transportation, which program was formerly known as CHAMPUS, and all laws, rules, regulations, manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“Type”, when used in respect of any Loan or Borrowing, shall refer to the rate by reference to which interest on such Loan or on the Loans comprising such Borrowing is determined.

“Unrestricted Subsidiary” shall mean any (i) Subsidiary of the Borrower that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors of the Borrower in the manner provided below; and (ii) any Subsidiary of an Unrestricted Subsidiary. The Board of Directors of the Borrower may designate any Subsidiary of the Borrower (including any newly acquired or newly formed Subsidiary) to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Equity Interests or Indebtedness of, or holds any Lien on any property of, the Borrower or any other Subsidiary of the Borrower that is not a Subsidiary of the Subsidiary to be so designated; provided, however, that either (A) the Subsidiary to be so designated has total assets of $1,000 or less or (B) if such Subsidiary has assets greater than $1,000, such designation would be permitted under Section 6.05. The Board of Directors of the Borrower may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided, however, that immediately after giving effect to such designation (A) the Borrower could Incur $1.00 of additional Coverage Indebtedness under Section 6.03(a) and (B) no Default shall have occurred and be continuing. Any such designation by the Board of Directors of the Borrower shall be evidenced to the Administrative Agent by promptly filing, with the Administrative Agent, a copy of the resolution of the Board of Directors of the Borrower giving effect to such designation and an Officers’ Certificate certifying that such designation complied with the foregoing provisions.

“U.S. Employee Plan” shall mean any “employee benefit plan” (as defined in Section 3(3) of ERISA) maintained for employees of the Borrower or any ERISA Affiliate or any such U.S. Employee Plan to which the Borrower or any ERISA Affiliate is required to contribute on behalf of any of its employees.

us\smolyju\8802494.13

“USA PATRIOT Act” shall mean The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. No. 107-56 (signed into law October 26, 2001)).

“Voting Stock” of a Person shall mean all classes of Equity Interests of such Person then outstanding and normally entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof.

“Wholly Owned Subsidiary” shall mean a Restricted Subsidiary, all the Equity Interests of which (other than directors’ qualifying shares) is owned by the Borrower or one or more other Wholly Owned Subsidiaries.

“Withdrawal Liability” shall mean liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.

SECTION 1.02. Terms Generally. The definitions in Section 1.01 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”; and the words “asset” and “property” shall be construed as having the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, (a) any reference in this Agreement to any Loan Document shall mean such document as amended, restated, supplemented or otherwise modified from time to time and (b) all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided, however, that if the Borrower notifies the Administrative Agent that the Borrower wishes to amend any provision contained or incorporated by reference in this Agreement or any related definition to eliminate the effect of any change in GAAP occurring after the date of this Agreement on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders wish to amend any provision contained or incorporated by reference in this Agreement or any related definition for such purpose), then the Borrower’s compliance with such provision shall be determined on the basis of GAAP in effect immediately before the relevant change in GAAP became effective, until either such notice is withdrawn or such provision is amended in a manner satisfactory to the Borrower and the Required Lenders.

SECTION 1.03. Pro Forma Calculations. Whenever it shall be necessary to calculate the Total Leverage Ratio, the Fixed Charge Ratio or EBITDA hereunder, such calculations shall be made by giving effect to all applicable adjustments contemplated by clauses (1) through (5) and the final paragraph of the definition of the term “Consolidated Coverage Ratio” hereunder.

us\smolyju\8802494.13

SECTION 1.04. Classification of Loans and Borrowings. For purposes of this Agreement, Loans may be classified and referred to by Type (e.g., a “LIBOR Loan”). Borrowings also may be classified and referred to by Type (e.g., a “LIBOR Borrowing”).

ARTICLE II

Amounts and Terms of Credit

SECTION 2.01. Term Loan Borrowing Commitments. (i) Subject to and upon the terms and conditions herein set forth, each Lender severally agrees to make a simultaneous loan or loans (each, a “Closing Date Term Loan”) on the Closing Date to the Borrower in Dollars, which Closing Date Term Loans shall not exceed for any such Lender, the Closing Date Term Loan Commitment of such Lender and in the aggregate for all such Lenders shall not exceed $23,500,000.

(b) In addition, subject to and upon the terms and conditions herein set forth, each Lender severally agrees to make a simultaneous delayed draw loan or loans (each, a “Delayed Draw Term Loan” and together with the Closing Date Term Loans, the “Loans”) to the Borrower in Dollars, as part of a single drawing during the Delayed Draw Availability Period. The Delayed Draw Term Loans shall not exceed for any such Lender the Delayed Draw Term Loan Commitment of such Lender and in the aggregate for all such Lenders shall not exceed $1,500,000.

Such Loans (i) may at the option of the Borrower be incurred and maintained as, and/or converted into, ABR Loans or LIBOR Loans; provided that all such Loans made by each of the Lenders pursuant to the same Borrowing shall, unless otherwise specifically provided herein, consist entirely of Loans of the same Type, (ii) may be repaid or prepaid in accordance with the provisions hereof, but once repaid or prepaid, may not be reborrowed, and (iii) shall not exceed for any such Lender its Closing Date Term Loan Commitments or its Delayed Draw Term Loan Commitment.

(c) The Borrower may elect, at any time following the Closing Date to terminate, in whole or in part, the Delayed Draw Term Loan Commitment subject to the payment by the Borrower to the Administrative Agent for the benefit of the Lenders on the date of such termination (i) any accrued and unpaid Delayed Draw Ticking Fee plus (ii) the Early Termination Fee payable as a result of such termination (to the extent required pursuant to clause (2) in the definition thereof).

SECTION 2.02. Minimum Amount of Each Borrowing. The aggregate principal amount of each Borrowing of Loans shall not be less than the Minimum Borrowing Amount. More than one Borrowing may be incurred on any date; provided that at no time shall there be outstanding more than two Borrowings of LIBOR Loans under this Agreement.

SECTION 2.03. Borrowing Procedure. (i) The Borrower shall give the Administrative Agent at the Administrative Agent’s Office prior to 1:00 p.m. (New York City time) (i) at least three Business Days’ prior written notice in the form of Borrowing Request (or telephonic notice promptly confirmed in writing) of the Borrowing of Loans if all or any of such Loans are to be initially LIBOR Loans, and (ii) prior written notice in the form of Borrowing Request (or telephonic notice promptly confirmed in writing) on the date of the Borrowing of Loans if all such

us\smolyju\8802494.13

Loans are to be ABR Loans. Such Borrowing Request shall be substantially in the form of Exhibit C-1 or C-2 hereto, as applicable, and shall specify (i) the aggregate principal amount of the Loans to be made, (ii) the date of the Borrowing and (iii) whether the Loans shall consist of ABR Loans and/or LIBOR Loans and, if the Loans are to include LIBOR Loans, the Interest Period to be initially applicable thereto. Each telephonic notice by the Borrower pursuant to this Section 2.03(a) must be confirmed promptly by delivery to the Administrative Agent of a written Borrowing Request by no later than 2:00 p.m. (New York City time). The Administrative Agent shall promptly give each Lender written notice (or telephonic notice promptly confirmed in writing) of the proposed Borrowing of Loans, of such ▇▇▇▇▇▇’s proportionate share thereof and of the other matters covered by the related Borrowing Request. If the Borrower fails to specify whether any Loans shall consist of ABR Loans or LIBOR Loans in the Borrowing Request, then the applicable Loans shall be made as ABR Loans.

(b) Following receipt of a Borrowing Request, the Administrative Agent shall promptly notify each Lender of the amount of its Pro Rata Percentage of the Loans.

(c) Without in any way limiting the obligation of the Borrower to confirm in writing any notice it may give hereunder by telephone, the Administrative Agent may act prior to receipt of written confirmation without liability upon the basis of such telephonic notice believed by the Administrative Agent in good faith to be from a Responsible Officer of the Borrower. In each such case, the Borrower hereby waives the right to dispute the Administrative Agent’s record of the terms of any such telephonic notice.

SECTION 2.04. Disbursement of Funds. (ii) Each Lender shall make the amount of its Loan available to the Administrative Agent in immediately available funds at the Administrative Agent’s Office not later than 2:00 p.m. (New York City time) on the Business Day specified in the applicable Borrowing Request. Upon satisfaction of the applicable conditions set forth in Article IV, the Administrative Agent shall make all funds so received available to the Borrower in like funds as received by the Administrative Agent either by wire transfer of such funds, in each case in accordance with instructions provided to (and reasonably acceptable to) the Administrative Agent by the Borrower.

(b) If any Lender makes available to the Administrative Agent funds for any Loan to be made by such Lender as provided in the foregoing provisions of this Article II, and such funds are not made available to the Borrower by the Administrative Agent because the applicable conditions to the Borrowing set forth in Article VI are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender on demand, without interest.

(c) The obligations of the Lenders hereunder to make Loans are several and not joint. The failure of any Lender to make any Loan on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no Lender shall be responsible for the failure of any other Lender to so make its Loan.

us\smolyju\8802494.13

(d) Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner.

SECTION 2.05. Evidence of Debt; Repayment of Loans. (i) The Borrower shall repay to the Administrative Agent in Dollars, for the benefit of each Lender the then unpaid principal amount of the Loans of such Lender on the Maturity Date.

(b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender from time to time, including the amounts of principal and interest payable and paid to such Lender from time to time under this Agreement.

(c) The Administrative Agent shall maintain accounts in which it will record (i) the amount of each Loan made hereunder, the Type thereof and, if applicable, the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder from the Borrower or any Subsidiary Guarantor and each Lender’s share thereof.

(d) The entries made in the accounts maintained pursuant to paragraph (c) above shall be prima facie evidence of existence and amounts of the obligations therein recorded; provided, however, that the failure of the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligations of the Borrower to repay the Loans in accordance with their terms.

(e) Any Lender may request that Loans made by it hereunder be evidenced by a promissory note. In such event, the Borrower shall execute and deliver to such Lender a promissory note payable to such Lender and its registered assigns and in a form and substance reasonably acceptable to the Administrative Agent and the Borrower. Notwithstanding any other provision of this Agreement, in the event any Lender shall request and receive such a promissory note, the interests represented by such note shall at all times (including after any assignment of all or part of such interests pursuant to Section 9.04) be represented by one or more promissory notes payable to the payee named therein or its registered assigns.

SECTION 2.06. Conversions and Continuations. (i) The Borrower shall have the right on any Business Day, upon prior irrevocable notice to the Administrative Agent, to convert all or a portion equal to at least the Minimum Borrowing Amount of the outstanding principal amount of Loans made to the Borrower (as applicable) of one Type into a Borrowing or Borrowings of another Type and the Borrower shall have the option on any Business Day to continue the outstanding principal amount of any LIBOR Loans as LIBOR Loans for an additional Interest Period on the last Business Day of the existing Interest Period, provided that (i) no partial conversion of LIBOR Loans shall reduce the outstanding principal amount of LIBOR Loans made pursuant to a single Borrowing to less than the Minimum Borrowing Amount, (ii) ABR Loans may not be converted into LIBOR Loans if a Default or Event of Default is in existence on the date of the conversion and the Administrative Agent has or the Required Lenders have determined in its or

us\smolyju\8802494.13

their sole discretion not to permit such conversion, and (iii) LIBOR Loans may not be continued as LIBOR Loans for an additional Interest Period if an Event of Default is in existence on the date of the proposed continuation and the Administrative Agent has or the Required Lenders have determined in its or their sole discretion not to permit such continuation. Each such conversion or continuation shall be effected by the Borrower by giving the Administrative Agent at the Administrative Agent’s Office written notice or telephonic notice (promptly confirmed in writing) prior to 1:00 p.m. (New York City time) (x) at least three Business Days’ in the case of conversion or continuation of LIBOR Loans and (y) on the same Business Day in the case of a conversion into ABR Loans, which notice shall specify the Loans to be so converted or continued, the Type of Loans to be converted or continued into and, if such Loans are to be converted into or continued as LIBOR Loans, the Interest Period to be initially applicable thereto. The Administrative Agent shall promptly give each Lender written notice (or telephonic notice promptly confirmed in writing) of the proposed conversion or continuation affecting any of its Loans, of such Lender’s proportionate share thereof and of the other matters covered by the related Borrowing Request, and if no timely notice of a conversion or continuation is provided by the Borrower, the Administrative Agent shall notify each Lender of the details of any automatic conversion to ABR Loans described in Section 2.06(b).

(b) If any Event of Default is in existence at the time of any proposed continuation of any LIBOR Loans and the Administrative Agent has or the Required Lenders have determined in its or their sole discretion not to permit such continuation, such LIBOR Loans shall be automatically converted on the last day of the current Interest Period into ABR Loans. If upon the expiration of any Interest Period in respect of LIBOR Loans, the Borrower has failed to elect a new Interest Period to be applicable thereto as provided in paragraph (a) above, the Borrower shall be deemed to have elected to continue such Borrowing of LIBOR Loans into a Borrowing of ABR Loans, effective as of the expiration date of such current Interest Period.

(c) The Administrative Agent shall promptly notify the Borrower and the Lenders of the interest rate applicable to any Interest Period for LIBOR Loans upon determination of such interest rate. The determination of the LIBOR Rate by the Administrative Agent shall be conclusive in the absence of manifest error. At any time that ABR Loans are outstanding, the Administrative Agent shall notify the Borrower and the Lenders of any change in JPMorgan Chase’s prime rate used in determining the ABR promptly following the public announcement of such change.

SECTION 2.07. Pro Rata Borrowings. Each Borrowing of Loans under this Agreement shall be granted by the Lenders pro rata on the basis of their then applicable Closing Date Term Loan Commitments or Delayed Draw Term Loan Commitments, as applicable. It is understood that (a) no Lender shall be responsible for any default by any other Lender in its obligation to make Loans hereunder and that each Lender shall be obligated to make the Loans provided to be made by it hereunder, regardless of the failure of any other Lender to fulfill its commitments hereunder and (b) failure by a Lender to perform any of its obligations under any of the Loan Documents shall not release any Person from performance of its obligation under any Loan Document.

us\smolyju\8802494.13

SECTION 2.08. Interest. (a) The unpaid principal amount of each ABR Loan shall bear interest from the date of the Borrowing thereof until maturity (whether by acceleration or otherwise) at a rate per annum that shall at all times be the Applicable ABR Margin plus the ABR in effect from time to time.

(b) The unpaid principal amount of each LIBOR Loan shall bear interest from the date of the Borrowing thereof until maturity thereof (whether by acceleration or otherwise) at a rate per annum that shall at all times be the Applicable LIBOR Margin in effect from time to time plus the relevant LIBOR Rate.

(c) (i) If any amount of principal of any Loan is not paid when due (without regard to any applicable grace periods) whether at stated maturity, by acceleration or otherwise, such amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable laws.

(ii) If any amount (other than principal of any Loan) payable by the Borrower under any Loan Document is not paid when due (without regard to any applicable grace periods), whether at stated maturity, by acceleration or otherwise, then such amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable laws.

(iii) While any Event of Default under Article VII exists, the Borrower shall pay interest on the principal amount of all outstanding Obligations hereunder at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable laws.

(iv) Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be due and payable upon demand.

(v) Payment or acceptance of the increased rates of interest provided for in this Section 2.08 is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Administrative Agent or any Lender.

(d) Interest on each Loan shall accrue from and including the date of any Borrowing to, but excluding the date of, any repayment thereof and shall be payable, in each case in cash, (i) on each Interest Payment Date and (ii) on any prepayment date (on the amount prepaid), at maturity (whether by acceleration or otherwise) and, after such maturity, on demand.

(e) All computations of interest hereunder shall be made in accordance with Section 2.16.

(f) The Administrative Agent, upon determining the interest rate for any Borrowing of LIBOR Loans, shall promptly notify the Borrower and the relevant Lenders thereof. Each such determination shall, absent clearly demonstrable error, be final and conclusive and binding on all parties hereto.

us\smolyju\8802494.13

(g) Interest hereunder shall be due and payable in accordance with the terms hereof before and after judgment and before and after the commencement of any proceeding under any Debtor Relief Law.

SECTION 2.09. Fees. (a) The Borrower shall pay to the Administrative Agent the Administrative Agent Fee on the Closing Date and thereafter on each anniversary of the Closing Date until this Agreement has terminated and the Loans and any amounts due to the Lenders under this Agreement have been paid in full. All such Administrative Agent Fees shall be deemed fully earned when due and payable.

(b) The Borrower agrees to pay to the Administrative Agent, for the ratable benefit of the Lenders, a non-refundable Closing Fee on terms provided in the Fee Letter. The Closing Fee shall be due and payable in full and be deemed fully earned on the Closing Date and, once paid, shall be non-refundable, and shall be netted from the proceeds of the Closing Date Term Loans funded by the Lenders to the Borrower on the Closing Date.

(c) The Borrower agrees to pay to the Administrative Agent, for the ratable benefit of the Lenders holding Delayed Draw Term Loan Commitments, the Delayed Draw Ticking Fee on terms provided in the Fee Letter.

SECTION 2.10. Optional Prepayment. (a) The Borrower shall have the right at any time and from time to time to prepay any Borrowing, in whole or in part, upon at least three Business Days’ prior written or fax notice (or telephone notice promptly confirmed by written or fax notice) in the case of LIBOR Loans, or written or fax notice (or telephone notice promptly confirmed by written or fax notice) on the Business Day of prepayment in the case of ABR Loans, to the Administrative Agent before 1:00 p.m., (New York City time). Each partial prepayment of a Borrowing shall be in an amount that is an integral multiple of $500,000 and each such partial prepayment shall be in an amount not less than $1,000,000.

(b) Each notice of prepayment shall specify the prepayment date and the principal amount of each Borrowing (or portion thereof) to be prepaid, shall be irrevocable unless conditioned upon a Refinancing, in which case it shall still be subject to Section 2.14, and shall commit the Borrower to prepay such Borrowing by the amount stated therein on the date stated therein. All prepayments under this Section 2.10 shall be subject to Section 2.14. All prepayments under this Section 2.10 shall be accompanied by the payment in cash of (i) accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment, plus (ii) the Early Termination Fee on the principal amount to be prepaid.

SECTION 2.11. Mandatory Prepayments.

(a) On each occasion that a Prepayment Event occurs, the Borrower shall, within one Business Day after the occurrence of a Debt Incurrence Prepayment Event and within five (5) Business Days after the occurrence of any other Prepayment Event (or, in the case of Deferred Net Cash Proceeds, within five (5) Business Days after the end of the Reinvestment Period relating to such Prepayment Event), prepay, in accordance with paragraph (b) below, the principal amount of Loans in an amount equal to 100% of the Net Cash Proceeds from such Prepayment Event if other

us\smolyju\8802494.13

than an Equity Issuance Prepayment Event and 50% of the Net Cash Proceeds therefrom if such Prepayment Event is an Equity Issuance Prepayment Event.

(b) All prepayments of Loans under this Section 2.11 shall be subject to Section 2.14, and shall be accompanied by the payment in cash of (i) accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment, plus (ii) the Early Termination Fee on the principal amount prepaid.

SECTION 2.12. Reserve Requirements; Change in Circumstances. (c) Notwithstanding any other provision of this Agreement, if any Change in Law (other than with respect to Excluded Taxes and Indemnified Taxes addressed in Section 2.17, which shall govern with respect thereto) shall impose, modify or deem applicable any reserve, special deposit or similar requirement against assets of, deposits with or for the account of or credit extended by any Lender (except any such reserve requirement which is reflected in the LIBOR Rate) or subjects any Lender to any Taxes or shall impose on such Lender or the London interbank market any other condition affecting this Agreement or LIBOR Loans made by such Lender, and the result of any of the foregoing shall be to increase the cost to such Lender of making or maintaining any LIBOR Loan or to reduce the amount of any sum received or receivable by such Lender hereunder (whether of principal, interest or otherwise) by an amount deemed by such Lender to be material, then the Borrower will pay to such Lender at the time set forth in paragraph (c) of this Section 2.12 such additional amount or amounts as will compensate such Lender for such additional costs incurred or reduction suffered.

(b) If any Lender shall have determined that any Change in Law regarding capital adequacy has or would have the effect of reducing the rate of return on such Lender’s capital or on the capital of such Lender’s holding company, if any, as a consequence of this Agreement or the Loans made pursuant hereto to a level below that which such Lender or such Lender’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s policies and the policies of such Lender’s holding company with respect to capital adequacy) by an amount deemed by such Lender to be material, then from time to time the Borrower shall pay to such Lender such additional amount or amounts as will compensate such Lender or such Lender’s holding company for any such reduction suffered.

(c) A certificate of a Lender setting forth the amount or amounts necessary to compensate such Lender or its holding company, as applicable, as specified in paragraph (a) or (b) above shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender the amount shown as due on any such certificate delivered by it within 10 days after its receipt of the same.

(d) Failure or delay on the part of any Lender to demand compensation for any increased costs or reduction in amounts received or receivable or reduction in return on capital shall not constitute a waiver of such Lender’s right to demand such compensation; provided that the Borrower shall not be under any obligation to compensate any Lender under paragraph (a) or (b) above with respect to increased costs or reductions with respect to any period prior to the date that is 120 days prior to such request if such Lender knew or could reasonably have been expected to know of the circumstances giving rise to such increased costs or reductions and of the fact that such circumstances would result in a claim for increased compensation by reason of such increased costs

us\smolyju\8802494.13

or reductions; provided further, that the foregoing limitation shall not apply to any increased costs or reductions arising out of the retroactive application of any Change in Law within such 120-day period. The protection of this Section 2.12 shall be available to each Lender regardless of any possible contention of the invalidity or inapplicability of the Change in Law that shall have occurred or been imposed.

SECTION 2.13. Change in Legality. (a) Notwithstanding any other provision of this Agreement, if any Change in Law shall make it unlawful for any Lender to make or maintain any LIBOR Loan or to give effect to its obligations as contemplated hereby with respect to any LIBOR Loan, then, by written notice to the Borrower and to the Administrative Agent: (i) such Lender may declare that LIBOR Loans will not thereafter (for the duration of such unlawfulness) be made by such Lender hereunder (or be continued for additional Interest Periods) and ABR Loans will not thereafter (for such duration) be converted into LIBOR Loans, whereupon any request for a LIBOR Borrowing (or to convert an ABR Borrowing to a LIBOR Borrowing or to continue a LIBOR Borrowing for an additional Interest Period) shall, as to such Lender only, be deemed a request for an ABR Loan (or a request to continue an ABR Loan as such for an additional Interest Period or to convert a LIBOR Loan into an ABR Loan, as the case may be), unless such declaration shall be subsequently withdrawn; and (ii) such Lender may require that all outstanding LIBOR Loans made by it be converted to ABR Loans, in which event all such LIBOR Loans shall be automatically converted to ABR Loans as of the effective date of such notice as provided in paragraph (b) below. In the event any Lender shall exercise its rights under (i) or (ii) above, all payments and prepayments of principal that would otherwise have been applied to repay the LIBOR Loans that would have been made by such Lender or the converted LIBOR Loans of such Lender shall instead be applied to repay the ABR Loans made by such Lender in lieu of, or resulting from the conversion of, such LIBOR Loans.

(b) For purposes of this Section 2.13, a notice to the Borrower by any Lender shall be effective as to each LIBOR Loan made by such Lender, if lawful, on the last day of the Interest Period then applicable to such LIBOR Loan; in all other cases such notice shall be effective on the date of receipt by the Borrower.

SECTION 2.14. Indemnity. The Borrower shall indemnify each Lender against any loss or expense that such Lender may sustain or incur as a consequence of (a) any event, other than a default by such Lender in the performance of its obligations hereunder, which results in (i) such Lender receiving or being deemed to receive any amount on account of the principal of any LIBOR Loan prior to the end of the Interest Period in effect therefor, (ii) the conversion of any LIBOR Loan to an ABR Loan, or the conversion of the Interest Period with respect to any LIBOR Loan, in each case other than on the last day of the Interest Period in effect therefor, or (iii) any LIBOR Loan to be made by such Lender (including any LIBOR Loan to be made pursuant to a conversion or continuation under Section 2.06) not being made after notice of such Loan shall have been given by the Borrower hereunder (any of the events referred to in this clause (a) being called a “Breakage Event”) or (b) any default in the making of any payment or prepayment required to be made hereunder. In the case of any Breakage Event, such loss shall include an amount equal to the excess, as reasonably determined by such Lender, of (i) its cost of obtaining funds for the LIBOR Loan that is the subject of such Breakage Event for the period from the date of such Breakage Event to the

us\smolyju\8802494.13

last day of the Interest Period in effect (or that would have been in effect) for such Loan over (ii) the amount of interest likely to be realized by such ▇▇▇▇▇▇ in redeploying the funds released or not utilized by reason of such Breakage Event for such period. A certificate of any Lender setting forth any amount or amounts which such Lender is entitled to receive pursuant to this Section 2.14 shall be delivered to the Borrower and shall be conclusive absent manifest error.

SECTION 2.15. Sharing of Setoffs. Each Lender agrees that if it shall, through the exercise of a right of banker’s lien, setoff or counterclaim against the Borrower or any other Loan Party, or pursuant to a secured claim under Section 506 of Title 11 of the United States Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means, obtain payment (voluntary or involuntary) in respect of any Loan or Loans as a result of which the unpaid principal portion of its Loans shall be proportionately less than the unpaid principal portion of the Loans of any other Lender, it shall be deemed simultaneously to have purchased from such other Lender at face value, and shall promptly pay to such other Lender the purchase price for, a participation in the Loans of such other Lender, so that the aggregate unpaid principal amount of the Loans and participations in Loans held by each Lender shall be in the same proportion to the aggregate unpaid principal amount of all Loans then outstanding as the principal amount of its Loans prior to such exercise of banker’s lien, setoff or counterclaim or other event was to the principal amount of all Loans outstanding prior to such exercise of banker’s lien, setoff or counterclaim or other event; provided, however, that (i) if any such purchase or purchases or adjustments shall be made pursuant to this Section 2.15 and the payment giving rise thereto shall thereafter be recovered, such purchase or purchases or adjustments shall be rescinded to the extent of such recovery and the purchase price or prices or adjustment restored without interest, and (ii) the provisions of this Section 2.15 shall not be construed to apply to any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans. The Borrower expressly consents to the foregoing arrangements and agrees that any Lender holding a participation in a Loan deemed to have been so purchased may exercise any and all rights of banker’s lien, setoff or counterclaim with respect to any and all moneys owing by the Borrower to such Lender by reason thereof as fully as if such ▇▇▇▇▇▇ had made a Loan directly to the Borrower in the amount of such participation.

SECTION 2.16. Payments. (a) The Borrower shall make each payment (including principal of or interest on any Borrowing or any other amounts) hereunder and under any other Loan Document not later than 1:00 p.m., New York City time, on the date when due in immediately available Dollars, without setoff, defense or counterclaim. Each such payment shall be made to the Administrative Agent at its offices at ▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇. All payments received by the Administrative Agent after 1:00 p.m., New York City time, shall be deemed received on the next Business Day (in the Administrative Agent’s sole discretion) and any applicable interest shall continue to accrue. The Administrative Agent shall promptly distribute to each Lender any payments received by the Administrative Agent on behalf of such ▇▇▇▇▇▇.

(b) Except as otherwise expressly provided herein, whenever any payment (including principal of or interest on any Borrowing or any other amounts) hereunder or under any

us\smolyju\8802494.13

other Loan Document shall become due, or otherwise would occur, on a day that is not a Business Day, such payment may be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of interest or fees, if applicable.

(c) Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders the amount due. In such event, if the Borrower does not in fact make such payment, then each of the Lenders severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender, and to pay interest thereon, for each day from and including the date such amount is distributed to it to, but excluding, the date of payment to the Administrative Agent, at a rate determined by the Administrative Agent to represent its cost of overnight or short-term funds (which determination shall be conclusive absent manifest error).

(d) All interest on LIBOR Loans shall be computed for the actual days elapsed, based on a year of 360 days. Interest on ABR Loans, as well as fees and other charges calculated on a per annum basis, shall be computed for the actual days elapsed, based on a year of 365 days (or 366, as the case may be). Each determination by the Administrative Agent of any interest, fees or interest rate hereunder shall be final, conclusive and binding for all purposes, absent manifest error. All fees shall be fully earned when due and shall not be subject to rebate, refund or proration. A certificate setting forth in reasonable detail amounts payable by the Borrower under Section 2.12, Section 2.13 and Section 2.17 and the basis therefor, submitted to the Borrower by the Administrative Agent shall be final, conclusive and binding for all purposes, absent manifest error, and the Borrower shall pay such amounts to the appropriate party within 10 Business Days following receipt of the certificate.

SECTION 2.17. Taxes. (a) Any and all payments by or on account of any obligation of the Borrower or any other Loan Party hereunder or under any other Loan Document shall be made free and clear of and without deduction for any Indemnified Taxes or Other Taxes; provided that, if the Borrower or any other Loan Party shall be required to deduct any Indemnified Taxes or Other Taxes from such payments, then (i) the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section) the Administrative Agent or each Lender (as the case may be) receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower or such Loan Party shall make such deductions and (iii) the Borrower or such Loan Party shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law.

(b) In addition, the Borrower shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.

(c) The Borrower shall indemnify the Administrative Agent and each Lender, within 10 days after written demand therefor, for the full amount of any Indemnified Taxes or Other Taxes paid by the Administrative Agent or such Lender, as the case may be, on or with respect to

us\smolyju\8802494.13

any payment by or on account of any obligation of the Borrower or any other Loan Party hereunder or under any other Loan Document (including Indemnified Taxes or Other Taxes imposed on amounts payable under this Section) and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment delivered to the Borrower by a Lender, or by the Administrative Agent on behalf of itself or a Lender, shall be conclusive absent manifest error.

(d) As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower or any other Loan Party to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.

(e) Each Foreign Lender hereby agrees that it shall, no later than the Closing Date, or in the case of a Foreign Lender that becomes a party hereto pursuant to an Assignment and Acceptance after the Closing Date no later than the date such Foreign Lender becomes a party hereto, or, in the case where a Foreign Lender changes its applicable lending office by designating a different lending office (a “New Lending Office”), no later than the date such Lender designates the New Lending Office, and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally able to do so, deliver to the Borrower and the Administrative Agent either (i) two accurate, complete and signed copies of either (x) U.S. Internal Revenue Service Form W‑8ECI or successor form, (y) U.S. Internal Revenue Service Form W‑8BEN or successor form, in each case, indicating that such Foreign Lender is on the date of delivery thereof entitled to receive payments of interest hereunder free from, or subject to a reduced rate of, withholding of United States Federal income tax, or (z) U.S. Internal Revenue Service Form W-8IMY (and required attachments or supporting statements) or successor form, (ii) in the case of such a Lender that is entitled to claim exemption from withholding of United States Federal income tax under Section 871(h) or Section 881(c) of the Code, (x) a certificate to the effect that such Lender is (A) not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, (B) not a “10 percent shareholder” within the meaning of Section 881(c)(3)(B) of the Code and (C) not a controlled foreign corporation described in Section 881(c)(3)(C) of the Code and (y) two accurate, complete and signed copies of U.S. Internal Revenue Service Form W‑8BEN or successor form, or (iii) any other form or documentation prescribed by applicable law indicating that such Foreign Lender is on the date of delivery thereof entitled to receive payments of interest hereunder free from, or subject to a reduced rate of, withholding of United States Federal income tax. In addition, each Foreign Lender shall deliver such forms promptly upon the obsolescence, expiration or invalidity of any form previously delivered by such Foreign Lender and shall deliver such forms within 5 days after receipt of a written request therefor from the Borrower or the Administrative Agent.

(f) The Administrative Agent and each Lender that is a U.S. person as that term is defined in Section 7701(a)(30) of the Code, other than a Lender that may be treated as an exempt recipient based on the indicators described in Treasury Regulation Section 1.6049-4(c)(1)(ii), hereby agrees that it shall, no later than the Closing Date or, in the case of a Lender that becomes a party

us\smolyju\8802494.13

hereto pursuant to an Assignment and Acceptance after the Closing Date no later than the date such Lender becomes a party hereto, deliver to the Borrower and the Administrative Agent two accurate, complete and signed copies of U.S. Internal Revenue Service Form W‑9 or successor form, certifying that the Administrative Agent and each such Lender is on the date of delivery thereof entitled to an exemption from United States backup withholding tax. Unless the Borrower and the Administrative Agent has received such forms or other documents required by this Section 2.17(f), the Borrower or the Administrative Agent, as applicable, shall withhold amounts as required by applicable requirements of law from such payments at the applicable statutory rate.

(g) If a Lender or the Administrative Agent determines that it has received a refund in respect of any Indemnified Taxes or Other Taxes with respect to which the Borrower has paid additional amounts pursuant to this Section 2.17 or made an indemnity payment, pursuant to this Section 2.17, it shall within 30 days from the date of such receipt pay over such refund to the Borrower, net of all out-of-pocket expenses of such Lender; provided, that the Borrower, upon the request of the Administrative Agent or such ▇▇▇▇▇▇, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender, in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. This Section shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes which it deems confidential) to the Borrower or any other person.

(h) Each Lender shall severally indemnify the Administrative Agent for (i) any Taxes and any penalties, interest and reasonable expenses arising therefrom or with respect thereto (but, in the case of any Indemnified Taxes or Other Taxes, only to the extent that the Borrower has not already indemnified the Administrative Agent for such Indemnified Taxes or Other Taxes and without limiting the obligation of the Borrower to do so) attributable to such Lender and (ii) any Taxes attributable to such ▇▇▇▇▇▇’s failure to comply with the provisions of Section 9.04(f) relating to maintenance of a Participant Register, in each case that are paid or payable by the Administrative Agent in connection with any Loan Document, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. The indemnity under this Section 2.17 shall be paid within 10 days after the Administrative Agent delivers to the applicable Lender a certificate stating the amount of Taxes so paid or payable by the Administrative Agent. Such certificate shall be conclusive of the amount so paid or payable absent manifest error.

(i) If a payment made to the Administrative Agent or a Lender under this Agreement may be subject to U.S. federal withholding tax under FATCA, the Administrative Agent or such Lender shall deliver to the Borrower (and, in the instance of a payment made to a Lender, to the Administrative Agent), at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or Administrative Agent, such documentation prescribed by applicable law and such additional documentation reasonably requested by the Borrower or Administrative Agent to comply with its withholding obligations, to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this Section 2.17(i), “FATCA” shall include any amendments made to FATCA after the date of this Agreement.

us\smolyju\8802494.13

SECTION 2.18. Assignment of Commitments Under Certain Circumstances; Duty to Mitigate. (a) In the event (i) any Lender delivers a certificate requesting compensation pursuant to Section 2.12, (ii) any Lender delivers a notice described in Section 2.13, (iii) the Borrower is required to pay any additional amount to any Lender or any Governmental Authority on account of any Lender pursuant to Section 2.17, (iv) any Lender refuses to consent to any amendment, waiver or other modification of any Loan Document requested by the Borrower that requires the consent of a greater percentage of the Lenders than the Required Lenders and such amendment, waiver or other modification is consented to by the Required Lenders, then, in each case, the Borrower may, at its sole expense and effort (including with respect to the processing and recordation fee referred to in Section 9.04(b)), upon notice to such Lender and the Administrative Agent, require such Lender to transfer and assign, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all of its interests, rights and obligations under this Agreement to an Eligible Assignee that shall assume such assigned obligations and, with respect to clause (v) above, shall consent to such requested amendment, waiver or other modification of any Loan Document (which Eligible Assignee may be another Lender, if a Lender accepts such assignment); provided that (x) such assignment shall not conflict with any law, rule or regulation or order of any court or other Governmental Authority having jurisdiction, (y) the Borrower shall have received the prior written consent of the Administrative Agent, which consent shall not unreasonably be withheld or delayed, and (z) the Borrower or such Eligible Assignee shall have paid to the affected Lender in immediately available funds an amount equal to the sum of the principal of and interest accrued to the date of such payment on the outstanding Loans of such Lender, plus all fees and other amounts accrued for the account of such Lender hereunder with respect thereto (including any amounts under Sections 2.12 and 2.14); provided further that, if prior to any such transfer and assignment the circumstances or event that resulted in such ▇▇▇▇▇▇’s claim for compensation under Section 2.12, notice under Section 2.13 or the amounts paid pursuant to Section 2.17, as the case may be, cease to cause such Lender to suffer increased costs or reductions in amounts received or receivable or reduction in return on capital, or cease to have the consequences specified in Section 2.13, or cease to result in amounts being payable under Section 2.17, as the case may be (including as a result of any action taken by such Lender pursuant to paragraph (b) below), or if such Lender shall waive its right to claim further compensation under Section 2.12 in respect of such circumstances or event or shall withdraw its notice under Section 2.12 or shall waive its right to further payments under Section 2.17 in respect of such circumstances or event or shall consent to the proposed amendment, waiver, consent or other modification, as the case may be, then such Lender shall not thereafter be required to make any such transfer and assignment hereunder. Each Lender hereby grants to the Administrative Agent an irrevocable power of attorney (which power is coupled with an interest) to execute and deliver, on behalf of such ▇▇▇▇▇▇, as assignor, any Assignment and Acceptance necessary to effectuate any assignment of such ▇▇▇▇▇▇’s interests hereunder in the circumstances contemplated by this Section 2.18.

(b) If (i) any Lender shall request compensation under Section 2.12, (ii) any Lender delivers a notice described in Section 2.13, or (iii) the Borrower is required to pay any additional amount to any Lender or any Governmental Authority on account of any Lender, pursuant to Section 2.17, then such Lender shall use reasonable efforts (which shall not require such Lender to incur an unreimbursed loss or unreimbursed cost or expense or otherwise take any action inconsistent with its internal policies or legal or regulatory restrictions or suffer any disadvantage

us\smolyju\8802494.13

or burden deemed by it to be significant) (x) to file any certificate or document reasonably requested in writing by the Borrower, or (y) to assign its rights and delegate and transfer its obligations hereunder to another of its offices, branches or affiliates, if such filing or assignment would reduce its claims for compensation under Section 2.12 or enable it to withdraw its notice pursuant to Section 2.13 or would reduce amounts payable pursuant to Section 2.17, as the case may be, in the future. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such filing or assignment, delegation and transfer.

ARTICLE III

Representations and Warranties

The Borrower (with respect to itself and its Restricted Subsidiaries) makes the following representations and warranties to the Administrative Agent and each of the Lenders, and each of such representations and warranties shall survive the execution and delivery of this Agreement and the making of the Loans:

SECTION 3.01. Organization; Powers. The Borrower and each of the Restricted Subsidiaries (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b) has all requisite power and authority to own its property and assets and to carry on its business as now conducted and as proposed to be conducted, (c) is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required, except where the failure so to qualify could not reasonably be expected to result in a Material Adverse Effect and (d) has the power and authority to execute, deliver and perform its obligations under each of the Loan Documents and each other agreement or instrument contemplated thereby to which it is or will be a party and, in the case of the Borrower, to borrow hereunder.

SECTION 3.02. Authorization. The Transactions (a) have been duly authorized by all requisite corporate and, if required, stockholder action and (b) will not (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents or by-laws of the Borrower or any Restricted Subsidiary, (B) any order of any Governmental Authority or (C) any provision of any indenture, agreement or other instrument to which the Borrower or any Restricted Subsidiary is a party or by which any of them or any of their property is or may be bound, (ii) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, or give rise to any right to accelerate or to require the prepayment, repurchase or redemption of any obligation under any such indenture, agreement or other instrument, or (iii) result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by the Borrower or any Restricted Subsidiary (other than any Lien created hereunder, under the Security Documents, under the Senior Secured Notes Documents or under the Junior Secured Notes Documents).

SECTION 3.03. Enforceability. This Agreement has been duly executed and delivered by the Borrower and constitutes, and each other Loan Document when executed and delivered by each Loan Party party thereto will constitute, a legal, valid and binding obligation of such Loan Party enforceable against such Loan Party in accordance with its terms, except as may

us\smolyju\8802494.13

be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally or by equitable principles relating to enforceability.

SECTION 3.04. Governmental Approvals. The execution, delivery and performance of each Loan Document does not require any consent or approval of, registration or filing with, or any other action by any Governmental Authority, except for (a) the filing of Uniform Commercial Code financing statements and filings with the United States Patent and Trademark Office and the United States Copyright Office and (b) such as have been made or obtained and are in full force and effect.

SECTION 3.05. Financial Statements. The Borrower has heretofore furnished to the Lenders its consolidated balance sheets and related statements of income, stockholder’s equity and cash flows as of and for the fiscal year ended December 31, 2011, audited by and accompanied by the opinion of Deloitte & Touche LLP, independent public accountants. Such financial statements present fairly the financial condition and results of operations and cash flows of the Borrower and its consolidated Subsidiaries as of such date and for such period. Such balance sheets and the notes thereto disclose all material liabilities, direct or contingent, of the Borrower and its consolidated Subsidiaries as of the date thereof. Such financial statements were prepared in accordance with GAAP applied on a consistent basis.

SECTION 3.06. No Material Adverse Change. No event, change or condition has occurred that has had or could reasonably be expected to have, Material Adverse Effect on the business, assets, liabilities, operations, condition (financial or otherwise) or operating results of the Borrower and the Restricted Subsidiaries, taken as a whole, since December 31, 2011.

SECTION 3.07. Title to Properties; Possession Under Leases. (a) Each of the Borrower and the Restricted Subsidiaries has good and marketable title to or valid leasehold interests in all its material properties and assets, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties and assets for their intended purposes. All such material properties and assets are free and clear of Liens, other than Permitted Liens.

(b) Each of the Borrower and the Restricted Subsidiaries has complied with all obligations under all material leases to which it is a party and all such leases are in full force and effect. Each of the Borrower and the Restricted Subsidiaries enjoys peaceful and undisturbed possession under all such material leases.

SECTION 3.08. Restricted Subsidiaries. Schedule 3.08 sets forth, as of the Closing Date, a list of all Restricted Subsidiaries and the percentage ownership interest of the Borrower and its Restricted Subsidiaries therein. The shares of capital stock or other ownership interests so indicated on Schedule 3.08 are fully paid and non-assessable and are owned by the Borrower, directly or indirectly, free and clear of all Liens other than Permitted Liens.

SECTION 3.09. Litigation; Compliance with Laws. (a) Except as set forth on Schedule 3.09, there are no actions, arbitrations, suits or proceedings at law or in equity or by or before any Governmental Authority now pending or, to the knowledge of the Borrower, threatened

us\smolyju\8802494.13

against or affecting the Borrower or any Restricted Subsidiary or any business, property or rights of any such person (i) that involve any Loan Document or the Transactions, or (ii) as to which there is a reasonable possibility of an adverse determination and that, if adversely determined, could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.

(b) Neither the Borrower nor any of the Restricted Subsidiaries or any of their respective material properties or assets is in violation of, nor will the continued operation of their material properties and assets as currently conducted violate, any law, rule or regulation (including, without limitation, any Healthcare Laws, zoning, building, ordinance, code or approval or any building permits), or is in default with respect to any judgment, writ, injunction, decree or order of any Governmental Authority, in each case where such violation or default could reasonably be expected to result in a Material Adverse Effect.

SECTION 3.10. Agreements. (a) Neither the Borrower nor any of the Restricted Subsidiaries is a party to any agreement or instrument or subject to any corporate restriction that has resulted or could reasonably be expected to result in a Material Adverse Effect.

(b) Neither the Borrower nor any of the Restricted Subsidiaries is in default in any manner under any provision of any indenture or other agreement or instrument evidencing Indebtedness, or any other material agreement or instrument to which it is a party or by which it or any of its properties or assets are or may be bound, where such default could reasonably be expected to result in a Material Adverse Effect.

SECTION 3.11. Federal Reserve Regulations. (a) Neither the Borrower nor any of the Restricted Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock.

(b) No part of the proceeds of any Loan will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, for any purpose that entails a violation of, or that is inconsistent with, the provisions of the Regulations of the Board, including Regulation T, U or X.

SECTION 3.12. Investment Company Act. Neither the Borrower nor any Restricted Subsidiary is an “investment company”, as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended.

SECTION 3.13. Use of Proceeds. The Borrower will use the proceeds of the Loans only for the purposes specified in the introductory statement to this Agreement and not to purchase or carry Margin Stock.

SECTION 3.14. Tax Returns and Payments. Each of the Borrower and the Subsidiaries has filed or caused to be filed all material Federal, state and local tax returns and all other material tax returns, domestic or foreign, required to be filed by it and has paid or caused to be paid all material taxes due and payable by it, except those (i) not yet delinquent, or (ii) contested in good faith by appropriate proceedings and for which the Borrower or such Subsidiary, as applicable, shall have set aside on its books adequate reserves.

us\smolyju\8802494.13

SECTION 3.15. No Material Misstatements. No information, report, financial statement, exhibit or schedule furnished by or on behalf of the Borrower or its Subsidiaries to the Administrative Agent or any Lender on or before the Closing Date in connection with the negotiation of any Loan Document or included therein or delivered pursuant thereto contained, contains or will contain any material misstatement of fact or omitted, omits or will omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were, are or will be made, not misleading; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or projection, the Borrower represents only that it acted in good faith and utilized reasonable assumptions and due care in the preparation of such information, report, financial statement, exhibit or schedule.

SECTION 3.16. Employee Benefit Plans; Compliance with ERISA. Each U.S. Employee Plan is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretation thereunder. No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in material liability of the Borrower or any of its ERISA Affiliates. The present value of all benefit liabilities under each Plan (based on the assumptions used for purposes of Accounting Standard Codification No. 715, as amended or revised from time to time) did not, as of the last annual valuation date applicable thereto, exceed by more than $1,000,000 the fair market value of the assets of such Plan, and the present value of all benefit liabilities of all underfunded Plans (based on the assumptions used for purposes of Accounting Standard Codifications No. 715, as amended or revised from time to time) did not, as of the last annual valuation dates applicable thereto, exceed by more than $1,000,000 the fair market value of the assets of all such underfunded Plans.

SECTION 3.17. Environmental Matters. (a) Except as set forth in Schedule 3.17 and except with respect to any other matters that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, neither the Borrower, nor any of the Restricted Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (i) has become subject to any Environmental Liability, (iii) has received notice of any claim with respect to any Environmental Liability, or (iv) knows of any basis for any Environmental Liability.

(b) Except as set forth in Schedule 3.17 and except with respect to any other matters that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, there has been no Release of any Hazardous Materials at any real property currently or formerly owned, leased or operated by the Borrower, any of the Restricted Subsidiaries or any of their respective predecessors reasonably expected to result in Environmental Liability.

SECTION 3.18. Insurance. Schedule 3.18 sets forth a true, complete and correct description of all insurance maintained by the Borrower or by the Borrower for its Restricted Subsidiaries as of the date hereof and the Closing Date. As of each such date, such insurance is in full force and effect and all premiums have been duly paid. The Borrower and its Restricted Subsidiaries have insurance in such amounts and covering such risks and liabilities as are in accordance with normal industry practice.

us\smolyju\8802494.13

SECTION 3.19. Security Documents. (a) The Collateral Agreement, upon execution and delivery thereof by the parties thereto, will create in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, a legal, valid and enforceable security interest in the Collateral (as defined in the Collateral Agreement) and the proceeds thereof and when financing statements or other filings in appropriate form are filed in the offices specified on Schedule 3.19(a) (or, in the case of Collateral delivered after the date hereof in accordance with the provisions of Section 5.12, in the appropriate filing offices), the Lien created under the Collateral Agreement will constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Collateral (other than Intellectual Property, as defined in the Collateral Agreement), in each case prior and superior in right to any other person, other than Permitted Liens that may take priority as a matter of law, and as otherwise provided in the Pari Passu Intercreditor Agreement.

(b) Upon the recordation of the Collateral Agreement (or a short-form security agreement in form and substance reasonably satisfactory to the Borrower and the Administrative Agent) with the United States Patent and Trademark Office and the United States Copyright Office, together with the financing statements or such other filings in appropriate form filed in the offices specified on Schedule 3.19(a) (or, in the case of Collateral delivered after the date hereof in accordance with the provisions of Section 5.12, in the appropriate filing offices), the Lien created under the Collateral Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in Patents and Trademarks (as each term is defined in the Collateral Agreement) registered or applied for with the United States Patent and Trademark Office or Copyrights (as defined in the Collateral Agreement) registered or applied for with the United States Copyright Office, as the case may be, in each case prior and superior in right to any other person other than Permitted Liens that may take priority as a matter of law, and as otherwise provided in the Pari Passu Intercreditor Agreement (it being understood that subsequent recordings in the United States Patent and Trademark Office and the United States Copyright Office may be necessary to perfect a Lien on registered or applied for Patents, Trademarks, or Copyrights, acquired by the Loan Parties after the date hereof).

SECTION 3.20. Location of Leased Premises. Schedule 3.20 lists completely and correctly as of the Closing Date all real property leased by the Borrower and the Restricted Subsidiaries and the addresses thereof. The Borrower and the Restricted Subsidiaries have valid leases in all the real property set forth on Schedule 3.20. On the Closing Date, neither the Borrower nor any Restricted Subsidiary owns any real property in fee.

SECTION 3.21. Labor Matters. As of the date hereof and the Closing Date, there are no strikes, lockouts or slowdowns against the Borrower or any Restricted Subsidiary pending or, to the knowledge of the Borrower, threatened. The hours worked by and payments made to employees of the Borrower and the Restricted Subsidiaries have not been in violation of the U.S. Fair Labor Standards Act of 1934, as amended, or any other applicable Federal, state, local or foreign law dealing with such matters. All payments due from the Borrower or any Restricted Subsidiary, or for which any claim may be made against the Borrower or any Restricted Subsidiary, on account of wages and employee health and welfare insurance and other benefits, have been paid or accrued as a liability on the books of the Borrower or such Restricted Subsidiary. The consummation of the Transactions will not give rise to any right of termination or right of renegotiation on the part

us\smolyju\8802494.13

of any union under any collective bargaining agreement to which the Borrower or any Restricted Subsidiary is bound.

SECTION 3.22. Solvency. Immediately after the consummation of the Transactions to occur on the Closing Date and immediately following the making of each Loan and after giving effect to the application of the proceeds of each Loan (if any) on the Closing Date, (a) the fair value of the assets of each Loan Party, at a fair valuation, will exceed its debts and liabilities, subordinated, contingent or otherwise; (b) the present fair saleable value of the property of each Loan Party will be greater than the amount that will be required to pay the probable liability of its debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured; (c) each Loan Party will be able to pay its debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured; and (d) each Loan Party will not have unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted following the Closing Date.

SECTION 3.23. Sanctioned Persons; OFAC. Neither the Borrower nor any Subsidiary nor, to the knowledge of the Borrower, any director, officer, agent, employee or Affiliate of the Borrower or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Borrower will not directly or indirectly use the proceeds of the Loans or otherwise make available such proceeds to any person, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.

SECTION 3.24. USA PATRIOT Act. To the knowledge of the Borrower, each Loan Party is in compliance, in all material respects, with the requirements of the Uniting And Strengthening America By Providing Appropriate Tools Required To Intercept And Obstruct Terrorism Act of 2001 (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “USA PATRIOT Act”).

SECTION 3.25. Foreign Corrupt Practices Act. The Borrower, each Subsidiary, and their respective directors, officers, and, to the knowledge of the Borrower, any agents, employees and persons acting on behalf of the Borrower or any of their subsidiaries have, within five years prior to the date of this Agreement, complied with, are now in compliance with, and will comply with, the U.S. Foreign Corrupt Practices Act of 1977, as amended, and all other applicable laws relating to anti-corruption.

8802861.1

SECTION 3.26. Health Care Matters. To the extent applicable and in all material respects, the Borrower is certified for participation in the Medicare and Medicaid programs and, to the knowledge of the Borrower, any other Federal and/or State Healthcare Programs for which it receives reimbursement, and is a party to valid provider agreements for payments by each of the Medicare and Medicaid programs and any other Federal and/or State Healthcare Programs for which it receives reimbursement, which material agreements, to the knowledge of the Borrower, are in full force and effect.

us\smolyju\8802494.13

ARTICLE IV

Conditions of Lending

SECTION 4.01. The Closing Date Term Loans. The obligation of the Lenders under this Agreement to make Closing Date Term Loans shall subject to the satisfaction of the following conditions precedent, except as otherwise agreed between the Borrower and the Administrative Agent:

(a) The Administrative Agent shall have received a notice of such Borrowing as required by Section 2.03.

(b) The representations and warranties set forth in Article III and in each other Loan Document shall be true and correct in all material respects on and as of the date of such Borrowing with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects on and as of such earlier date.

(c) At the time of and immediately after such Borrowing, no Default or Event of Default shall have occurred and be continuing.

(d) The Administrative Agent shall have received, on behalf of itself and the Lenders, a favorable written opinion of (i) ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇ LLP, counsel for the Borrower, substantially to the effect set forth in Exhibit F-1, and (ii) each local counsel listed on Schedule 4.01(d), substantially to the effect set forth in Exhibits F-2 and F-3, in each case (A) dated the Closing Date, (B) addressed to the Administrative Agent and the Lenders, and (C) covering such other matters relating to the Loan Documents and the Transactions as the Administrative Agent shall reasonably request, and the Borrower hereby requests such counsel to deliver such opinions.

(e) All legal matters incident to this Agreement, the Borrowings and extensions of credit hereunder and the other Loan Documents shall be satisfactory to the Lenders and to the Administrative Agent.

(f) The Administrative Agent shall have received:

(i) a copy of the certificate or articles of incorporation, including all amendments thereto, of each Loan Party, and a certificate as to the good standing of each Loan Party as of a recent date, from such Secretary of State;

(ii) a certificate of the Secretary or Assistant Secretary of each Loan Party dated the Closing Date and certifying (A) that attached thereto is a true and complete copy of the by-laws of such Loan Party as in effect on the Closing Date and at all times since a date prior to the date of the resolutions described in clause (B) below, (B) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors of such Loan Party authorizing the execution, delivery and performance of the

us\smolyju\8802494.13

Loan Documents to which such person is a party and, in the case of the Borrower, the borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect, (C) that the certificate or articles of incorporation of such Loan Party have not been amended since the date of the last amendment thereto and attached to the certificate and (D) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document delivered in connection herewith on behalf of such Loan Party;

(iii) a certificate of another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary executing the certificate pursuant to clause (ii) above; and

(iv) such other documents as the Lenders or the Administrative Agent may reasonably request.

(g) The Administrative Agent shall have received a certificate, dated the Closing Date and signed by a Financial Officer of the Borrower, confirming the conditions precedent set forth in paragraphs (b), (c), and (n) of this Section 4.01.

(h) The Administrative Agent shall have received from the Borrower (i) the Closing Fee, (ii) the Administrative Agent Fee, and (iii) all other amounts due and payable on or prior to the Closing Date as provided under the Fee Letter and, including, to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Borrower hereunder or under any other Loan Document.

(i) The definitive documentation with respect to the Loans, including this Agreement and the related documents, including, but not limited to the Guarantee Agreement and the Security Documents, shall be in form and substance satisfactory to the Administrative Agent and the Lenders and shall have been duly executed by each Loan Party that is to be a party thereto and shall be in full force and effect on the Closing Date. The Collateral Agent on behalf of the Secured Parties shall have a security interest in the Collateral of the type and priority described in each Security Document.

(j) The Administrative Agent shall have received a Perfection Certificate with respect to the Loan Parties dated the Closing Date and duly executed by a Responsible Officer of the Borrower, and shall have received the results of a search of the Uniform Commercial Code filings (or equivalent filings) made with respect to the Loan Parties in the states (or other jurisdictions) of formation of such persons, as indicated on such Perfection Certificate, together with copies of the financing statements (or similar documents) disclosed by such search, and accompanied by evidence satisfactory to the Administrative Agent that the Liens indicated in any such financing statement (or similar document) would be Permitted Liens or have been or will be contemporaneously released or terminated.

(k) The Administrative Agent shall have received a copy of, or a certificate as to coverage under, the insurance policies required by Section 5.02 and the applicable provisions of the Security Documents, each of which shall be endorsed or otherwise amended to include a

us\smolyju\8802494.13

customary lender’s loss payable endorsement and to name the Collateral Agent as additional insured, in form and substance reasonably satisfactory to the Administrative Agent.

(l) Immediately after giving effect to the Transactions and the other transactions contemplated hereby, the Borrower and the Subsidiaries shall have outstanding no Indebtedness other than (a) Indebtedness outstanding under this Agreement, (b) Indebtedness outstanding under the Senior Secured Notes Indenture, (c) Indebtedness outstanding under the Junior Secured Notes Indenture, (d) Indebtedness outstanding and set forth on Schedule 6.03(b)(v) and (e) other Indebtedness permitted to be incurred under this Agreement in an aggregate outstanding principal amount not in excess of $1,000,000.

(m) The Lenders shall have received the financial statements and opinion referred to in Section 3.05, none of which shall demonstrate a material adverse change in the financial condition of the Borrower and the Subsidiaries taken as a whole from (and shall not otherwise be materially inconsistent with) the financial statements or forecasts previously provided to the Lenders.

(n) The EBITDA of the Borrower for the twelve month period ended September 30, 2012, shall be not less than $87,000,000.

(o) The Administrative Agent shall have received a certificate from a Financial Officer of the Borrower, in form and substance reasonably satisfactory to the Administrative Agent, certifying that the Borrower and the Subsidiaries, on a consolidated basis after giving effect to the Transactions to occur on the Closing Date, are solvent (determined in a manner consistent with the representation in Section 3.22).

(p) The Lenders shall have received, to the extent requested, all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act.

(q) There shall be no actions, suits or proceedings at law or in equity or by or before any Governmental Authority now pending or threatened against or affecting the Borrower or any Subsidiary or any business, property or rights of any such person that involve any Loan Document or the Transactions.

SECTION 4.02. Delayed Draw Term Loans. The obligation of the Lenders under this Agreement to make Delayed Draw Term Loans shall be subject to the satisfaction of the following conditions precedent:

(a) The Administrative Agent shall have received a notice of such Borrowing as required by Section 2.03.

(b) The applicable borrowing of the Delayed Draw Term Loans shall occur during the Delayed Draw Availability Period.

us\smolyju\8802494.13

(c) The representations and warranties set forth in Article III and in each other Loan Documents shall be true and correct in all material respects on and as of such date as if made on and as of the date of such Borrowing with the same effect as through made on as of such date, except to the extent such representation and warranty expressly relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects on and as of such earlier date.

(d) At the time of and immediately after such Borrowing, no Default or Event of Default shall have occurred and be continuing.

(e) The Administrative Agent shall have received from the Borrower (i) any accrued and unpaid Delay Draw Ticking Fee through the date of the Delayed Draw Term Loan Borrowing and (ii) all other amounts due and payable on or prior to the Delayed Draw Term Loan Borrowing, including, to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Borrower hereunder or under any other Loan Document in connection with Delayed Draw Term Loan.

ARTICLE V

Affirmative Covenants

The Borrower covenants and agrees with each Lender that so long as this Agreement shall remain in effect and until the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document shall have been paid in full, unless the Required Lenders shall otherwise consent in writing, the Borrower will, and will cause each of the Restricted Subsidiaries to:

SECTION 5.01. Existence; Compliance with Laws; Businesses and Properties. (a) Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except as would otherwise be permitted in compliance with Article VI.

(b) Do or cause to be done all things necessary to obtain, preserve, renew, extend and keep in full force and effect the rights, licenses, permits, accreditations, consents and agreements of all insurers, Governmental Authorities, franchises, authorizations, patents, copyrights, trademarks and trade names material to the conduct of its business; maintain and operate such business in substantially the manner in which it is presently conducted and operated; comply in all material respects with all material applicable laws (including Healthcare Laws), rules, regulations and decrees and orders of any Governmental Authority, whether now in effect or hereafter enacted; and at all times maintain and preserve all property material to the conduct of such business and keep such property in good repair, working order and condition and from time to time make, or cause to be made, all needful and proper repairs, renewals, additions, improvements and replacements thereto necessary in order that the business carried on in connection therewith may be properly conducted at all times.

SECTION 5.02. Insurance. (a) Maintain such insurance, to such extent and against such risks, including fire and other risks insured against by extended coverage, as is customary with

us\smolyju\8802494.13

companies in the same or similar businesses operating in the same or similar locations, including public liability insurance against claims for personal injury or death or property damage occurring upon, in, about or in connection with the use of any properties owned, occupied or controlled by it and maintain such other insurance as may be required by law.

(b) Cause all such policies covering any Collateral to be endorsed or otherwise amended to include a customary lender’s loss payable endorsement, in form and substance satisfactory to the Administrative Agent.

SECTION 5.03. Obligations and Taxes. Pay its Indebtedness and other obligations promptly and in accordance with their terms and pay and discharge promptly when due all material taxes, assessments and governmental charges or levies imposed upon it or upon its income or profits or in respect of its property, as well as all lawful claims for labor, materials and supplies or otherwise, before the same shall become delinquent or in default, that, if unpaid, might give rise to a Lien upon such properties or any part thereof; provided, however, that such payment and discharge shall not be required with respect to any such tax, assessment, charge, levy or claim so long as the validity or amount thereof shall be contested in good faith by appropriate proceedings and the Borrower shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP and, with respect to a contested obligation, such contest operates to suspend collection and enforcement of a Lien.

SECTION 5.04. Financial Statements, Reports, etc. In the case of the Borrower, furnish to the Administrative Agent, which shall furnish to each Lender:

(a) within 90 days after the end of each fiscal year, beginning with the fiscal year ended December 31, 2012, (i) its consolidated balance sheet and related statements of income, stockholders’ equity and cash flows showing the financial condition of the Borrower and its consolidated Restricted Subsidiaries as of the close of such fiscal year and the results of its operations and the operations of such Restricted Subsidiaries during such year, together with comparative figures for the immediately preceding fiscal year, all audited by Deloitte & Touche LLP or other independent public accountants of recognized national standing and (ii) an opinion of such accountants (which opinion may include a “going concern” qualification, but shall be without other qualifications or exceptions as to the scope of such audit or otherwise) to the effect that the consolidated financial statements delivered pursuant to clause (i) above fairly present the financial condition and results of operations of the Borrower and its consolidated Restricted Subsidiaries on a consolidated basis in accordance with GAAP consistently applied;

(b) within 45 days after the end of each of the first three fiscal quarters of each fiscal year, beginning with the fiscal quarter ending March 31, 2013, (i) its consolidated balance sheet and related statements of income, stockholders’ equity and cash flows showing the financial condition of the Borrower and its consolidated Restricted Subsidiaries as of the close of such fiscal quarter and the results of its operations and the operations of such Restricted Subsidiaries during such fiscal quarter and the then elapsed portion of the fiscal year, and comparative figures for the same periods in the immediately preceding fiscal year and (ii) a certificate of a Financial Officer of the Borrower certifying that the consolidated financial statements delivered pursuant to clause (i) above fairly present the financial condition and results of operations of the Borrower and its

us\smolyju\8802494.13

consolidated Restricted Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments;

(c) notwithstanding the foregoing, (i) in the event that the Borrower delivers to the Administrative Agent an Annual Report for the Borrower on Form 10-K for such fiscal year, as filed with the Securities and Exchange Commission, within 90 days after the end of such fiscal year, such Form 10-K shall satisfy the requirements of paragraph (a) above; provided that, such Form 10-K, when filed with the Securities and Exchange Commission, is accompanied by an opinion of Deloitte & Touche LLP or other independent public accountants of recognized national standing that satisfies the requirements of clause (ii) of paragraph (a) above and (ii) in the event that the Borrower delivers to the Administrative Agent a Quarterly Report for the Borrower on Form 10-Q for such fiscal quarter, as filed with the Securities and Exchange Commission, within 45 days after the end of such fiscal quarter, such Form 10-Q shall satisfy the requirements of paragraph (b) above;

(d) concurrently with any delivery of financial statements under paragraph (a) or (b) above, a certificate of a Financial Officer in the form of Exhibit G (i) certifying that no Event of Default or Default has occurred or, if such an Event of Default or Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto and (ii) setting forth a reasonably detailed calculation of the Total Leverage Ratio, Fixed Charge Ratio and EBITDA as of the period then ended;

(e) promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by the Borrower or any Restricted Subsidiary with the Securities and Exchange Commission, or any Governmental Authority succeeding to any or all of the functions of the Securities and Exchange Commission, or with any national securities exchange, or distributed to its shareholders, as the case may be;

(f) upon request of the Administrative Agent or any Lender, promptly after the receipt thereof by the Borrower or any of the Restricted Subsidiaries, a copy of any “management letter” received by any such person from its certified public accountants and the management’s response thereto;

(g) promptly after the request by any Lender, all documentation and other information that such Lender reasonably requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act;

(h) promptly after the request by the Administrative Agent or any Lender, copies of (i) any documents described in Section 101(k)(1) of ERISA that the Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan and (ii) any notices described in Section 101(l)(1) of ERISA that the Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan; provided that if the Borrower or any of its ERISA Affiliates has not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plan, the Borrower or the applicable ERISA Affiliate shall promptly make a request for such documents or notices from such administrator or sponsor and shall provide copies of such documents and notices promptly after receipt thereof; and

us\smolyju\8802494.13

(i) promptly, from time to time, such other information regarding the operations, business affairs and financial condition of the Borrower or any Restricted Subsidiary, or compliance with the terms of any Loan Document, as the Administrative Agent or any Lender may reasonably request.

SECTION 5.05. Litigation and Other Notices. Furnish to the Administrative Agent and each Lender prompt written notice of the following:

(a) any Event of Default or Default, specifying the nature and extent thereof and the corrective action (if any) taken or proposed to be taken with respect thereto;

(b) the filing or commencement of, or any threat or notice of intention of any person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority, against the Borrower or any Affiliate thereof that could reasonably be expected to result in a Material Adverse Effect; and

SECTION 5.06. Information Regarding Collateral. Furnish to the Administrative Agent prompt written notice of any change (i) in any Loan Party’s corporate name, (ii) in the jurisdiction of organization or formation of any Loan Party, or (iii) in any Loan Party’s identity or corporate structure. The Borrower agrees not to effect or permit any change referred to in the preceding sentence unless all filings have been made under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected security interest in all the Collateral. The Borrower also agrees promptly to notify the Administrative Agent if any material portion of the Collateral is damaged or destroyed.

SECTION 5.07. Maintaining Records; Access to Properties and Inspections. Keep proper books of record and account in which full, true and correct entries in conformity with GAAP and all requirements of law are made of all dealings and transactions in relation to its business and activities. Each Loan Party will, and will cause each of its subsidiaries to, permit any representatives designated by the Administrative Agent or any Lender to visit and inspect the financial records and the properties of such person at reasonable times and as often as reasonably requested and to make extracts from and copies of such financial records, and permit any representatives designated by the Administrative Agent or any Lender to discuss the affairs, finances and condition of such person with the officers thereof and independent accountants therefor.

SECTION 5.08. Use of Proceeds. Use the proceeds of the Loans only for the purposes specified in the introductory statement to this Agreement.

SECTION 5.09. Employee Benefits. (a) Comply in all material respects with the applicable provisions of ERISA and the Code and (b) furnish to the Administrative Agent as soon as possible after, and in any event within ten days after any responsible officer of the Borrower or any ERISA Affiliate knows or has reason to know that, any ERISA Event has occurred that, alone

us\smolyju\8802494.13

or together with any other ERISA Event could reasonably be expected to result in liability of the Borrower or any ERISA Affiliate in an aggregate amount exceeding $1,000,000, a statement of a Financial Officer of the Borrower setting forth details as to such ERISA Event and the action, if any, that the Borrower proposes to take with respect thereto.

SECTION 5.10. Compliance with Environmental Laws. Comply, and cause all lessees and other persons occupying its properties to comply, in all material respects with all Environmental Laws applicable to its operations and properties, obtain and renew all material environmental permits necessary for its operations and properties and conduct any remedial action required by Environmental Laws; provided, however, that neither the Borrower nor any Subsidiary shall be required to undertake any remedial action required by Environmental Laws to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being maintained with respect to such circumstances in accordance with GAAP.

SECTION 5.11. Preparation of Environmental Reports. If a Default caused by reason of a breach of Section 3.17 or Section 5.10 shall have occurred and be continuing for more than 20 days without the Borrower or any Subsidiary commencing activities reasonably likely to cure such Default, at the written request of the Required Lenders through the Administrative Agent, provide to the Lenders within 45 days after such request, at the expense of the Loan Parties, an environmental site assessment report regarding the matters which are the subject of such Default prepared by an environmental consulting firm reasonably acceptable to the Administrative Agent and indicating the presence or absence of Hazardous Materials and the estimated cost of any compliance or remedial action in connection with such Default.

SECTION 5.12. Further Assurances. Execute any and all further documents, financing statements, agreements and instruments, and take all further action (including filing Uniform Commercial Code and other financing statements) that may be required under applicable law, or that the Required Lenders, the Administrative Agent may reasonably request, in order to effectuate the transactions contemplated by the Loan Documents and in order to grant, preserve, protect and perfect the validity and first priority of the security interests created or intended to be created by the Security Documents. The Borrower will cause any subsequently acquired or organized Domestic Subsidiary that is a Restricted Subsidiary and each other person that shall Guarantee any of the Senior Secured Notes or the Junior Secured Notes to become a Loan Party by executing or joining the Guarantee Agreement and each applicable Security Document in favor of the Collateral Agent. In addition, from time to time, each Loan Party will, at its cost and expense, promptly secure the Obligations by pledging or creating, or causing to be pledged or created, in accordance hereunder and with the applicable Security Documents, perfected security interests with respect to such of its assets and properties as the Administrative Agent or the Required Lenders shall designate (it being understood that it is the intent of the parties that the Obligations shall be secured by substantially all the assets of the Borrower and its Domestic Subsidiaries (including properties acquired subsequent to the Closing Date that secure any of the Senior Secured Notes or the Junior Secured Notes)). Such security interests and Liens will be created under the Security Documents and other security agreements and other instruments and documents in form and substance satisfactory to the Administrative Agent, and the relevant Loan Party shall deliver or cause to be delivered to the Lenders all such instruments and documents (including legal opinions,

us\smolyju\8802494.13

title insurance policies and lien searches) as the Administrative Agent shall reasonably request to evidence compliance with this Section 5.12. Each of the Loan Parties agrees to provide such evidence as the Administrative Agent shall reasonably request as to the perfection and priority status of each such security interest and Lien.

SECTION 5.13. Proceeds of Certain Dispositions. If, as a result of the receipt of any Net Cash Proceeds by the Borrower or any Subsidiary in connection with any Asset Disposition, the Borrower would be required by the terms of the Senior Secured Notes Documents or the Junior Secured Notes Documents to make an offer to purchase any Senior Secured Notes or Junior Secured Notes, respectively, then, prior to the first day on which the Borrower would be required to commence such an offer to purchase, the Borrower shall (i) prepay Loans in accordance with Section 2.10, or (ii) acquire assets in a manner that is permitted hereby, in each case in a manner that will eliminate any such requirement to make such an offer to purchase.

SECTION 5.14. Post Closing Deliverables. The Borrower shall deliver to the Administrative Agent by 5 p.m. (New York City time) on January 18, 2013, that certain Deposit Account Control Agreement, that certain Collection Account Agreement and that certain Securities Account Control Agreement, each amended and restated pursuant to the terms of the Collateral Agreement and this Agreement and (ii) within (45) forty five days from the Closing Date, documentation showing that Borrower and each Subsidiary of Borrower with $4,000,000 or more in revenues for calendar year 2011, is an entity duly qualified to do business and in good standing as a foreign entity in each jurisdiction where the nature of its business so requires.

ARTICLE VI

Negative Covenants

The Borrower hereby covenants and agrees with the Administrative Agent and each Lender that, so long as this Agreement shall remain in effect and until the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document have been paid in full, unless the Required Lenders shall otherwise consent in writing.

SECTION 6.01. Intentionally Omitted.

SECTION 6.02. Financial Covenants. The Borrower will not permit (i) the Total Leverage Ratio as of the last day of each fiscal quarter, as provided in the chart below, to be greater than the corresponding amount or ratio as provided in the applicable column in the chart below for such fiscal quarter end and (ii) the Fixed Charge Ratio and Minimum EBITDA, each as of the last day of each fiscal quarter, as provided in the chart below, to be less than the corresponding ratio as provided in the applicable column in the chart below for such fiscal quarter end:

us\smolyju\8802494.13



Fiscal Quarter End	Minimum EBITDA	Total Leverage Ratio	Fixed Charge Ratio
December 31, 2012	$84,000,000	6:75:1.00	0.750:1.00
March 31, 2013	$86,000,000	6.50:1.00	0.800:1.00
June 30, 2013	$88,000,000	6:25:1.00	0.800:1.00
September 30, 2013	$90,000,000	6:00:1.00	0.825:1.00
December 31, 2013	$92,000,000	5:75:1.00	0.850:1.00
March 31, 2014 and each fiscal quarter ending thereafter	$95,000,000	5:50:1.00	0.900:1.00

SECTION 6.03. Limitation on Indebtedness. (j) The Borrower shall not, and shall not permit any Restricted Subsidiary to, Incur, directly or indirectly, any Indebtedness; provided, however, that the Borrower and the Subsidiary Guarantors will be entitled to Incur Indebtedness if, (i) on the date of such Incurrence and after giving effect thereto on a pro forma basis, the Consolidated Coverage Ratio exceeds 2.0 to 1.0 (any such Indebtedness Incurred pursuant to this Section 6.03(a) being herein referred to as “Coverage Indebtedness”) and (ii) the Required Lenders have consented, in writing, to the Incurrence of such Indebtedness.

(b) Notwithstanding the foregoing Section 6.03(a), the Borrower and the Restricted Subsidiaries shall be entitled to Incur any or all of the following Indebtedness (any such Indebtedness Incurred pursuant to this Section 6.03(b) being herein referred to as “Permitted Indebtedness”):

(i) The Loans incurred pursuant to this Agreement;

(ii) Indebtedness Incurred pursuant to any letters of credit, surety bonds or other similar arrangements procured in the ordinary course of business not exceeding $35,000,000 aggregate principal amount at any one time outstanding (any such Indebtedness Incurred pursuant to this clause (ii) being herein referred to as “L/C Indebtedness”);

(iii) Indebtedness owed to and held by the Borrower or a Restricted Subsidiary; provided, however, that any subsequent issuance or transfer of any Equity Interests which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of such Indebtedness (other than to the Borrower or a Restricted Subsidiary) shall be deemed, in each case, to constitute the Incurrence of such Indebtedness by the obligor thereon;

(iv) Indebtedness represented by the Existing Notes and the Subsidiary Guarantees thereof and additional Indebtedness arising from the capitalization of any non-cash interest in respect of the Junior Lien Notes, pursuant to the terms of Junior Lien Notes and in accordance with their respective terms;

us\smolyju\8802494.13

(v) Indebtedness of the Borrower and the Restricted Subsidiaries outstanding on the Closing Date (other than Indebtedness described in clause (i), (ii), or (iii) of this Section 6.03(b) and set forth on Schedule 6.03(b)(v) hereto);

(vi) Indebtedness of a Restricted Subsidiary Incurred and outstanding on or prior to the date on which such Subsidiary was acquired by the Borrower or a Restricted Subsidiary (other than Indebtedness Incurred in connection with, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or series of related transactions pursuant to which such Subsidiary became a Subsidiary or was acquired by the Borrower or a Restricted Subsidiary) in the aggregate not exceeding $5,000,000;

(vii) Refinancing Indebtedness in respect of Coverage Indebtedness or of Permitted Indebtedness Incurred pursuant to clause (i), (ii) or (v) of this Section 6.03(b) or this clause (vii); provided, however, that to the extent such Refinancing Indebtedness directly or indirectly Refinances Indebtedness of a Subsidiary Incurred pursuant to clause (vi), such Refinancing Indebtedness shall be Incurred only by such Subsidiary;

(viii) Hedging Obligations (excluding Hedging Obligations entered into for speculative purposes) consisting of interest rate agreements;

(ix) Obligations in respect of workers’ compensation and auto claims, payment obligations in connection with health or other types of social security benefits, unemployment or other insurance or self-insurance obligations, insurance premium finance agreements, reclamation, statutory and regulatory obligations, bankers’ acceptances, performance, bid, surety or similar bonds and letters of credit or completion and performance guarantees or equipment leases or other similar obligations provided by the Borrower or any Restricted Subsidiary in the ordinary course of business;

(x) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; provided, however, that such Indebtedness is extinguished within five (5) Business Days of its Incurrence;

(xi) Indebtedness consisting of the Guarantee by any Subsidiary Guarantor of any Indebtedness of the Borrower or any Subsidiary Guarantor that was permitted to be Incurred by the Borrower or any Subsidiary Guarantor pursuant to this Agreement; provided, however, that if the Indebtedness being Guaranteed is subordinated to or pari passu with the Loans, then the Guarantee thereof shall be subordinated or pari passu, as applicable, to the same extent as the Indebtedness being Guaranteed;

(xii) Attributable Debt and Purchase Money Indebtedness or Capital Lease Obligations Incurred to finance all or any part of the purchase price or cost of design, development, construction, installation or improvement of property (real or personal and including acquisitions of Equity Interests), plant, equipment or vehicles used

us\smolyju\8802494.13

in the business of the Borrower or any of the Restricted Subsidiaries (in each case, whether through the direct purchase of such assets or the Equity Interests of any Person owning such assets), or repairs, additions or improvements to such assets, together with any Attributable Debt Incurred pursuant to this clause (xii) and any Refinancing Indebtedness Incurred to Refinance such Indebtedness, in an aggregate principal amount which, when added together with the amount of Attributable Debt and Indebtedness Incurred pursuant to this clause (xii) and then outstanding, does not exceed $15,000,000;

(xiii) Indebtedness arising from agreements of the Borrower or a Restricted Subsidiary providing for indemnification, adjustment of purchase price, earn outs, Guarantees or similar obligations, in each case, Incurred or assumed in connection with the disposition of any business, assets or a Subsidiary, other than Guarantees of Indebtedness Incurred or assumed by any Person acquiring all or any portion of such business, assets or Subsidiary, in an aggregate principal amount not to exceed the gross proceeds actually received by the Borrower or any Restricted Subsidiary, as applicable, in connection with such disposition; and

(xiv) Indebtedness of the Borrower or the Subsidiary Guarantors in an aggregate amount which, when taken together with all other Indebtedness of the Borrower and the Subsidiary Guarantors outstanding on the date of such Incurrence (other than Coverage Indebtedness and Permitted Indebtedness Incurred pursuant to clauses (i) through (xiii) above) does not exceed $2,000,000.

(i) any Indebtedness outstanding under letters of credit, surety bonds or similar arrangements on the Closing Date will be treated as L/C Indebtedness Incurred on the Closing Date under Section 6.03(b)(ii); and

(ii) the Borrower shall be entitled to divide and classify an item of Indebtedness in more than one of the types of Indebtedness described above.

(d) For purposes of determining compliance with any U.S. Dollar restriction on the Incurrence of Indebtedness where the Indebtedness Incurred is denominated in a different currency, the amount of such Indebtedness shall be the U.S. Dollar Equivalent, determined on the date of the Incurrence of such Indebtedness; provided, however, that if any such Indebtedness denominated in a different currency is subject to a Currency Agreement with respect to U.S. Dollars, covering all principal, premium, if any, and interest payable on such Indebtedness, the amount of such Indebtedness expressed in U.S. Dollars shall be as provided in such Currency Agreement. The principal amount of any Refinancing Indebtedness Incurred in the same currency as the Indebtedness being Refinanced shall be the U.S. Dollar Equivalent of the Indebtedness Refinanced, except to the extent that (1) such U.S. Dollar Equivalent was determined based on a Currency Agreement, in which case the Refinancing Indebtedness shall be determined in accordance with the preceding sentence and (2) the principal amount of the Refinancing Indebtedness exceeds the principal amount of the Indebtedness being Refinanced, in which case the U.S. Dollar Equivalent of such excess shall be determined on the date such Refinancing Indebtedness is Incurred.

us\smolyju\8802494.13

SECTION 6.04. Limitation on Restricted Payments. (d) The Borrower shall not, and shall not permit any Restricted Subsidiary, directly or indirectly, to make a Restricted Payment if at the time the Borrower or such Restricted Subsidiary makes such Restricted Payment:

(i) a Default shall have occurred and be continuing (or would result therefrom);

(ii) the Required Lenders have not consented, in writing, to the making of such Restricted Payment;

(iii) immediately after giving effect to such Restricted Payment on a pro forma basis, the Borrower would not be entitled to Incur an additional $1.00 of Coverage Indebtedness pursuant to Section 6.03(a); or

(iv) the aggregate amount of such Restricted Payment and all other Restricted Payments since the Closing Date (excluding Restricted Payments permitted by clauses (b)(i), (ii), (iv), (v), (vi) and (viii)) would exceed the sum of (without duplication):

(A) 50% of the Consolidated Net Income accrued during the period (treated as one accounting period) from the beginning of the fiscal quarter immediately following the fiscal quarter during which the Closing Date occurs to the end of the most recent fiscal quarter ending at least 45 days prior to the date of such Restricted Payment (or, in case such Consolidated Net Income shall be a deficit, minus 100% of such deficit); plus

(B) 100% of the aggregate Net Cash Proceeds and the Fair Market Value of marketable securities or other property received by the Borrower from the issuance or sale of its Qualified Equity Interests subsequent to the Closing Date and 100% of any cash (or the Fair Market Value of any Cash Equivalents) consisting of a capital contribution received by the Borrower from its stockholders subsequent to the Closing Date; plus

(C) the amount by which Indebtedness of the Borrower is reduced upon the conversion or exchange subsequent to the Closing Date of any Indebtedness of the Borrower convertible or exchangeable for Qualified Equity Interests of the Borrower (less the amount of any cash, or the Fair Market Value of any other property, distributed by the Borrower upon such conversion or exchange); provided, however, that the foregoing amount shall not exceed the Net Cash Proceeds received by the Borrower or any Restricted Subsidiary from the sale of such Indebtedness (excluding Net Cash Proceeds from sales to a Subsidiary of the Borrower or to an employee stock ownership plan or a trust established by the Borrower or any of its Subsidiaries for the benefit of their employees); plus

us\smolyju\8802494.13

(D) an amount equal to the sum of (x) the net reduction in the Investments (other than Permitted Investments) made by the Borrower or any Restricted Subsidiary in any Person resulting from repurchases, repayments or redemptions of such Investments by such Person, proceeds realized on the sale of such Investment and proceeds representing the return of capital (excluding dividends and distributions), in each case received by the Borrower or any Restricted Subsidiary, and (y) to the extent such Person is an Unrestricted Subsidiary, the portion (proportionate to the Borrower’s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Unrestricted Subsidiary at the time such Unrestricted Subsidiary is designated a Restricted Subsidiary; provided, however, that the foregoing sum shall not exceed, in the case of any such Person or Unrestricted Subsidiary, the amount of Investments (excluding Permitted Investments) previously made (and treated as a Restricted Payment) by the Borrower or any Restricted Subsidiary in such Person or Unrestricted Subsidiary.

(b) The provisions of Section 6.04(a) shall not prohibit:

(i) any Restricted Payment made out of the Net Cash Proceeds of the substantially concurrent sale of, or made by exchange for, Qualified Equity Interests of the Borrower or a substantially concurrent cash capital contribution received by the Borrower from its stockholders; provided, however, that the Net Cash Proceeds from such sale or such cash capital contribution (to the extent so used for such Restricted Payment) shall be excluded from the calculation of amounts under Section 6.04(a)(iv)(B);

(ii) any purchase, repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated Obligations of the Borrower or a Subsidiary Guarantor made in exchange for, or out of the proceeds of the substantially concurrent Incurrence of, Indebtedness of such Person which is permitted to be Incurred pursuant to Section 6.03;

(iii) the payment of any dividend or redemption of any Capital Stock or Subordinated Obligations within 60 days after the date of declaration thereof or call for redemption, if at such date of declaration or call for redemption such payment or redemption was permitted by the provisions of Section 6.04(a) (the declaration of such payment shall be deemed a Restricted Payment under Section 6.04(a) as of the date of declaration, and the payment itself shall be deemed to have been paid on such date of declaration and will not also be deemed a Restricted Payment under Section 6.04(a)) (it being understood that any Restricted Payment made in reliance on this clause (3) shall reduce the amount available for Restricted Payments pursuant to Section 6.04(a)(iv) only once);

(iv) the declaration and payments of cash dividends or cash distributions on Disqualified Stock issued pursuant to Section 6.03; provided, however, that,

us\smolyju\8802494.13

at the time of payment of such dividend or distribution, no Default shall have occurred and be continuing (or result therefrom);

(v) repurchases of Equity Interests deemed to occur upon exercise of stock options if such Equity Interests represents a portion of the exercise price of such options;

(vi) cash payments in lieu of the issuance of fractional shares in connection with the exercise of warrants, options or other securities convertible into or exchangeable for Equity Interests of the Borrower; provided, however, that any such cash payment shall not be for the purpose of evading the limitation of this Section 6.04 (as determined in good faith by the Board of Directors of the Borrower);

(vii) [reserved];

(viii) payments of intercompany subordinated Indebtedness, the Incurrence of which was permitted under Section 6.03(b)(iii); provided, however, that no Default has occurred and is continuing or would otherwise result therefrom;

(ix) the repurchase, redemption, defeasance or other acquisition or retirement for value of Junior Secured Notes for aggregate cash consideration not to exceed $15,000,000; provided, however, that, at the time of such repurchase, redemption, defeasance or other acquisition or retirement, no Default shall have occurred and be continuing (or result therefrom); and

(x) the repurchase, redemption or other acquisition or retirement for value of any Equity Interests of the Borrower held by any current or former officer, director or employee of the Borrower pursuant to any equity subscription agreement, stock option agreement, shareholders’ agreement or similar agreement; provided that the aggregate price paid for all such repurchased, redeemed, acquired or retired Equity Interests may not exceed $1,000,000 in any twelve-month period; provided further, that, at the time of such repurchase, redemption, defeasance or other acquisition or retirement, no Default shall have occurred and be continuing (or result therefrom).

SECTION 6.05. Limitation on Restrictions on Distributions from Restricted Subsidiaries. The Borrower shall not, and shall not permit any Restricted Subsidiary to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to (a) (i) pay dividends or make any other distributions to the Borrower or any of the Restricted Subsidiaries on its Capital Stock or with respect to any other interest or participation in, or measured by its profits, or (ii) pay any Indebtedness owed to the Borrower, (b) make any loans or advances to the Borrower or (c) sell, lease or transfer any of its properties or assets to the Borrower, except:

(i) with respect to clauses (a), (b) and (c),

us\smolyju\8802494.13

(a) any encumbrance or restriction pursuant to an agreement in effect at or entered into on the Closing Date;

(b) any encumbrance or restriction with respect to a Restricted Subsidiary pursuant to an agreement relating to any Indebtedness Incurred by such Restricted Subsidiary on or prior to the date on which such Restricted Subsidiary was acquired by the Borrower (other than Indebtedness Incurred as consideration in, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or series of related transactions pursuant to which such Restricted Subsidiary became a Restricted Subsidiary or was acquired by the Borrower) and outstanding on such date;

(c) any encumbrance or restriction pursuant to an agreement effecting a Refinancing of Indebtedness Incurred pursuant to an agreement referred to in Section 6.05(i)(a) or (b) or this clause (c) or contained in any amendment, modification, restatement, renewal, refunding, replacement or Refinancing to an agreement referred to in Section 6.05(i)(a) or (b) or this clause (c); provided, however, that the encumbrances and restrictions with respect to such Restricted Subsidiary contained in any such refinancing agreement or amendment are, as determined by an Officer in good faith, not materially less favorable to the Lenders than encumbrances and restrictions with respect to such Restricted Subsidiary contained in such predecessor agreements;

(d) any encumbrance or restriction with respect to a Restricted Subsidiary imposed pursuant to an agreement entered into for the sale or disposition of all or substantially all the Equity Interests or assets of such Restricted Subsidiary pending the closing of such sale or disposition;

(e) customary provisions in joint venture agreements, asset sale agreements, sale-leaseback agreements, stock sale agreements, limited liability company organizational documents and other similar agreements;

(f) restrictions on cash, Cash Equivalents, marketable securities, investment grade securities or other deposits or net worth imposed by customers or lessors (including governmental entities) under contracts or leases entered into in the ordinary course of business;

(g) this Agreement, the Secured Notes, the Subsidiary Guarantees and the Security Documents;

(h) applicable laws, rules, regulations and orders;

(i) customary restrictions in Indebtedness Incurred pursuant to Section 6.03(b)(i); provided, however, that such restrictions are not more restrictive than those contained in this Agreement or the Security Documents; and

(ii) with respect to clause (c) only,

us\smolyju\8802494.13

(a) any encumbrance or restriction consisting of customary nonassignment provisions in leases governing leasehold interests to the extent such provisions restrict the transfer of the lease or the property leased thereunder;

(b) any encumbrance or restriction contained in security agreements or mortgages securing Indebtedness of a Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such security agreements or mortgages; and

(c) agreements with respect to Purchase Money Indebtedness and Capital Lease Obligations that impose restrictions on the property purchased or leased.

SECTION 6.06. Limitation on Sales of Assets and Subsidiary Stock. (b) The Borrower shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, consummate any Asset Disposition unless:

(i) the Borrower or such Restricted Subsidiary receives consideration at the time of such Asset Disposition at least equal to the Fair Market Value (including as to the value of all non-cash consideration), of the shares and assets subject to such Asset Disposition; and

(ii) at least 75% of the consideration thereof received by the Borrower or such Restricted Subsidiary is in the form of cash or Cash Equivalents;

(iii) in the case of an Asset Disposition of Collateral, the consideration from such Asset Disposition is pledged as Collateral to secure the Securities; and

(iv) [reserved];

(v) the Net Cash Proceeds from any such Asset Disposition shall be applied by the Borrower (or such Restricted Subsidiary, as the case may be) to reduce the outstanding principal amount of the Loans pursuant to Section 2.11(a) of this Agreement

For the purposes of Section 6.06(a)(ii), the following are deemed to be cash or Cash Equivalents:

(i)

the assumption or discharge of Applicable Senior Indebtedness of the Borrower (other than obligations in respect of Disqualified Stock of the Borrower) or any Restricted Subsidiary (other than obligations in respect of Disqualified Stock or Preferred Stock of a Subsidiary Guarantor) and the release of the Borrower or such Restricted Subsidiary from all liability on such Applicable Senior Indebtedness in connection with such Asset Disposition;

us\smolyju\8802494.13


(ii)	securities, notes or other obligations received by the Borrower or any Restricted Subsidiary from the transferee that are converted by the Borrower or such Restricted Subsidiary into cash within 365 days of the consummation of the Asset Disposition, to the extent of the cash received in such conversion; and

(iii)

any Designated Non-cash Consideration received by the Borrower or any of its Restricted Subsidiaries in such Asset Disposition having an aggregate Fair Market Value, taken together with all other Designated Non-cash Consideration received pursuant to this clause (iii) that is at that time outstanding, not to exceed an amount equal to $10,000,000 at the time of the receipt of such Designated Non-cash Consideration (with the Fair Market Value of each item of Designated Non-cash Consideration being measured at the time received and without giving effect to subsequent changes in value).

(b) The Borrower shall comply, to the extent applicable, with the requirements of Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section 6.06. To the extent that the provisions of any securities laws or regulations conflict with provisions of this Section 6.06, the Borrower shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Section 6.06 by virtue of its compliance with such securities laws or regulations.

SECTION 6.07. Limitation on Affiliate Transactions. (a) The Borrower shall not, and shall not permit any Restricted Subsidiary to, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property, employee compensation arrangements or the rendering of any service) with, or for the benefit of, any Affiliate of the Borrower (an “Affiliate Transaction”) unless:

(i) the terms of the Affiliate Transaction are no less favorable to the Borrower or such Restricted Subsidiary than those that could be obtained at the time of the Affiliate Transaction in arm’s-length dealings with a Person who is not an Affiliate;

(ii) if such Affiliate Transaction involves an amount in excess of $5,000,000, the terms of the Affiliate Transaction are set forth in writing and a majority of the non-employee directors of the Borrower disinterested with respect to such Affiliate Transaction have determined in good faith that the criteria set forth in Section 6.07(a)(i) are satisfied and have approved the relevant Affiliate Transaction as evidenced by a resolution of the Board of Directors of the Borrower (unless the Board of Directors of the Borrower at the time of such Affiliate Transaction has no non-employee directors of the Borrower disinterested with respect to such Affiliate Transaction, in which case clause (iii) below will apply to such Affiliate Transaction); and

us\smolyju\8802494.13

(iii) if such Affiliate Transaction involves an amount in excess of $10,000,000 (or if such Affiliate Transaction involves an amount in excess of $5,000,000 and the Board of Directors of the Borrower at the time of such Affiliate Transaction has no non-employee directors of the Borrower disinterested with respect to such Affiliate Transaction), the Board of Directors of the Borrower shall have received a written opinion from an Independent Qualified Party to the effect that such Affiliate Transaction is fair, from a financial standpoint, to the Borrower and the Restricted Subsidiaries or is not materially less favorable to the Borrower and the Restricted Subsidiaries than could reasonably be expected to be obtained at the time in an arm’s-length transaction with a Person who was not an Affiliate.

(b) The provisions of Section 6.07(a) shall not apply to:

(i) any Permitted Investment, other than a Permitted Investment, referred to in clauses (1), (2) or (15) of Permitted Investment definition or other Restricted Payment, in each case permitted to be made pursuant to Section 6.04;

(ii) any issuance of securities, or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock options and stock ownership plans approved by the Board of Directors of the Borrower;

(iii) loans or advances to employees made in the ordinary course of business for bona fide business purposes and consistent with past practices of the Borrower or the Restricted Subsidiaries;

(iv) the payment of reasonable fees to directors of the Borrower and the Restricted Subsidiaries who are not employees of the Borrower or the Restricted Subsidiaries;

(v) any transaction with the Borrower, a Restricted Subsidiary or joint venture or similar entity which would constitute an Affiliate Transaction solely because the Borrower or a Restricted Subsidiary owns an equity interest in or otherwise controls such Restricted Subsidiary, joint venture or similar entity;

(vi) the issuance or sale of any Qualified Equity Interests of the Borrower;

(vii) any agreement as in effect on the Closing Date or any renewals or extensions of any such agreement (so long as such renewals or extensions are not less favorable to the Borrower or the Restricted Subsidiaries) and the transactions evidenced thereby; and

(viii) entering into and performing under indemnification arrangements or agreements in the ordinary course of business for the benefit of former, current or future directors or officers of the Borrower or any or its Restricted Subsidiaries.

us\smolyju\8802494.13

SECTION 6.08. Limitation on Line of Business. The Borrower shall not, and shall not permit any Restricted Subsidiary, to engage in any business other than a Related Business.

SECTION 6.09. Limitation on Liens. The Borrower shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create, Incur or suffer to exist or become effective any Lien of any kind upon any of their assets, now owned or hereafter acquired, other than:

(i) in the case of any asset that does not constitute Collateral, Permitted Liens; provided, however, that any Lien on such asset shall be permitted notwithstanding that it is not a Permitted Lien if all payments due under this Agreement are secured on an equal and ratable basis with the obligations so secured until such time as such obligations are no longer secured by a Lien; and

(ii) in the case of any asset that constitutes Collateral, Permitted Collateral Liens.

In the case of the clause (i) above, if the obligations so secured are expressly subordinated by their terms to the Loans, the Lien securing such obligations shall also be so subordinated by its terms at least to the same extent.

SECTION 6.10. Limitation on Sale/Leaseback Transactions. (a) The Borrower shall not, and shall not permit any Restricted Subsidiary to, enter into any Sale/Leaseback Transaction with respect to any property unless:

(i) the Borrower or such Restricted Subsidiary would be entitled to (A) Incur Indebtedness in an amount equal to the Attributable Debt with respect to such Sale/Leaseback Transaction pursuant to Section 6.03 and (B) create a Lien on such property securing such Indebtedness without equally and ratably securing the Securities pursuant to Section 6.10;

(ii) the net proceeds received by the Borrower or any Restricted Subsidiary in connection with such Sale/Leaseback Transaction are at least equal to the Fair Market Value of such property; and

(iii) the Borrower applies the proceeds of such transaction in compliance with Section 2.11(a), to the extent applicable.

SECTION 6.11. When Borrower May Merge or Transfer Assets. (b) The Borrower shall not consolidate with or merge with or into, or convey, transfer or lease, in one transaction or a series of transactions, directly or indirectly, all or substantially all its assets to, any Person, unless:

(i) (x) the Borrower shall be the surviving corporation or (y) the resulting, surviving or transferee Person (the “Successor Company”) shall be a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and the Successor Company (if not the Borrower) shall expressly

us\smolyju\8802494.13

assume, by an indenture supplemental thereto, executed and delivered to the Trustee, in form reasonably satisfactory to the Trustee, all the Obligations of the Borrower under this Agreement;

(ii) immediately after giving pro forma effect to such transaction (and treating any Indebtedness which becomes an Obligation of the Successor Company or any Subsidiary as a result of such transaction as having been Incurred by such Successor Company or such Subsidiary at the time of such transaction), no Default shall have occurred and be continuing;

(iii) immediately after giving pro forma effect to such transaction, the Successor Company would have been able to Incur an additional $1.00 of Coverage Indebtedness pursuant to Section 6.03(a); and

(iv) the Borrower shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Agreement;

provided, however, that clause (iii) shall not be applicable to (A) a Restricted Subsidiary consolidating with, merging into or transferring all or part of its properties and assets to the Borrower or (B) the Borrower merging with an Affiliate of the Borrower solely for the purpose and with the sole effect of reincorporating the Borrower in another jurisdiction.

For purposes of this Section 6.11, the sale, lease, conveyance, assignment, transfer or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the Borrower, which properties and assets, if held by the Borrower instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Borrower on a consolidated basis, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Borrower.

The Successor Company (if not the Borrower) shall be the successor to the Borrower and shall succeed to, and be substituted for, and may exercise every right and power of, the Borrower under this Agreement, and the predecessor Borrower, except in the case of a lease, shall be released from the obligation to pay the principal of and interest on the Securities.

(b) The Borrower shall not permit any Subsidiary Guarantor to consolidate with or merge with or into, or convey, transfer or lease, in one transaction or a series of transactions, all or substantially all of its assets to any Person unless immediately after giving effect to such transaction or transactions on a pro forma basis (and treating any Indebtedness which becomes an obligation of the resulting, surviving or transferee Person as a result of such transaction as having been issued by such Person at the time of such transaction), no Default shall have occurred and be continuing.

SECTION 6.12. Prepayments or Modification of Certain Debt. Without limiting the obligations of the Borrower and the Restricted Subsidiaries under Article VI, the Borrower will not, nor will it cause or permit any of the Restricted Subsidiaries to (a) make any

us\smolyju\8802494.13

distribution, whether in cash, property, securities or a combination thereof, other than regular scheduled payments of principal and interest as and when due, in respect of, or pay, or commit to pay, or directly or indirectly redeem, repurchase, retire or otherwise acquire for consideration, or set apart any sum for the aforesaid purposes, the Senior Secured Notes or the Junior Secured Notes, except prepayments of such Indebtedness in exchange for, or with the Net Cash Proceeds of, Refinancing Indebtedness or (b) permit any waiver, supplement, modification or amendment of the Senior Secured Notes Documents or the Junior Secured Notes Documents, in each case to the extent any such waiver, supplement, modification or amendment would be materially adverse to the Lenders.

ARTICLE VII

Events of Default

SECTION 7.01. Events of Default. Upon the occurrence of any of the following specified events (each, if the same shall occur for any reason whatsoever, whether voluntary or involuntary, by operation of law or otherwise, an “Events of Default”):

(a) any representation or warranty made or deemed made in or in connection with any Loan Document or the borrowings hereunder, or any representation, warranty, statement or information contained in any report, certificate, financial statement or other instrument furnished in connection with or pursuant to any Loan Document, shall prove to have been false or misleading in any material respect when so made, deemed made or furnished;

(b) default shall be made in the payment of any principal of any Loan when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or by acceleration thereof or otherwise;

(c) default shall be made in the payment of any interest on any Loan or any fee or any other amount (other than an amount referred to in (b) above) due under any Loan Document, when and as the same shall become due and payable, and such default shall continue unremedied for a period of three (3) Business Days;

(d) default shall be made in the due observance or performance by the Borrower or any Restricted Subsidiary of any covenant, condition or agreement contained in Section 5.01(a), 5.05 or 5.08 or in Article VI;

(e) default shall be made in the due observance or performance by the Borrower or any Restricted Subsidiary of any covenant, condition or agreement contained in any Loan Document (other than those specified in paragraph (b), (c) or (d) above) and such default shall continue unremedied for a period of 30 days after notice thereof from the Administrative Agent or any Lender to the Borrower;

(f) (i) the Borrower or any Restricted Subsidiary shall fail to pay any principal, interest or other amount due in respect of any Material Indebtedness, when and as the same shall become due and payable, or (ii) any other event or condition occurs that results in any Material

us\smolyju\8802494.13

Indebtedness becoming due prior to its scheduled maturity or that enables or permits (after the giving of notice and/or the lapse of any applicable grace period) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity or that results in the termination or permits (after the giving of notice and/or the lapse of any applicable grace period) any counterparty to terminate any Hedging Agreement the obligations under which constitute Material Indebtedness; provided that this clause (ii) shall not apply to secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness;

(g) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of the Borrower or any Significant Subsidiary, or of a substantial part of the property or assets of the Borrower or a Significant Subsidiary, under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Significant Subsidiary or for a substantial part of the property or assets of the Borrower or a Significant Subsidiary, or (iii) the winding-up or liquidation of the Borrower or any Significant Subsidiary; and such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered;

(h) the Borrower or any Significant Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking relief under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in (g) above, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Significant Subsidiary or for a substantial part of the property or assets of the Borrower or any Significant Subsidiary, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) become unable, admit in writing its inability or fail generally to pay its debts as they become due or (vii) take any action for the purpose of effecting any of the foregoing;

(i) one or more judgments shall be rendered against the Borrower, any Significant Subsidiary or any combination thereof and the same shall remain undischarged for a period of 60 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of the Borrower or any Significant Subsidiary to enforce any such judgment and such judgment is for the payment of money in an aggregate amount in excess of $10,000,000;

(j) an ERISA Event shall have occurred that, in the opinion of the Required Lenders, when taken together with all other such ERISA Events, could reasonably be expected to result in liability of the Borrower and its ERISA Affiliates in an aggregate amount exceeding $10,000,000;

us\smolyju\8802494.13

(k) any Guarantee under the Guarantee Agreement for any reason shall cease to be in full force and effect, or any Subsidiary Guarantor shall deny in writing that it has any further liability under the Guarantee Agreement (in each case, other than in accordance with its terms or other than as a result of the discharge or sale or other disposition of such Subsidiary Guarantor in accordance with the terms of the Loan Documents);

(l) (i) a default by the Borrower or any Subsidiary Guarantor in the performance of the Security Documents which adversely affects the enforceability, validity, perfection or priority of the Collateral Agent’s Lien on the Collateral in any material respect, (ii) repudiation or disaffirmation by the Borrower or any Subsidiary Guarantor of any of its material obligations under the Security Documents, or (iii) the determination in a judicial proceeding that any one or more material provisions of the Security Documents are unenforceable or invalid against the Borrower or any Subsidiary Guarantor for any reason except to the extent any such unenforceability or invalidity is caused by the failure of the Collateral Agent to maintain possession of certificates representing securities pledged under the Collateral Agreement or to make filings, renewals and continuations (or other equivalent filings) which the Borrower has indicated in the Perfection Certificate are required to be made; or

(m) there shall have occurred a Change in Control;

then, and in every such event (other than an event with respect to the Borrower described in paragraph (g) or (h) above), and at any time thereafter during the continuance of such event, the Administrative Agent may, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or different times: (i) terminate forthwith the Commitments and (ii) declare the Loans then outstanding to be forthwith due and payable in whole or in part, whereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and any unpaid accrued fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall become forthwith due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding; and in any event with respect to the Borrower described in paragraph (g) or (h) above, the principal of the Loans then outstanding, together with accrued interest thereon and any unpaid accrued fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding.

ARTICLE VIII

The Administrative Agent and the Collateral Agent

Each of the Lenders hereby irrevocably appoints the Administrative Agent and the Collateral Agent (for purposes of this Article VIII, the Administrative Agent and the Collateral Agent are referred to collectively as the “Agents”) its agent and authorizes the Agents to take such actions on its behalf and to exercise such powers as are delegated to such Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto. Without

us\smolyju\8802494.13

limiting the generality of the foregoing, the Agents are hereby expressly authorized to execute any and all documents (including releases) with respect to the Collateral and any rights of the Secured Parties with respect thereto, as contemplated by and in accordance with the provisions of this Agreement and the Security Documents.

The institution serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not an Agent, and such bank and its Affiliates may accept deposits from, lend money to and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if it were not an Agent hereunder.

Neither Agent shall have any duties or obligations except those expressly set forth in the Loan Documents. Without limiting the generality of the foregoing, (a) neither Agent shall be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing, (b) neither Agent shall have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby that such Agent is instructed in writing to exercise by the Required Lenders (or such other number or percentage of the Lenders or Secured Parties as shall be necessary under the circumstances as provided in Section 9.08 or in the Intercreditor Agreements, as applicable), and (c) except as expressly set forth in the Loan Documents, neither Agent shall have any duty to disclose, nor shall it be liable for the failure to disclose, any information relating to the Borrower or any of the Subsidiaries that is communicated to or obtained by the bank serving as Administrative Agent and/or Collateral Agent or any of their Affiliates in any capacity. Neither Agent shall be liable for any action taken or not taken by it with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders or Secured Parties as shall be necessary under the circumstances as provided in Section 9.08 or in the Intercreditor Agreements, as applicable) or in the absence of its own gross negligence or willful misconduct. Neither Agent shall be deemed to have knowledge of any Default unless and until written notice thereof is given to such Agent by the Borrower or a Lender, and neither Agent shall be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with any Loan Document, (ii) the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document, (iv) the validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document, or (v) the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to such Agent.

Each Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by it to be genuine and to have been signed or sent by the proper person. Each Agent may also rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper person, and shall not incur any liability for relying thereon. Each Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.

us\smolyju\8802494.13

Each Agent may perform any and all its duties and exercise its rights and powers by or through any one or more sub-agents appointed by it. Each Agent and any such sub-agent may perform any and all its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent.

Subject to the appointment and acceptance of a successor Agent as provided below, either Agent may resign at any time by notifying the Lenders and the Borrower. Upon any such resignation, the Required Lenders shall have the right, in consultation with the Borrower, to appoint a successor. If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Agent gives notice of its resignation, then the retiring Agent may, on behalf of the Lenders, appoint a successor Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank. If no successor Agent has been appointed pursuant to the immediately preceding sentence by the 30th day after the date such notice of resignation was given by such Agent, such resignation shall become effective and the Required Lenders shall thereafter perform all the duties of such Agent hereunder and/or under any other Loan Document until such time, if any, as the Required Lenders appoint a successor Administrative Agent and/or Collateral Agent, as the case may be. Upon the acceptance of its appointment as Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents. The fees payable by the Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After an Agent’s resignation hereunder, the provisions of this Article and Section 9.05 shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while acting as Agent.

Each Lender acknowledges that it has, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement or any other Loan Document, any related agreement or any document furnished hereunder or thereunder.

Each Lender hereby consents to and approves each and all of the provisions of the Intercreditor Agreements and irrevocably authorizes and directs the Collateral Agent to execute and deliver the same and to exercise and enforce its rights and remedies and perform its obligations thereunder.

Without limiting the foregoing, no Secured Party shall have any right individually to realize upon any of the Collateral or to enforce any Guarantee of the Obligations, it being understood and agreed that all powers, rights and remedies under the Loan Documents may be exercised solely by the Agents on behalf of the Secured Parties in accordance with the terms thereof (subject, in the

us\smolyju\8802494.13

case of the Collateral, to the provisions of the Intercreditor Agreements). In the event of a foreclosure by the Collateral Agent on any of the Collateral pursuant to a public or private sale or other disposition, any Lender may be the purchaser or licensor of any or all of such Collateral at any such sale or other disposition, and the Collateral Agent, as agent for and representative of the Secured Parties (but not any Lender or Lenders in its or their respective individual capacities) shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale, to use and apply any of the Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent on behalf of the Secured Parties at such sale or other disposition. Each Secured Party, whether or not a party hereto, will be deemed, by its acceptance of the benefits of the Collateral and of the Guarantees of the Obligations provided under the Loan Documents, to have agreed to the foregoing provisions. The provisions of this paragraph are for the sole benefit of the Lenders and shall not afford any right to, or contribute a defense available to, any Loan Party.

ARTICLE IX

Miscellaneous

SECTION 9.01. Notices; Electronic Communications. Notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by fax, as follows:

(a) if to the Borrower or any Subsidiary Guarantor, to the Borrower at Rotech Healthcare Inc., ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention of ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇, Chief Legal Officer (Fax No. (▇▇▇) ▇▇▇-▇▇▇▇);

(b) to the Administrative Agent, to Silver Point Finance, LLC, ▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇ (Fax. No. ▇▇▇.▇▇▇.▇▇▇▇), Email: ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇; and

(c) if to a Lender, to it at its address (or fax number) set forth on Schedule 2.01 or in the Assignment and Acceptance pursuant to which such Lender shall have become a party hereto.

All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt if delivered by hand or overnight courier service or sent by fax or on the date five Business Days after dispatch by certified or registered mail if mailed, in each case delivered, sent or mailed (properly addressed) to such party as provided in this Section 9.01 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 9.01. As agreed to among the Borrower, the Administrative Agent and the applicable Lenders from time to time, notices and other communications may also be delivered by e-mail to the e-mail address of a representative of the applicable person provided from time to time by such person.

The Borrower hereby agrees, unless directed otherwise by the Administrative Agent or unless the electronic mail address referred to below has not been provided by the Administrative Agent to

us\smolyju\8802494.13

the Borrower, that it will, or will cause the Subsidiaries to, provide to the Administrative Agent all information, documents and other materials that it is obligated to furnish to the Administrative Agent pursuant to the Loan Documents or to the Lenders under Article V, including all notices, requests, financial statements, financial and other reports, certificates and other information materials, but excluding any such communication that (a) is or relates to a Borrowing Request or a notice pursuant to Section 2.06, (b) relates to the payment of any principal or other amount due under this Agreement prior to the scheduled date therefor, (c) provides notice of any Default or Event of Default under this Agreement or any other Loan Document or (d) is required to be delivered to satisfy any condition precedent to the effectiveness of this Agreement and/or any Borrowing hereunder (all such non-excluded communications being referred to herein collectively as “Communications”), by transmitting the Communications in an electronic/soft medium that is properly identified in a format acceptable to the Administrative Agent to an electronic mail address as directed by the Administrative Agent. In addition, the Borrower agrees, and agrees to cause the Subsidiaries, to continue to provide the Communications to the Administrative Agent or the Lenders, as the case may be, in the manner specified in the Loan Documents but only to the extent requested by the Administrative Agent.

The Borrower hereby acknowledges that (a) the Administrative Agent will make available to the Lenders materials and/or information provided by or on behalf of it hereunder (collectively, the “Borrower Materials”) by posting the Borrower Materials on Intralinks or another similar electronic system (the “Platform”) and (b) certain of the Lenders may be “public side” Lenders (i.e., Lenders that do not wish to receive material non-public information with respect to the Borrower and its Subsidiaries or their securities) (each, a “Public Lender”). The Borrower hereby agrees that (i) all Borrower Materials that are to be made available to Public Lenders shall be clearly and conspicuously marked “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof; (ii) by marking Borrower Materials “PUBLIC,” the Borrower shall be deemed to have authorized the Administrative Agent and the Lenders to treat such Borrower Materials as not containing any material non-public information with respect to the Borrower and its Subsidiaries or their securities for purposes of United States federal and state securities laws (provided, however, that to the extent such Borrower Materials constitute Information, they shall be treated as set forth in Section 9.16); (iii) all Borrower Materials marked “PUBLIC” are permitted to be made available through a portion of the Platform designated as “Public Investor;” and (iv) the Administrative Agent shall be entitled to treat any Borrower Materials that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not marked as “Public Investor.” Notwithstanding the foregoing, the following Borrower Materials shall be marked “PUBLIC”, unless the Borrower notifies the Administrative Agent promptly that any such document contains material non-public information: (A) the Loan Documents and (B) notification of changes in the terms of this Agreement.

Each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable law, including United States Federal and state securities laws, to make reference to, and receive, Communications that are not made available through the “Public Side Information” portion of the Platform and that may

us\smolyju\8802494.13

contain material non-public information with respect to the Borrower and its Subsidiaries or their securities for purposes of United States Federal or state securities laws.

THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE”. NEITHER THE ADMINISTRATIVE AGENT NOR ANY OF ITS RELATED PARTIES WARRANTS THE ACCURACY OR COMPLETENESS OF THE COMMUNICATIONS OR THE ADEQUACY OF THE PLATFORM AND EACH EXPRESSLY DISCLAIMS LIABILITY FOR ERRORS OR OMISSIONS IN THE COMMUNICATIONS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS IS MADE BY THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES IN CONNECTION WITH THE COMMUNICATIONS OR THE PLATFORM. IN NO EVENT SHALL THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES HAVE ANY LIABILITY TO ANY LOAN PARTY, ANY LENDER OR ANY OTHER PERSON FOR DAMAGES OF ANY KIND, WHETHER OR NOT BASED ON STRICT LIABILITY AND INCLUDING DIRECT OR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES (WHETHER IN TORT, CONTRACT OR OTHERWISE) ARISING OUT OF ANY LOAN PARTY’S OR THE ADMINISTRATIVE AGENT’S TRANSMISSION OF COMMUNICATIONS THROUGH THE INTERNET, EXCEPT TO THE EXTENT THE LIABILITY OF ANY SUCH PERSON IS FOUND IN A FINAL RULING BY A COURT OF COMPETENT JURISDICTION TO HAVE RESULTED PRIMARILY FROM SUCH PERSON’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT.

The Administrative Agent agrees that the receipt of the Communications by the Administrative Agent at its e-mail address set forth above shall constitute effective delivery of the Communications to the Administrative Agent for purposes of the Loan Documents. Each Lender agrees that receipt of notice to it (as provided in the next sentence) specifying that the Communications have been posted to the Platform shall constitute effective delivery of the Communications to such Lender for purposes of the Loan Documents. Each Lender agrees to notify the Administrative Agent in writing (including by electronic communication) from time to time of such ▇▇▇▇▇▇’s e-mail address to which the foregoing notice may be sent by electronic transmission and that the foregoing notice may be sent to such e-mail address.

Nothing herein shall prejudice the right of the Administrative Agent or any Lender to give any notice or other communication pursuant to any Loan Document in any other manner specified in such Loan Document.

SECTION 9.02. Survival of Agreement. All covenants, agreements, representations and warranties made by the Borrower herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders and shall survive the making by the Lenders of the Loans, regardless of any investigation made by the Lenders or on their behalf, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement or any other

us\smolyju\8802494.13

Loan Document is outstanding and unpaid and so long as the Commitments have not been terminated. The provisions of Sections 2.12, 2.14, 2.17 and 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent or any Lender.

SECTION 9.03. Binding Effect. This Agreement shall become effective when it shall have been executed by the Borrower and the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto.

SECTION 9.04. Successors and Assigns. (a) Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of the Borrower, the Administrative Agent or the Lenders that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns.

(b) Each Lender may assign to one or more Eligible Assignees all or a portion of its interests, rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it); provided, however, that (i) the Administrative Agent must also give its prior written consent to such assignment (which consent shall not be unreasonably withheld or delayed), (ii) the amount of the Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Acceptance with respect to such assignment is delivered to the Administrative Agent) shall be not less than, $1,000,000 (or, if less, the entire remaining amount of such ▇▇▇▇▇▇’s Commitment or Loans); provided that simultaneous assignments by or to two or more Related Funds shall be combined for purposes of determining whether the minimum assignment requirement is met, (iii) the parties to each such assignment shall execute and deliver to the Administrative Agent an Assignment and Acceptance via an electronic settlement system acceptable to the Administrative Agent (or, if previously agreed with the Administrative Agent, manually), and the parties to each such assignment (except in the case of an assignment to a Lender, an Affiliate of a Lender or a Related Fund) shall pay to the Administrative Agent a processing and recordation fee of $3,500 (which fee may be waived or reduced in the sole discretion of the Administrative Agent), and (iv) the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire (in which the assignee shall designate one or more credit contacts to whom all syndicate-level information (which may contain material non-public information about the Loan Parties and their Related Parties or their respective securities) will be made available and who may receive such information in accordance with the assignee’s compliance procedures and applicable laws, including Federal and state securities laws) and all applicable tax forms required under Section 2.17(e) and 2.17(f). Upon acceptance and recording pursuant to paragraph (e) of this Section 9.04, from and after the effective date specified in each Assignment and Acceptance, (A) the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Acceptance, have the rights and obligations of a Lender under this Agreement and (B) the assigning Lender

us\smolyju\8802494.13

thereunder shall, to the extent of the interest assigned by such Assignment and Acceptance, be released from its obligations under this Agreement (and, in the case of an Assignment and Acceptance covering all or the remaining portion of an assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.12, 2.14, 2.17 and 9.05, as well as to any fees accrued for its account and not yet paid).

(c) By executing and delivering an Assignment and Acceptance, the assigning Lender thereunder and the assignee thereunder shall be deemed to confirm to and agree with each other and the other parties hereto as follows: (i) such assigning Lender warrants that it is the legal and beneficial owner of the interest being assigned thereby free and clear of any adverse claim and that its Commitment, and the outstanding balances of its Loans, in each case without giving effect to assignments thereof which have not become effective, are as set forth in such Assignment and Acceptance, (ii) except as set forth in (i) above, such assigning Lender makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with this Agreement, or the execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto, or the financial condition of the Borrower or any Subsidiary or the performance or observance by the Borrower or any Subsidiary of any of its obligations under this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto; (iii) such assignee represents and warrants that it is an Eligible Assignee and is legally authorized to enter into such Assignment and Acceptance; (iv) such assignee confirms that it has received a copy of this Agreement, together with copies of the most recent financial statements referred to in Section 3.05 or delivered pursuant to Section 5.04, the Intercreditor Agreements and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into such Assignment and Acceptance; (v) such assignee will independently and without reliance upon the Administrative Agent, the Collateral Agent, such assigning Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under this Agreement; (vi) such assignee agrees to be bound by the terms of the Intercreditor Agreements; (vii) such assignee appoints and authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its behalf and to exercise such powers under the Loan Documents as are delegated to the Administrative Agent and the Collateral Agent, respectively, by the terms hereof, together with such powers as are reasonably incidental thereto; and (viii) such assignee agrees that it will perform in accordance with their terms all the obligations which by the terms of this Agreement are required to be performed by it as a Lender.

(d) The Administrative Agent, acting for this purpose as an agent of the Borrower, shall maintain at one of its offices a copy of each Assignment and Acceptance delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of (and stated interest on) the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive, absent manifest error, and the Borrower, the Administrative Agent, the Collateral Agent and the Lenders may treat each person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The

us\smolyju\8802494.13

Register shall be available for inspection by the Borrower, the Collateral Agent and any Lender, at any reasonable time and from time to time upon reasonable prior notice.

(e) Upon its receipt of, and consent to, a duly completed Assignment and Acceptance executed by an assigning Lender and an assignee, an Administrative Questionnaire completed in respect of the assignee (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) above, if applicable, and the written consent of the Administrative Agent and, if required, the Borrower to such assignment and any applicable tax forms required under Section 2.17(e) and 2.17(f), the Administrative Agent shall (i) accept such Assignment and Acceptance and (ii) record the information contained therein in the Register. No assignment shall be effective unless it has been recorded in the Register as provided in this paragraph (e).

(f) Each Lender may, without the consent of the Borrower or the Administrative Agent, sell participations to one or more banks or other persons in all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it); provided, however, that (i) such Lender’s obligations under this Agreement and the other Loan Documents shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (iii) the participating banks or other persons shall be entitled to the benefit of the cost protection provisions contained in Sections 2.12, 2.14 and 2.17 (subject to the requirements and limitations therein (it being understood that such participating banks or persons shall be entitled to benefit from Section 2.17 only if the documentation required under Section 2.17(e) or Section 2.17(f) shall be have been delivered to the Lender selling a participation)) to the same extent as if they were Lenders (but, with respect to any particular participant, to no greater extent than the Lender that sold the participation to such participant) and (iv) the Borrower, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement and the other Loan Documents, and such Lender shall retain the sole right to enforce the obligations of the Borrower relating to the Loans and to approve any amendment, modification or waiver of any provision of this Agreement and the other Loan Documents (other than amendments, modifications or waivers decreasing any fees payable to such participating bank or person hereunder or the amount of principal of or the rate at which interest is payable on the Loans in which such participating bank or person has an interest, extending any scheduled principal payment date or date fixed for the payment of interest on the Loans in which such participating bank or person has an interest, increasing or extending the Commitments in which such participating bank or person has an interest or releasing any Subsidiary Guarantor (other than in connection with the sale of such Subsidiary Guarantor in a transaction permitted under Article VI) or all or substantially all of the Collateral). Each Lender that sells a participation shall, acting solely for this purpose as an agent of the Borrower, maintain a register on which it enters the name and address of each participant and the principal amounts (and stated interest) of each participant’s interest in obligations under this Agreement (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any person (including the identity of any participant or any information relating to a participant’s interest in any Commitments, Loans, or its other obligations under this Agreement) except to the extent that such disclosure is necessary to establish that such commitment, loan or other obligation is in registered form under Section 5f.103-1

us\smolyju\8802494.13

(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.

(g) Any Lender or participant may, in connection with any assignment or participation or proposed assignment or participation pursuant to this Section 9.04, disclose to the assignee or participant or proposed assignee or participant any information relating to the Borrower furnished to such Lender by or on behalf of the Borrower; provided that, prior to any such disclosure of information designated by the Borrower as confidential, each such assignee or participant or proposed assignee or participant shall execute an agreement whereby such assignee or participant shall agree (subject to customary exceptions) to preserve the confidentiality of such confidential information on terms no less restrictive than those applicable to the Lenders pursuant to Section 9.16.

(h) Any Lender may, at any time, assign all or any portion of its rights under this Agreement to secure extensions of credit to such Lender, or in support of obligations owed by such Lender; provided that no such assignment shall release a Lender from any of its obligations hereunder or substitute any such assignee for such Lender as a party hereto.

(i) Notwithstanding anything to the contrary contained herein, any Lender (a “Granting Lender”) may grant to a special purpose funding vehicle (an “SPC”), identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Borrower, the option to provide to the Borrower all or any part of any Loan that such Granting Lender would otherwise be obligated to make to the Borrower pursuant to this Agreement; provided that (i) nothing herein shall constitute a commitment by any SPC to make any Loan and (ii) if an SPC elects not to exercise such option or otherwise fails to provide all or any part of such Loan, the Granting Lender shall be obligated to make such Loan pursuant to the terms hereof. The making of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Loan were made by such Granting Lender. Each party hereto hereby agrees that no SPC shall be liable for any indemnity or similar payment obligation under this Agreement (all liability for which shall remain with the Granting Lender). In furtherance of the foregoing, each party hereto hereby agrees (which agreement shall survive the termination of this Agreement) that, prior to the date that is one year and one day after the payment in full of all outstanding commercial paper or other senior indebtedness of any SPC, it will not institute against, or join any other person in instituting against, such SPC any bankruptcy, reorganization, arrangement, insolvency or liquidation proceedings under the laws of the United States or any State thereof. In addition, notwithstanding anything to the contrary contained in this Section 9.04, any SPC may (i) with notice to, but without the prior written consent of, the Borrower and the Administrative Agent and without paying any processing fee therefor, assign all or a portion of its interests in any Loans to the Granting Lender or to any financial institutions (consented to by the Borrower and Administrative Agent) providing liquidity and/or credit support to or for the account of such SPC to support the funding or maintenance of Loans and (ii) disclose on a confidential basis any non-public information relating to its Loans to any rating agency, commercial paper dealer or provider of any surety, guarantee or credit or liquidity enhancement to such SPC.

us\smolyju\8802494.13

(j) The Borrower shall not assign or delegate any of its rights or duties hereunder without the prior written consent of the Administrative Agent and each Lender, and any attempted assignment without such consent shall be null and void.

SECTION 9.05. Expenses; Indemnity. (a) The Borrower agrees to pay all out-of-pocket expenses incurred by the Administrative Agent in connection with the preparation and administration of this Agreement and the other Loan Documents or in connection with any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions hereby or thereby contemplated shall be consummated) or incurred by the Administrative Agent or any Lender in connection with the enforcement or protection of its rights in connection with this Agreement and the other Loan Documents or in connection with the Loans made hereunder, including the fees, charges and disbursements of Fried ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, counsel for the Administrative Agent, and, in connection with any such enforcement or protection, the fees, charges and disbursements of one local counsel for the Administrative Agent or any Lender in each appropriate jurisdiction.

(b) Except with respect to Taxes (other than Taxes that represent losses, claims, damages, etc. arising from any non-Tax claim), the Borrower agrees to indemnify the Administrative Agent, each Lender and each Related Party of any of the foregoing persons (each such person being called an “Indemnitee”) against, and to hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees, charges and disbursements, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (i) the execution or delivery of this Agreement or any other Loan Document or any agreement or instrument contemplated thereby, the performance by the parties thereto of their respective obligations thereunder or the consummation of the Transactions and the other transactions contemplated thereby, (ii) the use of the proceeds of the Loans, (iii) any claim, litigation, investigation or proceeding relating to any of the foregoing, whether or not any Indemnitee is a party thereto (and regardless of whether such matter is initiated by a third party or by the Borrower, any other Loan Party or any of their respective Affiliates), or (iv) any actual or alleged presence or Release of Hazardous Materials on any property currently or formerly owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or the Subsidiaries; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted primarily from the gross negligence or willful misconduct of such Indemnitee.

(c) To the extent that the Borrower fails to pay any amount required to be paid by it to the Administrative Agent under paragraph (a) or (b) of this Section 9.05, each Lender severally agrees to pay to the Administrative Agent such ▇▇▇▇▇▇’s Pro Rata Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent in its capacity as such.

us\smolyju\8802494.13

(d) To the extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or any agreement or instrument contemplated hereby, the Transactions, any Loan or the use of the proceeds thereof.

(e) The provisions of this Section 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent or any Lender. All amounts due under this Section 9.05 shall be payable on written demand therefor.

SECTION 9.06. Right of Setoff. If an Event of Default shall have occurred and be continuing, each Lender is hereby authorized at any time and from time to time, except to the extent prohibited by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by such Lender to or for the credit or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement and other Loan Documents held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement or such other Loan Document and although such obligations may be unmatured. The rights of each Lender under this Section 9.06 are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.

SECTION 9.07. Applicable Law. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (OTHER THAN AS EXPRESSLY SET FORTH IN OTHER LOAN DOCUMENTS) AND ALL CLAIMS AND CONTROVERSIES IN CONNECTION THEREWITH SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.

SECTION 9.08. Waivers; Amendment. (a) No failure or delay of the Administrative Agent, the Collateral Agent or any Lender in exercising any power or right hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent, the Collateral Agent and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or any other Loan Document or consent to any departure by the Borrower or any other Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) below, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on the Borrower in any case shall entitle the Borrower to any other or further notice or demand in similar or other circumstances.

us\smolyju\8802494.13

(b) Neither this Agreement nor any provision hereof nor any other Loan Document or any provision thereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Borrower and the Required Lenders; provided, however, that no such agreement shall (i) decrease the principal amount of, or extend the maturity of or any scheduled principal payment date or date for the payment of any interest on any Loan, or waive or excuse any such payment or any part thereof, or decrease the rate of interest on any Loan, without the prior written consent of each Lender directly adversely affected thereby, (ii) increase or extend the Commitment or decrease or extend the date for payment of any fees of any Lender without the prior written consent of such Lender, (iii) amend or modify the pro rata requirements, the provisions of Section 9.04(j) or the provisions of this Section 9.08 or release one or more Subsidiary Guarantors representing all or substantially all of the value of the Guarantees hereunder or all or substantially all of the Collateral, without the prior written consent of each Lender, (iv) modify the protections afforded to an SPC pursuant to the provisions of Section 9.04(i) without the written consent of such SPC or (v) reduce the percentage contained in the definition of the term “Required Lenders” without the prior written consent of each Lender (it being understood that with the consent of the Required Lenders, additional extensions of credit pursuant to this Agreement may be included in the determination of the Required Lenders on substantially the same basis as the Commitments on the date hereof); provided further that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent hereunder or under any other Loan Document without the prior written consent of the Administrative Agent.

(c) The Administrative Agent and the Borrower may amend any Loan Document to correct administrative or manifest errors or omissions, or to effect administrative changes that are not adverse to any Lender; provided, however, that no such amendment shall become effective until the fifth Business Day after it has been posted to the Lenders, and then only if the Required Lenders have not objected in writing thereto within such five Business Day period.

SECTION 9.09. Interest Rate Limitation. Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively the “Charges”), shall exceed the maximum lawful rate (the “Maximum Rate”) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of this Section 9.09 shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender.

SECTION 9.10. Entire Agreement. This Agreement and the other Loan Documents constitute the entire contract between the parties relative to the subject matter hereof. Any other previous agreement among the parties with respect to the subject matter hereof is superseded by this Agreement and the other Loan Documents. Nothing in this Agreement or in the other Loan Documents, expressed or implied, is intended to confer upon any person (other than the

us\smolyju\8802494.13

parties hereto and thereto, their respective successors and assigns permitted hereunder and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Collateral Agent and the Lenders) any rights, remedies, obligations or liabilities under or by reason of this Agreement or the other Loan Documents.

SECTION 9.11. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.11.

SECTION 9.12. Severability. In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not, in any way, be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

SECTION 9.13. Counterparts. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract, and shall become effective as provided in Section 9.03. Delivery of an executed signature page to this Agreement by facsimile or other customary means of electronic transmission (e.g., “pdf”) shall be as effective as delivery of a manually signed counterpart of this Agreement.

SECTION 9.14. Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.

SECTION 9.15. Jurisdiction; Consent to Service of Process. (a) The Borrower hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York

us\smolyju\8802494.13

State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that the Administrative Agent, the Collateral Agent or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or the other Loan Documents against the Borrower or its properties in the courts of any jurisdiction.

(b) The Borrower hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or the other Loan Documents in any New York State or Federal court. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.

(c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.

SECTION 9.16. Confidentiality. The Administrative Agent and each of the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its and its Affiliates’ officers, directors, employees and agents, including accountants, legal counsel and other advisors (it being understood that the persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent requested by any regulatory authority or quasi-regulatory authority (such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) in connection with the exercise of any remedies hereunder or under the other Loan Documents or any suit, action or proceeding relating to the enforcement of its rights hereunder or thereunder, (e) subject to an agreement containing provisions substantially the same as those of this Section 9.16, to (i) any actual or prospective assignee of or participant in any of its rights or obligations under this Agreement and the other Loan Documents, or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower or any Subsidiary or any of their respective obligations, (f) with the consent of the Borrower or (g) to the extent such Information becomes publicly available other than as a result of a breach of this Section 9.16. For the purposes of this Section 9.16, “Information” shall mean all information received from the Borrower or any Subsidiary and related to the Borrower or any Subsidiary, or their respective business, other than any such information that was available to the Administrative Agent or any Lender on a nonconfidential basis prior to its disclosure by the Borrower; provided that, in the case of Information received from the Borrower or any Subsidiary after the date hereof, such information is clearly identified at the time of delivery as confidential. Any person required to maintain the confidentiality of Information as provided in this Section 9.16 shall be considered to have complied with its obligation to do so if such person has exercised the same degree of care to maintain the confidentiality of such Information as such person would accord its own confidential information.

us\smolyju\8802494.13

SECTION 9.17. Lender Action. Each Lender agrees that it shall not take or institute any actions or proceedings, judicial or otherwise, for any right or remedy against any Loan Party or any other obligor under any of the Loan Documents (including the exercise of any right of setoff, rights on account of any banker’s lien or similar claim or other rights of self-help), or institute any actions or proceedings, or otherwise commence any remedial procedures, in each case with respect to any Collateral owned by such Loan Party, unless expressly provided for herein or in any other Loan Document, without the prior written consent of the Administrative Agent. The provisions of this Section 9.17 are for the sole benefit of the Lenders and shall not afford any right to, or constitute a defense available to, any Loan Party.

SECTION 9.18. USA PATRIOT Act Notice. Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the USA PATRIOT Act.

SECTION 9.19. Application of Proceeds. Upon receipt from the Collateral Agent of the proceeds of any collection, sale, foreclosure or other realization upon any Collateral, including any Collateral consisting of cash, following the exercise of remedies provided for in Article VII (or after the Loans have automatically become due and payable as set forth in Article VII), the Administrative Agent shall apply such proceeds as follows:

FIRST, to the payment of all costs and expenses incurred by the Administrative Agent (in its capacity as such hereunder or under any other Loan Document) in connection with such collection, sale, foreclosure or realization or otherwise in connection with this Agreement or any other Loan Document, including all court costs and the fees and expenses of its agents and legal counsel, the repayment of all advances made by the Administrative Agent hereunder or under any other Loan Document on behalf of any Loan Party and any other costs or expenses incurred in connection with the exercise of any right or remedy hereunder or under any other Loan Document;

SECOND, to the payment in full of all other Obligations (the amounts so applied to be distributed among the Secured Parties pro rata in accordance with the amounts of the Obligations owed to them on the date of any such distribution).

The Administrative Agent shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Agreement.

us\smolyju\8802494.13

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.



ROTECH HEALTHCARE INC.,
By:
	/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
	Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
	Title: President and Chief Executive Officer

[Signature Page to Credit Agreement]

us\smolyju\8802494.13



SILVER POINT FINANCE, LLC, as Administrative Agent,
By:
	/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
	Name: ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
	Title: Authorized Signatory

[Signature Page to Credit Agreement]

us\smolyju\8802494.13

LENDER SIGNATURE PAGE



LENDER: SPCP GROUP, LLC
By:
	/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
	Name: ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
	Title: Authorized Signatory

[Signature Page to Credit Agreement]

us\smolyju\8802494.13

EXECUTION VERSION

SCHEDULE 1.01(a)

TO CREDIT AGREEMENT

Subsidiary Guarantors

A-1 Medical Equipment, Inc.

Abba Medical Equipment, Inc.

Acadia Home Care

Allied Medical Supply, Inc.

Always Medical Equipment, Inc.

▇▇▇▇ ▇▇▇▇’▇ InHome Medical, Inc., West

▇▇▇▇ ▇▇▇▇’▇ InHome Medical/InHome Medical Inc.

Anniston Health & Sickroom Supplies, Inc.

Berkeley Medical Equipment, Inc.

Best Care HHC Acquisition Company LLC

Beta Medical Equipment, Inc.

Cambria Medical Supply, Inc.

Camden Medical Supply, Inc.

Care Medical Supplies, Inc.

Centennial Medical Equipment, Inc.

Charlotte Medical Supply, Inc.

▇▇▇▇▇▇▇ Rentals, Inc.

Community Home Oxygen, Inc.

Contour Medical Supply, Inc.

▇▇▇▇▇▇ Home Health Care, Inc.

CPO 2, Inc.

▇▇▇▇▇▇ Medical Systems, Inc.

Distinct Home Health Care, Inc.

▇▇▇ ▇▇▇▇ Respiratory Services, Inc.

DuMEd, Inc.

East Tennessee Infusion & Respiratory, Inc.

▇▇▇▇▇ County Home Medical Equipment, LLC

Encore Home Health Care, Inc.

Excel Medical of Fort Dodge, Inc.

Excel Medical of Marshalltown, Inc.

First Community Care of Niagara, Inc.

Firstcare, Inc.

▇▇▇▇▇▇▇ Medical Equipment, Inc.

Four Rivers Home Health Care, Inc.

G&G Medical, Inc.

Gate City Medical Equipment, Inc.

Georgia Medical Resources, Inc.

Gladwin Area Home Care, Inc.

▇▇▇▇▇▇▇▇ Medical Equipment Service, Inc.

Health Care Services of Mississippi, Incorporated

Holland Medical Services, Inc.

EXECUTION VERSION

Home Care Oxygen Service, Inc.

Home Medical Systems, Inc.

IHS Acquisition XXVII, Inc.

Integrated Health Services at Jefferson Hospital, Inc.

Intensive Home Care Services, Inc.

IOTA Medical Equipment, Inc.

LAMBDA Medical Equipment, Inc.

LAMS, Inc.

▇▇▇▇▇▇▇ Medical, Inc.

Major Medical Supply, Inc.

Medco Professional Services, Corp.

MedCorp International, Inc.

Medic-Aire Medical Equipment, Inc.

Medical Electro-Therapeutics, Inc.

Medicare Rental Supply, Inc.

Michigan Medical Supply, Inc.

National Medical Equipment Centers, Inc.

NeighborCare Home Medical Equipment, LLC

NeighborCare Home Medical Equipment of Maryland, LLC

Neumann’s Home Medical Equipment, Inc.

Nightingale Home Health Care, Inc.

North Central Washington Respiratory Care Services, Inc.

Northeast Medical Equipment, Inc.

Northwest Home Medical, Inc.

OMICRON Medical Equipment, Inc.

Oxygen of Oklahoma, Inc.

Oxygen Plus Medical Equipment, Inc.

Oxygen Plus, Inc.

Oxygen Therapy Associates, Inc.

▇▇▇▇▇▇▇▇’▇ Home Care, Inc.

PHI Medical Equipment, Inc.

Pioneer Medical Services, Inc.

Preferential Home Health Care, Inc.

Principal Medical Equipment, Inc.

Professional Breathing Associates, Inc.

Professional Respiratory Home Healthcare, Inc.

PSI Health Care, Inc.

Pulmo-Dose, Inc.

Qualicare Home Medical, Inc.

Quality Home Health Care, Inc.

R.C.P.S., Inc.

RCG Information Services Corporation

Regency Medical Equipment, Inc.

Resp-A-Care, Inc.

Respiracare Medical Equipment, Inc.

Respiratory Medical Equipment of Ga., Inc.

EXECUTION VERSION

Respitech Home Health Care, Inc.

Responsive Home Health Care, Inc.

Rhema, Inc.

▇▇▇▇ Medical Group, Inc.

RN Home Care Medical Equipment Company, Inc.

Roswell Home Medical, Inc.

Rotech Employee Benefits Corporation

Rotech Home Medical Care, Inc.

RoTech Oxygen and Medical Equipment, Inc.

▇▇▇▇ Medical, Inc.

▇▇▇▇▇▇▇’▇ Hospital Equipment, Inc.

▇▇▇▇▇▇▇ Convalescent Medical Supply, Inc.

Select Home Health Care, Inc.

SIGMA Medical Equipment, Inc.

Southeastern Home Health, Inc.

Sun Medical Supply, Inc.

Sunshine Home Health Care, Inc.

The ▇▇▇▇▇▇ Company

Theta Home Health Care, Inc.

Tupelo Home Health, Inc.

Valley Medical Equipment, Inc.

Value Care, Inc.

VitalCare Health Services, Inc.

VitalCare of Texas, Inc.

White's Medical Rentals, Inc.

Wichita Medical Care, Inc.

Zeta Home Health Care, Inc.

EXECUTION VERSION

SCHEDULE 2.01

TO CREDIT AGREEMENT

Lenders and Commitments

Closing Date Term Loan Lender: SPCP Group, LLC - $23,500,000

Delayed Draw Term Loan Lender: SPCP Group, LLC - $1,500,000

Closing Date Term Loan Lender Notice:

▇▇▇ ▇▇▇▇▇

Senior Analyst

Silver Point Capital LP

Fax: (▇▇▇) ▇▇▇-▇▇▇▇

E-mail: ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇

Delayed Draw Term Loan Lender Notice:

▇▇▇ ▇▇▇▇▇

Senior Analyst

Silver Point Capital LP

Fax: (▇▇▇) ▇▇▇-▇▇▇▇

E-mail: ▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇

EXECUTION VERSION

SCHEDULE 3.08

TO CREDIT AGREEMENT

Restricted Subsidiaries

Rotech Healthcare Inc. holds 100% ownership interest for the Restricted Subsidiaries listed below.




ISSUER	CLASS OF	STOCK	NO. OF
ISSUER	STOCK	CERT #	SHARES
A-1 Medical Equipment, Inc.	***	***	***
Abba Medical Equipment, Inc.	***	***	***
Acadia Home Care	***	***	***
Allied Medical Supply, Inc.	***	***	***
Always Medical Equipment, Inc.	***	***	***
▇▇▇▇ ▇▇▇▇’▇ InHome Medical, Inc., West	***	***	***
▇▇▇▇ ▇▇▇▇’▇ InHome Medical/InHome Medical Inc.	***	***	***
Anniston Health & Sickroom Supplies, Inc.	***	***	***
Berkeley Medical Equipment, Inc.	***	***	***
Best Care HHC Acquisition Company LLC	***	***	***
Beta Medical Equipment, Inc.	***	***	***
Cambria Medical Supply, Inc.	***	***	***
Camden Medical Supply, Inc.	***	***	***
Care Medical Supplies, Inc.	***	***	***
Centennial Medical Equipment, Inc.	***	***	***
Charlotte Medical Supply, Inc.	***	***	***
▇▇▇▇▇▇▇ Rentals, Inc.	***	***	***
Community Home Oxygen, Inc.	***	***	***
Contour Medical Supply, Inc.	***	***	***
▇▇▇▇▇▇ Home Health Care, Inc.	***	***	***
CPO 2, Inc.	***	***	***
▇▇▇▇▇▇ Medical Systems, Inc.	***	***	***
Distinct Home Health Care, Inc.	***	***	***
▇▇▇ ▇▇▇▇ Respiratory Services, Inc.	***	***	***
DuMEd, Inc.	***	***	***
East Tennessee Infusion & Respiratory, Inc.	***	***	***
▇▇▇▇▇ County Home Medical Equipment, LLC	***	***	***
Encore Home Health Care, Inc.	***	***	***
Excel Medical of Fort Dodge, Inc.	***	***	***
Excel Medical of Marshalltown, Inc.	***	***	***
First Community Care of Niagara, Inc.	***	***	***
Firstcare, Inc.	***	***	***
▇▇▇▇▇▇▇ Medical Equipment, Inc.	***	***	***

EXECUTION VERSION



Four Rivers Home Health Care, Inc.	Common	***	***
G&G Medical, Inc.	***	***	***
Gate City Medical Equipment, Inc.	***	***	***
Georgia Medical Resources, Inc.	***	***	***
Gladwin Area Home Care, Inc.	***	***	***
▇▇▇▇▇▇▇▇ Medical Equipment Service, Inc.	***	***	***
Health Care Services of Mississippi, Incorporated	***	***	***
Holland Medical Services, Inc.	***	***	***
Home Care Oxygen Service, Inc.	***	***	***
Home Medical Systems, Inc.	***	***	***
IHS Acquisition XXVII, Inc.	***	***	***
Integrated Health Services at Jefferson Hospital, Inc.	***	***	***
Intensive Home Care Services, Inc.	***	***	***
IOTA Medical Equipment, Inc.	***	***	***
LAMBDA Medical Equipment, Inc.	***	***	***
LAMS, Inc.	***	***	***
▇▇▇▇▇▇▇ Medical, Inc.	***	***	***
Major Medical Supply, Inc.	***	***	***
Medco Professional Services, Corp.	***	***	***
MedCorp International, Inc.	***	***	***
Medic-Aire Medical Equipment, Inc.	***	***	***
Medical Electro-Therapeutics, Inc.	***	***	***
Medicare Rental Supply, Inc.	***	***	***
Michigan Medical Supply, Inc.	***	***	***
National Medical Equipment Centers, Inc.	***	***	***
NeighborCare Home Medical Equipment, LLC	***	***	***
NeighborCare Home Medical Equipment of Maryland, LLC	***	***	***
▇▇▇▇▇▇▇’▇ Home Medical Equipment, Inc.	***	***	***
Nightingale Home Health Care, Inc.	***	***	***
North Central Washington Respiratory Care Services, Inc.	***	***	***
Northeast Medical Equipment, Inc.	***	***	***
Northwest Home Medical, Inc.	***	***	***
OMICRON Medical Equipment, Inc.	***	***	***
Oxygen of Oklahoma, Inc.	***	***	***
Oxygen Plus, Inc.	***	***	***
Oxygen Plus Medical Equipment, Inc.	***	***	***
Oxygen Therapy Associates, Inc.	***	***	***
▇▇▇▇▇▇▇▇’▇ Home Care, Inc.	***	***	***
PHI Medical Equipment, Inc.	***	***	***
Pioneer Medical Services, Inc.	***	***	***
Preferential Home Health Care, Inc.	***	***	***
Principal Medical Equipment, Inc.	***	***	***
Professional Breathing Associates, Inc.	***	***	***
Professional Breathing Associates, Inc.	***	***	***
Professional Respiratory Home Healthcare, Inc.	***	***	***

EXECUTION VERSION



PSI Health Care, Inc.	***	***	***
Pulmo-Dose, Inc.	***	***	***
Qualicare Home Medical, Inc.	***	***	***
Quality Home Health Care, Inc.	***	***	***
R.C.P.S., Inc.	***	***	***
RCG Information Services Corporation	***	***	***
Regency Medical Equipment, Inc.	***	***	***
Resp-A-Care, Inc.	***	***	***
Respiracare Medical Equipment, Inc.	***	***	***
Respiratory Medical Equipment of Ga., Inc.	***	***	***
Respitech Home Health Care, Inc.	***	***	***
Responsive Home Health Care, Inc.	***	***	***
Rhema, Inc.	***	***	***
▇▇▇▇ Medical Group, Inc.	***	***	***
RN Home Care Medical Equipment Company, Inc.	***	***	***
Roswell Home Medical, Inc.	***	***	***
Rotech Employee Benefits Corporation	***	***	***
Rotech Home Medical Care, Inc.	***	***	***
RoTech Oxygen and Medical Equipment, Inc.	***	***	***
▇▇▇▇ Medical, Inc.	***	***	***
▇▇▇▇▇▇▇’▇ Hospital Equipment, Inc.	***	***	***
▇▇▇▇▇▇▇ Convalescent Medical Supply, Inc.	***	***	***
Select Home Health Care, Inc.	***	***	***
SIGMA Medical Equipment, Inc.	***	***	***
Southeastern Home Health, Inc.	***	***	***
Sun Medical Supply, Inc.	***	***	***
Sunshine Home Health Care, Inc.	***	***	***
The ▇▇▇▇▇▇ Company	***	***	***
Theta Home Health Care, Inc.	***	***	***
Tupelo Home Health, Inc.	***	***	***
Valley Medical Equipment, Inc.	***	***	***
Value Care, Inc.	***	***	***
VitalCare Health Services, Inc.	***	***	***
VitalCare of Texas, Inc.	***	***	***
White’s Medical Rentals, Inc.	***	***	***
Wichita Medical Care, Inc.	***	***	***
Zeta Home Health Care, Inc.	***	***	***

*** Certain information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

EXECUTION VERSION

SCHEDULE 3.09

TO CREDIT AGREEMENT

Litigation

None.

EXECUTION VERSION

SCHEDULE 3.17

TO CREDIT AGREEMENT

Environmental Matters

None.

EXECUTION VERSION

SCHEDULE 3.18

TO CREDIT AGREEMENT

Insurance



Policy Type	Coverage Notes	Carrier	Policy Period	Policy #	Limits
Management Liability
Directors & Officers	***	Travelers Casualty and Surety Co. of America	***	***	***
	***	Continental Casualty Company (C.N.A)	***	***	***
	***	Axis Insurance Company	***	***	***
	***	ACE American Ins. Company	***	***	***
	***	Illinois National Insurance Company (Chartis)	***	***	***
	***	XL Specialty Ins. Co.	***	***	***
	***	Aspen	***	***	***
Employment Practices	***	Axis Insurance Company	***	***	***
	***	Axis Specialty Limited - New this year	***	***	***
Employed Lawyers	***	Illinois National Insurance Company (Chartis)	***	***	***

EXECUTION VERSION



Fiduciary Liability	***	Travelers Casualty and Surety Co. of America	***	***	***
Crime	***	Zurich American Ins Co	***	***	***
Special Crime	***	HCC Specialty - US Specialty Insurance Company	***	***	***
Property
Property-Primary ▇▇▇▇.▇▇	***	Great Northern Ins. Co. (Chubb)	***	***	***
Primary Casualty
Retention Clash Coverage	***	Illinois Union Insurance Company (ACE)	***	***	***
Workers Compensation / Employers Liability		Ace American Insurance. Co.	***	***	***
Automobile Liability		Ace American Insurance. Co.	***	***	***
ESIS Charges-Casualty		ESIS	***		***
General Liability / Professional Liability	***	Columbia Casualty Company (CNA)	***	***	***
Excess Liability
Umbrella Liability (EL/AL/GL/PL)	***	Columbia Casualty Company (CNA)	***	***	***

EXECUTION VERSION



Excess Liability (EL/AL/GL/PL)	***	Homeland Insurance Company of New York (One Beacon)	***	***	***
Excess Liability	***	Ironshore	***	***	***

***Certain information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

EXECUTION VERSION

SCHEDULE 3.19(a)

TO CREDIT AGREEMENT

UCC Filing Offices



Guarantor Name	Filing Office
A-1 Medical Equipment, Inc.	Florida, Secured Transaction Registry
Abba Medical Equipment, Inc.	Florida, Secured Transaction Registry
Acadia Home Care	Maine, Secretary of State
Allied Medical Supply, Inc.	Arizona, Secretary of State
Always Medical Equipment, Inc.	Florida, Secured Transaction Registry
▇▇▇▇ ▇▇▇▇'▇ InHome Medical, Inc., West	West Virginia, Secretary of State
▇▇▇▇ ▇▇▇▇'▇ InHome Medical/InHome Medical Inc.	West Virginia, Secretary of State
Anniston Health & Sickroom Supplies, Inc.	Alabama, Secretary of State
Best Care HHC Acquisition Company LLC	Delaware, Department of State
Berkeley Medical Equipment, Inc.	Florida, Secured Transaction Registry
Beta Medical Equipment, Inc.	Florida, Secured Transaction Registry
Cambria Medical Supply, Inc.	Florida, Secured Transaction Registry
Camden Medical Supply, Inc.	Florida, Secured Transaction Registry
Care Medical Supplies, Inc.	Illinois, Secretary of State
Centennial Medical Equipment, Inc.	Florida, Secured Transaction Registry
Charlotte Medical Supply, Inc.	Florida, Secured Transaction Registry
▇▇▇▇▇▇▇ Rentals, Inc.	Missouri, Secretary of State
Community Home Oxygen, Inc.	Montana, Secretary of State
Contour Medical Supply, Inc.	Florida, Secured Transaction Registry
▇▇▇▇▇▇ Home Health Care, Inc.	Georgia, ▇▇▇▇▇▇▇ County Clerk of Superior Court
CPO 2, Inc.	Pennsylvania, Department of State
▇▇▇▇▇▇ Medical Systems, Inc.	Oklahoma, County Clerk's Office
Distinct Home Health Care, Inc.	Florida, Secured Transaction Registry
▇▇▇ ▇▇▇▇ Respiratory Services, Inc.	Colorado, Secretary of State
DuMEd, Inc.	Iowa, Secretary of State
East Tennessee Infusion & Respiratory, Inc.	Florida, Secured Transaction Registry
▇▇▇▇▇ County Home Medical Equipment, LLC	Texas, Secretary of State
Encore Home Health Care, Inc.	Florida, Secured Transaction Registry
Excel Medical of Fort Dodge, Inc.	Iowa, Secretary of State
Excel Medical of Marshalltown, Inc.	Iowa, Secretary of State
First Community Care of Niagara, Inc.	New York, Department of State
Firstcare, Inc.	Kansas, Secretary of State
▇▇▇▇▇▇▇ Medical Equipment, Inc.	Idaho, Secretary of State
Four Rivers Home Health Care, Inc.	Missouri, Secretary of State
G&G Medical, Inc.	Colorado, Secretary of State
Gate City Medical Equipment, Inc.	Florida, Secured Transaction Registry
Georgia Medical Resources, Inc.	Georgia, ▇▇▇▇▇▇▇ County Clerk of Superior Court
Gladwin Area Home Care, Inc.	Michigan, Department of State
▇▇▇▇▇▇▇▇ Medical Equipment Service, Inc.	Iowa, Secretary of State

EXECUTION VERSION



Health Care Services of Mississippi, Incorporated	Florida, Secured Transaction Registry
Holland Medical Services, Inc.	Florida, Secured Transaction Registry
Home Care Oxygen Service, Inc.	Minnesota, Secretary of State
Home Medical Systems, Inc.	South Carolina, Secretary of State
IHS Acquisition XXVII, Inc.	Delaware, Department of State
Integrated Health Services at Jefferson Hospital, Inc.	Delaware, Department of State
Intensive Home Care Services, Inc.	Texas, Secretary of State
IOTA Medical Equipment, Inc.	Florida, Secured Transaction Registry
LAMBDA Medical Equipment, Inc.	Florida, Secured Transaction Registry
LAMS, Inc.	Texas, Secretary of State
▇▇▇▇▇▇▇ Medical, Inc.	Kentucky, Secretary of State
Major Medical Supply, Inc.	Texas, Secretary of State
Medco Professional Services, Corp.	Colorado, Secretary of State
MedCorp International, Inc.	Arizona, Secretary of State
Medic-Aire Medical Equipment, Inc.	Florida, Secured Transaction Registry
Medical Electro-Therapeutics, Inc.	Florida, Secured Transaction Registry
Medicare Rental Supply, Inc.	West Virginia, Secretary of State
Michigan Medical Supply, Inc.	Michigan, Department of State
National Medical Equipment Centers, Inc.	Florida, Secured Transaction Registry
NeighborCare Home Medical Equipment, LLC	Pennsylvania, Department of State
NeighborCare Home Medical Equipment of Maryland, LLC	Maryland, Department of Assessments & Taxation
▇▇▇▇▇▇▇'▇ Home Medical Equipment, Inc.	Illinois, Secretary of State
Nightingale Home Health Care, Inc.	Florida, Secured Transaction Registry
North Central Washington Respiratory Care Services, Inc.	Washington, Department of Licensing
Northeast Medical Equipment, Inc.	Florida, Secured Transaction Registry
Northwest Home Medical, Inc.	Idaho, Secretary of State
OMICRON Medical Equipment, Inc.	Florida, Secured Transaction Registry
Oxygen of Oklahoma, Inc.	Oklahoma, County Clerk's Office
Oxygen Plus Medical Equipment, Inc.	Florida, Secured Transaction Registry
Oxygen Plus, Inc.	Colorado, Secretary of State
Oxygen Therapy Associates, Inc.	Texas, Secretary of State
▇▇▇▇▇▇▇▇'▇ Home Care, Inc.	California, Secretary of State
PHI Medical Equipment, Inc.	Florida, Secured Transaction Registry
Pioneer Medical Services, Inc.	West Virginia, Secretary of State
Preferential Home Health Care, Inc.	Florida, Secured Transaction Registry
Principal Medical Equipment, Inc.	Florida, Secured Transaction Registry
Professional Breathing Associates, Inc.	Michigan, Department of State
Professional Respiratory Home Healthcare, Inc.	Florida, Secured Transaction Registry
PSI Health Care, Inc.	South Dakota, Secretary of State
Pulmo-Dose, Inc.	Florida, Secured Transaction Registry
Qualicare Home Medical, Inc.	Pennsylvania, Department of State
Quality Home Health Care, Inc.	Florida, Secured Transaction Registry
R.C.P.S., Inc.	California, Secretary of State
RCG Information Services Corporation	Florida, Secured Transaction Registry
Regency Medical Equipment, Inc.	Florida, Secured Transaction Registry
Resp-A-Care, Inc.	Kentucky, Secretary of State

EXECUTION VERSION



Respiracare Medical Equipment, Inc.	Florida, Secured Transaction Registry
Respiratory Medical Equipment of Ga., Inc.	Florida, Secured Transaction Registry
Respitech Home Health Care, Inc.	Wyoming, Secretary of State
Responsive Home Health Care, Inc.	Florida, Secured Transaction Registry
Rhema, Inc.	Texas, Secretary of State
▇▇▇▇ Medical Group, Inc.	Arizona, Secretary of State
RN Home Care Medical Equipment Company, Inc.	Florida, Secured Transaction Registry
Roswell Home Medical, Inc.	Florida, Secured Transaction Registry
Rotech Employee Benefits Corporation	Florida, Secured Transaction Registry
Rotech Healthcare Inc.	Delaware, Department of State
Rotech Home Medical Care, Inc.	Florida, Secured Transaction Registry
RoTech Oxygen and Medical Equipment, Inc.	Florida, Secured Transaction Registry
▇▇▇▇ Medical, Inc.	Colorado, Secretary of State
▇▇▇▇▇▇▇'▇ Hospital Equipment, Inc.	Kentucky, Secretary of State
▇▇▇▇▇▇▇ Convalescent Medical Supply, Inc.	North Carolina, Secretary of State
Select Home Health Care, Inc.	Florida, Secured Transaction Registry
SIGMA Medical Equipment, Inc.	Florida, Secured Transaction Registry
Southeastern Home Health, Inc.	Florida, Secured Transaction Registry
Sun Medical Supply, Inc.	North Carolina, Secretary of State
Sunshine Home Health Care, Inc.	Florida, Secured Transaction Registry
The ▇▇▇▇▇▇ Company	North Carolina, Secretary of State
Theta Home Health Care, Inc.	Florida, Secured Transaction Registry
Tupelo Home Health, Inc.	Florida, Secured Transaction Registry
Valley Medical Equipment, Inc.	Utah, Department of Commerce
Value Care, Inc.	Florida, Secured Transaction Registry
VitalCare Health Services, Inc.	Florida, Secured Transaction Registry
VitalCare of Texas, Inc.	Texas, Secretary of State
White's Medical Rentals, Inc.	South Carolina, Secretary of State
Wichita Medical Care, Inc.	Kansas, Secretary of State
Zeta Home Health Care, Inc.	Florida, Secured Transaction Registry



Guarantor Name	Filing Office
Rotech Healthcare Inc.	United States Patent and Trademark Office

EXECUTION VERSION

SCHEDULE 3.20

TO CREDIT AGREEMENT

Leased Real Property



Legal Entity Name	Address 1	City	County	State	Zip
A-1 MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ABBA MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇., #▇	▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ACADIA HOME CARE	▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇
ACADIA HOME CARE	▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇
ACADIA HOME CARE	▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇
ALLIED MEDICAL SUPPLY, INC.	▇▇▇ & ▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇.	▇▇▇▇▇▇▇	▇▇▇▇▇▇	AZ	86047
ALWAYS MEDICAL EQUIPMENT, INC.	▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ALWAYS MEDICAL EQUIPMENT, INC.	▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ALWAYS MEDICAL EQUIPMENT, INC.	▇▇▇ ▇ ▇▇▇▇ ▇▇, ▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇ ▇▇▇▇'▇ INHOME MEDICAL, INC., WEST	▇▇ ▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇ ▇▇▇▇'▇ INHOME MEDICAL/INHOME MEDICAL INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
ANNISTON HEALTH & SICKROOM SUPPLIES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ANNISTON HEALTH & SICKROOM SUPPLIES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	AL	36274
BERKELEY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇ ▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
BERKELEY MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇.	▇▇▇▇▇▇	▇▇▇▇▇▇	KS	67114
BERKELEY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇., ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
BERKELEY MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇.	▇▇▇▇▇▇▇	▇▇▇▇▇	KS	67880
BETA MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMBRIA MEDICAL SUPPLY, INC.	▇▇▇-▇▇▇ ▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMBRIA MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMBRIA MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇.	ERIE	ERIE	PA	16509
CAMBRIA MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMBRIA MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇/▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	2104 HARKRIDER STE 109	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	AR	72032
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇▇	▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



CAMDEN MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇▇ ▇▇.	MAGNOLIA	COLUMBIA	AR	71753
CAMDEN MEDICAL SUPPLY, INC.	14 ▇▇▇▇▇▇▇ CIRCLE	MAYFLOWER	MAYFLOWER	AR	72106
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇ ▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇ ▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	AR	72455
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	212-▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇-▇ ▇▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇ ▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇/▇▇▇▇▇▇▇	OK	73080
CAMDEN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇ ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
CARE MEDICAL SUPPLIES, INC.	▇▇▇▇ ▇. ▇▇▇▇ ▇▇., ▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇. CLAIR	IL	62223
CARE MEDICAL SUPPLIES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇	▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CARE MEDICAL SUPPLIES, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
CARE MEDICAL SUPPLIES, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
CENTENNIAL MEDICAL EQUIPMENT, INC	▇▇▇ ▇. ▇▇▇▇▇ ▇▇. STE F	CENTRAL POINT	▇▇▇▇▇▇▇	OR	97502
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇ ▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇.	PASADENA	LOS ANGELES	CA	91103
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇.	SANTA ▇▇▇▇	SONOMA	CA	95403
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇ ▇▇▇.	▇▇▇▇▇▇	▇▇▇▇	OR	97402
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ ▇	▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CENTENNIAL MEDICAL EQUIPMENT, INC.	▇▇▇▇-▇▇▇▇ ▇▇▇^▇▇ ▇▇▇▇▇▇. NE	REDMOND	▇▇▇▇	WA	98052
CHARLOTTE MEDICAL SUPPLY, INC.	▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ RENTALS, INC.	▇▇▇▇ ▇ ▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇. NORTH	BILLINGS	YELLOWSTONE	MT	59101
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇., ▇▇▇▇ ▇.	BOZEMAN	GALLATIN	MT	59715
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇. STE 1	BUTTE	SILVER BOW	MT	59701
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇. ▇^▇▇ ▇▇▇▇▇▇.	▇▇▇▇▇▇	BIG ▇▇▇▇	MT	59034
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇^▇▇ ▇▇▇▇▇▇ ▇	▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇ AND ▇▇▇▇▇	MT	59601
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇ ▇▇▇▇▇ ▇^▇▇	▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇/▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇. ▇▇▇▇▇ ▇▇▇., ▇▇▇. A	RIVERTON	FREMONT	WY	82501
COMMUNITY HOME OXYGEN, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇. UNIT F	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	WY	82801
COMMUNITY HOME OXYGEN, INC.	▇▇▇ ▇. ▇▇▇ ▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CONTOUR MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇, ▇▇▇. 5A	LEDGEWOOD	MIDDLESEX	NJ	7852
CONTOUR MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	PA	18974
▇▇▇▇▇▇ HOME HEALTH CARE, INC.	▇▇▇-▇▇▇ ▇▇▇▇▇▇ ▇▇.	LAGRANGE	▇▇▇▇▇	GA	30240
CPO 2, INC.	▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇.	BERWICK	COLUMBIA	PA	18603
CPO 2, INC.	▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇	CHAMBERSBURG	FRANKLIN	PA	17201
CPO 2, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇.	CLARKS SUMMIT	LACKAWANNA	PA	18411
CPO 2, INC.	▇▇▇▇ ▇ ▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
CPO 2, INC.	260 GRANITE RUN ▇▇.	▇▇▇▇▇▇▇▇▇	LANCASTER	PA	17601
CPO 2, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇.	MECHANICSBURG	CUMBERLAND	PA	17055
CPO 2, INC.	150, 200, & ▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
CPO 2, INC.	2880 POTTSVILLE-MINERSVILLE HWY#100	MINERSVILLE	SCHUYLKILL	PA	17954
CPO 2, INC.	▇▇ ▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
CPO 2, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇., ▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇ MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇	NATCHITOCHES	NATCHITOCHES	LA	71457
DISTINCT HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇. STE 101	SOUTHAVEN	DESOTO	MS	38671
DISTINCT HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇.	LONGVIEW	▇▇▇▇▇	TX	75605
DISTINCT HOME HEALTH CARE, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



DISTINCT HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇ ▇▇▇▇ RESPIRATORY SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇ ▇▇▇▇ RESPIRATORY SERVICES, INC.	▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇.	FT. ▇▇▇▇▇▇	▇▇▇▇▇▇	CO	80701
▇▇▇ ▇▇▇▇ RESPIRATORY SERVICES, INC.	▇▇▇ ▇▇^▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
DUMED, INC.	▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
EAST TENNESSEE INFUSION & RESPIRATORY, INC.	▇▇▇ ▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇ COUNTY HOME MEDICAL EQUIPMENT, LLC	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
ENCORE HOME HEALTH CARE, INC.	▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇	▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
ENCORE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇ ▇▇.	SIKESTON	▇▇▇▇▇	MO	63801
EXCEL MEDICAL OF FORT DODGE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇	▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
EXCEL MEDICAL OF MARSHALLTOWN, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
FIRST COMMUNITY CARE OF NIAGARA, INC.	▇▇ ▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇
FIRST COMMUNITY CARE OF NIAGARA, INC.	26 TOWER OFFICE PARK	WOBURN	HAMOEN	MA	1801
FIRSTCARE, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
FIRSTCARE, INC.	▇▇▇ ▇. ▇▇▇▇	▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
FIRSTCARE, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
FOUR RIVERS HOME HEALTH CARE, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇, ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
FOUR RIVERS HOME HEALTH CARE, INC.	▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇.	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	MO	63080
G&G MEDICAL, INC.	▇▇ ▇ ▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
G&G MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
G&G MEDICAL, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇. STE 1	DURANGO	LA PLATA	CO	81301
G&G MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
G&G MEDICAL, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇.	GRAND JUNCTION	MESA	CO	81501
G&G MEDICAL, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
GATE CITY MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇ ▇▇▇▇▇▇	▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
GATE CITY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
GEORGIA MEDICAL RESOURCES INC.	▇▇▇ ▇▇▇▇ ▇▇, ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
GLADWIN AREA HOME CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇/▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇ MEDICAL EQUIPMENT SERVICE, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇ MEDICAL EQUIPMENT SERVICE, INC.	▇▇▇ ▇ ▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇ MEDICAL EQUIPMENT SERVICE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇	▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇ MEDICAL EQUIPMENT SERVICE, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇ MEDICAL EQUIPMENT SERVICE, INC.	▇▇▇ ▇. ▇▇▇▇▇ ▇▇.	FAIRMONT	▇▇▇▇▇▇	MN	56031

EXECUTION VERSION



HEALTH CARE SERVICES OF MISSISSIPPI, INCORPORATED	▇▇▇-▇ ▇. ▇▇▇▇▇ ▇▇▇.	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	MS	38732
HEALTH CARE SERVICES OF MISSISSIPPI, INCORPORATED	▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇/▇▇▇▇▇	▇▇	▇▇▇▇▇
HOLLAND MEDICAL SERVICES, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ▇▇.	MARION	WILLIAMSON	IL	62959
HOLLAND MEDICAL SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇.	MADISONVILLE	▇▇▇▇▇▇▇	KY	42431
HOLLAND MEDICAL SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇.	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	KY	48064
HOLLAND MEDICAL SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOLLAND MEDICAL SERVICES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME CARE OXYGEN SERVICE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇., ▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
HOME CARE OXYGEN SERVICE, INC	▇▇▇ ▇▇▇▇ ▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇. LOUIS	MN	55805
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇. ▇,▇ & ▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇ ▇▇ ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇ ▇▇, ▇▇▇▇ ▇,▇ & F	▇▇▇▇▇▇	▇▇▇▇▇▇▇	GA	30143
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇ ▇▇▇ ▇▇▇▇▇▇	▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ & ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇-▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇. #▇▇▇	▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇ ▇. ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇, ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇. STE 6A	MOORESVILLE	IRDELL	NC	28117
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
HOME MEDICAL SYSTEMS, INC.	11692 BYPASS 17	MURRELLS INLET	HORRY	SC	29576
IHS ACQUISITION XXVII, INC.	▇▇▇ ▇ ▇▇▇▇▇▇▇ ▇▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



IHS ACQUISITION XXVII, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
IHS ACQUISITION XXVII, INC.	▇▇▇▇ ▇▇▇ ▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
INTEGRATED HEALTH SERVICES AT JEFFERSON HOSPITAL, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇.	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	NM	88310
INTENSIVE HOME CARE SERVICES, INC.	▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇	▇▇ ▇▇▇▇	▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
IOTA MEDICAL EQUIPMENT, INC.	▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
IOTA MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
LAMBDA MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇ ▇▇.	READING	BERKS	PA	19605
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇/▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇ & ▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇ MEDICAL, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MAJOR MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇ ▇▇▇	▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
MAJOR MEDICAL SUPPLY, INC.	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDCO PROFESSIONAL SERVICES, CORP.	▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDCO PROFESSIONAL SERVICES, CORP.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDCORP INTERNATIONAL, INC.	▇▇▇▇ ▇. ▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDIC-AIRE MEDICAL EQUIPMENT, INC.	▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDIC-AIRE MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇ ▇	▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDIC-AIRE MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇	▇. ▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇.	MURFREESBORO	▇▇▇▇▇▇▇▇▇▇	TN	37129
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇ ▇▇▇▇▇▇▇ ▇▇.	CROSSVILLE	CUMBERLAND	TN	38555
MEDICAL ELECTRO-THERAPEUTICS, INC.	▇▇▇ ▇ ▇▇▇▇▇ ▇▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MEDICARE RENTAL SUPPLY, INC.	▇▇▇▇ ▇▇▇ ▇▇▇▇▇ ▇▇. SOUTH, STE A	ELKVIEW	KANAWHA	WV	25071
MICHIGAN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇. NE, STE. A	▇▇▇▇▇▇▇	▇▇▇▇	MI	49306
MICHIGAN MEDICAL SUPPLY, INC.	▇▇ ▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
MICHIGAN MEDICAL SUPPLY, INC.	▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇ ▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NATIONAL MEDICAL EQUIPMENT CENTERS, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NATIONAL MEDICAL EQUIPMENT CENTERS, INC.	▇▇▇▇ ▇▇▇-▇-▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



NEIGHBORCARE HOME MEDICAL EQUIPMENT, LLC	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇., ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NEIGHBORCARE HOME MEDICAL EQUIPMENT, LLC	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇., ▇▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NEIGHBORCARE HOME MEDICAL EQUIPMENT OF MARYLAND, LLC	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NEIGHBORCARE HOME MEDICAL EQUIPMENT OF MARYLAND, LLC	▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇'▇ HOME MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇/▇▇▇▇	▇▇	▇▇▇▇▇
NIGHTINGALE HOME HEALTH CARE, INC.	▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTH CENTRAL WASHINGTON RESPIRATORY CARE SERVICES, INC.	▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇	▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTH CENTRAL WASHINGTON RESPIRATORY CARE SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇, ▇▇▇ E & F	OMAK	OMAK	WA	98841
NORTH CENTRAL WASHINGTON RESPIRATORY CARE SERVICES, INC.	▇▇▇ ▇ ▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇ ▇▇▇▇▇▇ ▇▇▇.	LONDONDERRY	HILLSBOROUGH	NH	3053
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇, ▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇ ▇▇.	EAST SYRACUSE	ONONDAGA	NY	13057
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇. STE 500	JAMESTOWN	CHATUTAUQUA	NY	14701
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇ & ▇▇▇ ▇ ▇▇▇▇ ▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇ ▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇. ▇▇▇▇▇▇▇▇	NY	13676
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇.	CRANSTON	PROVIDENCE	RI	2907
NORTHEAST MEDICAL EQUIPMENT, INC.	▇▇ ▇▇▇▇▇▇ ▇▇.	WHITE RIVER JUNCTION	WINDSOR	VT	5001
NORTHWEST HOME MEDICAL, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇	▇▇▇▇▇ D'ALENE	KOOTENAI	ID	83814
NORTHWEST HOME MEDICAL, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
NORTHWEST HOME MEDICAL, INC.	▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OMICRON MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OMICRON MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN OF OKLAHOMA, INC.	1172 NORTH HILLS SHOPPING CENTRE	ADA	PONTOTOC	OK	74820
OXYGEN OF OKLAHOMA, INC.	1020 E ▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	POTTAWATOMIE	OK	74804
OXYGEN PLUS MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN PLUS, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇, ▇▇▇ ▇▇▇ & ▇▇▇	▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇	▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN PLUS, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇. #306	DELTA	DELTA	CO	81416

EXECUTION VERSION



OXYGEN PLUS, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ▇▇▇▇. STE J	LAKEWOOD	JEFFERSON	CO	80117
OXYGEN PLUS, INC.	▇▇▇▇ ▇▇▇▇ ▇▇, #▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN THERAPY ASSOCIATES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇	▇▇▇ ▇▇▇▇▇▇	▇▇▇▇ ▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN THERAPY ASSOCIATES, INC.	▇▇▇▇ ▇. ▇▇▇▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN THERAPY ASSOCIATES, INC.	▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ - ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN THERAPY ASSOCIATES, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
OXYGEN THERAPY ASSOCIATES, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
▇▇▇▇▇▇▇▇'▇ HOME CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇.	▇▇▇▇▇▇	▇▇ ▇▇▇	AZ	85344
PHI MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇, #▇▇ & #▇▇	▇▇▇▇▇ ▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
PHI MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ ▇▇	▇▇. ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	UT	84770
PIONEER MEDICAL SERVICES, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PIONEER MEDICAL SERVICES, INC.	▇▇▇ ▇▇▇▇ ▇▇	▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
PREFERENTIAL HOME HEALTH CARE, INC.	1818-A S. DIVISION ST	BLYTHEVILLE	MISSISSIPPI	AR	72315
PREFERENTIAL HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PRINCIPAL MEDICAL EQUIPMENT, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PRINCIPAL MEDICAL EQUIPMENT, INC.	3125-▇▇▇▇ ▇. ▇▇▇▇ ▇▇.	LAS VEGAS	▇▇▇▇▇	NV	89118
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇	ESCANABA	DELTA	MI	2500
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇ ▇ ▇▇▇▇▇ ▇▇. STE B	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	MI	48624
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇ & ▇▇ ▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇ ▇▇▇ ▇▇ ▇ ▇	▇▇▇▇ ▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇ ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇ ▇▇ ▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	1683 STAR-BATT DR.	ROCHESTER HILLS	OAKLAND	MI	48309
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇	SAULT SAINTE ▇▇▇▇▇	CHIPPEWA	MI	49783
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇, ▇▇▇▇	▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL BREATHING ASSOCIATES, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇▇▇. SUITE B103	▇▇▇▇▇▇	▇▇▇▇▇▇	TX	78751
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇ ▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇. STE E	ROCKDALE	▇▇▇▇▇	TX	76567
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇	▇▇▇ ▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
PROFESSIONAL RESPIRATORY HOME HEALTHCARE, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇ ▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇. SOUTH STE ▇▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇-▇ ▇▇▇▇ ▇▇ ▇▇▇▇	▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇.	FERGUS FALLS	OTTERTAIL	MN	56537
PSI HEALTH CARE, INC.	▇▇▇ ▇▇▇▇ ▇▇▇. ▇▇ ▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇.	▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇.	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	IA	52801
PSI HEALTH CARE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇	▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇▇ ▇▇▇ ▇▇▇. SE	ABERDEEN	BROWN	SD	57401
PSI HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇▇ ▇. ▇▇▇▇ ▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇/▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PSI HEALTH CARE, INC.	▇▇▇-▇ ▇ ▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
PULMO-DOSE, INC.	120 ▇▇▇ ▇▇▇▇ ▇▇.	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	KY	42071
PULMO-DOSE, INC.	104 ▇▇▇ ▇▇▇▇ ▇▇.	▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	KY	42071
QUALICARE HOME MEDICAL, INC.	▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
QUALITY HOME HEALTH CARE, INC.	153 ALTAMA CONNECTOR	BRUNSWICK	▇▇▇▇▇	GA	31525
R.C.P.S., INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
R.C.P.S., INC.	99-▇▇▇ ▇▇▇▇▇▇ ▇▇	▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RCG INFORMATION SERVICES CORPORATION	▇▇▇▇ ▇▇▇▇▇ ▇▇▇	▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇-▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇ ▇. ▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇	▇▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇

EXECUTION VERSION



REGENCY MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇.	TUCSON	PIMA	AZ	85714
RESP-A-CARE, INC	▇▇▇▇ ▇▇▇▇ ▇▇. STE 105	ELIZABETHTOWN	▇▇▇▇▇▇	KY	42701
RESP-A-CARE, INC.	▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
RESP-A-CARE, INC.	▇▇▇▇-▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESP-A-CARE, INC.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPIRACARE MEDICAL EQUIPMENT, INC.	▇▇▇ ▇ ▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPIRACARE MEDICAL EQUIPMENT, INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇. SUITE 103	URBANA	CHAMPAIGN	IL	61802
RESPIRATORY MEDICAL EQUIPMENT OF GA., INC.	▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇. NE	MILLEDGEVILLE	▇▇▇▇▇▇▇	GA	31061
RESPIRATORY MEDICAL EQUIPMENT OF GA., INC.	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPIRATORY MEDICAL EQUIPMENT OF GA., INC.	▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	▇▇▇ ▇. ▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇ ▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	▇▇▇▇ ▇. ▇▇▇ ▇▇, ▇▇▇ ▇▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	240 N. ELK (transfill only)	CASPER	NATRONA	WY	82601
RESPITECH HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇ ▇▇▇ ▇▇, ▇▇▇▇ ▇	▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇ ▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPITECH HOME HEALTH CARE, INC.	. ▇▇▇ ▇^▇▇ ▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇▇ ▇ ▇▇▇▇ ▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇. STE 16	JACKSONVILLE	▇▇▇▇▇	IL	62650
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇.	▇▇▇▇▇▇	▇▇▇▇▇	IL	62301
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇ ▇▇.	COLUMBUS	▇▇▇▇▇▇▇▇▇▇▇	IN	47201
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇ ▇▇▇.	EVANSVILLE	VANDERBURGH	IN	47724
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇	FT. ▇▇▇▇▇	▇▇▇▇▇	IN	46804
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇., ▇▇▇ ▇	▇▇▇▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇	▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇.	MERRILVILLE	LAKE	IN	46304
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ ▇. ▇▇▇ ▇▇.	MISHAWKA	SAINT ▇▇▇▇▇▇	IN	46544
RESPONSIVE HOME HEALTH CARE, INC.	▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇	▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ & ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇▇▇ ▇▇	▇▇▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇, ▇▇▇▇▇ ▇	▇▇▇▇▇▇▇	▇▇▇▇▇▇▇▇	▇▇	▇▇▇▇▇
RESPONSIVE HOME HEALTH CARE, INC.	▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇ ▇▇.	MIDDLETON	▇▇▇▇▇▇	OH	45044

EXECUTION VERSION



RESPONSIVE HOME HEALTH CARE, INC.	603 A BROOKLYN AVE	MILFORD	HAMILTON	OH	45150
RESPONSIVE HOME HEALTH CARE, INC.	826 COOKSON AVE. SE	NEW PHILADELPHIA	TUSCANAWAS	OH	44663
RESPONSIVE HOME HEALTH CARE, INC.	1093 UPPER VALLEY PIKE	SPRINGFIELD	SANGAMON	OH	45503
RESPONSIVE HOME HEALTH CARE, INC.	745 W. ELM ST.	WASHINGTON CH	FAYETTE	OH	43160
RESPONSIVE HOME HEATLH CARE, INC.	1056 S. DIXON RD	KOKOMO	HOWARD	IN	46902
RESPONSIVE HOME HEATLH CARE, INC.	3434 N. BROADWAY	MUNCIE	DELAWARE	IN	47303
RHEMA, INC.	2550 BECKLEYMEADE AVENUE	DALLAS	DALLAS	TX	75237
RHEMA, INC.	1108 DALLAS DRIVE STE 333	DENTON	DENTON	TX	76205
RHEMA, INC.	9665 CAMP BOWIE WEST	FORT WORTH	TARRANT	TX	76116
RHEMA, INC.	314 S. MORGAN	GRANBURY	HOOD	TX	76048
RHEMA, INC.	143 Taylor Plaza Dr.	GREENVILLE	GREENVILLE	TX	75402
RHEMA, INC.	1511 PRUITT LANE	HILLSBORO	HILL	TX	76645
RHEMA, INC.	15031 WOODHAM DRIVE	HOUSTON	CHICKASAW	TX	77073
RHEMA, INC.	2845 W. AIRPORT FREEWAY #120	IRVING	DALLAS	TX	75062
RHEMA, INC.	1201 N. PLANO ROAD	RICHARDSON	DALLAS	TX	75081
RHEMA, INC.	2001 LOY LAKE ROAD	SHERMAN	GRAYSON	TX	75090
RHEMA, INC.	100 E. NASA ROAD ONE	WEBSTER	HARRIS	TX	77598
RITT MEDICAL GROUP, INC.	18434 N. 99TH AVE., STE 3 & 4	SUN CITY	MARICOPA	AZ	85373
RN HOME CARE MEDICAL EQUIPMENT COMPANY, INC.	319 N. MAIN ST.	AMORY	MONROE	MS	38821
RN HOME CARE MEDICAL EQUIPMENT COMPANY, INC.	2231 SOUTH COMMERCE STREET	GRENADA	GRENADA	MS	38901
ROSWELL HOME MEDICAL, INC.	4201 YALE BLVD. N.E., STE D	ALBUQUERQUE	BERNALILLO	NM	87107
ROSWELL HOME MEDICAL, INC.	3620 N. PRINCE ST, STE B	CLOVIS	CURRY	NM	88101
ROSWELL HOME MEDICAL, INC.	814 S BOARDMAN AVE	GALLUP	MCKINLEY	NM	87301
ROSWELL HOME MEDICAL, INC.	3920 N. LOVINGTON HWY STE 100	HOBBS	LEA	NM	88240
ROSWELL HOME MEDICAL, INC.	107 S. UNION ST.	ROSWELL	CHAVES	NM	88201
ROSWELL HOME MEDICAL, INC.	1549 6TH ST., STE C	SANTA FE	SANTA FE	NM	87505
ROSWELL HOME MEDICAL, INC.	2948 HIGHWAY 180 E	SILVER CITY	GRANT	NM	88061
ROSWELL HOME MEDICAL, INC.	1398 WEIMER RD., STE 200-202	TAOS	TAOS	NM	87571
ROTECH HOME MEDICAL CARE, INC.	1508 - 1510 N FRANKLIN ST	CHRISTIANSBURG	MONTGOMERY	VA	24073
ROTECH HOME MEDICAL CARE, INC.	1095 PLAZA DR.	GRUNDY	BUCHANAN	VA	24614
ROTECH HOME MEDICAL CARE, INC.	509 MOUNTAIN LAKE AVE	PEARISBURG	GILES	VA	24134
ROTECH HOME MEDICAL CARE, INC.	4118 PLANTATION RD. NE	ROANOKE	RANDOLPH	VA	24012
ROTECH HOME MEDICAL CARE, INC.	1308 PLANTATION RD. NE	ROANOKE	RANDOLPH	VA	24012

EXECUTION VERSION



ROTECH HOME MEDICAL CARE, INC.	106 ROWE RD., STE 102	STAUNTON	AUGUSTA	VA	24401
ROTECH HOME MEDICAL CARE, INC.	257 VIRGINIA AVE	WELCH	MCDOWELL	WV	24801
ROTECH HOME MEDICAL CARE, INC.	116 MAGNOLIA DR	DANVILLE	PITTSYLVANIA	VA	24541
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	774 NORTHLAKE BLVD, STE 1016	ALTAMONTE SPRINGS	SEMINOLE	FL	32701
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	7931 W GULF TO LAKE HWY	CRYSTAL RIVER	CITRUS	FL	34429
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	919 N. SPRING GARDEN AVENUE	DELAND	VOLUSIA	FL	32720
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	34894 EMERALD COAST PKWY #99 & #112	DESTIN	OKALOOSA	FL	32540
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	12700 METRO PKWY	FT. MYERS	LEE	FL	33912
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	8400 BAYMEADOWS WAY	JACKSONVILLE	DUVAL	FL	32256
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	5315 Great Oak Dr.	LAKELAND	POLK	FL	33815
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	6830 NEW TAMPA HIGHWAY, STE 300	LAKELAND	POLK	FL	33815
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	2032 TALLEY ROAD	LEESBURG	LAKE	FL	34748
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	2886-C JEFFERSON STREET	MARIANNA	JACKSON	FL	32446
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	4450 W. EAU GALLIE BLVD	MELBOURNE	BREVARD	FL	32934
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	2900 HORSESHOE DR. SOUTH, #300	NAPLES	COLLIER	FL	34104
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	2620 SW 17TH RD. STE 100	OCALA	MARION	FL	34474
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	3600 VINELAND ROAD	ORLANDO	ORANGE	FL	32811
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	3216 CRILL AVENUE	PALATKA	PUTNAM	FL	32177
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	2175 JENKS AVENUE	PANAMA CITY	BAY	FL	32405
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	1211 CREIGHTON ROAD	PENSACOLA	ESCAMBIA	FL	32504
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	115-B EAST DREW STREET	PERRY	TAYLOR	FL	32347
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	4360 OAKES ROAD.	DAVIE	BROWARD	FL	33314
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	8300 US HWY 19	PORT RICHEY	PASCO	FL	34668
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	9770 16TH STREET NORTH	SAINT PETERSBURG	PINELLAS	FL	33716
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	1799 DESOTO ROAD	SARASOTA	SARASOTA	FL	34234
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	7897 SW JACK JAMES DRIVE	STUART	MARTIN	FL	34997
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	3640 WEST CYPRESS STREET	TAMPA	HILLSBOROUGH	FL	33607
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	1122 E. WADE ST STE B	TRENTON	GILCHRIST	FL	32693
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	1860 OLD OKEECHOBEE RD	WEST PALM BEACH	PALM BEACH	FL	33409
ROTECH OXYGEN AND MEDICAL EQUIPMENT, INC.	S. RT 19S, RT 1 BOX 780	CLARKSBURG	HARRISON	WV	26301
ROTH MEDICAL, INC.	215 CARSON AVE.	ALAMOSA	ALAMOSA	CO	81101
ROTH MEDICAL, INC.	4715 TOWN CENTER DR., STE AB	COLORADO SPRINGS	EL PASO	CO	80916
ROTH MEDICAL, INC.	565 & 605 E 70TH STE 1	DENVER	ADAMS	CO	80229

EXECUTION VERSION



ROTH MEDICAL, INC.	9540 E. JEWELL AVE, STE C	DENVER	ADAMS	CO	80247
ROTH MEDICAL, INC.	225 N LEMAY AVE	FT. COLLINS	LARIMER	CO	80524
ROTH MEDICAL, INC.	960 W. 124^th AVE., STE. 300	WESTMINISTER	ADAMS	CO	80234
ROTH MEDICAL, INC.	109 W. LEE AVE., UNIT #8 & 9	LAMAR	PROWERS	CO	81052
ROTH MEDICAL, INC.	729 –C FORTINO BLVD.	PUEBLO	PUEBLO	CO	81008
ROTHERT'S HOSPITAL EQUIPMENT, INC.	1850 AUGUSTINE AVE. STE A & B	COVINGTON,	KENTON	KY	41014
ROTHERT'S HOSPITAL EQUIPMENT, INC.	103 BARNES RD. STE 1	WILLIAMSTOWN	GRANT	KY	41097
SAMPSON CONVALESCENT MEDICAL SUPPLY, INC.	357 NORTH BLVD.	CLINTON	SAMPSON	NC	28328
SELECT HOME HEALTH CARE, INC.	136 HOSPITAL DRIVE	BLAIRSVILLE	UNION	GA	30512
SELECT HOME HEALTH CARE, INC.	116 BEASLEY CIRCLE	BLAIRSVILLE	UNION	GA	30512
SELECT HOME HEALTH CARE, INC.	118 PROFESSIONAL RD.	BLUE RIDGE	FANNIN	GA	30513
SELECT HOME HEALTH CARE, INC.	547 DEPOT ST	FRANKLIN	MACON	NC	28734
SELECT HOME HEALTH CARE, INC.	4332 E. US 64 ALTERNATE	MURPHY	CHEROKEE	NC	28906
SELECT HOME HEALTH CARE, INC.	391 JACKSON PLAZA	SYLVA	JACKSON	NC	28779
SELECT HOME HEALTH CARE, INC.	59 HAYWOOD OFFICE PARK, BLDG D	WAYNESVILLE	HAYWOOD	NC	28786
SELECT HOME HEALTH CARE, INC.	34 CREEKSIDE CIRCLE, STE 15	HAYESVILLE	CLAY	NC	28904
SIGMA MEDICAL EQUIPMENT, INC.	748 LIBERTY ST.	FRANKLIN	MACON	PA	16323
SIGMA MEDICAL EQUIPMENT, INC.	1464 N. MAIN ST., STE 3	PUNXSUTAWNEY	JEFFERSON	PA	15767
SIGMA MEDICAL EQUIPMENT, INC.	128 E CENTRAL AVE	TITUSVILLE	CRAWFORD	PA	16354
SOUTHEASTERN HOME HEALTH, INC.	1200 OCILLA ROAD	DOUGLAS	COCHISE	GA	31533
SUN MEDICAL SUPPLY, INC.	946-P WEST ANDREWS AVENUE	HENDERSON	VANCE	NC	27536
SUNSHINE HOME HEALTH CARE, INC.	1748 ROSS CLARK CIRCLE S.E.	DOTHAN	HOUSTON	AL	36301
THE KILROY COMPANY	2732 INTERSTATE ST., SUITE F	CHARLOTTE	MECKLENBURG	NC	28208
THE KILROY COMPANY	914 MOOSE ST. UNITS A-C	GASTONIA	GASTON	NC	28056
THETA HOME HEALTH CARE, INC.	1649 HWY 22 WEST STE 2	ALEXANDER CITY	TALLAPOOSA	AL	35010
THETA HOME HEALTH CARE, INC.	931 HIGHWAY 80 WEST	DEMOPOLIS	MARENGO	AL	36732
THETA HOME HEALTH CARE, INC.	1311 S. BRUNDIDGE ST.	TROY	PIKE	AL	36081
THETA HOME HEALTH CARE, INC.	1500 A 14TH ST.	MERIDIAN	LAUDERDALE	MS	39301
THETA HOME HEALTH CARE, INC.	6043 HWY 63	MOSS POINT	JACKSON	MS	39563
TUPELO HOME HEALTH, INC.	611 GARFIELD	TUPELO	LEE	MS	38801
VALLEY MEDICAL EQUIPMENT, INC	1821 WEST 4000 SOUTH STE 100	ROY	DAVIS	UT	84067
VALLEY MEDICAL EQUIPMENT, INC.	731 N MCCORMICK WAY #1	LAYTON	DAVIS	UT	84041
VALLEY MEDICAL EQUIPMENT, INC.	6973 SOUTH 300 WEST	MIDVALE	SALT LAKE	UT	84047
VALLEY MEDICAL EQUIPMENT, INC.	538 S. COMMERCE DR.	OREM	UTAH	UT	84058
VALLEY MEDICAL EQUIPMENT, INC.	395 VERNAL AVE.	VERNAL	UNITAH	UT	84078

EXECUTION VERSION



VALUE CARE, INC.	302 GILBERT ST	CHARLES CITY	FLOYD	IA	50616
VALUE CARE, INC.	1800-1804 N. BALTIMORE	KIRKSVILLE	ADAIR	MO	63501
VALUE CARE, INC.	1282 NW MAIN ST	LEES SUMMIT	MACON	MO	64086
VALUE CARE, INC.	3160 WEST ARROW ST	MARSHALL	SALINE	MO	65340
VITALCARE HEALTH SERVICES, INC.	1572 COLLEGE PKWY #162	CARSON CITY	CARSON	NV	89706
VITALCARE HEALTH SERVICES, INC.	1250 LAMOILLE HWY #517	ELKO	ELKO	NV	89801
VITALCARE HEALTH SERVICES, INC.	5301 LONGLEY LN BLDG E	RENO	WASHOE	NV	89509
VITALCARE HEALTH SERVICES, INC.	1360 GREG ST., STE 103/104	SPARKS	WASHOE	NV	89431
VITALCARE HEALTH SERVICES, INC.	170 SHADY LANE	STATELINE	DOUGLAS	NV	89449
VITALCARE HEALTH SERVICES, INC.	4135 W. WINNEMUCCA BLVD.	WINNEMUCCA	HUMBOLDT	NV	89445
VITALCARE OF TEXAS, INC.	151 N.E. 27TH STREET	PARIS	LAMAR	TX	75460
WHITE'S MEDICAL RENTALS, INC.	1891 SAINT MATHEWS ROAD	ORANGEBURG	ORANGEBURG	SC	29118
WICHITA MEDICAL CARE, INC.	620 TURTLE CREEK BLVD	MANHATTAN	POTTAWATOMIE	KS	66502
ZETA HOME HEALTH CARE, INC.	11944 CLOVERLAND COURT	BATON ROUGE	E. BATON ROUGE	LA	70809
ZETA HOME HEALTH CARE, INC.	401 WEST 2ND STREET	BROUSSARD	LAFAYETTE	LA	70518
ZETA HOME HEALTH CARE, INC.	4901 COMMON STREET	LAKE CHARLES	CALCASIEU	LA	70607
ZETA HOME HEALTH CARE, INC.	203 N 16TH STREET	OAKDALE	ALLEN	LA	71463
ZETA HOME HEALTH CARE, INC.	4050 WASHINGTON BLVD.	BEAUMONT	JEFFERSON	TX	77705
ZETA HOME HEALTH CARE, INC.	701 SOUTH BECKHAM STREET	TYLER	SMITH	TX	75701

EXECUTION VERSION

SCHEDULE 4.01(d)

TO CREDIT AGREEMENT

Local Counsel

Proskauer Rose LLP

One Boca Place

2255 Glades Road

Suite 421 Atrium

Boca Raton, FL 33431

Greenberg Traurig

1200 17^th Street

Suite 2400

Denver, CO 80202

EXECUTION VERSION

SCHEDULE 6.03(b)(v)

TO CREDIT AGREEMENT

Indebtedness


1.	Capital leases between Borrower and IBM Credit LLC., for computer equipment and software in the amount of $1,173,830.44 as of October 31, 2012.

Capital leases between Borrower and Canon Financial Services, Inc. for copiers in the amount of $362.46 as of October 31, 2012.

Capital leases between Borrower and Oracle Corporation, for computer equipment and software in the amount of $54,168.09 as of October 31, 2012.

Capital leases between Borrower and Cisco Systems Capital Corporation, for telephone equipment and software in the amount of $294,494.04 as of October 31, 2012.


.	Capital leases between Borrower and Philips Medical Capital, for portable oxygen concentrators in the amount of $2,089,978.34 as of October 31, 2012.

Line of Credit drawn on September 10, 2012 by the Borrower from Credit Suisse in the amount of $10,000,000.

No Promissory Notes.


2.	Letters of Credit for the account of Borrower and Subsidiary:


(a)	$7,465,486 Irrevocable Standby Letter of Credit No. 55103668 issued to beneficiary Pacific Employers Insurance Company by Regions Bank.


3.	Indebtedness related to Surety Bonds in favor of Florida Medicaid Contract Management and Medicare.

EXECUTION VERSION

EXHIBIT A

ADMINISTRATIVE QUESTIONNAIRE

I. General Information



Borrower Name:	Rotech Healthcare Inc.
Lender Institution's Legal Name for Documentation Purposes:
Name, Phone and Fax Number of Individual(s) to Receive Draft(s):


Number of Signature Lines Required:

II. Lender Contact Information



	Credit Contact	Closing Contact
Primary Contact Name:
Back-up Name:
Street Address (for courier purposes):
Primary Contact Phone Number:
Back-up Contact Phone Number:
Primary Contact Fax Number:
Back-up Contact Fax Number:
Primary Contact E-mail Address:
Back-up Contact E-mail Address:

EXECUTION VERSION

EXHIBIT A



	Deal Administrator
Primary Contact Name:
Back-up Name:
Street Address (for courier purposes):
Primary Contact Phone Number:

Primary Contact Fax Number:

Primary Contact E-mail Address:

III. Financial Information, Compliance, Intralinks, Executed Closing Documents, Etc.



Bank Name:
Address:
Department:
Contact Name:
Contact Phone:
Contact Fax:
Contact Email:

IV. Lender Fed Payment Instructions*



Bank Name:
City and State:
ABA Routing Number:
Account Name:
Account Number:
Re:
Attention:

* Please list any additional or non-Fed payment instructions on a separate sheet.

V. Tax Reporting Information¹

TAX ID #:

¹ Include tax form as applicable to lender

EXECUTION VERSION

EXHIBIT B

Assignment and Acceptance

This Assignment and Acceptance (this “Assignment and Acceptance”) is dated as of the Effective Date set forth below and is entered into by and between the Assignor identified in item 1 below (the “Assignor”) and the Assignee identified in item 2 below (the “Assignee”). Capitalized terms used but not defined herein shall have the meanings given to them in the Credit Agreement identified below (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), receipt of a copy of which is hereby acknowledged by the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference and made a part of this Assignment and Acceptance as if set forth herein in full.

For an agreed consideration, the Assignor hereby irrevocably sells and assigns to the Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date inserted by the Administrative Agent as contemplated below (i) all of the Assignor's rights and obligations in its capacity as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to the amount and percentage interest identified below of all of such outstanding rights and obligations of the Assignor under the Credit Agreement and (ii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any person, whether known or unknown, arising under or in connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i) above (the rights and obligations sold and assigned by the Assignor to the Assignee pursuant to clauses (i) and (ii) above being referred to herein collectively as the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except as expressly provided in this Assignment and Acceptance, without representation or warranty by the Assignor.

1. Assignor: ________________________________


2.	Assignee: ________________________________

[for each Assignee, indicate [Affiliate][Related Fund] of [identify Lender]


3.	Borrower: Rotech Healthcare Inc.

4. Administrative Agent: Silver Point Finance, LLC, as the Administrative Agent under the Credit

Agreement


5.	Credit Agreement: Credit Agreement dated as of [_______] [] 201[_], among Rotech Healthcare Inc., the lenders from time to time party thereto and Silver Point Finance, LLC, as Administrative Agent


6.	Assigned Interest:



Aggregate Amount of Commitment/Loans of all Lenders	Amount of Commitment/Loans Assigned	Percentage Assigned of Commitment/Loans¹
$	$	%

¹ Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder.

Effective Date: _____________ ___, 20___ [TO BE INSERTED BY ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.]

The terms set forth in this Assignment and Acceptance are hereby agreed to:

ASSIGNOR

[NAME OF ASSIGNOR]

By: ______________________________

Name:

Title:

ASSIGNEE

[NAME OF ASSIGNEE]

By: ______________________________

Name:

Title:

Consented to and Accepted:

SILVER POINT FINANCE, LLC,

as Administrative Agent

By: _________________________________

Name

Title:

By: _________________________________

Name

Title:

ANNEX 1

STANDARD TERMS AND CONDITIONS FOR

ASSIGNMENT AND ACCEPTANCE

1. Representations and Warranties.

1.1 Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim, (iii) its Commitment, and the outstanding balance of its Loans, in each case without giving effect to assignments thereof which have not become effective, are as set forth herein, and (iv) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Acceptance and to consummate the transactions contemplated hereby; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with the Credit Agreement or any other Loan Document, (ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Loan Documents or any collateral thereunder, (iii) the financial condition of the Borrower, any of the Subsidiaries or its Affiliates or any other person obligated in respect of any Loan Document or (iv) the performance or observance by the Borrower, any of the Subsidiaries or its Affiliates or any other person of any of their respective obligations under any Loan Document.

1.2. Assignee. The Assignee (a) represents and warrants that (i) it is an Eligible Assignee and has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Acceptance and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it meets all the requirements to be an assignee under Section 9.04 of the Credit Agreement (subject to such consents, if any, as may be required under Section 9.04 of the Credit Agreement), (iii) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to the extent of the Assigned Interest, shall have the obligations of a Lender thereunder, (iv) it is sophisticated with respect to decisions to acquire assets of the type represented by the Assigned Interest and either it, or the person exercising discretion in making its decision to acquire the Assigned Interest, is experienced in acquiring assets of such type, (v) it has received a copy of the Credit Agreement and the Intercreditor Agreements, and has received or has been accorded the opportunity to receive copies of the most recent financial statements referred to in Section 3.05 or delivered pursuant to Section 5.04 thereof, as applicable, and such other documents and information as it deems appropriate to make its own credit analysis and decision to enter into this Assignment and Acceptance and to purchase the Assigned Interest, (vi) it has, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Assignment and Acceptance and to purchase the Assigned Interest, and (vii) if it is a Foreign Lender, attached to this Assignment and Acceptance is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, duly completed and executed by the Assignee; and (b) agrees that (i) it will, independently and without reliance on the Administrative Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents, (ii) from and after the Effective Date, it shall be bound by the terms of the Intercreditor Agreements, (iii) it appoints and authorizes the Administrative Agent and the Collateral Agent to take such action on its behalf and to exercise such powers under the Loan Documents as are delegated to the Administrative Agent and the Collateral Agent, as applicable, by the terms thereof, together with such powers as are reasonably incidental thereto, and (iv) it will perform in accordance with their terms all of the obligations which by the terms of the Loan Documents are required to be performed by it as a Lender.

2. Payments. From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective Date.

3. General Provisions. This Assignment and Acceptance shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment and Acceptance may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a signature

page of this Assignment and Acceptance by telecopy or other customary means of electronic transmission (e.g., “pdf”) shall be effective as delivery of a manually executed counterpart of this Assignment and Acceptance. The parties hereto shall (a) execute and deliver to the Administrative Agent this Assignment and Acceptance via an electronic system acceptable to the Administrative Agent or (b) if previously agreed with the Administrative Agent, manually execute and deliver to the Administrative Agent this Assignment and Acceptance. This Assignment and Acceptance shall be governed by, and construed in accordance with, the law of the State of New York.

EXECUTION VERSION

EXHIBIT C-1

[FORM OF]

BORROWING REQUEST

Silver Point Finance, LLC

As Administrative Agent for the Lenders referred to below

2 Greenwich Plaza

Greenwich CT 06830

Attention: Thomas Banks

December [_], 2012

Reference is made to the Term Loan Credit Agreement, dated as of December [___], 2012, among Rotech Healthcare Inc., (the “Borrower”), the Lenders party thereto, and Silver Point Finance, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement.

The undersigned hereby gives you notice pursuant to Section 2.03 of the Credit Agreement that it requests a Borrowing under the Credit Agreement, and in that connection sets forth below the terms on which such Borrowing is requested to be made:

Term Loan:


o	Date of Borrowing December [___], 2012

o ABR Loans: $___________


o	LIBOR Loans (monthly Interest Period) $____________


o	Account Number and Location: ____________

The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that, on the date of the Borrowing set forth herein, the conditions to lending specified in paragraphs (b) and (c) of Section 4.01 of the Credit Agreement shall have been satisfied.

ROTECH HEALTHCARE INC.,

By:

Name:

Title:

EXECUTION VERSION

EXHIBIT C-2

[FORM OF]

BORROWING REQUEST FOR DELAYED DRAW LOAN

Silver Point Finance, LLC

As Administrative Agent for the Lenders referred to below

2 Greenwich Plaza

Greenwich CT 06830

Attention: Thomas Banks

[ ]

Reference is made to the Term Loan Credit Agreement, dated as of December 21, 2012, among Rotech Healthcare Inc., (the “Borrower”), the Lenders party thereto, and Silver Point Finance, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement.

Delayed Draw Term Loan:


o	Date of Borrowing [___]

o ABR Loans: $___________


o	LIBOR Loans (monthly Interest Period) $____________


o	Account Number and Location: ____________

The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that, on the date of the Borrowing set forth herein, the conditions to lending specified in paragraphs (c) and (d) of Section 4.02 of the Credit Agreement shall have been satisfied.

ROTECH HEALTHCARE INC.,

By:

Name:

Title:

EXECUTION VERSION

EXHIBIT D

[FORM OF] COLLATERAL AGREEMENT

made among

ROTECH HEALTHCARE INC.,

THE SUBSIDIARY GRANTORS

and

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,

as Collateral Agent,

Dated as of [_____], 201[_],

as amended and restated as of [____], 201[_] and as further

amended and restated as of [_____], 201[_]

TABLE OF CONTENTS



			Page
SECTION 1.		DEFINED TERMS	1
1.1	Definitions		1
1.2	Other Definitional Provisions		10

SECTION 2.		RESERVED	10

SECTION 3.		GRANT OF SECURITY INTEREST	10

SECTION 4.		REPRESENTATIONS AND WARRANTIES	12
4.1	Representations in the Purchase Agreement and the Term Loan Agreement		12
4.2	Title; No Other Liens		13
4.3	Perfected First Priority Liens		13
4.4	Power and Authority		13
4.5	Third-Party Approval		13
4.6	Jurisdiction of Organization; Chief Executive Office		14
4.7	Farm Products		14
4.8	Investment Property		14
4.9	Receivables		15
4.10	Intellectual Property		15
4.11	Inventory and Equipment		15
4.12	Deposit Accounts; Securities Accounts; Commodity Accounts; Commercial Tort Claims		15
4.13	Letter-of-Credit Rights		15

SECTION 5.		COVENANTS	16
5.1	Covenants in Indenture, Purchase Agreement and Term Loan Agreement		16
5.2	Delivery of Instruments and Chattel Paper		16
5.3	Maintenance of Insurance		16
5.4	Payments of Obligations		17
5.5	Maintenance of Perfected Security Interest; Further Documentation and Information		17
5.6	Changes in Locations, Names, etc.		19
5.7	Investment Property		19
5.8	Receivables		20
5.9	Intellectual Property		20
5.10	Notices		22
5.11	Impairment of Collateral		22
5.12	Pledged Notes		22
5.13	Schedules		22
5.14	Commercial Tort Claims		22
5.15	Landlord Lien Waivers and Warehouseman Letters		22



5.16	Encumbrances		23
5.17	Warehouse Receipts Non-Negotiable		23
5.18	Limitations on Dispositions of Collateral		23
5.19	Letters of Credit Rights		23
5.20	Leasehold Mortgages		23

SECTION 6.		REMEDIAL PROVISIONS	23
6.1	Certain Matters Relating to Receivables		23
6.2	Communications with Obligors; Grantors Remain Liable		24
6.3	Pledged Securities		25
6.4	Proceeds to be Turned Over To Collateral Agent		25
6.5	Application of Proceeds		26
6.6	NY UCC and Other Remedies		26
6.7	Registration Rights		27
6.8	Deficiency		28
6.9	Sales on Credit		28
6.10	Intellectual Property		28

SECTION 7.		THE COLLATERAL AGENT	28
7.1	Collateral Agent's Appointment as Attorney-in-Fact, etc.		28
7.2	Duty of Collateral Agent		29
7.3	Financing Statements		3
7.4	Authority of Collateral Agent		30
7.5	Certain Rights of Collateral Agent		30

SECTION 8.		MISCELLANEOUS	32
8.1	Amendments in Writing		32
8.2	Notices		32
8.3	No Waivers by Course of Conduct; Cumulative Remedies		32
8.4	Enforcement Expenses; Indemnification		32
8.5	Subrogation		33
8.6	Successors and Assigns		33
8.7	Sefoff		33
8.8	Counterparts		33
8.9	Severability		33
8.10	Section Headings		33
8.11	Integration		33
8.12	GOVERNING LAW		34
8.13	Submission to Jurisdiction; Waivers		34
8.14	Acknowledgments		34
8.15	Additional Grantors		34
8.16	Releases		34



8.17	WAIVERS OF JURY TRIAL	35
8.18	Reinstatement	35
8.19	Pari Passu Indebtedness; Junior Lien Indebtedness; Intercreditor Agreements	35
8.20	Bank of America Deposit Accounts	36
8.21	Confirmation of Appointment of Collateral Agent	36



Schedules
Schedule 1	Notice Addresses of Subsidiary Grantors
Schedule 2	Description of Pledged Securities
Schedule 3	Filings and Other Actions Required to Perfect Security Interest
Schedule 3.1	Commercial Tort Claims
Schedule 4	Jurisdiction of Organization and Identification Number
Schedule 4.9	Locations of Inventory and Equipment
Schedule 4.10	Deposit Accounts, Securities Accounts, Commodity Accounts
Schedule 4.11	Letters of Credit
Schedule 5	Intellectual Property



Annexes
Annex I	Assumption Agreement
Annex II	Copyright Security Agreement
Annex III	Patent Security Agreement
Annex IV	Trademark Security Agreement
Annex V	Deposit Account Control Agreement
Annex VI	Collection Account Agreement
Annex VII	Acknowledgment of Pledge
Annex VIII	Landlord's Waiver and Consent
Annex IX	Bailee Letter
Annex X	Perfection Certificate

iii

COLLATERAL AGREEMENT, dated as of [____], 201[_] (the “Original Collateral Agreement”), as amended and restated as of [_____], 201[_], as further amended and restated as of [_____], 201[_], made among Rotech Healthcare Inc. (the “Issuer”), each of the other signatories party hereto (together with the Issuer and any other entity that may become a party hereto as provided herein, the “Grantors”), in favor of The Bank of New York Mellon Trust Company, N.A., as collateral agent (in such capacity, the “Collateral Agent”) for the ratable benefit of the Secured Parties (as defined below).

W I T N E S S E T H:

Reference is made to (a) the Indenture, dated as of [____], 201[_] (as amended, restated, supplemented or otherwise modified from time to time, the “Indenture”), among the Issuer, each Subsidiary Grantor (as defined below) party to the Original Collateral Agreement (the “Initial Subsidiary Grantors”) and the Trustee and (b) the Purchase Agreement dated as of [______], 201[_] (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”), among the Issuer, the Initial Subsidiary Grantors and Credit Suisse Securities (USA) LLC, as initial purchaser (the “Initial Purchaser”). The Trustee entered into the Indenture and the Initial Purchaser purchased the securities issued under the Indenture (the “Notes”), in each case on the terms and subject to the conditions set forth in the Purchase Agreement.

Reference is made to the Term Loan Agreement dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time , the “Term Loan Agreement”) among the Issuer, the Lenders (as defined in the Term Loan Agreement) and Silver Point Finance, LLC, as administrative agent for the Lenders, pursuant to which the Lenders agreed to make loans to the Issuer on the terms and subject to the conditions set forth in the Term Loan Agreement and such loans will be used to repay in full the obligations of the Issuer under that certain Credit Agreement dated [______], 201[_], as amended, and to provide for the working capital of the Issuer and its subsidiaries.

The obligations of the Initial Purchaser to purchase the Notes were conditioned upon, among other things, the execution and delivery of the Original Collateral Agreement. The obligations of the Lenders to make loans to the Issuer are conditioned upon, among other things, the execution and delivery of this Agreement by the Issuer and each Subsidiary Grantor. Each Subsidiary Grantor is an affiliate of the Issuer, derived substantial benefits from the purchase of the Notes from the Issuer by the Initial Purchaser pursuant to the Purchase Agreement, and will derive substantial benefits from the funding of loans to the Issuer under the Term Loan Agreement. Each Grantor is willing to execute and deliver this Agreement in order to induce the Lenders to make loans to the Issuer under the Term Loan Agreement.

Accordingly, the parties hereto agree as follows:

SECTION 1. DEFINED TERMS

1.2Definitions. (a) Unless otherwise defined herein, or the context hereof otherwise requires, each term defined in either of the Indenture or in the New York UCC is used in this Agreement with the same meaning; provided that, if the definition given to such term in the Indenture conflicts with the definition given to such term in the New York UCC, the Indenture definition shall control to the extent legally allowable; and if any definition given to such term in Chapter 9 of the New York UCC conflicts with the definition given to such term in any other chapter of the New York UCC, the Chapter 9 definition shall prevail. The following terms are used herein as defined in the New York UCC: Accounts,

Certificated Security, Chattel Paper, Commercial Tort Claims, Commodity Accounts, Commodity Intermediary, Control, Documents, Equipment, Farm Products, Financial Assets, Fixtures, General Intangibles, Goods, Instruments, Inventory, Letter-of-Credit Rights, Payment Intangibles, Securities Accounts, Securities Intermediary, Security Entitlement and Supporting Obligations.

(b) The following terms shall have the following meanings:

“Administrative Agent”: Silver Point Finance, LLC, acting through one or more of its affiliates, in its capacity as administrative agent for the Lenders under the Term Loan Agreement (and any successor thereto acting in such capacity).

“Agreement”: this Collateral Agreement, dated as of [_______], 201[_], as amended and restated as of [______], 201[_], as further amended and restated on the date hereof, among the Issuer, the other Grantors and the Collateral Agent, as the same may be further amended, restated, supplemented or otherwise modified from time to time.

“Applicable Authorized Representative”: (a) prior to the discharge of the Notes Documents Obligations and the Loan Document Obligations, the Applicable Authorized Representative (as defined in the Term Loan Agreement Pari Passu Intercreditor Agreement), (b) prior to the discharge of the Notes Documents Obligations, but after the discharge of the Loan Document Obligations, the Required Holders or (c) prior to the discharge of the Loan Document Obligations, but after the discharge of the Notes Documents Obligations, the Required Lenders.

“Bailee Letter”: a bailee letter, substantially in the form of Annex IX, executed by a bailee holding Inventory or Equipment owned by any Grantor, delivered by such Grantor to the Collateral Agent.

“CHAMPUS”: collectively, the Civilian Health and Medical Program of the Uniformed Services, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, which is now known as TRICARE, financed and administered by the United States Departments of Defense, Health and Human Services and Transportation, and all laws, rules, regulations, manuals, orders, guidelines or requirements pertaining to such program including (a) all Federal statutes (whether set forth in 10 U.S.C. §§1071-1107 or elsewhere) affecting such program; and (b) all rules, regulations (including 32 C.F.R. §§199.1-199.22), manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“CHAMPUS Receivable”: an Account payable pursuant to CHAMPUS.

“CHAMPVA”: collectively, the Civilian Health and Medical Program of the Department of Veteran Affairs, a program of medical benefits covering retirees and dependents of former members of the armed services administered by the United States Department of Veteran Affairs, and all laws, rules, regulations, manuals, orders, guidelines or requirements pertaining to such program including (a) all Federal statutes (whether set forth in 38 U.S.C. §1713 or elsewhere) affecting such program; (b) to the extent applicable to CHAMPVA, the CHAMPUS regulations; and (c) all rules, regulations (including 38 C.F.R. §§17.270-17.278), manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in

connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“CHAMPVA Receivable”: an Account payable pursuant to CHAMPVA.

“Closing Date”: means [_______] 201[_].

“Collateral”: as defined in Section 3.

“Collateral Account”: any collateral account established by the Collateral Agent as provided in Section 6.1 or 6.4.

“Collection Account Agreement”: any agreement in respect of any Government Receivables Account substantially in the form of Annex VI.

“Commitment”: as defined in the Term Loan Agreement.

“Copyrights”: (i) All copyrights (whether arising under statutory or common law, registered or unregistered), works protectable by copyright, copyright registrations, Copyright Licenses, and copyright applications of any Grantor, including all of any Grantor's right, title and interest in and to all copyrights registered in the United States Copyright Office or anywhere else in the world and also including the copyrights set forth on Schedule 5; (ii) all renewals, extensions and modifications thereof; (iii) all income, licenses, royalties, damages, profits and payments relating to or payable under any of the foregoing; (iv) the right to sue for past, present or future infringements of any of the foregoing; and (v) all other rights and benefits relating to any of the foregoing throughout the world; in each case, whether now owned or hereafter acquired by any Grantor.

“Copyright Licenses”: any written agreement naming any Grantor as licensor or licensee (including those listed in Schedule 5), granting any right under any Copyright, including the grant of rights to manufacture, distribute, exploit and sell materials derived from any Copyright.

“Deposit Account”: any and all deposit accounts (as defined in Chapter 9 of the New York UCC), bank accounts, investment accounts or Securities Accounts, now owned or hereafter acquired or opened by any Grantor, including any such accounts set forth on Schedule 4.10, and any account which is a replacement or substitute for any of such accounts, together with all monies, instruments, certificates, checks, drafts, wire transfer receipts and other property deposited therein and all balances therein.

“Disposition”: with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or other disposition thereof. The terms “Dispose” and “Disposed of” shall have correlative meanings.

“Disregarded Subsidiary”: any Subsidiary that is disregarded as an entity separate from its sole owner under Treasury Regulation Sections 301, 7701-2(c)(2) or -3(b).

“Event of Default”: an “Event of Default” under and as defined in the Indenture or the Term Loan Agreement.

“Excluded Assets”: (i) Excluded Equipment; (ii) Excluded L/C Collateral; (iii) Excluded Real Property, (iv) any Intangible Assets or any Retained Rights, in each case, to the extent the grant by the relevant Grantor of a security interest pursuant to this Agreement in such Grantor's right, title and interest in such Intangible Asset or Retained Right, as the case may be, (a) is prohibited by any contract, agreement, instrument or indenture governing such Intangible Asset or Retained Right, as applicable, provided, however, such Intangible Asset or Retained Right shall cease to be an Excluded Asset immediately at such time as the condition causing such prohibition shall be remedied, (b) would terminate such contract, agreement, instrument or indenture or give any other party to such contract, agreement, instrument or indenture the right to terminate its obligations thereunder or (c) is permitted only with the consent of another party, if such consent has not been obtained; provided, however any Receivable or any money or other amounts due or to become due under any such contract, agreement, instrument or indenture shall not be Excluded Assets; and provided however, to the extent severable, any portion of such contract, agreement, instrument or indenture that does not result in any of the consequences specified in (a), (b) or (c) of this paragraph shall not be an Excluded Asset; and (v) with respect to the Equity Interests described herein, (a) an amount in excess of 65% of the Foreign Corporation Voting Stock of any Foreign Corporation that is “first tier” Subsidiary of the Issuer or any Subsidiary Grantor, (b) any Capital Stock of any “second-tier” or lower tier Subsidiary that is a Foreign Corporation; or (c) an amount in excess of 65% of the Capital Stock in any Disregarded Subsidiary substantially all of the assets of which constitute Equity Interests in Foreign Corporations.

“Excluded Equipment”: any equipment or other asset of any Grantor that is subject to a Permitted Lien referred to in clause (18) of the definition thereof in the Indenture to the extent the documents relating to such Permitted Lien would not permit such asset to be subject to the Liens created under the Notes Documents or under the Loan Documents; provided, however, that immediately upon the ineffectiveness, lapse or termination of any such restriction, such asset shall cease to be an “Excluded Asset”.

“Excluded L/C Collateral”: any Cash Equivalents of any Grantor that are subject to a Permitted Lien referred to in clause (4) or (17) of the definition thereof in the Indenture that cash collateralize letters of credit, surety bonds or similar arrangements, in each case to the extent the documents relating to such Permitted Lien would not permit such Cash Equivalents to be subject to the Liens created under the Notes Documents or under the Loan Documents; provided, however, that immediately upon the cancellation or other termination of the related letters of credit, surety bonds or similar arrangements, or the ineffectiveness, lapse or termination of any such restriction, such Cash Equivalents shall cease to be an “Excluded Asset”.

“Excluded Real Property”: any fee interest in real property if the greater of the cost and the book value of such fee interest is less than $1,000,000 for any individual parcel and improvements thereto and less than $5,000,000 in the aggregate for all such parcels and improvements thereto.

“Foreign Corporation”: any Subsidiary that is a “controlled foreign corporation” under Section 957 of the Code.

“Foreign Corporation Voting Stock”: the voting Capital Stock of any Foreign Corporation.

“Governmental Authority”: any nation or government, any state or other political subdivision thereof and any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

“Government Receivable Account”: means any deposit account or other account into which any payment under Government Receivables is directly paid by the Governmental Authority, but, for the avoidance of doubt, shall not include any other deposit account or other account into which such funds are subsequently transferred.

“Government Receivables”: means, collectively, any and all Accounts which are (a) Medicare Receivables, (b) Medicaid Receivables, (c) TRICARE Receivables, (d) CHAMPUS Receivables, (e) CHAMPVA Receivables, (f) payable by the Veterans Administration and (g) any other Accounts payable by any Governmental Authority.

“Holders”: means the holders of the Notes.

“Indenture”: as defined in the recitals to this Agreement.

“Intangible Assets”: any contract, General Intangible, Copyright License, Patent License or Trademark License.

“Intellectual Property”: the collective reference to all rights, priorities and privileges relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including the Copyrights, the Copyright Licenses, the Patents, the Patent Licenses, the Trademarks and the Trademark Licenses and trade secrets, and all rights to sue at law or in equity for any infringement or other impairment thereof, including the right to receive all proceeds and damages therefrom.

“Intercompany Note”: any promissory note evidencing loans made by any Grantor to the Issuer or any of its Subsidiaries.

“Intercreditor Agreements”: the collective reference to the Term Loan Agreement Pari Passu Intercreditor Agreement and the Junior Notes Intercreditor Agreement.

“Investment Property” means all (i) “investment property”, as such term is defined in Section 9-102(a)(49) of the New York UCC (other than any Foreign Corporation Voting Stock excluded from the definition of “Pledged Stock”), now owned or hereafter acquired by any Grantor, and, in any event, shall include each of the following, whether now owned or hereafter acquired by any Grantor: (a) any security, whether certificated or uncertificated; (b) any Security Entitlement; (c) any Securities Account; (d) any commodity contract; and (e) any Commodity Account and (ii) whether or not constituting “investment property” as so defined, all Pledged Notes and all Pledged Equity.

“Investment Property Issuers”: the collective reference to each issuer of any Investment Property.

“Junior Notes Intercreditor Agreement”: the Junior Lien Intercreditor Agreement dated as of [______], 201[_], as amended by that certain First Amendment to Junior Lien Intercreditor Agreement, dated as of [_______] 201[_], among the Issuer, the other Grantors and the Collateral Agent, as first party representative, and The Bank of New York Mellon Trust Company, N.A., as

junior priority representative, as further amended, restated, supplemented or otherwise modified from time to time, among the Issuer, the other Grantors, the Collateral Agent, as first priority representative, and The Bank of New York Mellon Trust Company, N.A., as junior priority representative.

“Landlord Waiver”: a landlord agreement, substantially in the form of Annex VIII to the Indenture, executed by a landlord of a location leased by any Person at which Inventory or Equipment of any Grantor is held or stored, delivered by such Grantor to the Collateral Agent.

“Lender”: as defined in the Term Loan Agreement.

“Loans”: as defined in the Term Loan Agreement.

“Loan Documents”: means (a) the Term Loan Agreement, the Term Loan Agreement Guarantee, this Agreement, any deposit account control agreement, any Collection Account Agreement, other applicable security documents and any applicable intercreditor agreement entered into on or after the date hereof, including the Term Loan Agreement Pari Passu Intercreditor Agreement, and (b) any other related document or instrument executed and delivered pursuant to any Loan Document described in clause (a) evidencing or governing any Loan Document Obligations.

“Loan Document Obligations”: means up to an aggregate principal amount of $25,000,000 of Credit Facility Indebtedness (as defined in the Indenture) at any time outstanding, together with accrued interest thereon and, to the extent permitted by the Indenture, all other Obligations (as defined in the Indenture) arising in connection with such Credit Facility Indebtedness (including, without limitation, interest that has been capitalized to principal).

“Material Adverse Effect”: a material adverse effect on (a) the business, assets, liabilities, operations, condition (financial or otherwise) or operating results of the Issuer and its Subsidiaries, taken as a whole, (b) the prospects of the Issuer and its Subsidiaries taken as a whole, or (c) the validity or enforceability of the Indenture, any other Notes Document, the Term Loan Agreement, or any other Loan Document or the rights or remedies of the Secured Parties hereunder or thereunder.

“Medicaid”: collectively, the healthcare assistance program established by Title XIX of the Social Security Act (42 U.S.C. §§1396 et seq.), as amended, and all laws, rules, regulations, manuals, orders, guidelines or requirements pertaining to such program including (a) all Federal statutes (whether set forth in Title XIX of the Social Security Act or elsewhere) affecting such program and all Federal rules and regulations promulgated in connection with such program; (b) all state statutes and regulations promulgated thereunder in connection with individual state programs, as well as state plans submitted to and approved by the Centers for Medicare and Medicaid Services; and (c) all Federal and state manuals, orders and administrative guidelines and requirements issued in connection with Medicaid programs (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“Medicaid Receivable”: an Account payable pursuant to a claim filed under a valid Medicaid provider or supplier number.

“Medicare”: collectively, the health insurance program for the qualified aged, disabled, and persons with end stage renal disease established by Title XVIII of the Social Security Act (42 U.S.C. §§1395 et seq.), as amended, and all laws, rules, regulations, manuals, orders or guidelines pertaining to such program including (a) all Federal statutes (whether set forth in Title XVIII of the Social Security Act or elsewhere) affecting such program; and (b) all applicable provisions of all rules, regulations, manuals, orders and administrative guidelines and requirements issued in connected with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“Medicare Receivable”: an Account payable pursuant to a claim filed under a valid Medicare provider or supplier number.

“New York UCC”: the Uniform Commercial Code as from time to time in effect in the State of New York.

“Notes”: as defined in the recitals to this Agreement.

“Notes Documents”: means (a) the Notes, the Notes Guarantees, the Indenture, this Agreement, any deposit account control agreement, any Collection Account Agreement, any other applicable security documents and any applicable intercreditor agreement entered into on or after the date hereof, including the Term Loan Agreement Pari Passu Intercreditor Agreement, and (b) any other related document or instrument executed and delivered pursuant to any Notes Document described in clause (a) evidencing or governing any Obligations thereunder.

“Notes Documents Obligations”: means any principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities payable by any Grantor pursuant to any Notes Document.

“Notes Guarantees”: means the guarantee pursuant to the Indenture by each Grantor (other than the Issuer) of the Issuer's Notes Documents Obligations.

“Obligations”: means (a) the Notes Documents Obligations and (b) the Loan Documents Obligations.

“Original Collateral Agreement”: as defined in the recitals to this Agreement.

“Other Collateral”: means any personal and fixture property of any Grantor not included within the defined terms Accounts, Chattel Paper, Collateral Accounts, Documents, Equipment, General Intangibles, Goods, Financial Assets, Intellectual Property, Instruments, Letter-of-Credit Rights, Commercial Tort Claims, Inventory, Investment Property, Vehicles and Deposit Accounts, it being intended that the Collateral include all property of any Grantor other than Excluded Assets.

“Patent License”: all agreements, whether written or oral, providing for the grant by or to any Grantor of any right to manufacture, use or sell any invention covered in whole or in part by a Patent, including any of the foregoing referred to in Schedule 5.

“Patents”: (i) All patents, patent applications, Patent Licenses and patentable inventions of any Grantor, including registrations, recordings and applications thereof in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state

thereof or any other country or any political subdivision thereof, including those set forth on Schedule 5, and all of the inventions and improvements described and claimed therein; (ii) all continuations, divisions, renewals, extensions, modifications, substitutions, reexaminations, continuations-in-part or reissues of any of the foregoing; (iii) all income, royalties, profits, damages, awards and payments relating to or payable under any of the foregoing; (iv) the right to sue for past, present and future infringements of any of the foregoing; and (v) all other rights and benefits relating to any of the foregoing throughout the world; in each case, whether now owned or hereafter acquired by any Grantor.

“Patient Receivable”: with respect to the Issuer or any applicable Subsidiary, the patient accounts of such Subsidiary existing or hereinafter created, any and all rights to receive payments due on such accounts from any obligor or other third-party payor under or in respect of such accounts (including all insurance companies, Blue Cross/Blue Shield, Medicare, Medicaid and health maintenance organizations), and all proceeds of, or in any way derived, whether directly or indirectly, from any of the foregoing (including all interest, finance charges and other amounts payable by an obligor in respect thereof).

“Perfection Certificate”: means a certificate substantially in the form of Annex X.

“Pledged Equity”: means, collectively, the Pledged Stock, the Pledged Partnership Interests and the Pledged LLC Interests.

“Pledged LLC Interests”: means all of any Grantor's right, title and interest as a member of any limited liability company and all of such Grantor's right, title and interest in, to and under any LLC Agreement to which it is a party, including those set forth on Schedule 2.

“Pledged Notes”: all promissory notes listed on Schedule 2, all Intercompany Notes at any time issued to any Grantor, all other promissory notes issued to or held by any Grantor, and all rights, titles, interests and liens any Grantor may have, be, or become entitled to under all present and future loan agreements, security agreements, pledge agreements, deeds of trust, mortgages, guarantees or other documents assuring or securing payment of or otherwise evidencing the Pledged Notes (other than promissory notes issued in connection with extensions of trade credit by any Grantor in the ordinary course of business).

“Pledged Partnership Interests”: shall mean all right, title and interest of any Grantor in any partnership or joint venture and all right, title and interest of any Grantor in, to and under any partnership or joint venture agreements to which it is a party, including those set forth on Schedule 2.

“Pledged Securities”: the collective reference to the Pledged Notes and the Pledged Equity.

“Pledged Stock”: the shares of Capital Stock listed on Schedule 2, together with any other shares, stock certificates, options or rights of any nature whatsoever in respect of the Capital Stock of any Subsidiary that may be issued or granted to, or held by, any Grantor while this Agreement is in effect; provided that in no event shall more than sixty-five percent (65%) of the total outstanding Foreign Corporation Voting Stock of any Foreign Corporation be required to be pledged hereunder.

“Proceeds”: means any and all “proceeds”, as such term is defined in Section 9-102(a)(64) of the New York UCC and, in any event, including all dividends or other income from the Investment Property, collections thereon or distributions or payments with respect thereto.

“Property”: any right or interest in or to property of any kind whatsoever, whether real, personal or mixed and whether tangible or intangible, including Capital Stock.

“Receivable”: any right to payment for goods, merchandise or inventory sold or leased or for services rendered, whether or not such right is evidenced by an Instrument or Chattel Paper and whether or not it has been earned by performance (including any Account).

“Required Holders”: means, at any time, Holders of a majority in principal amount of the outstanding Notes at such time.

“Required Lenders”: means, at any time, Lenders having Loans representing more than 50% of the sum of all Loans outstanding at such time.

“Requirement of Law”: as to any Person, the certificate of incorporation and by-laws or other organizational or governing documents of such Person, and any law, treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its Property or to which such Person or any of its Property is subject.

“Retained Rights”: with respect to any Patient Receivable owing from any Governmental Authority, the right of the Issuer or any applicable Subsidiary, to the extent mandated by applicable law, to have unfettered control over such Patient Receivable, including the collection thereof and discretion over the transfer thereof to any party (including the Collateral Agent) and to enforce the claim giving rise to such Patient Receivable against such Governmental Authority, in the absence of a court order in the manner expressly contemplated under 42 U.S.C. §1395 and applicable state law.

“Secured Parties”: shall mean (a) the Holders, (b) the Collateral Agent, (c) the Trustee, (d) the beneficiaries of each indemnification obligation undertaken by any Grantor under any Notes Document or any Loan Document, (e) the Lenders, (f) the Administrative Agent and (g) the permitted successors and assigns of each of the foregoing.

“Securities Act”: the Securities Act of 1933, as amended.

“Subsidiary Grantors”: the collective reference to each Grantor other than the Issuer.

“Term Loan Agreement”: as defined in the recitals to this Agreement.

“Term Loan Agreement Guarantee”: the guarantee by each Grantor (other than the Issuer) pursuant to the Guarantee Agreement dated as of [_______] 201[_], as amended, restated, supplemented or otherwise modified from time to time, among each Grantor (other than the Issuer) and Silver Point Finance, LLC, as administrative agent, of the Issuer's Loan Documents Obligations.

“Term Loan Agreement Pari Passu Intercreditor Agreement”: the Pari Passu Intercreditor Agreement, dated as of [______], 201[_], as amended, restated, supplemented or otherwise modified from time to time, among the Issuer, the other Grantors, the Collateral Agent, The Bank

of New York Mellon Trust Company, N.A. as the Authorized Representative for the Indenture Secured Parties (each as defined therein), Credit Suisse AG, as the Initial Authorized Representative (as defined therein), Silver Point Finance, LLC as Additional Authorized Representative (as defined therein) and any other Additional Authorized Representative from time to time party thereto.

“Trademark License”: any agreement, whether written or oral, providing for the grant by or to any Grantor of any right to use any Trademark, including any of the foregoing referred to in Schedule 5.

“Trademarks”: (i) all trademarks, Trademark Licenses, trade names, corporate names, company names, business names, fictitious business names, trade styles, service marks, certification marks, collective marks, logos, other business identifiers, all registrations, recordings and applications thereof, including registrations, recordings and applications in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state thereof or any other country or any political subdivision thereof, including those set forth on Schedule 5; (ii) all reissues, extensions and renewals thereof; (iii) all income, royalties, damages and payments now or hereafter relating to or payable under any of the foregoing, including damages or payments for past or future infringements of any of the foregoing; (iv) the right to sue for past, present and future infringements of any of the foregoing; (v) all rights corresponding to any of the foregoing throughout the world; and (vi) all goodwill associated with and symbolized by any of the foregoing, in each case, whether now owned or hereafter acquired by any Grantor.

“TRICARE”: means, collectively, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, financed and administered by the United States Departments of Defense, Health and Human Services and Transportation, which program was formerly known as CHAMPUS, and all laws, rules, regulations, manuals, orders and administrative guidelines of all Governmental Authorities promulgated pursuant to or in connection with such program (whether or not having the force of law), in each case as the same may be amended, supplemented or otherwise modified from time to time.

“TRICARE Receivable”: an Account payable pursuant to TRICARE.

“Vehicles”: means all vehicles covered by a certificate of title law of any state.

1.2Other Definitional Provisions. (a) The words “hereof”, “herein”, “hereto” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section and Schedule references are to this Agreement unless otherwise specified.

(b) The meanings given to terms defined herein shall be equally applicable to both the singular and plural forms of such terms.

(c)Where the context requires, terms relating to the Collateral or any part thereof, when used in relation to a Grantor, shall refer to such Grantor's Collateral or the relevant part thereof.

SECTION 2. RESERVED

SECTION 3. GRANT OF SECURITY INTEREST

Each Grantor hereby collaterally assigns and transfers to the Collateral Agent, and hereby grants to the Collateral Agent (and confirms its original collateral arrangement and grant under the

Original Collateral Agreement), for the ratable benefit of the Secured Parties, a security interest in all of the following property now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the “Collateral”), as collateral security for the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of such Grantor's Obligations:

(a)all Accounts;

(b)all Chattel Paper;

(c)all Commercial Tort Claims, including those listed on Schedule 3.1;

(d)all Deposit Accounts;

(e)all Documents;

(f)all Equipment;

(g)all General Intangibles, including all Payment Intangibles;

(h)all Instruments;

(i)all Intellectual Property;

(j)all Inventory;

(k)all Investment Property;

(l)all Letter-of-Credit Rights;

(m)all Goods;

(n)all Collateral Accounts;

(o)all Vehicles;

(p)all property of any Grantor held by the Trustee, the Collateral Agent, any Holder, the Administrative Agent or any Lender, including all property of every description, in the possession or custody of or in transit to the Trustee, the Collateral Agent, any Holder, the Administrative Agent or any Lender for any purpose, including safekeeping, collection or pledge, for the account of such Grantor, or as to which such Grantor may have any right or power;

(q)all Other Collateral;

(r)all books and records pertaining to the Collateral; and

(s)to the extent not otherwise included, (i) all Proceeds and products of any and all of the foregoing, all Supporting Obligations in respect of any of the foregoing and all collateral security and guarantees given by any Person with respect to any of the foregoing; (ii) all present and future distributions, income, increases, profits, combinations, reclassifications, improvements and products of, accessions, attachments and other additions to, tools, parts and equipment used in connection with, and substitutes and replacements for, all or part of the Collateral described above; and (iii) all present and future accounts, contract rights, general intangibles, chattel paper, documents, instruments, cash and noncash proceeds, and other rights arising from or by virtue of, or from the voluntary or involuntary sale or other disposition of, or collections with respect to, or insurance proceeds payable with respect to, or proceeds payable by virtue of warranty or other claims against the manufacturer of, or claims against any other Person with respect to, all or any part of the Collateral heretofore described in this clause or otherwise;

provided that the Collateral shall not include the Excluded Assets.

Notwithstanding anything herein to the contrary, in no event shall the security interest granted hereunder attach to, nor shall “Collateral” include, any contract, agreement, instrument or indenture to which a Grantor is a party or any of its rights or interests thereunder if and for so long as the grant of such security interest shall constitute or result in (i) the unenforceability of any right of the Grantor therein or (ii) in a

breach or termination pursuant to the terms of, or a default under, any such contract or agreement (other than to the extent that any such term would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the New York UCC or any other applicable law or principles of equity); provided, however, that such security interest shall attach immediately at such time as the condition causing such unenforceability, breach, termination or default shall be remedied; provided, however, that any Receivable or any money or other amounts due or to become due under any such contract, agreement, instrument or indenture shall not be Excluded Assets; and provided, however, to the extent severable, such security interest shall attach immediately to any portion of such contract or agreement that does not result in any of the consequences specified in (i) or (ii) including any proceeds of such contract, agreement, instrument or indenture.

Notwithstanding the foregoing, the capital stock and securities of any Subsidiary Grantor will constitute Collateral with respect to the Notes only to the extent that the securing of the Notes with such capital stock and securities would not require such Subsidiary Grantor to file separate financial statements with the SEC under Rule 3-16 of Regulation S-X under the Securities Act. In the event that Rule 3-16 of Regulation S-X under the Securities Act requires or is amended, modified or interpreted by the SEC to require (or is replaced with another rule or regulation that would require) the filing with the SEC of separate financial statements of any Subsidiary Grantor due to the fact that such Subsidiary Grantor's capital stock and securities secure the Notes, then the capital stock and securities of such Subsidiary Grantor shall automatically be deemed not to be part of the Collateral (but only to the extent necessary for such Subsidiary Grantor to not be subject to such requirement to provide separate financial statements) and such excluded portion of the capital stock and securities is referred to as the “Excluded Stock Collateral”. In such event, the Notes Documents may be amended, modified or supplemented, without the consent of any Secured Party, to the extent necessary to release the security interests on the Excluded Stock Collateral. In the event that Rule 3-16 of Regulation S-X under the Securities Act is amended, modified or interpreted by the SEC to permit (or is replaced with another rule or regulation that would permit) any Subsidiary Grantor's Excluded Stock Collateral to secure the Notes in excess of the amount then pledged without the filing with the SEC of separate financial statements of such Subsidiary Grantor, then the capital stock and securities of such Subsidiary Grantor shall automatically be deemed to be a part of the Collateral (but only to the extent possible without such Subsidiary Grantor becoming subject to any such filing requirement). In such event, the Notes Documents may be amended or modified, without the consent of any Secured Party, to the extent necessary to subject to the Liens under the Notes Documents such additional capital stock and securities.

SECTION 4. REPRESENTATIONS AND WARRANTIES

Each Grantor represents, warrants and covenants to and with the Collateral Agent, for the benefit of the applicable Secured Parties, that:

4.1Representations in the Purchase Agreement and the Term Loan Agreement. (a) in the case of the Secured Parties (other than the Lenders, the Administrative Agent, the beneficiaries of each indemnification obligation undertaken by any Grantor under any Loan Document and the permitted successors and assigns of each of the foregoing), the representations and warranties set forth in Section 4 of the Purchase Agreement as they relate to the Issuer and such Subsidiary Grantor of the Notes Documents to which the Issuer and such Subsidiary Grantor is a party, each of which is hereby incorporated herein by reference, are true and correct in all material respects, and each Secured Party shall be entitled to rely on each of them as if they were fully set forth herein, provided that each reference in each such representation and warranty to the Issuer's knowledge shall, for the purposes of this Section 4.1, be deemed to be a reference to the Issuer's or such Subsidiary Grantor's knowledge, as applicable; and (b) in the case of the Secured Parties (other than the Holders, the Trustee, the beneficiaries of each

indemnification obligation undertaken by any Grantor under any Notes Document and the permitted successors and assigns of each of the foregoing), the representations and warranties set forth in Article III of the Term Loan Agreement as they relate to the Issuer and such Subsidiary Grantor of the Loan Documents to which the Issuer and such Subsidiary Grantor is a party, each of which is hereby incorporated herein by reference, are true and correct in all material respects, and each Secured Party shall be entitled to rely on each of them as if they were fully set forth herein, provided that each reference in each such representation and warranty to the Issuer's knowledge shall, for the purposes of this Section 4.1, be deemed to be a reference to the Issuer's or such Subsidiary Grantor's knowledge, as applicable.

4.1Title; No Other Liens. Except for the security interest granted to the Collateral Agent for the ratable benefit of the Secured Parties pursuant to this Agreement and the other Liens permitted to exist on the Collateral by the Indenture and the Term Loan Agreement, such Grantor owns each item of the Collateral free and clear of any and all Liens or claims of others. No financing statement or other public notice with respect to all or any part of the Collateral is on file or of record in any public office, except such as have been filed in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, pursuant to this Agreement or as are permitted by the Indenture or by the Term Loan Agreement or for which authorization to terminate has been provided by the secured party of record on or prior to the date hereof. For the avoidance of doubt, it is understood and agreed that any Grantor may, as part of its business, grant licenses to third parties to use Intellectual Property owned or developed by a Grantor. For purposes of this Agreement, the other Notes Documents and the other Loan Documents, such licensing activity shall not constitute a “Lien” on such Intellectual Property. Each of the Secured Parties understands that any such licenses may be exclusive to the applicable licensees, and such exclusivity provisions may limit the ability of the Collateral Agent to utilize, sell, lease or transfer the related Intellectual Property or otherwise realize value from such Intellectual Property pursuant hereto.

4.Perfected First Priority Liens. The security interests granted pursuant to this Agreement (a) upon completion of the filings and other actions specified on Schedule 3, (which, in the case of all filings and other documents referred to on said Schedule, have been delivered to the Collateral Agent in completed and, if and to the extent applicable, duly executed form) will constitute valid and continuing perfected security interests in all of the Collateral in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, as collateral security for such Grantor's Obligations, enforceable in accordance with the terms hereof against all creditors of such Grantor and any Persons purporting to purchase any Collateral from such Grantor and (b) are prior to all other Liens on the Collateral in existence on the date hereof except for Liens permitted by the Indenture or the Term Loan Agreement which have priority over the Liens on the Collateral by operation of law; provided however that no representation is made in this Section 4.3 as to the perfection of the security interests in (i) Vehicles, (ii) Deposit Accounts for which control agreements are not required pursuant to the terms hereof (including Government Receivable Accounts), (iii) Commercial Tort Claims, but only to the extent that such Commercial Tort Claims do not constitute Additional Commercial Tort Claims (as defined in Section 5.14) or (iv) Letter of Credit Rights, but only to the extent that the proceeds of the applicable letter of credit are not required to have been assigned to the Collateral Agent or for which the Collateral Agent is not required to have become the transferee beneficiary of such letter of credit, in each case pursuant to Section 5.19.

4.4Power and Authority. Each Grantor (i) has the power and authority to pledge the Collateral pledged by it hereunder in the manner hereby done or contemplated and (ii) will defend its title or interest thereto or therein against any and all Liens (other than any Lien created or permitted by the Notes Documents or the Loan Documents), however arising, of all persons whomsoever.

4.5Third-Party Approval. No consent or approval of any Governmental Authority, any securities exchange or any other person was or is necessary to the validity of the pledge effected hereby (other than such as have been obtained by such Grantor and are in full force and effect).

4.6Jurisdiction of Organization; Chief Executive Office. On the date hereof, such Grantor's exact legal name, jurisdiction of organization and identification number from the jurisdiction of organization (if any) are specified on Schedule 4. Such Grantor has furnished to the Collateral Agent a charter, certificate of incorporation or other organizational document certified by the corporate secretary of such Grantor and a good standing certificate as of a date which is recent to the date hereof.

4.7Farm Products. None of the Collateral constitutes, or is the Proceeds of, Farm Products.

4.8Investment Property. (a) The Pledged Stock, Pledged LLC Interests, and Pledged Partnership Interests pledged by such Grantor hereunder are set forth on Schedule 2 and constitute (i) all the issued and outstanding shares of all classes of the Capital Stock or other equity interest of each Investment Property Issuer owned by such Subsidiary Grantor or (ii) in the case of Foreign Corporation Voting Stock, if less, sixty-five percent (65%) of the outstanding Foreign Corporation Voting Stock of each relevant Investment Property Issuer.

(b)All the shares of the Pledged Stock have been duly and validly issued and are fully paid and nonassessable and are not subject to any restrictions other than restrictions imposed by applicable securities and corporate laws. Each Grantor has delivered to the Collateral Agent (i) all stock certificates, or other instruments representing or evidencing the Pledged Equity together with corresponding assignment or transfer powers duly executed in blank by the relevant Grantor, and such powers have been duly and validly executed and are binding and enforceable against each such Grantor in accordance with their terms or (ii) to the extent such Pledged Equity is uncertificated and held by a Securities Intermediary in a Securities Account, an executed securities account control agreement in form and substance satisfactory to the Collateral Agent with respect to such Pledged Stock.

(c)Each partnership, joint venture and limited liability company issuing the Pledged Partnership Interests and Pledged LLC Interests is duly organized, currently existing and in good standing under all applicable laws; there have been no amendments, modifications or supplements to any agreement or certificate creating any partnership, joint venture or limited liability company or any material contract relating to the partnerships, joint ventures or limited liability companies, of which the Collateral Agent has not been advised in writing; no default or breach or potential default or breach has occurred and is continuing under any partnership, joint venture or limited liability company agreement and no approval or consent of the partners, joint venturers or members, as the case may be, of any partnership, joint venture or limited liability company is required as a condition to the validity and enforceability of the security interest created hereby or the consummation of the transactions contemplated hereby which has not been duly obtained by the relevant Grantor. All capital contributions required to be made by the terms of the partnership, joint venture and limited liability company agreements for each partnership, joint venture and limited liability company have been made.

(d)Each of the Pledged Notes are set forth on Schedule 2 and (i) constitutes the legal, valid and binding obligation of the obligor with respect thereto, enforceable in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors' rights generally, general equitable principles (whether considered in a proceeding in equity or at law) and (ii) have been delivered to the Collateral Agent together with corresponding endorsements duly executed by the relevant Grantor in favor of Collateral Agent, and such endorsements have been duly and validly executed and are binding and

enforceable against the relevant Grantor in accordance with their terms. Each of the Pledged Notes and the documents evidencing the Pledged Notes are in full force and effect; there have been no renewals or extensions of, or amendments, modifications, or supplements to, any thereof about which the Collateral Agent has not been advised in writing; and no “default” or “potential default” has occurred and is continuing under any such Pledged Note or documents evidencing the Pledged Note. Such Grantor has good title to the Pledged Notes, and such Pledged Notes are free from any claim for credit, deduction or allowance and free from any defense, condition, dispute, setoff or counterclaim, and there is no extension or indulgence with respect thereto.

(e)Such Grantor is the record and beneficial owner of, and has good and marketable title to, the Investment Property pledged by it hereunder, free of any and all Liens or options in favor of, or claims of, any other Person, except the security interest created by this Agreement and other Liens permitted by the Indenture or the Term Loan Agreement. No Person other than the Collateral Agent has Control over any Investment Property of such Grantor (other than any Securities Intermediary or Commodities Intermediary having automatic Control).

4.9Receivables. No amount payable to such Grantor under or in connection with any Receivable is evidenced by any Instrument or Chattel Paper which has not been delivered to the Collateral Agent to the extent required by Section 5.2. All Collateral that is Accounts, contract rights, Chattel Paper, Instruments, Payment Intangibles or General Intangibles is free from any claim for credit, deduction or allowance of an obligor and free from any defense, condition, dispute, setoff or counterclaim, and there is no extension or indulgence with respect thereto, in each case that could reasonably be expected to have a Material Adverse Effect.

4.10Intellectual Property.

(a)Schedule 5 lists all Intellectual Property owned by such Grantor in its own name on the date hereof.

(b)On the date hereof, such Grantor owns, or is licensed to use, all Intellectual Property described on Schedule 5 necessary for the conduct of its business as currently conducted.

(c)No material claim has been asserted and is pending by any Person challenging or questioning such Grantor's use of any Intellectual Property or the validity or effectiveness of any of such Grantor's Intellectual Property that could reasonably be expected to have a Material Adverse Effect, nor does such Grantor know of any basis for any such claim.

(d)To the best knowledge of such Grantor, the use of such Intellectual Property by such Grantor does not infringe on the rights of any Person in a manner that could reasonably be expected to have a Material Adverse Effect.

(e)Grantors have performed and will continue to perform all acts and have paid and will continue to pay all required fees and taxes to maintain each and every item of the Intellectual Property in full force and effect throughout the world, as applicable.

4.11Inventory and Equipment. On the date hereof, Schedule 4.9 sets forth all locations in the United States where the aggregate value of Inventory and Equipment of the Grantors exceeds $250,000.

4.12Deposit Accounts; Securities Accounts; Commodity Accounts; Commercial Tort Claims. The only Deposit Accounts, Collateral Accounts, Securities Accounts or Commodity Accounts maintained by any Grantor on the Issue Date are those listed on Schedule 4.10, which sets forth such information separately for each Grantor. On the Closing Date, no Grantor holds any Commercial Tort Claims having a face value individually or in the aggregate in excess of $500,000, except as specified on Schedule 3.1.

4.13Letter-of-Credit Rights. Such Grantor is not a beneficiary or assignee under any letter of credit as of the Closing Date other than the letters of credit described on Schedule 4.11. Each letter of credit listed on Schedule 4.11 constitutes a Supporting Obligation for another item of the Collateral.

The foregoing representations and warranties will be true and correct in all respects with respect to any additional Collateral or additional specific descriptions of certain Collateral delivered to the Collateral Agent in the future by any Grantor. The failure of any of these representations or warranties or any description of Collateral therein to be accurate or complete shall not impair the security interest in any such Collateral.

SECTION 5. COVENANTS

Each Grantor covenants and agrees with the Collateral Agent for the benefit of the Secured Parties that, from and after the date of this Agreement until the Obligations shall have been paid in full:

5.1Covenants in Indenture, Purchase Agreement and Term Loan Agreement. Each Grantor shall comply with, perform, and be bound by all covenants and agreements in the Indenture, the Purchase Agreement and the Term Loan Agreement that are applicable to it, its assets or its operations, each of which is hereby ratified and confirmed (including the indemnification and related provisions in Section 8 of the Purchase Agreement, in the Indenture and in the Term Loan Agreement).

5.2Delivery of Instruments and Chattel Paper. If any amount payable under or in connection with any of the Collateral shall be or become evidenced by any Instrument, Certificated Security or Chattel Paper, such Instrument, Certificated Security or Chattel Paper shall be immediately delivered to the Collateral Agent, duly indorsed and accompanied by undated stock powers duly executed in blank or other undated instruments of transfer duly executed in blank and by such other instruments and documents as the Collateral Agent may reasonably request, to be held as Collateral pursuant to this Agreement; provided that the Grantors shall not be obligated to deliver to the Collateral Agent any Instruments or Chattel Paper held by any Grantor at any time to the extent that the aggregate face amount of all such Instruments and Chattel Paper held by all Grantors at such time does not exceed $500,000.

5.3Maintenance of Insurance. (a) Such Grantor will maintain, with financially sound and reputable companies, insurance policies (i) insuring the Inventory and Equipment against loss by fire, explosion, theft and such other casualties as is customary for similarly situated businesses and (ii) insuring such Grantor, the Secured Parties against liability for personal injury and property damage relating to such Inventory and Equipment, such policies to be in such form and amounts and having such coverage as is customary for similarly situated businesses.

(b)All such insurance shall (i) provide that no cancellation, material reduction in amount or material change in coverage thereof shall be effective until at least 30 days (10 days in the case of

nonpayment of premiums) after receipt by the Collateral Agent of written notice thereof and (ii) name the Collateral Agent as insured party or additional loss payee.

5.4Payment of Obligations. Such Grantor will pay and discharge or otherwise satisfy at or before maturity or before they become delinquent, as the case may be, all taxes, assessments and governmental charges or levies imposed upon the Collateral or in respect of income or profits therefrom, as well as all claims of any kind (including claims for labor, materials and supplies) against or with respect to the Collateral, except that no such charge need be paid if the amount or validity thereof is currently being contested in good faith by appropriate proceedings, reserves in conformity with GAAP with respect thereto have been provided on the books of such Grantor or to the extent that the failure to discharge or satisfy such obligations could not, in the aggregate, reasonably be expected to result in a material adverse effect on the Collateral.

5.5Maintenance of Perfected Security Interest; Further Documentation and Information. (a) Such Grantor shall maintain the security interest created by this Agreement as a perfected security interest (except as provided in Section 4.3) having at least the priority described in Section 4.3 and shall defend such security interest against the claims and demands of all Persons whomsoever.

(b)At any time and from time to time, at the sole expense of such Grantor, such Grantor will promptly and duly execute and deliver, and have recorded, such further instruments and documents and take such further actions (i) as are necessary for the purpose of obtaining or preserving the full benefits of this Agreement and of the rights and powers herein granted, including (A) the filing of any financing or continuation statements under the Uniform Commercial Code (or other similar laws) in effect in any jurisdiction with respect to the security interests created hereby; provided however that the Grantors shall not be required to note the security interest in any Vehicles on such Vehicle's certificate of title and (B) in the case of Investment Property, Deposit Accounts (other than Government Receivables Accounts) and any other relevant Collateral, delivering a deposit account control agreement substantially in the form attached hereto as Annex V or an executed securities account control agreement, in form and substance sufficient to enable the Collateral Agent to obtain Control with respect to such accounts, and taking any other actions necessary to enable the Collateral Agent to obtain Control with respect thereto, except for (x) Deposit Accounts into which Government Receivables are deposited by payors to the extent applicable law and regulations prohibit the Collateral Agent from obtaining Control over such Deposit Accounts and (y) subject to Section 8.20, the Deposit Accounts listed on Schedule 4.10 that are maintained with Bank of America, N.A. or (ii) as the Collateral Agent may reasonably request from time to time, including the delivery of landlord lien waivers and warehouseman letters pursuant to Section 5.15.

(c)Maintain, at the place where each Grantor is entitled to receive notices under the Notes Documents and the Loan Documents, a current record of where all its Collateral is located, permit representatives of the Collateral Agent at any time during normal business hours to inspect and make abstracts from such records, and furnish to the Collateral Agent such documents, lists, descriptions, certificates and other information as may be reasonably necessary or proper to keep the Collateral Agent informed with respect to the identity, location, status, condition and value of the Collateral. In addition, from time to time at the request of the Collateral Agent, deliver to the Collateral Agent such information regarding each such Grantor as the Collateral Agent may reasonably request.

(d)On each October 1 of each calendar year, the Issuer shall deliver to the Collateral Agent a certificate executed by an Officer of the Issuer:

(i)setting forth the information required in the Perfection Certificate or confirming that there has been no change in any such information since the date of the Perfection Certificate

delivered on the Closing Date or the date of the most recent certificate delivered pursuant to this Section;

(ii)identifying any Restricted Subsidiary that has been created or acquired since the date of the most recent certificate delivered pursuant to this Section 5.5;

(iii)certifying that all notices and information required to be given prior to the date of such certificate by this Section 5 have been given; and

(iv)certifying that the Grantors have complied with their obligations under this Section 5 with respect to the creation and maintenance of the validity, perfection and priority of the security interest required by this Agreement.

(e)The Grantors shall establish (or cause to be established), and shall at all times during the term of this Agreement maintain (or cause to be maintained), in accordance with all applicable laws and regulations, Government Receivables Accounts into which Government Receivables shall be initially deposited. The Grantors, the applicable depository bank maintaining the Government Receivables Accounts and the Collateral Agent shall execute and deliver on or prior to the Closing Date in respect of each Government Receivables Account in existence on the Closing Date, and with respect to any Government Receivables Account created after the Closing Date, on or prior to the creation of such Government Receivables Account, a Collection Account Agreement wherein the applicable Grantor shall direct each such depositary bank to transfer all amounts received in each Government Receivables Account, within 48 hours of the receipt thereof, to a deposit account established by the applicable Grantor to satisfy the requirements set forth in this clause and any additional or replacement deposit account otherwise satisfying the requirements set forth in this clause (the “Concentration Account”). Each Grantor agrees that (a) the Concentration Account shall at all times be subject to a deposit account control agreement in favor of the Collateral Agent, for the ratable benefit of the Secured Parties and (b) no Collection Account Agreement described in the previous sentence shall, at any time during the term of the Indenture or the Term Loan Agreement, be revoked, amended, withdrawn or otherwise modified in a manner adverse to the Secured Parties without the prior written consent of the Collateral Agent, acting at the direction of the Applicable Authorized Representative.

(f)In the event that the Issuer or any other Grantor is merged or consolidated with the Issuer or any other Grantor, as applicable;

(i)the surviving Person will cause such amendments or other instruments to be filed and recorded in such jurisdictions as may be required by applicable law to preserve and protect the perfected security interest on the Collateral (with the same priority described in Section 4.3) owned by or transferred to such Person, together with such financing statements as may be required to perfect any security interests in such Collateral which may be perfected by the filing of a financing statement under the Uniform Commercial Code of the relevant states;

(ii)the Collateral owned by or transferred to the surviving Person, as applicable, shall

(A) continue to constitute Collateral under the Notes Documents and the Loan Documents;

(B) be subject to the Lien in favor of the Collateral Agent; and

(iii)the assets of the Person which is merged or consolidated with or into the relevant surviving Person, to the extent that they are assets of the types which would constitute Collateral

under the Notes Documents and the Loan Documents and which would be required to be pledged thereunder, shall be treated as after acquired property and such surviving Person shall take such action as may be reasonably necessary to cause such assets to be made subject to the Lien of the Notes Documents and the Loan Documents in the manner and to the extent required in the Notes Documents, including the Indenture, and the Loan Documents, including the Term Loan Agreement (in each case with the same priority described in Section 4.3).

5.6Changes in Locations, Name, etc. Such Grantor will not, except upon 10 days' prior written notice to the Collateral Agent and the filing of all additional financing statements and other documents required to maintain the validity, perfection and priority of the security interests provided for herein:

(i)change its jurisdiction of organization from that referred to in Section 4.3;

(ii)change its legal name; or

(iii)change its identity or corporate structure.

5.7Investment Property. (a) If such Grantor shall become entitled to receive or shall receive any certificate (including any certificate representing a dividend or a distribution in connection with any reclassification, increase or reduction of capital or any certificate issued in connection with any reorganization), option or rights in respect of the Investment Property of any Investment Property Issuer, whether in addition to, in substitution of, as a conversion of, or in exchange for, any shares of the Pledged Equity, or otherwise in respect thereof, such Grantor shall accept the same as the agent of the Secured Parties, hold the same in trust for the Collateral Agent, for the ratable benefit of the Secured Parties and deliver the same forthwith to the Collateral Agent in the exact form received, duly indorsed by such Grantor to the Collateral Agent, if required, together with an undated stock power or other undated instruments of transfer reasonably satisfactory to the Collateral Agent, covering such certificate duly executed in blank by such Grantor and with, if the Collateral Agent so requests, signature guaranteed, to be held by the Collateral Agent, subject to the terms hereof, as additional collateral security for the Obligations, provided that in no event shall more than sixty five percent 65% of the total outstanding Foreign Corporation Voting Stock of any Foreign Corporation that is an Investment Property Issuer be pledged as collateral security hereunder. Any sums paid upon or in respect of the Investment Property of any Investment Property Issuer upon the liquidation or dissolution of such Investment Property Issuer shall be paid over to the Collateral Agent to be held by it hereunder as additional collateral security for the Obligations, and in case any distribution of capital shall be made on or in respect of the Investment Property, or any property shall be distributed upon or with respect to the Investment Property pursuant to the recapitalization or reclassification of the capital of any Investment Property Issuer or pursuant to the reorganization thereof, the property so distributed shall, unless otherwise subject to a perfected security interest in favor of the Collateral Agent, be delivered to the Collateral Agent to be held by it hereunder as additional collateral security for the Obligations. If any sums of money or property so paid or distributed in respect of the Investment Property shall be received by such Grantor, such Grantor shall, until such money or property is paid or delivered to the Collateral Agent, hold such money or property in trust for the Secured Parties, segregated from other funds of such Grantor, as additional collateral security for the Obligations. Notwithstanding the foregoing, the Grantors shall not be required to pay over to the Collateral Agent or deliver to the Collateral Agent as Collateral any proceeds of any liquidation or dissolution of any Investment Property Issuer, or any distribution of capital or property in respect of any Investment Property, to the extent that (i) such liquidation, dissolution or distribution, if treated as a Disposition of the relevant Investment Property Issuer, would be permitted by the Indenture and (ii) the proceeds thereof are applied toward prepayment of the Obligations to the extent required under the Indenture and the Term Loan Agreement.

(b)Without the prior written consent of the Collateral Agent, acting at the direction of the Applicable Authorized Representative, and unless such is permitted under the Indenture and the Term Loan Agreement, such Grantor will not (i) vote to enable, or take any other action to permit, any Investment Property Issuer to issue any stock or other equity securities of any nature or to issue any other securities convertible into or granting the right to purchase or exchange for any stock or other equity securities of any nature of such Investment Property Issuer, unless such securities are delivered to the Collateral Agent, concurrently with the issuance thereof, to be held by the Collateral Agent as Collateral (except in the case of any Investment Property Issuer which is a joint venture, provided that (x) the percentage of such joint venture owned by such Grantor remains the same after giving effect to such issuance and (y) any such securities are delivered to the Collateral Agent, currently with the issuance thereof, to be held by the Collateral Agent as Collateral), (ii) sell, assign, transfer, exchange or otherwise dispose of, or grant any option with respect to, the Investment Property or Proceeds thereof (except pursuant to a transaction permitted under the Indenture and the Term Loan Agreement), (iii) create, incur or permit to exist any Lien or option in favor of, or any claim of any Person with respect to, any of the Investment Property or Proceeds thereof, or any interest therein, except for the security interests created by this Agreement or permitted under the Indenture and the Term Loan Agreement or (iv) except as otherwise permitted under the Indenture and the Term Loan Agreement, enter into any agreement or undertaking restricting the right or ability of such Grantor or the Collateral Agent to sell, assign or transfer any of the Pledged Securities or Proceeds thereof.

(c)In the case of each Grantor that is an Investment Property Issuer, such Grantor agrees that (i) it will be bound by the terms of this Agreement relating to the Pledged Securities issued by it and will comply with such terms insofar as such terms are applicable to it, (ii) it will notify the Collateral Agent promptly in writing of the occurrence of any of the events described in Section 5.7(a) with respect to the Pledged Securities issued by it and (iii) the terms of Sections 6.3(c) and 6.7 shall apply to it, mutatis mutandis, with respect to all actions that may be required of it pursuant to Sections 6.3(c) or 6.7 with respect to the Pledged Securities issued by it.

(d)Each Investment Property Issuer that is a partnership, joint venture or a limited liability company (i) confirms that none of the terms of any equity interest issued by it provides that such equity interest is a “security” within the meaning of Sections 8-102 and 8-103 of the New York UCC (a “Security”), (ii) agrees that it will take no action to cause or permit any such equity interest to become a Security, (iii) agrees that it will not issue any certificate representing any such equity interest without the prior written consent of the Collateral Agent acting at the direction of the Applicable Authorized Representative, (iv) agrees that if, notwithstanding the foregoing, any such equity interest shall be or become a Security, such Investment Property Issuer will (and the Grantor that holds such equity interest hereby instructs such Investment Property Issuer to) comply with instructions originated by the Collateral Agent without further consent by such Grantor and (v) shall deliver to the Collateral Agent a fully-executed Acknowledgment of Pledge, substantially in the form of Annex VII for each Pledged Partnership Interest and Pledged LLC Interest.

5.8Receivables. Other than in the ordinary course of business consistent with its past practice, such Grantor will not (a) grant any extension of the time of payment of any Receivable, (b) compromise or settle any Receivable for less than the full amount thereof, (c) release, wholly or partially, any Person liable for the payment of any Receivable, (d) allow any credit or discount whatsoever on any Receivable or (e) amend, supplement or modify any Receivable in any manner that could adversely affect the value thereof, except where such grant, compromise, release, credit, discount, settlement, allowance, amendment, supplement or modification in the aggregate could not be reasonably expected to have a material adverse effect on the value of the Receivables.

5.9Intellectual Property. To the extent the failure to do so would be reasonably likely to result in a material adverse effect on the value of the Collateral:

(a)such Grantor (either itself or through licensees) will (i) continue to use each Trademark on each and every trademark class of goods applicable to its current line as reflected in its current catalogs, brochures and price lists in order to maintain such Trademark in full force free from any claim of abandonment for non-use, (ii) maintain as in the past the quality of products and services offered under such Trademark, (iii) use such Trademark with the appropriate notice of registration and all other notices and legends required by applicable Requirements of Law, (iv) not adopt or use any mark which is confusingly similar or a colorable imitation of such Trademark unless the Collateral Agent, for the ratable benefit of the Secured Parties, shall obtain a perfected security interest in such mark pursuant to this Agreement and (v) not (and not permit any licensee or sublicensee thereof to) do any act or knowingly omit to do any act whereby such Trademark may become invalidated or impaired in any way;

(b)such Grantor (either itself or through licensees) will not do any act, or omit to do any act, whereby any Patent may become forfeited, abandoned or dedicated to the public;

(c)such Grantor (either itself or through licensees) (i) will employ each Copyright and (ii) will not (and will not permit any licensee or sublicensee thereof to) do any act or knowingly omit to do any act whereby any portion of the Copyrights may become invalidated or otherwise impaired. Such Grantor will not (either itself or through licensees) do any act whereby any portion of the Copyrights may fall into the public domain;

(d)such Grantor (either itself or through licensees) will not do any act that knowingly uses any Intellectual Property to infringe the intellectual property rights of any other Person;

(e)such Grantor will notify the Collateral Agent, the Holders, the Administrative Agent and the Lenders immediately if it knows, or has reason to know, that any application or registration relating to any Intellectual Property may become forfeited, abandoned or dedicated to the public, or of any adverse determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, the United States Copyright Office or any court or tribunal in any country) regarding such Grantor's ownership of, or the validity of, any material Intellectual Property or such Grantor's right to register the same or to own and maintain the same;

(f)whenever such Grantor, either by itself or through any agent, employee, licensee or designee, shall file an application for the registration of any Intellectual Property with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency in any other country or any political subdivision thereof, such Grantor shall report such filing to the Collateral Agent within five Business Days after the last day of the fiscal quarter in which such filing occurs. Unless otherwise agreed to by the Collateral Agent, such Grantor will execute and deliver to the Collateral Agent for filing in (i) the United States Copyright Office a short-form copyright security agreement substantially in the form attached hereto as Annex II, (ii) the United States Patent and Trademark Office a short-form patent security agreement substantially in the form attached hereto as Annex III and (iii) the United States Patent and Trademark Office a short-form trademark security agreement substantially in the form attached hereto as Annex IV (in each case with such changes as may be agreed to by the Collateral Agent). Such Grantor shall execute and deliver, and have recorded, any and all additional agreements, instruments, documents and papers as may be necessary to evidence the Collateral Agent's and the Secured Parties' security interest in any Copyright, Patent or Trademark and the goodwill and general intangibles of such Grantor relating thereto or represented thereby;

(g)such Grantor will take all reasonable and necessary steps, including in any proceeding before the United States Patent and Trademark Office, the United States Copyright Office or

any similar office or agency in any other country or any political subdivision thereof, to maintain and pursue each application relating to any Intellectual Property (and to obtain the relevant registration) and to maintain each registration of the Intellectual Property, including filing of applications for renewal, affidavits of use and affidavits of incontestability; and

(h)in the event that any Intellectual Property is infringed, misappropriated or diluted by a third party, such Grantor shall (i) take such actions as such Grantor shall reasonably deem appropriate under the circumstances to protect such Intellectual Property and (ii) promptly notify the Collateral Agent after it learns thereof and sue for infringement, misappropriation or dilution, to seek injunctive relief where appropriate and to recover any and all damages for such infringement, misappropriation or dilution.

5.10Notices. (a) Except as may be otherwise expressly permitted under the Indenture and the Term Loan Agreement, each relevant Grantor shall promptly notify the Collateral Agent of (i) any change in any fact or circumstances represented or warranted by such Grantor with respect to any of the Collateral or Obligations, (ii) any claim, action or proceeding affecting title to all or any of the Collateral or the security interest created hereunder and appear in and defend, at the Grantors' expense, any such action or proceeding, (iii) any material change in the nature of the Collateral, (iv) any material damage to or loss of Collateral and (v) the occurrence of any other event or condition (including matters as to Lien priority) that could have a material adverse effect on the Collateral (taken as a whole) or the security interest created hereunder and (b) give the Collateral Agent thirty (30) days written notice before any proposed relocation of its principal place of business or chief executive office.

5.11Impairment of Collateral. Not use any of the Collateral, or permit the same to be used, for any unlawful purpose, in any manner that is reasonably likely to adversely impair the value or usefulness of the Collateral, or in any manner inconsistent with the provisions or requirements of any policy of insurance thereon nor affix or install any accessories, equipment or device on the Collateral or on any component thereof if such addition will impair the original intended function or use of the Collateral or such component.

5.12Pledged Notes. Without the prior written consent of the Collateral Agent not materially modify, or permit the material modification of, any Pledged Note or release any collateral with respect to any Pledged Note unless specifically required by the terms thereof.

5.13Schedules. Promptly update all schedules hereto if any information therein shall become inaccurate or incomplete in any material respect. Notwithstanding any other provision herein, any Grantor's failure to describe any Collateral required to be listed on any schedule hereto shall not impair the security interest in the Collateral.

5.14Commercial Tort Claims. If such Grantor shall at any time hold or acquire a Commercial Tort Claim other than or in addition to those set forth on Schedule 3.1 relating to any of the Collateral and having a face value individually or in the aggregate in excess of $1,000,000 (each such Commercial Tort Claim, an “Additional Commercial Tort Claim”), such Grantor shall promptly notify the Collateral Agent in a writing authenticated by such Grantor of the brief details of such Additional Commercial Tort Claim. Such Grantor shall grant to the Collateral Agent in such writing a security interest in such Additional Commercial Tort Claim and in the Proceeds thereof, all in accordance with and subject to the terms of this Agreement and such writing shall be in form and substance satisfactory to create a valid and perfected security interest in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, under the New York UCC. Each Grantor hereby agrees to execute and deliver any additional documents or instruments, including any financing statements or amendments to any then existing financing statements, that the Collateral Agent reasonably deems necessary to create, perfect and protect the Collateral Agent's Lien on and security interest in such Additional Commercial Tort Claim.

5.15Landlord Lien Waivers and Warehouseman Letters. Upon the request of the Collateral Agent, acting at the direction of the Applicable Authorized Representative, with respect to locations where the aggregate value of Inventory, Equipment or other tangible personal property of the Grantors on hand exceeds $1,000,000, Grantors shall use their commercially reasonable efforts to deliver to Collateral Agent: (i) Landlord Waivers for leased locations, (ii) acknowledged Bailee Letters for locations where Inventory or Equipment is stored with a bailee and (iii) mortgagee waivers for locations subject to a mortgage in favor of a Secured Party other than the Collateral Agent.

5.16Encumbrances. No Grantor shall create, permit or suffer to exist, and each such Grantor shall defend the Collateral against, any lien or other encumbrance on the Collateral, and shall defend such Grantor's rights in the Collateral and the Collateral Agent's security interest in, the Collateral against the claims and demands of all Persons except those holding or claiming Liens permitted under the Indenture and the Term Loan Agreement. Such Grantor shall do nothing to impair the rights of the Collateral Agent in the Collateral.

5.17Warehouse Receipts Non-Negotiable. If any warehouse receipt or receipt in the nature of a warehouse receipt is issued in respect of any of the Collateral, each Grantor agrees that such warehouse receipt or receipt in the nature thereof shall not be “negotiable” (as such term is use in Section 7-104 of the New York UCC) unless such warehouse receipt or receipt in the nature thereof is delivered to the Collateral Agent.

5.18Limitations on Dispositions of Collateral. Such Grantor shall not sell, transfer, lease or otherwise dispose of the Collateral, or attempt, offer or contract to do so except as expressly permitted under the Indenture and the Term Loan Agreement.

5.19Letter of Credit Rights. If any Grantor is at any time a beneficiary of a letter of credit that has a face amount individually or in the aggregate in excess of $100,000 now or hereafter issued in favor of such Grantor, such Grantor shall promptly notify the Collateral Agent in a writing authenticated by such Grantor. Such Grantor shall either (i) arrange for the issuer and any confirmer of such letter of credit to consent to an assignment to the Collateral Agent of the proceeds of any drawing under the letter of credit or (ii) arrange for the Collateral Agent to become the transferee beneficiary of the letter of credit, with the Collateral Agent agreeing, in each case, that the proceeds of any drawing under the letter of credit are to be paid to the applicable Grantor unless an Event of Default has occurred and is continuing.

5.20Leasehold Mortgages. Upon the request of the Collateral Agent, acting at the direction of the Applicable Authorized Representative, each Grantor shall execute and deliver a mortgage, deed of trust, assignment of leases and rents, or other security document (a “Leasehold Mortgage”) granting a Lien on each parcel of real property and the improvements thereto leased by any Grantor (a “Leasehold Mortgaged Property”) under the laws of the applicable jurisdiction to cause such Leasehold Mortgaged Property to be subjected to a Lien having at least the priority described in Section 4.3 securing the Obligations and will take all such actions as shall be and customary in a transaction of this nature to grant and perfect such Lien, including to execute any and all further documents, financing statements, agreements and instruments, and take all such further actions (including (i) the filing and recording of financing statements, fixture filings, the Leasehold Mortgage and other documents, (ii) conducting lien searches and providing title insurance insuring the first priority Lien of the Mortgage subject only to Permitted Liens and including such endorsements as are customarily issued in connection with transactions of this nature, (iii) providing legal opinions and (iv) obtaining landlords' consents). Notwithstanding the foregoing, the Grantors shall not be required to execute and deliver a Leasehold Mortgage with respect to any Leasehold Mortgaged Property if such Grantor shall have determined in good faith that the higher of (a) the book value or (b) the fair market value of the requested Leasehold Mortgage is less than $3,000,000 and provided evidence of such determination to the Collateral Agent.

SECTION 6. REMEDIAL PROVISIONS

6.1Certain Matters Relating to Receivables. (a) At any time and from time to time after the occurrence and during the continuance of an Event of Default, upon the Collateral Agent's request, at the direction of the Applicable Authorized Representative, and at the expense of the relevant Grantor, such Grantor shall cause nationally recognized independent registered public accountants or other appropriately qualified experts to furnish to the Collateral Agent reports showing reconciliations, aging and test verifications of, and trial balances for, the Receivables.

(b)Each Grantor is hereby authorized to collect such Grantor's Receivables, subject to the Collateral Agent's direction and control after the occurrence and during the continuance of an Event of Default, and the Collateral Agent may curtail or terminate said authority at any time after the occurrence and during the continuance of an Event of Default. If required by the Collateral Agent, at the direction of the Applicable Authorized Representative, at any time after the occurrence and during the continuance of an Event of Default, any payments of Receivables, when collected by any Grantor, (i) shall be forthwith (and, in any event, within two Business Days) deposited by such Grantor in the exact form received, duly indorsed by such Grantor to the Collateral Agent if required, in a Collateral Account maintained under the sole dominion and control of the Collateral Agent, subject to withdrawal by the Collateral Agent for the account of the Secured Parties only as provided in Section 6.5 and (ii) until so turned over, shall be held by such Grantor in trust for the Collateral Agent, for the ratable benefit of the Secured Parties, segregated from other funds of such Grantor; provided however that insofar as the foregoing applies to Government Receivables or any other Receivables subject to Healthcare Laws, such actions shall be authorized only to the extent permitted by law and in a manner consistent with applicable law and regulations and with each Grantor agreeing to cooperate with the Collateral Agent to effectuate the foregoing. Each such deposit of Proceeds of Receivables shall be accompanied by a report identifying in reasonable detail the nature and source of the payments included in the deposit.

(c)Each Grantor shall deliver to the Collateral Agent all original and other documents evidencing, and relating to, the agreements and transactions which gave rise to the Receivables (except for any such original documents of which it is necessary or advisable for such Grantor to maintain possession in compliance with any Requirement of Law, in which case, a copy of such document shall be delivered), including all original orders, invoices and shipping receipts.

6.2Communications with Obligors; Grantors Remain Liable. (a) The Collateral Agent in its own name or in the name of others shall at the direction of the Applicable Authorized Representative at any time after the occurrence and during the continuance of an Event of Default, communicate with obligors under the Receivables to verify with them to the Collateral Agent's satisfaction the existence, amount and terms of any Receivables.

(b)Upon the request of the Collateral Agent, at the direction of the Applicable Authorized Representative, at any time after the occurrence and during the continuance of an Event of Default, each Grantor shall notify obligors on the Receivables that the Receivables have been assigned to the Collateral Agent for the ratable benefit of the Secured Parties and that payments in respect thereof shall be made directly to the Collateral Agent; provided however that insofar as the foregoing applies to Government Receivables, such actions shall be required only to the extent permitted by law and in a manner consistent with applicable law and regulations.

(c)Anything herein to the contrary notwithstanding, each Grantor shall remain liable under each of the Receivables (or any agreement giving rise thereto) to observe and perform all the conditions and obligations to be observed and performed by it thereunder, all in accordance with the terms of any agreement giving rise thereto. No Secured Party shall have any obligation or liability under any Receivable (or any agreement giving rise thereto) by reason of or arising out of this Agreement or the receipt by any Secured Party of any payment relating thereto, nor shall any Secured Party be obligated in any manner to perform any of the obligations of any Grantor under or pursuant to any Receivable (or any agreement giving rise thereto), to make any payment, to make any inquiry as to the nature or the sufficiency of any payment received by it or as to the sufficiency of any performance by any party thereunder, to present or file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned to it or to which it may be entitled at any time or times.

6.3Pledged Securities. (a) Unless an Event of Default shall have occurred and be continuing and the Collateral Agent shall have given written notice to the relevant Grantor of the Collateral Agent's intent to exercise its corresponding rights pursuant to Section 6.3(b) (which notice shall be deemed to have been given immediately upon the occurrence of an Event of Default under Sections 6.01(7) or 6.01(8) of the Indenture or under paragraphs (g) or (h) of Article VII of the Term Loan Agreement), each Grantor shall be permitted to receive all cash dividends paid in respect of the Pledged Equity and all payments made in respect of the Pledged Notes and to exercise all voting and corporate rights with respect to the Pledged Securities; provided however that no vote shall be cast or corporate right exercised or other action taken which could reasonably be expected to impair the Collateral or which would be inconsistent with or result in any violation of any provision of the Indenture, this Agreement, any other Notes Document, the Term Loan Agreement or any other Loan Document.

(b)If an Event of Default shall occur and be continuing and the Collateral Agent, at the direction of the Applicable Authorized Representative, gives notice (or shall be deemed to have given notice pursuant to Section 6.3(a)) of its intent to exercise such rights to the relevant Grantor or Grantors, (i) the Collateral Agent shall have the right to receive any and all cash dividends, payments or other Proceeds paid in respect of the Pledged Securities and make application thereof to the Obligations in the order set forth in Section 6.5 and (ii) any or all of the Pledged Securities shall be registered in the name of the Collateral Agent or its nominee, and the Collateral Agent or its nominee may thereafter exercise (x) all voting, corporate and other rights pertaining to such Pledged Securities at any meeting of shareholders of the relevant Investment Property Issuer or Investment Property Issuers or otherwise and (y) any and all rights of conversion, exchange and subscription and any other rights, privileges or options pertaining to such Pledged Securities as if it were the absolute owner thereof (including the right to exchange at its

discretion any and all of the Pledged Securities upon the merger, consolidation, reorganization, recapitalization or other fundamental change in the corporate structure of any Investment Property Issuer, or upon the exercise by any Grantor or the Collateral Agent of any right, privilege or option pertaining to such Pledged Securities, and in connection therewith, the right to deposit and deliver any and all of the Pledged Securities with any committee, depositary, transfer agent, registrar or other designated agency upon such terms and conditions as the Collateral Agent may determine), all without liability except to account for property actually received by it, but the Collateral Agent shall have no duty to any Grantor to exercise any such right, privilege or option and shall not be responsible for any failure to do so or delay in so doing.

(c)Each Grantor hereby authorizes and instructs each Investment Property Issuer of any Pledged Securities pledged by such Grantor hereunder to (i) comply with any instruction received by it from the Collateral Agent in writing that (x) states that an Event of Default has occurred and is continuing and (y) is otherwise in accordance with the terms of this Agreement, without any other or further instructions from such Grantor, and each Grantor agrees that each Investment Property Issuer shall be fully protected in so complying and (ii) pay any dividends or other payments with respect to the Pledged Securities directly to the Collateral Agent, to the extent such dividend or payment to the relevant Grantor is prohibited under this Agreement, the Indenture or the Term Loan Agreement.

6.4Proceeds to be Turned Over To Collateral Agent. In addition to the rights of the Secured Parties specified in Section 6.1 with respect to payments of Receivables, if an Event of Default shall occur and be continuing, at the written request of the Collateral Agent, at the direction of the Applicable Authorized Representative, all Proceeds received by any Grantor consisting of cash, checks and Instruments shall be held by such Grantor in trust for the Collateral Agent, for the ratable benefit of the Secured Parties, segregated from other funds of such Grantor, and shall, forthwith upon receipt by such Grantor, be turned over to the Collateral Agent in the exact form received by such Grantor (duly indorsed by such Grantor to the Collateral Agent, if required); provided however that insofar as the foregoing applies to Government Receivables, such actions shall be required only to the extent permitted by law and in a manner consistent with applicable law and regulations. All Proceeds received by the Collateral Agent hereunder shall be held by the Collateral Agent in a Collateral Account maintained under its sole dominion and control. All Proceeds while held by the Collateral Agent in a Collateral Account (or by such Grantor in trust for the Collateral Agent, for the ratable benefit of the Secured Parties), shall continue to be held as collateral security for all the Obligations and shall not constitute payment thereof until applied as provided in Section 6.5.

6.5Application of Proceeds. If an Event of Default shall have occurred and be continuing, at any time at the Collateral Agent's election, at the direction of the Applicable Authorized Representative, the Collateral Agent may apply all or any part of Proceeds constituting Collateral, whether or not held in any Collateral Account, and any proceeds of the guarantee, in payment of the Obligations in the following order:

First, to pay all costs and expenses incurred by the Trustee and the Collateral Agent (if not the Trustee) in connection with the collection of proceeds or sale of any Collateral or otherwise in connection with the Indenture, the other Notes Documents, the Term Loan Agreement and the other Loan Documents, including all court costs and the fees and expenses of its agents and legal counsel, the repayment of all advances made by the Trustee and the Collateral Agent (if not the Trustee) on behalf of the Issuer or any other Grantor and any other costs or expenses incurred in connection with the exercise of any right or remedy of the Holders and the Lenders and such other Obligations;

Second, to the Trustee and the Administrative Agent, as their interests may appear, for application by each of them towards payment of the Notes and the Loans, any accrued and unpaid interest thereon and such other Obligations on a pro rata basis based on the respective amount of

the Notes, the Loans and other Obligations then outstanding as determined in accordance with Article III of the Term Loan Agreement Pari Passu Intercreditor Agreement; and

Third, to the extent of any balance of such Proceeds after application in accordance with the foregoing, to the Issuer or such other Grantor, as applicable, their successors or assigns, or as a court of competent jurisdiction may otherwise direct.

6.6NY UCC and Other Remedies. If an Event of Default shall occur and be continuing, the Collateral Agent, on behalf of the Secured Parties, may, whether or not at the direction of the Applicable Authorized Representative, and shall at the direction of the Applicable Authorized Representative, exercise all remedies, in addition to all other rights and remedies granted to them in this Agreement and in any other instrument or agreement securing, evidencing or relating to the Obligations, all rights and remedies of a secured party under the New York UCC or any other applicable law. Without limiting the generality of the foregoing, the Collateral Agent, without demand of performance or other demand, presentment, protest, advertisement or notice of any kind (except any notice required by law referred to below) to or upon any Grantor or any other Person (all and each of which demands, defenses, advertisements and notices are hereby waived), may in such circumstances forthwith enter upon the premises of any Grantor where any Collateral is located through self-help, without judicial process, without first obtaining a final judgment or giving such Grantor or any other Person notice and opportunity for a hearing on Collateral Agent's claim or action and may collect, receive, appropriate and realize upon the Collateral, or any part thereof, and/or may forthwith sell, lease, assign, give option or options to purchase, or otherwise dispose of and deliver the Collateral or any part thereof (or contract to do any of the foregoing), in one or more parcels at public or private sale or sales, at any exchange, broker's board or office of any Secured Party or elsewhere upon such terms and conditions as it may deem advisable and at such prices as it may deem best, for cash or on credit or for future delivery without assumption of any credit risk. Each Secured Party shall have the right upon any such public sale or sales, and, to the extent permitted by law, upon any such private sale or sales, to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption in any Grantor, which right or equity is hereby waived and released. Each Grantor further agrees, at the Collateral Agent's request, to assemble the Collateral and make it available to the Collateral Agent at places which the Collateral Agent shall reasonably select, whether at such Grantor's premises or elsewhere. The Collateral Agent shall apply the net proceeds of any action taken by it pursuant to this Section 6.6, after deducting all reasonable costs and expenses of every kind incurred in connection therewith or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights of the Secured Parties hereunder, including reasonable attorneys' fees and disbursements, to the payment in whole or in part of the Obligations, in such order as the Collateral Agent may elect, acting at the direction of the Applicable Authorized Representative, and only after such application and after the payment by the Collateral Agent of any other amount required by any provision of law, including Section 9-615(a)(3) of the New York UCC, need the Collateral Agent account for the surplus, if any, to any Grantor. To the extent permitted by applicable law, each Grantor waives all claims, damages and demands it may acquire against any Secured Party arising out of the exercise by them of any rights hereunder. If any notice of a proposed sale or other disposition of Collateral shall be required by law, such notice shall be deemed reasonable and proper if given at least 10 days before such sale or other disposition.

6.7Registration Rights. (a) Each Grantor agrees to cause such Investment Property Issuer to comply with the provisions of the securities or “Blue Sky” laws of any and all applicable jurisdictions applicable to any sale or disposition of Pledged Equity pursuant to this Agreement, and to make available to its security holders, as soon as practicable, an earnings statement (which need not be audited) which will satisfy the provisions of Section 11(a) of the Securities Act. (a) Each Grantor recognizes that the Collateral Agent may be unable to effect a public sale of any or all the Pledged Equity, by reason of certain prohibitions contained in the Securities Act and applicable state securities laws or

otherwise, and may be compelled to resort to one or more private sales thereof to a restricted group of purchasers which will be obliged to agree, among other things, to acquire such securities for their own account for investment and not with a view to the distribution or resale thereof. Each Grantor acknowledges and agrees that any such private sale may result in prices and other terms less favorable than if such sale were a public sale and, notwithstanding such circumstances, agrees that any such private sale shall be deemed to have been made in a commercially reasonable manner. The Collateral Agent shall be under no obligation to delay a sale of any of the Pledged Equity for the period of time necessary to permit the Investment Property Issuer thereof to register such securities for public sale under the Securities Act, or under applicable state securities laws, even if such Investment Property Issuer would agree to do so.

(b)Each Grantor agrees to use its best efforts to do or cause to be done all such other acts as may be necessary to make such sale or sales of all or any portion of the Pledged Equity pursuant to this Section 6.7 valid and binding and in compliance with any and all other applicable Requirements of Law; provided that no registration under the Securities Act shall be required. Each Grantor further agrees that a breach of any of the covenants contained in this Section 6.7 will cause irreparable injury to the Secured Parties, that the Secured Parties have no adequate remedy at law in respect of such breach and, as a consequence, that each and every covenant contained in this Section 6.7 shall be specifically enforceable against such Grantor, and such Grantor hereby waives and agrees not to assert any defenses against an action for specific performance of such covenants except for a defense that no Event of Default has occurred under the Indenture or the Term Loan Agreement, as applicable.

6.8Deficiency. Each Grantor shall remain liable for any deficiency if the proceeds of any sale or other disposition of the Collateral are insufficient to pay its Obligations and the fees and disbursements of any attorneys employed by any Secured Party to collect such deficiency.

6.9Sales on Credit. If the Collateral Agent sells any of the Collateral upon credit, Grantors will be credited only with payments actually made by the purchaser, received by the Collateral Agent and applied to the indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, the Collateral Agent may resell the Collateral and the Grantors shall be credited with the proceeds of the sale.

6.10Intellectual Property. For purposes of enabling the Collateral Agent to exercise its rights and remedies under this Agreement and enabling the Collateral Agent and its successors and assigns to enjoy the full benefits of the Collateral, each Grantor hereby grants to the Collateral Agent an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to such Grantor) to use, license or sublicense any of the Intellectual Property. Each Grantor shall provide the Collateral Agent with reasonable access to all media in which any of the Intellectual Property may be recorded or stored and all computer programs used for the completion or printout thereof. This license shall also inure to the benefit of all successors, assigns and transferees of the Collateral Agent. Upon the occurrence of an Event of Default, the Collateral Agent may require that each Grantor assign all of its right, title, and interest in and to the Intellectual Property or any part thereof to the Collateral Agent or such other Person as the Collateral Agent may designate pursuant to documents satisfactory to the Collateral Agent. If no Event of Default exists, each Grantor shall have the exclusive, non-transferable right and license to use its Intellectual Property in the ordinary course of business and the exclusive right to grant to other Persons licenses and sublicenses with respect to the Intellectual Property for full and fair consideration.

SECTION 7. THE COLLATERAL AGENT

7.1Collateral Agent's Appointment as Attorney-in-Fact, etc. (a) Each Grantor hereby irrevocably constitutes and appoints the Collateral Agent and any officer or agent thereof, with full

power of substitution, as its true and lawful attorney-in-fact with full irrevocable power and authority in the place and stead of such Grantor and in the name of such Grantor or in its own name, for the purpose of carrying out the terms of this Agreement, to take any and all appropriate action and to execute any and all documents and instruments which may be necessary or desirable to accomplish the purposes of this Agreement, and, without limiting the generality of the foregoing, each Grantor hereby gives the Collateral Agent the power and right, on behalf of such Grantor, without notice to or assent by such Grantor, to do any or all of the following:

(i)in the name of such Grantor or its own name, or otherwise, take possession of and indorse and collect any checks, drafts, notes, acceptances or other instruments for the payment of moneys due under any Receivable or with respect to any other Collateral and file any claim or take any other action or proceeding in any court of law or equity or otherwise deemed appropriate by the Collateral Agent for the purpose of collecting any and all such moneys due under any Receivable or with respect to any other Collateral whenever payable;

(ii)in the case of any Intellectual Property, execute and deliver, and have recorded, any and all agreements, instruments, documents and papers as the Collateral Agent may request to evidence the Secured Parties' security interest in such Intellectual Property and the goodwill and general intangibles of such Grantor relating thereto or represented thereby;

(iii)pay or discharge taxes and Liens levied or placed on or threatened against the Collateral, effect any repairs or any insurance called for by the terms of this Agreement and pay all or any part of the premiums therefor and the costs thereof;

(iv)execute, in connection with any sale provided for in Sections 6.6 or 6.7, any indorsements, assignments or other instruments of conveyance or transfer with respect to the Collateral; and

(v)(1) direct any party liable for any payment under any of the Collateral to make payment of any and all moneys due or to become due thereunder directly to the Collateral Agent or as the Collateral Agent shall direct; (2) ask or demand for, collect and receive payment of and receipt for, any and all moneys, claims and other amounts due or to become due at any time in respect of or arising out of any Collateral; (3) sign and indorse any invoices, freight or express bills, bills of lading, storage or warehouse receipts, drafts against debtors, assignments, verifications, notices and other documents in connection with any of the Collateral; (4) commence and prosecute any suits, actions or proceedings at law or in equity in any court of competent jurisdiction to collect the Collateral or any portion thereof and to enforce any other right in respect of any Collateral; (5) defend any suit, action or proceeding brought against such Grantor with respect to any Collateral; (6) settle, compromise or adjust any such suit, action or proceeding and, in connection therewith, give such discharges or releases as the Collateral Agent may deem appropriate; (7) assign any Copyright, Patent or Trademark (along with the goodwill of the business to which any such Copyright, Patent or Trademark pertains), throughout the world for such term or terms, on such conditions, and in such manner, as the Collateral Agent shall in its sole discretion determine; and (8) generally, sell, transfer, pledge and make any agreement with respect to or otherwise deal with any of the Collateral as fully and completely as though the Collateral Agent were the absolute owner thereof for all purposes, and do, at the Collateral Agent's option and such Grantor's expense, at any time, or from time to time, all acts and things which the Collateral Agent deems necessary to protect, preserve or realize upon the Collateral and the Secured Parties' security interests therein and to effect the intent of this Agreement, all as fully and effectively as such Grantor might do.

Anything in this Section 7.1(a) to the contrary notwithstanding, the Collateral Agent agrees that it will not be entitled to exercise any rights under the power of attorney provided for in this Section 7.1(a) unless an Event of Default shall have occurred and be continuing.

(b)If any Grantor fails to perform or comply with any of its agreements contained herein, the Collateral Agent, at its option, but without any obligation so to do, may perform or comply, or otherwise cause performance or compliance, with such agreement.

(c)The expenses of the Collateral Agent incurred in connection with actions undertaken as provided in this Section 7.1, together with interest thereon at a rate per annum equal to the rate per annum at which interest would then be payable on interest payments past due under the Indenture, from the date of payment by the Collateral Agent to the date reimbursed by the relevant Grantor, shall be payable by such Grantor to the Collateral Agent on demand.

(d)Each Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof. All powers, authorizations and agencies contained in this Agreement are coupled with an interest and are irrevocable until this Agreement is terminated and the security interests created hereby are released.

7.1Duty of Collateral Agent. (a) Beyond the exercise of reasonable care in the custody thereof, the Collateral Agent shall have no duty as to any Collateral in its possession or control or in the possession or control of any agent or bailee or any income thereon or as to preservation of rights against prior parties or any other rights pertaining thereto and the Collateral Agent shall not be responsible for filing any financing or continuation statements or recording any documents or instruments in any public office at any time or times or otherwise perfecting or maintaining the perfection of any security interest in the Collateral. The Collateral Agent shall be deemed to have exercised reasonable care in the custody of the Collateral in its possession if the Collateral is accorded treatment substantially equal to that which it accords its own property and shall not be liable or responsible for any loss or diminution in the value of any of the Collateral, by reason of the act or omission of any carrier, forwarding agency or other agent or bailee selected by the Collateral Agent in good faith.

(b)The Collateral Agent shall not be responsible for the existence, genuineness or value of any of the Collateral or for the validity, perfection, priority or enforceability of the Liens in any of the Collateral, whether impaired by operation of law or by reason of any of any action or omission to act on its part hereunder, except to the extent such action or omission constitutes gross negligence, bad faith or willful misconduct on the part of the Collateral Agent, for the validity or sufficiency of the Collateral or any agreement or assignment contained therein, for the validity of the title of the Grantors to the Collateral, for insuring the Collateral or for the payment of taxes, charges, assessments or Liens upon the Collateral or otherwise as to the maintenance of the Collateral.

(c)The powers conferred on the Secured Parties hereunder are solely to protect the Secured Parties' interests in the Collateral and shall not impose any duty upon any Secured Party to exercise any such powers. The Secured Parties shall be accountable only for amounts that they actually receive as a result of the exercise of such powers, and neither they nor any of their officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder, except for their own gross negligence or willful misconduct.

7.3Financing Statements. Each Grantor agrees to record and file, at its own expense, financing statements (and continuation statements when applicable) with respect to the Collateral now existing or hereafter created meeting the requirements of applicable state law in such manner and in such jurisdictions as are necessary to perfect, and maintain perfected the Collateral, and to promptly deliver a file stamped copy of each such financing statement or other evidence of filing to the Collateral Agent. The Collateral Agent shall be under no obligation whatsoever to file such financing or continuation statements or to make any other filing under the UCC hereunder.

7.4Authority of Collateral Agent. Each Grantor acknowledges that the rights and responsibilities of the Collateral Agent under this Agreement with respect to any action taken by the

Collateral Agent or the exercise or non-exercise by the Collateral Agent of any option, voting right, request, judgment or other right or remedy provided for herein or resulting or arising out of this Agreement shall, as between the Collateral Agent and the Secured Parties, be governed by the Indenture, the Term Loan Agreement and the Term Loan Agreement Pari Passu Intercreditor Agreement, as applicable, and by such other agreements with respect thereto as may exist from time to time among them, but, as between the Collateral Agent and the Grantors, the Collateral Agent shall be conclusively presumed to be acting as agent for the Secured Parties with full and valid authority so to act or refrain from acting, and no Grantor shall be under any obligation, or entitlement, to make any inquiry respecting such authority.

7.5Certain Rights of Collateral Agent. (a) The Collateral Agent may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties.

(b)The Collateral Agent may consult with counsel of its selection and the advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.

(c)The Collateral Agent shall be under no obligation to exercise any of the rights or powers vested in it by this Agreement at the request or direction of any of the Required Holders or Required Lenders pursuant to this Agreement, unless such Holders or Lenders shall have offered to the Collateral Agent security or indemnity satisfactory to the Collateral Agent against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.

(d)The Collateral Agent may execute any of its powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and may employ or retain such counsel, accountants, appraisers or other experts or advisers as it may reasonably require for the purpose of determining and discharging its rights and duties hereunder and the Collateral Agent shall not be responsible for any misconduct on the part of any of them.

(e)The Collateral Agent shall not be liable for any action taken, suffered, or omitted to be taken by it in good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Agreement.

(f)In no event shall the Collateral Agent be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Collateral Agent has been advised of the likelihood of such loss or damage and regardless of the form of action.

(g)The Collateral Agent shall not be deemed to have notice of any Event of Default unless a responsible officer of the Collateral Agent has actual knowledge thereof or unless written notice of any event which is in fact such a default is received by the Collateral Agent at its corporate trust office, and such notice references this Agreement.

(h)In no event shall the Collateral Agent be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Collateral Agent shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.

(i)The rights, privileges, protections, immunities and benefits given to the Trustee under the Indenture and to the Administrative Agent under the Term Loan Agreement, including, without limitation, the right to be indemnified, are extended to, and shall be enforceable by, the Collateral Agent hereunder, and by each agent, custodian and other Person employed to act hereunder.

(j)The rights and powers granted to the Collateral Agent hereunder are being granted in order to preserve and protect the security interest of the Collateral Agent and the other Secured Parties in and to the Collateral granted hereby and shall not be interpreted to, and shall not, impose any duties on the Collateral Agent in connection therewith.

(k)Notwithstanding anything in this Agreement to the contrary and for the avoidance of doubt, the Collateral Agent shall have no duty to act outside of the United States in respect of any Collateral located in the jurisdiction other than the United States (“Foreign Collateral”) but shall at the specific request of the Applicable Authorized Representative appoint a Person or Persons selected by the Applicable Authorized Representative to act on behalf of the Secured Parties with respect to such Foreign Collateral. Such qualified Person or Persons and the Collateral Agent shall, provided the same are reasonably acceptable to the Collateral Agent, enter into a collateral assignment pledge agreement, mortgage, enforcing document or other security agreement to enforce rights with respect to Foreign Collateral and such Person or Persons shall exercise the rights and remedies of the Collateral Agent and the Secured Parties in the Foreign Collateral for their respective benefit. The duties and responsibilities of the Collateral Agent with respect to any Person or Persons and any Collateral are limited to those set forth in this Section.

SECTION 8. MISCELLANEOUS

8.1Amendments in Writing. None of the terms or provisions of this Agreement may be waived, amended, supplemented or otherwise modified except in accordance with the Indenture and the Term Loan Agreement; provided that any waiver, amendment, supplement or modification of this Agreement that by its terms affects only the Indenture or the Term Loan Agreement may be waived, amended, supplemented or modified in accordance with the Indenture or the Term Loan Agreement, as applicable.

8.2Notices. All notices, requests and demands to or upon the Collateral Agent or any Grantor hereunder shall be effected in the manner provided for under the Indenture and the Term Loan Agreement; provided that any such notice, request or demand to or upon any Subsidiary Grantor shall be addressed to such Subsidiary Grantor at its notice address set forth on Schedule 1.

8.3No Waiver by Course of Conduct; Cumulative Remedies. Neither the Collateral Agent nor any other Secured Party shall by any act (except by a written instrument pursuant to Section 8.1), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any Event of Default. No failure to exercise, nor any delay in exercising, on the part of the Collateral Agent or any other Secured Party, any right, power or privilege hereunder shall operate as a waiver thereof. No single or partial exercise of any right, power or privilege hereunder shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. A waiver by the Collateral Agent or any other Secured Party of any right or remedy hereunder on any one occasion shall not be construed as a bar to any right or remedy which the Collateral Agent or such Secured Party would otherwise have on any future occasion. The rights and remedies herein provided are cumulative, may be exercised singly or concurrently and are not exclusive of any other rights or remedies provided by law.

8.4Enforcement Expenses; Indemnification. (a) Each Subsidiary Grantor agrees to pay, or reimburse each Secured Party for, all its costs and expenses incurred in collecting against such Subsidiary Grantor under the guarantee contained in the Indenture, the Term Loan Agreement Guarantee

or otherwise enforcing or preserving any rights under this Agreement, the other Notes Documents and the other Loan Documents to which such Subsidiary Grantor is a party, including the fees and disbursements of counsel (including the allocated fees and expenses of in-house counsel) to each Secured Party and of counsel to the Collateral Agent.

(b)Except to the extent otherwise provided in the Indenture or the Term Loan Agreement, each Subsidiary Grantor agrees to pay, and to save the Secured Parties harmless from, any and all liabilities with respect to, or resulting from any delay in paying, any and all stamp, excise, sales or other taxes which may be payable or determined to be payable with respect to any of the Collateral or in connection with any of the transactions contemplated by this Agreement.

(c)Each Grantor, jointly and severally, agrees to indemnify, and to save the Secured Parties harmless from, any and all liabilities, claims, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever with respect to the execution, delivery, enforcement, performance and administration of this Agreement to the extent such Grantor would be required to do so under the Indenture or the Term Loan Agreement.

(d)The agreements in this Section 8.4 shall survive repayment of the Obligations and all other amounts payable under the Indenture, the other Notes Documents, the Term Loan Agreement and the other Loan Documents.

8.5Subrogation. If any Obligation is given in renewal or extension or applied toward the payment of indebtedness secured by any Lien, the Collateral Agent shall be, and is hereby, subrogated to all of the rights, titles, interests and Liens securing the indebtedness so renewed, extended or paid.

8.6Successors and Assigns. This Agreement shall be binding upon the successors and assigns of each Grantor and shall inure to the benefit of the Secured Parties and their permitted successors and assigns; provided that no Grantor may assign, transfer or delegate any of its rights or obligations under this Agreement without the prior written consent of the Collateral Agent acting at the direction of the Applicable Authorized Representative.

8.7Setoff. Each Grantor hereby irrevocably authorizes each Secured Party at any time and from time to time, without notice to such Grantor or any other Grantor, any such notice being expressly waived by each Grantor, to setoff and appropriate and apply any and all deposits (general or special, time or demand, provisional or final), in any currency, and any other credits, indebtedness or claims, in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Secured Party to or for the credit or the account of such Grantor, or any part thereof in such amounts as such Secured Party may elect, against and on account of the obligations and liabilities of such Grantor to such Secured Party hereunder and claims of every nature and description of such Secured Party against such Grantor, in any currency, whether arising hereunder, under the Indenture, any other Notes Document, the Term Loan Agreement, any other Loan Document or otherwise, as such Secured Party may elect, whether or not such Secured Party has made any demand for payment and although such obligations, liabilities and claims may be contingent or unmatured. Each Secured Party shall notify such Grantor promptly of any such setoff and the application made by such Secured Party of the proceeds thereof, provided that the failure to give such notice shall not affect the validity of such setoff and application. The rights of each Secured Party under this Section 8.7 are in addition to other rights and remedies (including other rights of setoff) which such Secured Party may have.

8.8Counterparts. This Agreement may be executed by one or more of the parties to this Agreement on any number of separate counterparts (including by telecopy), and all of said counterparts taken together shall be deemed to constitute one and the same instrument.

8.9Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

8.10Section Headings. The Section headings used in this Agreement are for convenience of reference only and are not to affect the construction hereof or be taken into consideration in the interpretation hereof.

8.11Integration. This Agreement, the other Notes Documents and the other Loan Documents represent the agreement of the Grantors and the Secured Parties with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties by any Secured Party relative to subject matter hereof and thereof not expressly set forth or referred to herein, the other Notes Documents or the other Loan Documents.

8.12GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

8.13Submission To Jurisdiction; Waivers. Each party hereto hereby irrevocably and unconditionally:

(a)submits for itself and its property in any legal action or proceeding relating to this Agreement, the other Notes Documents and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the non‑exclusive general jurisdiction of the Courts of the State of New York, the courts of the United States of America for the Southern District of New York and appellate courts from any thereof;

(b)consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same;

(c)agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such Grantor at its address referred to in Section 8.2 or at such other address of which the Collateral Agent shall have been notified pursuant thereto;

(d)agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction; and

(e)waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this Section 8.13 any special, exemplary, punitive or consequential damages.

8.14Acknowledgments. Each party hereto hereby acknowledges that:

(a)it has been advised by counsel in the negotiation, execution and delivery of this Agreement, the other Notes Documents and the other Loan Documents to which it is a party;

(b)none of the Collateral Agent or any other Secured Party in its respective capacity as such has any fiduciary relationship with or duty to any Grantor arising out of or in connection with this Agreement, any of the other Notes Documents or any other Loan Documents, and the relationship between the Grantors, on the one hand, and the Secured Parties, on the other hand, in connection herewith or therewith is solely that of debtor and creditor; and

(c)no joint venture is created hereby, by the other Notes Documents, by the other Loan Documents or otherwise exists by virtue of the transactions contemplated hereby among the Secured Parties or among the Grantors and the Secured Parties.

8.15Additional Grantors. Each Subsidiary of the Issuer that is required to become a party to this Agreement under the Indenture or the Term Loan Agreement shall become a Subsidiary Grantor for all purposes of this Agreement upon execution and delivery by such Subsidiary of an Assumption Agreement in the form of Annex I hereto.

8.16Releases. (a) At such time as the Obligations shall have been paid in full, the Collateral shall be released from the Liens created hereby, and this Agreement and all obligations (other than those expressly stated to survive such termination) of the Collateral Agent and each Grantor hereunder shall terminate, all without delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall revert to the Grantors. At the request and sole expense of any Grantor following any such termination, the Collateral Agent shall deliver to such Grantor any Collateral held by the Collateral Agent hereunder, and execute and deliver to such Grantor such documents as such Grantor shall reasonably request to evidence such termination. Any release of Collateral pursuant hereto shall be without recourse to, or warranty by, the Collateral Agent.

(b)If any of the Collateral shall be sold, transferred or otherwise disposed of by any Grantor in a transaction permitted under the Indenture and the Term Loan Agreement, then the Collateral Agent, at the request and sole expense of such Grantor, shall execute and deliver to such Grantor all releases or other documents reasonably necessary or desirable for the release of the Liens created hereby on such Collateral. At the request and sole expense of the Issuer, a Subsidiary Grantor shall be released from its obligations hereunder in the event that all the Capital Stock of such Subsidiary Grantor shall be sold, transferred or otherwise disposed of in a transaction permitted under the Indenture and the Term Loan Agreement; provided that the Issuer shall have delivered to the Collateral Agent, at least five Business Days prior to the date of the proposed release, a written request for release identifying the relevant Subsidiary Grantor and a summary of the terms of the sale or other disposition in reasonable detail, including the price thereof and any expenses in connection therewith, together with a certification by the Issuer stating that such transaction is in compliance with the Indenture, the other Notes Documents and the other Loan Documents. Any release of Collateral pursuant hereto shall be without recourse to, or warranty by, the Collateral Agent.

(c)The Collateral shall be released in whole or in part from the Liens created hereby upon the occurrence of any event described in Section 11.02 of the Indenture. At the request and sole expense of any Grantor following any such termination, the Collateral Agent shall deliver to such Grantor any Collateral held by the Collateral Agent hereunder, and execute and deliver to such Grantor such documents as such Grantor shall reasonably request to evidence such termination. Any release of Collateral pursuant hereto shall be without recourse to, or warranty by, the Collateral Agent.

(d)Upon certification by any Grantor to the Collateral Agent that the maker of any Pledged Note has satisfied such maker's obligations under such Pledged Note in full, the Collateral Agent shall promptly return such Pledged Note to the address specified by such Grantor for return.

8.17WAIVER OF JURY TRIAL. THE COLLATERAL AGENT, EACH GRANTOR AND, BY ACCEPTANCE OF THE BENEFITS HEREOF, EACH SECURED PARTY, HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT, ANY OTHER NOTES DOCUMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN.

8.18Reinstatement. This Agreement shall remain in full force and effect and continue to be effective should any petition be filed by or against any Grantor for liquidation or

reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors or should a receiver or trustee be appointed for all or any significant part of any Grantor's assets, and shall continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Obligations, or any part thereof is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Obligations, whether as a “voidable preference”, “fraudulent conveyance” or otherwise, all as though such payment or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned.

8.19Pari Passu Indebtedness; Junior Lien Indebtedness; Intercreditor Agreements. (a) The Issuer may from time to time designate Indebtedness, to the extent then permitted by the Indenture and the Term Loan Agreement, to be secured by a Lien on the Collateral, in which case the Grantors shall (i) cause any representatives for such Indebtedness to enter into a Pari Passu Intercreditor Agreement (as defined in the Indenture) or Junior Lien Intercreditor Agreement (as defined in the Indenture), as applicable, and (ii) enter into and file such other agreements, amendments, financing statements or other documents as are necessary in order to comply with the requirements of this Agreement, the Indenture and the Term Loan Agreement. Each representative for such Indebtedness agrees to the appointment of the Collateral Agent as agent for the holders of such Indebtedness and such representative for such Indebtedness shall, on behalf of itself and each holder of such Indebtedness it represents, be bound by this Agreement.

(b)Upon receipt of an Officers' Certificate certifying compliance with the terms of the Note Documents and the Loan Documents, the Collateral Agent shall enter into a Pari Passu Intercreditor Agreement (as defined in the Indenture), including the Term Loan Agreement Pari Passu Intercreditor Agreement, or a Junior Lien Intercreditor Agreement (as defined in the Indenture), including the Junior Notes Intercreditor Agreement, as applicable, as contemplated by the definition of “Permitted Liens” set forth in the Indenture.

(c)Notwithstanding anything herein to the contrary, the security interest granted to the Collateral Agent pursuant to any Notes Document and any Loan Documents (including, without limitation, this Agreement) and the exercise of any right or remedy by the Collateral Agent hereunder, under any other Notes Document or under any other Loan Document are subject to the provisions of each Intercreditor Agreement, as applicable, including, in the case of this Agreement, the Term Loan Agreement Pari Passu Intercreditor Agreement and the Junior Notes Intercreditor Agreement. In the event of any conflict between the terms of any Intercreditor Agreement, this Agreement, any Notes Document and any Loan Document, the terms of the applicable Intercreditor Agreement, including, in the case of this Agreement, the Term Loan Agreement Pari Passu Intercreditor Agreement and the Junior Notes Intercreditor Agreement, shall govern and control with respect to any right or remedy (except for the rights of the Collateral Agent under Section 7 hereof).

8.20Bank of America Deposit Accounts. Each Grantor covenants and agrees that, as promptly as possible, but in any event no later than 45 days after the Issue Date, such Grantor shall (a) terminate each Deposit Account maintained with Bank of America, N.A. listed on Schedule 4.10 and any other Deposit Account maintained with Bank of America, N.A. with respect to which a deposit account control agreement in the form of Annex V has not been executed and delivered to the Collateral Agent and the Collateral Agent has not obtained Control (collectively, the “BofA Accounts”) and (b) deliver to the Collateral Agent evidence of each such termination. Notwithstanding the foregoing, the Grantors shall not be required to close such accounts and deliver such a deposit account control agreement with respect to (i) any single Deposit Account having less than $50,000 deposited therein on any day or (ii) Deposit Accounts having less than $250,000 in the aggregate deposited therein on any day. The failure of any

Grantor to comply with this Section 8.20 if such failure shall continue for 5 Business Days (without giving effect to any other grace period that may be provided for in any other Notes Document) shall constitute an Event of Default.

8.21Confirmation of Appointment of Collateral Agent. Each of the Secured Parties, by acceptance of the benefits conferred by this Agreement, hereby irrevocably confirms its appointment of The Bank of New York Mellon Trust Company, N.A. to act, and The Bank of New York Mellon Trust Company, N.A. ▇▇▇▇▇▇ agrees to act, as the Collateral Agent for the Secured Parties pursuant to the terms of this Agreement, the other Notes Documents and the other Loan Documents, and authorizes the Collateral Agent to take such actions on its behalf and to exercise such rights, powers and discretions as are delegated to the Collateral Agent by the terms of this Agreement, the other Notes Documents and the other Loan Documents, together with such actions and powers as are reasonably incidental thereto. Without limiting the generality of the foregoing, the Collateral Agent is hereby expressly authorized to execute any and all documents (including releases) with respect to the Collateral, and the rights of the Secured Parties with respect thereto, as contemplated by and in accordance with the provisions of this Agreement, the other Notes Documents and the other Loan Documents.

[Signatures begin on the Following Page]

IN WITNESS WHEREOF, each of the undersigned has caused this Collateral Agreement to be duly executed and delivered as of the date first above written.

ROTECH HEALTHCARE INC.

By:

Printed Name:

Title:

A-1 Medical Equipment, Inc.

Abba Medical Equipment, Inc.

Acadia Home Care,

Allied Medical Supply, Inc.

Always Medical Equipment, Inc.

▇▇▇▇ ▇▇▇▇'▇ InHome Medical, Inc., West

▇▇▇▇ ▇▇▇▇'▇ InHome Medical/InHome Medical Inc.

Anniston Health & Sickroom Supplies, Inc.

Berkeley Medical Equipment, Inc.

Best Care HHC Acquisition Company, LLC

Beta Medical Equipment, Inc.

Cambria Medical Supply, Inc.

Camden Medical Supply, Inc.

Care Medical Supplies, Inc.

Centennial Medical Equipment, Inc.

Charlotte Medical Supply, Inc.

▇▇▇▇▇▇▇ Rentals, Inc.

Community Home Oxygen, Inc.

Contour Medical Supply, Inc.

▇▇▇▇▇▇ Home Health Care, Inc.

CPO 2, Inc.

▇▇▇▇▇▇ Medical Systems, Inc.

Distinct Home Health Care, Inc.

▇▇▇ ▇▇▇▇ Respiratory Services, Inc.

DuMEd, Inc.

East Tennessee Infusion & Respiratory, Inc.

▇▇▇▇▇ County Home Medical Equipment, LLC

Encore Home Health Care, Inc.

Excel Medical of Fort Dodge, Inc.

Excel Medical of Marshalltown, Inc.

First Community Care of Niagara, Inc.

Firstcare, Inc.

▇▇▇▇▇▇▇ Medical Equipment, Inc.

Four Rivers Home Health Care, Inc.

G&G Medical, Inc.

Gate City Medical Equipment, Inc.

[Signature Page to Collateral Agreement]

Georgia Medical Resources, Inc.

[Signature Page to Collateral Agreement]

Gladwin Area Home Care, Inc.

▇▇▇▇▇▇▇▇ Medical Equipment Service, Inc.

Health Care Services of Mississippi, Incorporated,

Holland Medical Services, Inc.

Home Care Oxygen Service, Inc.

Home Medical Systems, Inc.

IHS Acquisition XXVII, Inc.

Integrated Health Services at Jefferson Hospital, Inc.

Intensive Home Care Services, Inc.

IOTA Medical Equipment, Inc.

LAMBDA Medical Equipment, Inc.

LAMS, Inc.

▇▇▇▇▇▇▇ Medical, Inc.

Major Medical Supply, Inc.

Medco Professional Services, Corp.

MedCorp International, Inc.

Medic-Aire Medical Equipment, Inc.

Medical Electro-Therapeutics, Inc.

Medicare Rental Supply, Inc.

Michigan Medical Supply, Inc.

National Medical Equipment Centers, Inc.

NeighborCare Home Medical Equipment, LLC

NeighborCare Home Medical Equipment of Maryland, LLC

▇▇▇▇▇▇▇'▇ Home Medical Equipment, Inc.

Nightingale Home Health Care, Inc.

North Central Washington Respiratory Care Services, Inc.

Northeast Medical Equipment, Inc.

Northwest Home Medical, Inc.

OMICRON Medical Equipment, Inc.

Oxygen of Oklahoma, Inc.

Oxygen Plus Medical Equipment, Inc.

Oxygen Plus, Inc.

Oxygen Therapy Associates, Inc.

▇▇▇▇▇▇▇▇'▇ Home Care, Inc.

PHI Medical Equipment, Inc.

Pioneer Medical Services, Inc.

Preferential Home Health Care, Inc.

Principal Medical Equipment, Inc.

Professional Breathing Associates, Inc.

Professional Respiratory Home Healthcare, Inc.

PSI Health Care, Inc.

Pulmo-Dose, Inc.

Qualicare Home Medical, Inc.

Quality Home Health Care, Inc.

R.C.P.S., Inc.

RCG Information Services Corporation

Regency Medical Equipment, Inc.

Resp-A-Care, Inc.

Respiracare Medical Equipment, Inc.

Respiratory Medical Equipment of Ga., Inc.

Respitech Home Health Care, Inc.

Responsive Home Health Care, Inc.

Rhema, Inc.

▇▇▇▇ Medical Group, Inc.

RN Home Care Medical Equipment Company, Inc.

Roswell Home Medical, Inc.

Rotech Employee Benefits Corporation,

Rotech Home Medical Care, Inc.

RoTech Oxygen and Medical Equipment, Inc.

▇▇▇▇ Medical, Inc.

▇▇▇▇▇▇▇'▇ Hospital Equipment, Inc.

▇▇▇▇▇▇▇ Convalescent Medical Supply, Inc.

Select Home Health Care, Inc.

SIGMA Medical Equipment, Inc.

Southeastern Home Health, Inc.

Sun Medical Supply, Inc.

Sunshine Home Health Care, Inc.

The ▇▇▇▇▇▇ Company

Theta Home Health Care, Inc.

Tupelo Home Health, Inc.

Valley Medical Equipment, Inc.

Value Care, Inc.

VitalCare Health Services, Inc.

VitalCare of Texas, Inc.

White's Medical Rentals, Inc.

Wichita Medical Care, Inc.

Zeta Home Health Care, Inc.

By: __________________________

Printed Name:

Title:

[Signature Page to Collateral Agreement]

Acknowledged and agreed:

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,

as Collateral Agent

By:__________________________

Printed Name:

Title

[Signature Page to Collateral Agreement]

EXECUTION VERSION

EXHIBIT E

[Form of] Guarantee Agreement

This GUARANTEE AGREEMENT (this “Guarantee”), dated as of _____________, 20___, is made by the subsidiaries of ROTECH HEALTHCARE INC. (the “Borrower”) identified on the signature pages hereto and any Additional Subsidiary Guarantor (as defined below) who may become a party to this Guarantee (each a “Subsidiary Guarantor” and collectively, the “Subsidiary Guarantors”), in favor of SILVER POINT FINANCE LLC, as Administrative Agent (in such capacity, the “Administrative Agent”) for the ratable benefit of itself and the Guaranteed Parties identified below.

PRELIMINARY STATEMENTS

Pursuant to the terms of the Term Loan Credit Agreement dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrower, the Lenders (as defined in the Credit Agreement), and the Administrative Agent, the Lenders have agreed to make loans to the Borrower upon the terms and subject to the conditions set forth therein.

Each Subsidiary Guarantor will benefit from the funding of loans made and to be made to the Borrower under the Credit Agreement.

Each Subsidiary Guarantor is required to enter into this Guarantee pursuant to the terms of the Credit Agreement.

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, and to induce the Administrative Agent and the Lenders to enter into the Credit Agreement and to induce the Lenders to make loans under the Credit Agreement to the Borrower thereunder, the Subsidiary Guarantors hereby agree with the Administrative Agent, for the ratable benefit of the Guaranteed Parties, as follows:

SECTION 1.Defined Terms. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed in the Credit Agreement. The following terms when used herein shall have the meanings set forth below:

“Additional Subsidiary Guarantor” means each subsidiary of the Borrower which hereafter becomes a Subsidiary Guarantor pursuant to Section 19 hereof and Section 5.12 of the Credit Agreement.

“Guaranteed Obligations” means (a) the full and punctual payment by the Borrower of (i) the principal of and interest on (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) the Loans, when and as due, whether at maturity, by acceleration or otherwise, and (ii) all other monetary obligations of the Borrower under the Credit Agreement or any other Loan Document, including obligations to pay fees, expense

EXECUTION VERSION

reimbursement obligations and indemnification obligations, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and (b) the full and punctual performance within applicable grace periods of all obligations of the Borrower under or pursuant to each Loan Document (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding).

“Guaranteed Parties” means (a) each Lender, (b) the Administrative Agent, (c) the beneficiaries of each indemnification obligation undertaken by any Loan Party under any Loan Document, and (d) the permitted successors and assigns of each of the foregoing.

SECTION 2.Guarantee. Each Subsidiary Guarantor unconditionally and irrevocably guarantees to each of the Guaranteed Parties, jointly and severally on a senior secured basis, with the other Subsidiary Guarantors and severally, as a primary obligor and not merely as a surety, by way of an independent payment obligation, the full and punctual payment and performance of the Guaranteed Obligations. Anything contained herein to the contrary notwithstanding, the obligations of each Subsidiary Guarantor hereunder at any time shall be limited to an aggregate amount equal to the largest amount that would not render its obligations hereunder subject to avoidance as a fraudulent transfer or conveyance under Section 548 of the Bankruptcy Code (Title 11, United States Code) or any comparable provisions of any similar federal or state law affecting the rights of creditors generally.

SECTION 3.No Setoff or Deductions; Taxes; Payments. Each Subsidiary Guarantor shall make all payments hereunder without setoff or counterclaim and free and clear of and without deduction for any taxes, levies, imposts, duties, charges, fees, deductions, withholdings, compulsory loans, restrictions or conditions of any nature now or hereafter imposed or levied by any jurisdiction or any political subdivision thereof or taxing or other authority therein unless such Subsidiary Guarantor is compelled by law to make such deduction or withholding (other than Excluded Taxes). If any such obligation (other than one arising with respect to Excluded Taxes) is imposed upon each Subsidiary Guarantor with respect to any amount payable by it hereunder, such Subsidiary Guarantor will pay to the applicable Guaranteed Party, on the date on which such amount is due and payable hereunder, such additional amount in dollars as shall be necessary to enable such Guaranteed Party to receive the same net amount which such Guaranteed Party would have received on such due date had no such obligation been imposed upon such Subsidiary Guarantor. Each Subsidiary Guarantor will deliver promptly to such Guaranteed Party certificates or other valid vouchers for all taxes or other charges deducted from or paid with respect to payments made by such Subsidiary Guarantor hereunder. The obligations of each Subsidiary Guarantor under this paragraph shall survive the payment in full of the Guaranteed Obligations and termination of this Guarantee.

SECTION 4.Rights of Guaranteed Parties. Each Subsidiary Guarantor consents and agrees that the Guaranteed Parties may, at any time and from time to time, without notice or demand, and without affecting the enforceability or continuing effectiveness hereof: (a) amend, extend, renew, compromise, discharge, accelerate or otherwise change the time for payment or

EXECUTION VERSION

the terms of the Guaranteed Obligations or any part thereof, (b) take, hold, exchange, enforce, waive, release, fail to perfect, sell, or otherwise dispose of any security for the payment of any Guaranteed Obligations, (c) apply such security and direct the order or manner of sale thereof as the Guaranteed Parties in their sole discretion may determine and (d) release or substitute one or more of any endorsers or other guarantors of any of the Guaranteed Obligations. Without limiting the generality of the foregoing, such Subsidiary Guarantor consents to the taking of, or failure to take, any action which might in any manner or to any extent vary the risks of such Subsidiary Guarantor under this Guarantee or which, but for this provision, might operate as a discharge of such Subsidiary Guarantor.

SECTION 5.Certain Waivers. Each Subsidiary Guarantor waives, to the fullest extent permitted under applicable law, (a) any defense arising by reason of any disability or other defense of the Borrower or any other Subsidiary Guarantor, or the cessation from any cause whatsoever (including any act or omission of any Guaranteed Party) of the liability of the Borrower other than indefeasible payment and performance in full of the Guaranteed Obligations, (b) the benefit of any statute of limitations affecting such Subsidiary Guarantor's liability hereunder, (c) any right to require any Guaranteed Party to proceed against the Borrower, proceed against or exhaust any security for the Guaranteed Obligations, or pursue any other remedy in any Guaranteed Party's power whatsoever, (d) any benefit of and any right to participate in any security now or hereafter held by any Guaranteed Party and (e) any and all other defenses or benefits that may be derived from or afforded by applicable law limiting the liability of or exonerating guarantors or sureties. Each Subsidiary Guarantor expressly waives all setoffs and counterclaims and all presentments, demands for payment or performance, notices of nonpayment or nonperformance, protests, notices of protest, notices of dishonor and all other notices or demands of any kind or nature whatsoever with respect to the Guaranteed Obligations, and all notices of acceptance of this Guarantee or of the existence, creation or incurrence of new or additional Guaranteed Obligations.

SECTION 6.Obligations Independent. The obligations of each Subsidiary Guarantor hereunder are those of primary obligor, and not merely as surety, and are independent of the Guaranteed Obligations and the obligations of any other Subsidiary Guarantor, and a separate action may be brought against such Subsidiary Guarantor to enforce this Guarantee whether or not the Borrower or any other person or entity is joined as a party.

SECTION 7.Subrogation. Each Subsidiary Guarantor shall not exercise any right of subrogation, contribution, indemnity, reimbursement or similar rights with respect to any payments it makes under this Guarantee until all of the Guaranteed Obligations and any amounts payable under this Guarantee have been indefeasibly paid and performed in full and any commitments of each Guaranteed Party or facilities provided by each Guaranteed Party with respect to the Guaranteed Obligations are terminated or repaid in full, as applicable (other than, in each case, Guaranteed Obligations in respect of contingent indemnification or expense reimbursement obligations for which no claim has been made). If any amounts are paid to any Subsidiary Guarantor in violation of the foregoing limitation, then such amounts shall be held in trust for the benefit of the Guaranteed Parties and shall forthwith be paid to the Administrative Agent (for the ratable benefit of itself and the other Guaranteed Parties) to reduce the amount of the Guaranteed Obligations, whether matured or unmatured.

SECTION 8.Contribution. Subject to Section 7, each Subsidiary Guarantor that makes a payment under this Guarantee shall be entitled upon payment in full of all Guaranteed

EXECUTION VERSION

Obligations under this Guarantee to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor's pro rata portion of such payment based on the respective net assets of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. The payment obligations of any Subsidiary Guarantor under this Section shall be subordinate and subject in right of payment to the Guaranteed Obligations until such time as the Guaranteed Obligations have been indefeasibly paid and performed in full, and no Subsidiary Guarantor shall exercise any right or remedy under this Section against any other Subsidiary Guarantor until such Guaranteed Obligations have been indefeasibly paid and performed in full. Each Subsidiary Guarantor recognizes and acknowledges that the rights to contribution arising hereunder shall constitute an asset in favor of the party entitled to such contribution. This Section shall not be deemed to affect any right of subrogation, indemnity, reimbursement or contribution that any Subsidiary Guarantor may have under applicable law against the Borrower in respect of any payment of Guaranteed Obligations.

SECTION 9.Termination; Reinstatement. This Guarantee is a continuing and irrevocable Guarantee of all Guaranteed Obligations now or hereafter existing and shall remain in full force and effect until all Guaranteed Obligations and any other amounts payable under this Guarantee are indefeasibly paid in full in cash and any commitments of each Guaranteed Party or facilities provided by each Guaranteed Party with respect to the Guaranteed Obligations are terminated or repaid in full, as applicable (other than, in each case, Guaranteed Obligations in respect of contingent indemnification or expense reimbursement obligations for which no claim has been made). Notwithstanding the foregoing, this Guarantee shall continue in full force and effect or be revived, as the case may be, if any payment by or on behalf of the Borrower or any Subsidiary Guarantor is made, or any Guaranteed Party exercises its right of setoff, in respect of the Guaranteed Obligations and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by any Guaranteed Party in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any bankruptcy, insolvency, receivership or similar law or otherwise, all as if such payment had not been made or such setoff had not occurred and whether or not any Guaranteed Party is in possession of or has released this Guarantee and regardless of any prior revocation, rescission, termination or reduction. The obligations of each Subsidiary Guarantor under this paragraph shall survive termination of this Guarantee.

SECTION 10.Subordination. Each Subsidiary Guarantor hereby subordinates the payment of all obligations and Indebtedness of the Borrower owing to such Subsidiary Guarantor, whether now existing or hereafter arising, including but not limited to any obligation of the Borrower to such Subsidiary Guarantor as subrogee of any Guaranteed Party or resulting from such Subsidiary Guarantor's performance under this Guarantee, to the indefeasible payment in full in cash of all Guaranteed Obligations. If the Administrative Agent so requests when an Event of Default has occurred and is continuing, any such obligation or Indebtedness of the Borrower to any Subsidiary Guarantor shall be enforced and performance received by such Subsidiary Guarantor as trustee for the Administrative Agent and the proceeds thereof, as well as any other amounts received by such Subsidiary Guarantor in violation of this Section, shall be paid over to the Administrative Agent on account of the Guaranteed Obligations, but without reducing or affecting in any manner the liability of such Subsidiary Guarantor under this Guarantee.

EXECUTION VERSION

SECTION 11.Stay of Acceleration. In the event that acceleration of the time for payment of any of the Guaranteed Obligations is stayed, in connection with any case commenced by or against the Borrower or any Subsidiary Guarantor under any bankruptcy, insolvency, receivership or similar law, or otherwise, all such amounts shall nonetheless be payable by such Subsidiary Guarantor immediately upon demand by the Administrative Agent, to the fullest extent permitted by applicable law.

SECTION 12.Condition of Borrower. Each Subsidiary Guarantor acknowledges and agrees that it has the sole responsibility for, and has adequate means of, obtaining from the Borrower and any other guarantor such information concerning the financial condition, business and operations of the Borrower and any such other guarantor as such Subsidiary Guarantor requires, and that no Guaranteed Party has a duty, and such Subsidiary Guarantor is not relying on any Guaranteed Party at any time, to disclose to such Subsidiary Guarantor any information relating to the business, operations or financial condition of the Borrower or any other Subsidiary Guarantor (such Subsidiary Guarantor waiving any duty on the part of any Guaranteed Parties to disclose such information and any defense relating to the failure to provide the same).

SECTION 13.Representations and Warranties. Each Subsidiary Guarantor represents and warrants that (a) it is duly organized and in good standing under the laws of the jurisdiction of its organization and has full capacity and right to make and perform this Guarantee, and all necessary authority has been obtained, (b) this Guarantee constitutes its legal, valid and binding obligation enforceable against such Subsidiary Guarantor in accordance with its terms, (c) the making and performance of this Guarantee does not and will not violate the provisions of any applicable law, regulation or order, and does not and will not result in the breach of, or constitute a default or require any consent under, any material agreement, instrument, or document to which it is a party or by which it or any of its property may be bound or affected, except in each case any violation, breach, default or consent that could not reasonably be expected to have a Material Adverse Effect and (d) all consents, approvals, licenses and authorizations of, and filings and registrations with, any governmental authority required under applicable law and regulations for the making and performance of this Guarantee have been obtained or made and are in full force and effect, except for such consents, approvals, licenses, authorizations, filings or registrations which the failure to make or obtain could not reasonably be expected to have a Material Adverse Effect.

SECTION 14.Amendments, Waivers and Consents. None of the terms or provisions of this Guarantee may be waived, amended, supplemented or otherwise modified, nor any consent be given, except in accordance with Section 9.08 of the Credit Agreement.

SECTION 15.Notices. All notices and communications hereunder or under any Guarantee Joinder Agreement (as defined in Section 19) shall be given to the addresses and otherwise made in accordance with Section 9.01 of the Credit Agreement; provided that notices and communications to the Subsidiary Guarantors shall be directed to the Subsidiary Guarantors, at the address of the Borrower set forth in Section 9.01 of the Credit Agreement.

SECTION 16.Indemnity. (a) Each Subsidiary Guarantor agrees to indemnify the Administrative Agent, each Guaranteed Party and each Related Party of any of the foregoing persons (each such person being called an “Indemnitee”) against, and to hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees, charges and disbursements, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (i) the execution or

EXECUTION VERSION

delivery of this Guarantee or any agreement or instrument contemplated hereby, the performance by the Subsidiary Guarantors of their respective obligations hereunder or the consummation of the transactions contemplated hereby or (ii) any claim, litigation, investigation or proceeding relating to any of the foregoing, whether or not any Indemnitee is a party thereto (and regardless of whether such matter is initiated by a third party or by such Subsidiary Guarantor or any of their respective Affiliates); provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted primarily from the gross negligence or willful misconduct of such Indemnitee.

(b) To the extent permitted by applicable law, each Subsidiary Guarantor shall not assert, and each Subsidiary Guarantor hereby waives, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Guarantee or any agreement or instrument contemplated hereby.

SECTION 17.Right of Setoff; Governing Law; Submission to Jurisdiction; Venue; WAIVER OF JURY TRIAL. THIS GUARANTEE AND ALL CLAIMS AND CONTROVERSIES IN CONNECTION HEREWITH SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. Without limiting the general applicability of the foregoing and the terms of the other Loan Documents to this Guarantee and the parties hereto, the terms of Sections 9.06, 9.11 and 9.15 of the Credit Agreement are incorporated herein by reference, mutatis mutandis, with each reference to the “Borrower” (whether express or by reference to the Borrower as a “party” thereto) therein being a reference to the Subsidiary Guarantors, and the parties hereto agree to such terms.

SECTION 18.Counterparts; Electronic Execution. This Guarantee may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Guarantee by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Guarantee.

SECTION 19.Additional Guarantors. Each Subsidiary of the Borrower that is required to become a party to this Guarantee pursuant to Section 5.12 of the Credit Agreement shall become a Subsidiary Guarantor for all purposes of this Guarantee upon execution and delivery by such Subsidiary of a supplement substantially in the form of Exhibit A hereto (each, a “Guarantee Joinder Agreement”).

SECTION 20.Miscellaneous. No failure by any Guaranteed Party to exercise, and no delay in exercising, any right, remedy or power hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy or power hereunder preclude any other or further exercise thereof or the exercise of any other right, power or remedy. The remedies herein provided are cumulative and not exclusive of any remedies provided by law or in equity. The unenforceability or invalidity of any provision of this Guarantee shall not affect the enforceability or validity of any other provision herein. Unless otherwise agreed by the Administrative Agent and each Subsidiary Guarantor in writing, this Guarantee is not intended to supersede or otherwise affect any other Guarantee now or hereafter given by any Subsidiary

EXECUTION VERSION

Guarantor or any other guarantor for the benefit of the Guaranteed Parties or any term or provision thereof.

SECTION 21.Release of Subsidiary Guarantors. A Subsidiary Guarantor will be released from its obligations under this Guarantee (other than any obligation that may have arisen under Section 8):


(1)	upon the sale (including any sale pursuant to any exercise of remedies by or for the benefit of a Guaranteed Party) or other disposition (including by way of consolidation or merger) of such Subsidiary Guarantor (including the sale or disposition of equity interests of such Subsidiary Guarantor) following which such Subsidiary Guarantor is no longer a subsidiary of the Borrower;


(2)	upon the sale or disposition of all or substantially all the assets of such Subsidiary Guarantor;


(3)	upon the designation of such Subsidiary Guarantor as an Unrestricted Subsidiary (as defined under and to the extent permitted by the Credit Agreement); or


(4)	upon the indefeasible payment in full in cash of the Guaranteed Obligations;

provided, however, that in the case of clauses (1) and (2) above, (i) such sale or other disposition is made to a person other than the Borrower or a subsidiary of the Borrower, (ii) such sale or disposition is permitted by the Credit Agreement and (iii) the Borrower provides a certificate of a Responsible Officer to the Administrative Agent to the foregoing effect.

At the request of the Borrower, the Administrative Agent shall execute and deliver an appropriate instrument evidencing such release.

SECTION 22.Survival of Agreement. All covenants, agreements, representations and warranties made by the Subsidiary Guarantors herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Guarantee shall be considered to have been relied upon by the Guaranteed Parties, regardless of any investigation made by the Guaranteed Parties or on their behalf, and shall continue in full force and effect as long as any Guaranteed Obligation or any other amount payable under this Guarantee is outstanding and unpaid. The provisions of Section 16 shall remain operative and in full force and effect regardless of the termination of this Guarantee or the invalidity or unenforceability of any term or provision of this Guarantee.

[Signature Pages Follow]

IN WITNESS WHEREOF, each of the parties hereto has caused this Guarantee to be duly executed as of the date first above written.

A-1 Medical Equipment, Inc.

Abba Medical Equipment, Inc.

Acadia Home Care,

Allied Medical Supply, Inc.

Always Medical Equipment, Inc.

▇▇▇▇ ▇▇▇▇'▇ InHome Medical, Inc., West

▇▇▇▇ ▇▇▇▇'▇ InHome Medical/InHome Medical Inc.

Anniston Health & Sickroom Supplies, Inc.

Berkeley Medical Equipment, Inc.

Best Care HHC Acquisition Company, LLC

Beta Medical Equipment, Inc.

Cambria Medical Supply, Inc.

Camden Medical Supply, Inc.

Care Medical Supplies, Inc.

Centennial Medical Equipment, Inc.

Charlotte Medical Supply, Inc.

▇▇▇▇▇▇▇ Rentals, Inc.

Community Home Oxygen, Inc.

Contour Medical Supply, Inc.

▇▇▇▇▇▇ Home Health Care, Inc.

CPO 2, Inc.

▇▇▇▇▇▇ Medical Systems, Inc.

Distinct Home Health Care, Inc.

▇▇▇ ▇▇▇▇ Respiratory Services, Inc.

DuMEd, Inc.

East Tennessee Infusion & Respiratory, Inc.

▇▇▇▇▇ County Home Medical Equipment, LLC

Encore Home Health Care, Inc.

Excel Medical of Fort Dodge, Inc.

Excel Medical of Marshalltown, Inc.

First Community Care of Niagara, Inc.

Firstcare, Inc.

▇▇▇▇▇▇▇ Medical Equipment, Inc.

Four Rivers Home Health Care, Inc.

G&G Medical, Inc.

Gate City Medical Equipment, Inc.

Georgia Medical Resources, Inc.

Gladwin Area Home Care, Inc.

▇▇▇▇▇▇▇▇ Medical Equipment Service, Inc.

Health Care Services of Mississippi, Incorporated,

Holland Medical Services, Inc.

Home Care Oxygen Service, Inc.

Home Medical Systems, Inc.

IHS Acquisition XXVII, Inc.

Integrated Health Services at Jefferson Hospital, Inc.

Intensive Home Care Services, Inc.

IOTA Medical Equipment, Inc.

LAMBDA Medical Equipment, Inc.

LAMS, Inc.

▇▇▇▇▇▇▇ Medical, Inc.

Major Medical Supply, Inc.

Medco Professional Services, Corp.

MedCorp International, Inc.

Medic-Aire Medical Equipment, Inc.

Medical Electro-Therapeutics, Inc.

Medicare Rental Supply, Inc.

Michigan Medical Supply, Inc.

National Medical Equipment Centers, Inc.

NeighborCare Home Medical Equipment, LLC

NeighborCare Home Medical Equipment of Maryland, LLC

▇▇▇▇▇▇▇'▇ Home Medical Equipment, Inc.

Nightingale Home Health Care, Inc.

North Central Washington Respiratory Care Services, Inc.

Northeast Medical Equipment, Inc.

Northwest Home Medical, Inc.

OMICRON Medical Equipment, Inc.

Oxygen of Oklahoma, Inc.

Oxygen Plus Medical Equipment, Inc.

Oxygen Plus, Inc.

Oxygen Therapy Associates, Inc.

▇▇▇▇▇▇▇▇'▇ Home Care, Inc.

PHI Medical Equipment, Inc.

Pioneer Medical Services, Inc.

Preferential Home Health Care, Inc.

Principal Medical Equipment, Inc.

Professional Breathing Associates, Inc.

Professional Respiratory Home Healthcare, Inc.

PSI Health Care, Inc.

Pulmo-Dose, Inc.

Qualicare Home Medical, Inc.

Quality Home Health Care, Inc.

R.C.P.S., Inc.

RCG Information Services Corporation

Regency Medical Equipment, Inc.

Resp-A-Care, Inc.

Respiracare Medical Equipment, Inc.

Respiratory Medical Equipment of Ga., Inc.

Respitech Home Health Care, Inc.

Responsive Home Health Care, Inc.

Rhema, Inc.

▇▇▇▇ Medical Group, Inc.

RN Home Care Medical Equipment Company, Inc.

[Signature Page to Guarantee Agreement]

Roswell Home Medical, Inc.

Rotech Employee Benefits Corporation,

Rotech Home Medical Care, Inc.

RoTech Oxygen and Medical Equipment, Inc.

▇▇▇▇ Medical, Inc.

▇▇▇▇▇▇▇'▇ Hospital Equipment, Inc.

▇▇▇▇▇▇▇ Convalescent Medical Supply, Inc.

Select Home Health Care, Inc.

SIGMA Medical Equipment, Inc.

Southeastern Home Health, Inc.

Sun Medical Supply, Inc.

Sunshine Home Health Care, Inc.

The ▇▇▇▇▇▇ Company

Theta Home Health Care, Inc.

Tupelo Home Health, Inc.

Valley Medical Equipment, Inc.

Value Care, Inc.

VitalCare Health Services, Inc.

VitalCare of Texas, Inc.

White's Medical Rentals, Inc.

Wichita Medical Care, Inc.

Zeta Home Health Care, Inc.

By:

Printed Name:

Title:

[Signature Page to Guarantee Agreement]



SILVER POINT FINANCE, LLC, as Administrative Agent, on behalf of itself and the other Guaranteed Parties,
by:

	Name:
	Title:

[Signature Page to Guarantee Agreement]

EXHIBIT A

Form of Joinder Agreement

This JOINDER AGREEMENT, dated as of __________, 20__ (this “Agreement”), is by and between __________, a __________ (the “New Subsidiary”), and SILVER POINT FINANCE LLC, in its capacity as Administrative Agent (the “Administrative Agent”) under that certain Term Loan Credit Agreement dated as of December [__], 2012 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among ROTECH HEALTHCARE INC., a Delaware corporation (the “Borrower”), the Lenders (as defined in the Credit Agreement) from time to time party thereto and the Administrative Agent. All capitalized terms used and not defined herein shall have the meanings given thereto in the Credit Agreement or the applicable Loan Document referred to herein.

The Loan Parties are required by Section 5.12 of the Credit Agreement to cause the New Subsidiary to become a “Subsidiary Guarantor”.

Accordingly, the New Subsidiary hereby agrees as follows with the Administrative Agent, for the benefit of the Lenders:

SECTION 1.The New Subsidiary hereby agrees that by execution of this Agreement it is a Subsidiary Guarantor (as defined in the Guarantee Agreement) under the Guarantee Agreement as if a signatory thereof on the Closing Date, and the New Subsidiary (a) shall comply with, and be subject to, and have the benefit of, all of the terms, conditions, covenants, agreements and obligations set forth in the Guarantee Agreement and (b) hereby makes each representation and warranty set forth in the Guarantee Agreement. The New Subsidiary hereby agrees that (i) each reference to a “Subsidiary Guarantor” or the “Subsidiary Guarantors” in the Guarantee Agreement and the other Loan Documents shall include the New Subsidiary and (ii) each reference to the “Guarantee” as used therein shall mean the Guarantee Agreement as supplemented hereby. Without limiting the generality of the foregoing terms of this Section 1, the New Subsidiary hereby, jointly and severally together with the other Subsidiary Guarantors, guarantees to each Guaranteed Party (as defined in the Guarantee Agreement), as provided in the Guarantee Agreement, the prompt payment and performance of the Guaranteed Obligations (as defined in the Guarantee Agreement) strictly in accordance with the terms thereof.

SECTION 2.All notices and communications to the New Subsidiary shall be given to the addresses and otherwise made in accordance with Section 9.01 of the Credit Agreement; provided that notices and communications shall be directed to the New Subsidiary, at the address of the Borrower set forth in Section 9.01 of the Credit Agreement.

SECTION 3.The New Subsidiary hereby waives acceptance by the Administrative Agent and the other Guaranteed Parties of the guarantee by the New Subsidiary under the Guarantee Agreement upon the execution of this Agreement by the New Subsidiary.

SECTION 4.This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of

which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.

SECTION 5.This Agreement and all claims and controversies in connection herewith shall be governed by and construed and interpreted in accordance with the laws of the State of New York.

[Signature Pages Follow]

IN WITNESS WHEREOF, the New Subsidiary has caused this Agreement to be duly executed by its authorized officer, and the Administrative Agent, for the benefit of itself and the other Guaranteed Parties, has caused the same to be accepted by its authorized officers, as of the day and year first above written.



[____________], as New Subsidiary
By:
	Name:
	Title:



Acknowledged and accepted: SILVER POINT FINANCE, LLC, as Administrative Agent
By:
	Name:
	Title:



By:
	Name:
	Title:

EXECUTION VERSION

EXHIBIT F-1

[Form of] Opinion of ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇ LLP

[_______], 201[_]

The lenders listed on Exhibit A hereto

and

Silver Point Finance, LLC,

as administrative agent for the lenders

listed on Exhibit A hereto

▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇

Greenwich, Connecticut 06830

Re: Rotech Healthcare Inc. Term Loan Credit Agreement

Ladies and Gentlemen:

We have acted as special counsel to Rotech Healthcare Inc., a Delaware corporation (the “Borrower”), each of the subsidiaries of the Borrower listed on Annex A-1 hereto (the “California Guarantors”), each of the subsidiaries of the Borrower listed on Annex A-2 hereto (the “Delaware Guarantors”), each of the subsidiaries of the Borrower listed on Annex A-3 hereto (the “Illinois Guarantors”), the subsidiary of the Borrower listed on Annex A-4 hereto (the “New York Guarantor”), each of the subsidiaries of the Borrower listed on Annex A-5 hereto (the “Texas Guarantors” and, together with the California Guarantors, the Delaware Guarantors, the Illinois Guarantors and the New York Guarantor, the “Specified Guarantors”) and each of the subsidiaries of the Borrower listed on Annex A-6 hereto (together with the Specified Guarantors, the “Guarantors”), in connection with (i) that certain Term Loan Credit Agreement dated as of [______], 201[_] (the “Credit Agreement”), among the Borrower, the lenders party thereto (the “Lenders”) and Silver Point Finance, LLC, as administrative agent (the “Administrative Agent”) for the Lenders, and (ii) the other Loan Documents (as defined below).

This letter is being delivered to you pursuant to Section 4.01(d) of the Credit Agreement. Capitalized terms defined in the Credit Agreement, used herein and not otherwise defined herein, shall have the meanings given them in the Credit Agreement. As used herein, “Loan Parties” means the Borrower and the Guarantors, collectively.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter, except where a specific fact confirmation procedure is stated to have been performed (in which case we have with your consent performed the stated procedure). We have examined, among other things, the following:


(a)	The Credit Agreement;

(b) The Guarantee Agreement dated as of [_______], 201[_] (the “Guarantee Agreement”), by the Guarantors in favor of the Administrative Agent;


(c)	The Collateral Agreement dated as of [_______], 201[_], as amended and restated as of [______], 201[_], as further amended and restated as of [______], 201[_] (the “Collateral Agreement”), among the Borrower, the Guarantors and The Bank of New York Mellon Trust Company, N.A., as collateral agent (the “Collateral Agent”);


(d)	The Trademark Security Agreement dated as of [_______], 201[_], as amended and restated as of [______], 201[_], as further amended and restated as of [______], 201[__] (the “Trademark Security Agreement”), by the Borrower in favor of the Collateral Agent;


(e)	The Pari Passu Intercreditor Joinder Agreement dated as of [____], 201[_], among the Borrower, Silver Point Finance, LLC, as an Additional Authorized Representative and The Bank of New York Mellon Trust Company, N.A., as Collateral Agent and Trustee;


(f)	The First Amendment to Junior Lien Intercreditor Agreement, dated as of [______], 201[_], among the Borrower, the Guarantors and The Bank of New York Mellon Trust Company, N.A., as First Priority Representative and as Junior Priority Representative;


(g)	The indentures identified to us by an officer of the Borrower as material to the Borrower and listed in Exhibit B hereto (the “Specified Agreements”);

(h)

The Certificate of Incorporation and Bylaws of the Borrower, the Delaware Guarantors (other than Best Care HHC Acquisition Company LLC (the “Delaware LLC”)) and the New York Guarantor, the Articles of Incorporation and Bylaws of the California Guarantors, the Illinois Guarantors and the Texas Guarantors (other than ▇▇▇▇▇ County Home Medical Equipment, LLC (the “Texas LLC”)) and the Operating Agreements of the Delaware LLC and the Texas LLC which, with your consent, we have assumed is (i) a valid and binding agreement of the parties thereto, enforceable in accordance with the plain meaning of its terms, (ii) in full force and effect, and (iii) the entire agreement of the parties pertaining to the subject matter thereof (collectively, the “Governing Documents”); and

(i)

A photocopy of the UCC-1 financing statements naming the Borrower and the Specified Guarantors as debtors and the Collateral Agent as secured party, together with all schedules and exhibits to such financing statements, which we have assumed will be filed (i) in the case of each California Guarantor, in the Office of the Secretary of State of California (the “California Filing Office”), copies of which are attached hereto as Exhibit C (collectively, the “California Financing Statements”); (ii) in the case of the Borrower and each Delaware Guarantor, in the Office of the Secretary of State of Delaware (the “Delaware Filing Office”), copies of which are attached hereto as Exhibit D (collectively, the “Delaware Financing Statements”); (iii) in the case of each Illinois Guarantor, in the Office of the Secretary of State of Illinois (the “Illinois Filing Office”), copies of which are attached hereto as Exhibit E

(collectively, the “Illinois Financing Statements”); (iv) in the case of the New York Guarantor, in the Office of the Secretary of State of New York (the “New York Filing Office”), a copy of which is attached hereto as Exhibit F (the “New York Financing Statement”); and (v) in the case of each Texas Guarantor, in the Office of the Secretary of State of Texas (the “Texas Filing Office”), copies of which are attached hereto as Exhibit G (collectively, the “Texas Financing Statements” and, together with the California Financing Statements, the Delaware Financing Statements, the Illinois Financing Statements and the New York Financing Statement, the “Financing Statements”).

The documents described in subsections (a) - (f) above are referred to herein collectively as the “Loan Documents”. The documents described in subsections (a) - (c) above are referred to herein collectively as the “Opinion Documents”. As used in this letter, the “California UCC” shall mean the Uniform Commercial Code as now in effect in the State of California, “Illinois UCC” shall mean the Uniform Commercial Code as now in effect in the State of Illinois, “New York UCC” shall mean the Uniform Commercial Code as now in effect in the State of New York and “Texas UCC” shall mean the Uniform Commercial Code as now in effect in the State of Texas. As used in this letter, “Applicable UCC” shall mean the California UCC and/or the Delaware UCC (as defined below) and/or the Illinois UCC and/or the New York UCC and/or the Texas UCC, as applicable.

Except as otherwise stated herein, as to factual matters, we have, with your consent, relied upon the foregoing and upon oral or written statements and representations of officers and other representatives of the Loan Parties and others, including the representations and warranties of the Loan Parties in the Loan Documents. We have not independently verified such factual matters.

Except as otherwise stated herein, we are opining as to the effect on the subject transaction only of (A) the federal laws of the United States; (B) the internal laws of the State of New York; (C) with respect to numbered paragraphs 1(a), 2(a), 3(a), 4 and 5 of this letter, the Delaware General Corporation Law (the “DGCL”) or the Delaware Limited Liability Company Act (“DLLCA”); (D) with respect to numbered paragraphs 1(b), 3(a), 4(a) and 5 of this letter, the California Corporations Code (the “CCC”); (E) with respect to numbered paragraphs 1(c), 3(a), 4(a) and 5 of this letter, the Illinois Business Corporation Act (the “IBCA”); (F) with respect to numbered paragraphs 1(e), 3(a), 4(a) and 5 of this letter, the Texas Business Organizations Code (the “TBOC”); (G) with respect to numbered paragraph 8(b) of this letter, the California UCC; (H) with respect to numbered paragraph 8(a) of this letter, the Delaware UCC (as defined below); (I) with respect to numbered paragraph 8(c) of this letter, the Illinois UCC; (J) with respect to numbered paragraphs 7, 8(d) and 9 of this letter, the New York UCC; and (K) with respect to numbered paragraph 8(e) of this letter, the Texas UCC and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or, in the case of Delaware, any other laws, or as to any matters of municipal law or the laws of any local agencies within any state. With your permission, we have based our opinions set forth in paragraph 8(a) exclusively upon our review of Article 9 of the Uniform Commercial Code of the State of Delaware as set forth in the CCH Secured Transactions Guide without regard to judicial interpretations thereof or any regulations promulgated thereunder or any other laws of the State of Delaware (the “Delaware UCC”).

Except as otherwise stated herein, our opinions are based upon our consideration of only those statutes, rules and regulations which, in our experience, are normally applicable to borrowers and guarantors in secured loan transactions. We express no opinion as to any state or federal laws or regulations applicable to the subject transactions because of the legal or regulatory status of any parties to the Loan Documents or the legal or regulatory status of any of their affiliates. Various matters concerning the internal laws of the States of Colorado and Florida are respectively addressed in the opinions of ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, LLP and Proskauer Rose LLP, which have been separately provided to you. We express no opinion with respect to those matters herein and to the extent elements of those opinions are necessary to the conclusions expressed herein, we have, with your consent, assumed such matters.

Subject to the foregoing and the other matters set forth herein, as of the date hereof:

1. (a) The Borrower and each of the Delaware Guarantors (other than the Delaware LLC) is a corporation under the DGCL with corporate power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. The Delaware LLC is a limited liability company under the DLLCA with limited liability company power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. With your consent, based solely on certificates from public officials, we confirm that the Borrower and each of the Delaware Guarantors is validly existing and in good standing under the laws of the State of Delaware.

(b) Each of the California Guarantors is a corporation under the CCC with corporate power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. With your consent, based solely on certificates from public officials, we confirm that each of the California Guarantors is validly existing and in good standing under the laws of the State of California.

(c) Each of the Illinois Guarantors is a corporation under the IBCA with corporate power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. With your consent, based solely on certificates from public officials, we confirm that each of the Illinois Guarantors is validly existing and in good standing under the laws of the State of Illinois.

(d) The New York Guarantor is a corporation under the general corporation law of the State of New York with corporate power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. With your consent, based solely on certificates from public officials, we confirm that the New York Guarantor is validly existing and in good standing under the laws of the State of New York.

(e) Each of the Texas Guarantors (other than the Texas LLC) is a corporation under the TBOC with corporate power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. The Texas LLC is a limited liability company under the TBOC with limited liability company power and authority to enter into the Loan Documents to which it is a party and perform its obligations thereunder. With your consent, based solely on

certificates from public officials, we confirm that each of the Texas Guarantors is validly existing and in good standing under the laws of the State of Texas.

2. (a) The execution, delivery and performance of the Credit Agreement has been duly authorized by all necessary corporate action of the Borrower, and the Credit Agreement has been duly executed and delivered by the Borrower.

(b) The Credit Agreement is the legally valid and binding agreement of the Borrower, enforceable against the Borrower in accordance with its terms.

3. (a) The Guarantee Agreement has been duly authorized by all necessary corporate or limited liability company action, as applicable, of each of the Specified Guarantors, has been duly executed and delivered by each of the Specified Guarantors.

(b) The Guarantee Agreement is the legally valid and binding agreement of each of the Specified Guarantors, enforceable against each such Specified Guarantor in accordance with its terms.

4. (a) The Collateral Agreement has been duly authorized by all necessary corporate or limited liability company action, as applicable, of the Borrower and each of the Specified Guarantors, and has been duly executed and delivered by the Borrower and each of the Specified Guarantors.

(b) The Collateral Agreement is the legally valid and binding agreement of the Borrower and each of the Guarantors, enforceable against each of them in accordance with its terms.

5. The execution and delivery of the Opinion Documents by the Borrower and the Specified Guarantors, the borrowing of the loans by the Borrower pursuant to the Credit Agreement, the making of the guarantees by the Specified Guarantors pursuant to the Guarantee Agreement and the granting of liens by the Borrower and the Specified Guarantors pursuant to the Opinion Documents do not on the date hereof:


(i)	violate the provisions of the Governing Documents;


(ii)	result in the breach of or a default under any of the Specified Agreements;

(iii)

violate any federal or New York statute, rule or regulation applicable to the Borrower (including, without limitation, Regulations T, U or X of the Board of Governors of the Federal Reserve System, assuming the Borrower complies with the provisions of the Loan Documents relating to the use of proceeds) or, in the case of the applicable Loan Party, violate the DGCL, DLLCA, the CCC, the IBCA or the TBOC, as applicable; or


(iv)	require any consents, approvals, or authorizations to be obtained by the Borrower or the Specified Guarantors from, or any registrations, declarations or filings to be made by the Borrower or the Specified Guarantors with, any governmental authority under any federal or New York statute, rule or regulation applicable to the Borrower

or the Specified Guarantors or the DGCL, DLLCA, the CCC, the IBCA or the TBOC, as applicable, in each case on or prior to the date hereof that have not been obtained or made.

6. The Borrower is not required to be registered as an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

7. The Collateral Agreement creates a valid security interest in favor of the Collateral Agent in that portion of the collateral described in Section 3 of the Collateral Agreement in which the Borrower and the Guarantors have rights and a valid security interest may be created under Article 9 of the New York UCC (the “UCC Collateral”), which security interest secures, among other things, the Loan Documents Obligations (as defined in the Collateral Agreement).

8. (a) The Delaware Financing Statements are in appropriate form for filing in the Delaware Filing Office. Upon the proper filing of the Delaware Financing Statements in the Delaware Filing Office, the security interest in favor of the Collateral Agent in the Borrower's and the Delaware Guarantors' rights in the UCC Collateral described in the Delaware Financing Statements will be perfected to the extent a security interest in such UCC Collateral can be perfected under the Delaware UCC by the filing of a financing statement in that office.

(b) The California Financing Statements are in appropriate form for filing in the California Filing Office. Upon the proper filing of the California Financing Statements in the California Filing Office, the security interest in favor of the Collateral Agent in the California Guarantors' rights in the UCC Collateral described in the California Financing Statements will be perfected to the extent a security interest in such UCC Collateral can be perfected under the California UCC by the filing of a financing statement in that office.

(c) The Illinois Financing Statements are in appropriate form for filing in the Illinois Filing Office. Upon the proper filing of the Illinois Financing Statements in the Illinois Filing Office, the security interest in favor of the Collateral Agent in the Illinois Guarantors' rights in the UCC Collateral described in the Illinois Financing Statements will be perfected to the extent a security interest in such UCC Collateral can be perfected under the Illinois UCC by the filing of a financing statement in that office.

(d) The New York Financing Statement is in appropriate form for filing in the New York Filing Office. Upon the proper filing of the New York Financing Statement in the New York Filing Office, the security interest in favor of the Collateral Agent in the New York Guarantor's rights in the UCC Collateral described in the New York Financing Statement will be perfected to the extent a security interest in such UCC Collateral can be perfected under the New York UCC by the filing of a financing statement in that office.

(e) The Texas Financing Statements are in appropriate form for filing in the Texas Filing Office. Upon the proper filing of the Texas Financing Statements in the Texas Filing Office, the security interest in favor of the Collateral Agent in the Texas Guarantors' rights in the UCC Collateral described in the Texas Financing Statements will be perfected to the extent a security interest in

such UCC Collateral can be perfected under the Texas UCC by the filing of a financing statement in that office.

9. Assuming that the Collateral Agent has and retains continuous possession of that portion of the UCC Collateral that constitutes “certificated securities” within the meaning of Section 8-102(a)(4) of the New York UCC (the “Pledged Securities”) in, and while located in, the State of New York, pursuant to the Collateral Agreement and the Intercreditor Agreements, indorsed to the Collateral Agent or in blank, in each case, by an effective endorsement, or accompanied by stock powers with respect thereto duly indorsed in blank by an effective endorsement, the security interest in favor of the Collateral Agent in the Pledged Securities is perfected. Assuming that the Collateral Agent (and each of the Secured Parties) acquires its interest in the Pledged Securities without notice of any adverse claim and that each of the Pledged Securities is either in bearer form or in in registered form issued in the name of the Collateral Agent or accompanied by an effective indorsement to the Collateral Agent or in blank, the Collateral Agent will acquired its security interest in the Pledged Securities free of any adverse claim.

10. The Trademark Security Agreement has been duly authorized, executed and delivered by the Borrower.

Except as expressly set forth in paragraphs 7, 8 and 9 we do not express any opinion with respect to the creation, validity, attachment, perfection or priority of any security interest or lien or the effectiveness of any sale or other conveyance or transfer of real or personal property. The opinions above do not include any opinions with respect to compliance with laws relating to permissible rates of interest.

Our opinions are subject to: (i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights or remedies of creditors; (ii) the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which a proceeding is brought; (iii) the invalidity under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy; and (iv) we express no opinion with respect to (a) consents to, or restrictions upon, governing law, jurisdiction, venue, service of process, arbitration, remedies or judicial relief;(b) advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law, or other procedural rights; (c) waivers of broadly or vaguely stated rights and restrictions upon non-written modifications and waivers; (d) covenants not to compete; (e) provisions for exclusivity, election or cumulation of rights or remedies; (f) provisions authorizing or validating conclusive or discretionary determinations; (g) grants of setoff rights; (h) provisions to the effect that a guarantor is liable as a primary obligor, and not as a surety and provisions purporting to waive modifications of any guaranteed obligation to the extent such modification constitutes a novation; (i) provisions for the payment of attorneys' fees where such payment is contrary to law or public policy and we call to your attention the provisions of Sections 1717 and 1717.5 of the California Civil Code, which limit

and create obligations for the payment of attorneys' fees; (j) proxies, powers and trusts; (k) provisions prohibiting, restricting, or requiring consent to assignment or transfer of any right or property; (l) provisions for liquidated damages, default interest, late charges, monetary penalties, prepayment or make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty; (m) provisions permitting, upon acceleration of any indebtedness, collection of that portion of the stated principal amount thereof which might be determined to constitute unearned interest thereon or collection of any premium due upon acceleration; and (n) the severability, if invalid, of provisions to the foregoing effect. We express no opinion or confirmation as to federal or state securities laws (except as expressly set forth in paragraph 6 as to federal securities laws), tax laws, antitrust or trade regulation laws, insolvency or fraudulent transfer laws, antifraud laws, compliance with fiduciary duty requirements, pension or employee benefit laws, usury laws, environmental laws, margin regulations (except as expressly set forth in paragraph 5(ii)), laws and regulations relating to commodities trading, futures and swaps, Financial Industry Regulatory Authority Rules, National Futures Association rules or the rules of any stock exchange, clearing organization, designated contract market or other regulated entity for trading, processing, clearing or reporting transactions in securities, commodities, futures or swaps (without limiting other laws or rules excluded by customary practice).

The opinions set forth above are also subject to (i) the unenforceability of contractual provisions waiving or varying the rules listed in Section 9-602 of the Applicable UCC; (ii) the unenforceability under certain circumstances of contractual provisions respecting self-help or summary remedies without notice of or opportunity for hearing or correction; (iii) the effect of provisions of the Applicable UCC and other general legal principles that impose a duty to act in good faith and in a commercially reasonable manner; and (iv) the effect of Sections 9-406, 9‑407, 9-408 and 9-409 of the Applicable UCC (or Sections 9406, 9407, 9408, and 9409 of the California UCC) on any provision of any Loan Document or Financing Statement that purports to prohibit, restrict, require consent for or otherwise condition the assignment of rights under such Loan Document or Financing Statement. Additionally, we express no opinion with respect to California Civil Code Section 711 on any provisions of the Loan Documents or Financing Statements which could be a restraint on alienation of property.

With your consent, we have assumed that (i) the Loan Documents have been duly authorized, executed and delivered by the parties thereto other than the Borrower and each of the Specified Guarantors; (ii) the genuineness of all signatures and the legal capacity of all natural persons; (iii) the Loan Documents constitute legally valid and binding obligations of the parties thereto other than the Borrower and each of the Specified Guarantors, enforceable against each of them in accordance with their respective terms; and (iv) the status of the Loan Documents as legally valid and binding obligations of the parties is not affected by any (a) breaches of, or defaults under, agreements or instruments; (b) violations of statutes, rules, regulations or court or governmental orders; or (c) failures to obtain required consents, approvals or authorizations from, or make required registrations, declarations or filings with, governmental authorities, provided that we make no such assumption to the extent we have expressly opined as to such matters with respect to the Borrower and the Specified Guarantors herein.

Insofar as our opinions require interpretation of the Specified Agreements, with your consent, (i) we have assumed that courts of competent jurisdiction would enforce such agreements in accordance with their plain meaning; (ii) to the extent that any questions of legality or legal construction have arisen in connection with our review, we have applied the laws of the State of New York in resolving such questions, although certain of the Specified Agreements may be governed by other laws which differ from the State of New York; (iii) we express no opinion with respect to any breach or default under a Specified Agreement that would occur only upon the happening of a contingency; and (iv) we express no opinion with respect to any matters which would require us to perform a mathematical calculation or make a financial or accounting determination.

Our opinions in paragraphs 7 and 8(d) above are limited to Article 9 of the New York UCC, our opinions in paragraph 8(a) are limited to Article 9 of the Delaware UCC, our opinions in paragraph 8(b) are limited to Division 9 of the California UCC, our opinions in paragraph 8(c) are limited to Article 9 of the Illinois UCC, our opinions in paragraph 8(e) are limited to Article 9 of the Texas UCC, and our opinions in paragraph 9 are limited to Articles 8 and 9 of the New York UCC, and therefore those opinion paragraphs, among other things, do not address collateral of a type not subject to, or excluded from the coverage of, Articles 8 and 9, as the case may be, of the Applicable UCC.

Additionally,

(i) Except as expressly set forth in paragraph 9, we express no opinion with respect to the priority of any security interest or lien.

(ii) We express no opinion with respect to any agricultural lien or any collateral that consists of letter-of-credit rights, commercial tort claims, goods covered by a certificate of title, claims against any government or governmental agency, consumer goods, crops growing or to be grown, timber to be cut, goods which are or are to become fixtures, or as-extracted collateral or cooperative interests.

(iii) We assume the descriptions of collateral contained in, or attached as schedules to, the Loan Documents and any Financing Statements accurately and sufficiently describe the collateral intended to be covered by the Loan Documents or such Financing Statements. Additionally, we express no opinion as to whether the phrases “all personal property” or “all assets” or similarly general phrases would be sufficient to create a valid security interest in the collateral or particular item or items of collateral; however, we note that pursuant to Section 9-504 of the Applicable UCC (or Section 9504 of the California UCC) the phrases “all assets” or “all personal property” can be a sufficient description of collateral for purposes of perfection by the filing of a financing statement.

(iv) We have assumed that each grantor of any security interest has, or with respect to after-acquired property will have, rights in the collateral granted by it or the power to transfer rights in such collateral, and that each such grantor has received value, and express no opinion as to the nature or extent of any grantor's rights in any of the collateral and we note that with respect to any after-acquired property, the security interest will not attach until the applicable grantor acquires such rights or power.

(v) We call to your attention the fact that the perfection of a security interest in “proceeds” (as defined in the Applicable UCC) of collateral is governed and restricted by Section 9-315 of the Applicable UCC (or Section 9315 of the California UCC).

(vi) We have assumed that the exact legal name of the Borrower and the Specified Guarantors is as set forth in the copy of the organizational documents certified by the Borrower's and the Specified Guarantors' Secretary of State in its jurisdiction of incorporation, and we have also assumed the accuracy of the other factual information set forth on the Financing Statements.

(vii) Section 552 of the federal Bankruptcy Code limits the extent to which property acquired by a debtor after the commencement of a case under the federal Bankruptcy Code may be subject to a security interest arising from a security agreement entered into by the debtor before the commencement of such case.

(viii) We express no opinion with respect to any property subject to a statute, regulation or treaty of the United States whose requirements for a security interest's obtaining priority over the rights of a lien creditor with respect to the property preempt Section 9-310(a) of the Applicable UCC (or Section 9310(a) of the California UCC).

(ix) We express no opinion with respect to any goods which are accessions to, or commingled or processed with, other goods to the extent that the security interest is limited by Section 9-335 or 9-336 of the Applicable UCC (or Section 9335 or 9336 of the California UCC).

(x) We call to your attention that a security interest may not attach or become enforceable or be perfected as to contracts, licenses, permits, equity interests or other property that are not assignable under applicable law, or are subject to consent requirements or contractual or other prohibitions or restrictions on assignment, except to the extent that any such prohibitions, restrictions or consent requirements may be rendered ineffective to prevent the attachment of the security interest pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the Applicable UCC (or Sections 9406, 9407, 9408 or 9409 of the California UCC), as applicable, and we note that the extent of any security interest created in reliance on such UCC provisions may be limited. In addition, we call to your attention that your rights under the Loan Documents and Financing Statements as secured parties may be subject to the provisions of the organizational and governing documents of any entity in which any equity interests (or other rights of equity holders or investors) are pledged and the provisions of the applicable laws under which any such entity is organized.

(xi) We express no opinion regarding any security interest in any copyrights, patents, trademarks, service marks or other intellectual property, or any license or sublicense thereof or the proceeds of any of the foregoing except to the extent Article 9 of the Applicable UCC (or Division 9 of the California UCC) may be applicable to the foregoing and, without limiting the generality of the foregoing, we express no opinion as to the effect of any federal laws relating to copyrights, patents, trademarks, service marks or other intellectual property on the opinions expressed herein. In addition, we call to your attention that any license or sublicense of copyrights, patents, trademarks or other intellectual property may not be assignable unless such license or sublicense affirmatively permits the creation, perfection and enforcement of a security interest therein.

(xii) We express no opinion as to the enforceability of any provision of any Loan Document or Financing Statement purporting to agree to the classification or type of any property for purposes of the Applicable UCC.

(xiii) We express no opinion as to the security interest of the Collateral Agent in any deposit accounts into which Government Receivables (as defined in the Collateral Agreement) are directly deposited by any Governmental Authority (as defined in the Collateral Agreement).

(xiv) We express no opinion with respect to the security interest of the Collateral Agent except to the extent that the Collateral Agent has been duly appointed as collateral agent for such persons on or prior to the date hereof.

(xv) We call to your attention that in the case of interests in limited liability companies such interests are unlikely to be securities unless their terms expressly provide, and continue to provide, that they are securities governed by Article 8 of the Applicable UCC of the relevant jurisdiction. Our opinion in paragraph 9 with respect to the Pledged Securities is limited to those limited liability company interests which are, and continue to be, certificated securities

We advise you of California statutory provisions and case law to the effect that a guarantor may be discharged, in whole or in part, if the beneficiary of the guaranty alters the obligation of the principal, fails to inform the guarantor of material information pertinent to the principal or any collateral, elects remedies that may impair either the subrogation or reimbursement rights of the guarantor against the principal or the value of any collateral, fails to accord the guarantor the protections afforded a debtor under Division 9 of the California UCC or otherwise takes any action that prejudices the guarantor, unless, in any such case, the guarantor has effectively waived such rights or the consequences of such action or has consented to such action. While California Civil Code Section 2856 and case law provide that express waivers of a guarantor's right to be discharged, such as those contained in the Guarantee Agreement executed by the California Guarantors, are generally enforceable under California law, we express no opinion with respect to the effectiveness of the waivers in the Guarantee Agreement executed by the California Guarantors.

We note that the enforceability of the “Environmental Provisions” (as hereinafter defined) within the Loan Documents may be limited by California's anti-deficiency and one-form-of-action rules (as set forth in Sections 580a, 580b, 580d and 726 of the California Code of Civil Procedure) and judicial decisions interpreting such rules, notwithstanding that by the terms of the Loan Documents all or part of such Environmental Provisions purport to be obligations that are not secured by an interest in real property or obligations that will survive repayment of the secured borrowings and/or foreclosure of the Collateral. We further note that Sections 726.5 and 736 of the California Code of Civil Procedure establish certain additional limitations and procedural requirements with respect to the enforcement of Environmental Provisions. For purposes of the foregoing, the term “Environmental Provision” means (i) any provision within the Loan Documents which falls within the definition of “environmental provision” as set forth in Section 736 of the California Code of Civil Procedure; or (ii) any other provision set forth in the Loan Documents which purports to, or the effect of which could be to, (a) obligate the Borrower or any other person or entity to take any action (or to refrain from taking any action) with respect to environmental matters, or to indemnify the Collateral Agent against costs, claims, actions, expenses, damages, obligations, losses or any

other matters arising out of environmental matters; or (b) guaranty or secure any such obligations; or (c) afford the Collateral Agent any additional rights, remedies or recoveries with respect to environmental matters.

We express no opinions with respect to the effect of California Code of Civil Procedure Section 564 on the enforceability of Section 8.18 of the Collateral Agreement.

Illinois case law calls into question the enforceability under certain circumstances of contractual provisions of the Loan Documents providing for the compounding of interest or the payment of interest on interest.

We note the effect of New York law and court decisions which provide that certain suretyship rights and defenses are available to a party that encumbers its property to secure the obligations of another.

Certain provisions of the Loan Documents reference certain provisions and agreements contained in other agreements that are not Loan Documents. Our opinions expressed herein with respect to the Loan Documents, however, address only the express terms of the Loan Documents (excluding any provisions incorporating any document or agreement, or the provisions of any other document or agreement, by reference) and not any other document or agreement, or the provisions of such other document or agreement, incorporated therein or made a part thereof by reference.

This letter is furnished only to you and the Lenders listed on Schedule A hereto and is solely for your and their benefit in connection with the transactions referenced in the first paragraph. This letter may not be relied upon by you or the Lenders listed on Schedule A hereto for any other purpose, or furnished to, assigned to, quoted to, or relied upon by any other person, firm or other entity for any purpose without our prior written consent, which may be granted or withheld in our sole discretion. At your request, we hereby consent to reliance hereon by any future assignee of your interest in the loans under the Credit Agreement pursuant to an assignment that is made and consented to in accordance with the express provisions of Section 9.04 of the Credit Agreement, on the condition and understanding that (i) this letter speaks only as of the date hereof, (ii) we have no responsibility or obligation to update this letter, to consider its applicability or correctness to other than its addressee(s), or to take into account changes in law, facts or any other developments of which we may later become aware, and (iii) any such reliance by a future assignee must be actual and reasonable under the circumstances existing at the time of assignment, including any changes in law, facts or any other developments known to or reasonably knowable by the assignee at such time.

Very truly yours,

ANNEX A-1

California Guarantors

ANNEX A-2

Delaware Guarantors

ANNEX A-3

Illinois Guarantors

.ANNEX A-4

New York Guarantor

ANNEX A-5

Texas Guarantors

ANNEX A-6

Other Guarantors

EXHIBIT A

Lenders

EXHIBIT B

Specified Agreements

EXHIBIT C

California Financing Statements

EXHIBIT D

Delaware Financing Statements

EXHIBIT E

Illinois Financing Statements

EXHIBIT F

New York Financing Statement

EXHIBIT G

Texas Financing Statements

EXHIBIT F-2

Form of Local Counsel Opinion (Colorado)

, 201

Silver Point Finance, LLC

as Administrative Agent under the Term Loan Credit Agreement

▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇

Greenwich, CT 06830

SPCP Group, LLC

as Lender under the Term Loan Credit Agreement

▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇

Greenwich, CT 06830

Re: Term Loan Credit Agreement dated as of ___________, 20 (the “Credit Agreement”) among Rotech Healthcare Inc., a Delaware corporation (the “Borrower”), Silver Point Finance, LLC, as administrative agent (the “Administrative Agent”), and SPCP Group, LLC, as lender (the “Lender”), with obligations thereunder (i) guaranteed by certain subsidiaries of the Borrower (the “Guarantors”), as described in and pursuant to the Guarantee Agreement (the “Guarantee Agreement”) dated as of ____________, 201__, among the Borrower, the Guarantors and the Administrative Agent, and (ii) secured by substantially all of the existing and future assets (the “Collateral”), as described in and pursuant to the Collateral Agreement (the “Collateral Agreement”) dated as of ____________, 201__, as amended and restated as of ________, 201__, among the Borrower, the Guarantors and The Bank of New York Mellon Trust Comixany, N.A., as collateral agent (in such capacity, the “Collateral Agent”).

Ladies and Gentlemen:

We have acted as special Colorado counsel to the Borrower, in connection with its commitments under the Credit Agreement. (the 'Transaction”) for the limited purposes of reviewing the corporate records of five (5) wholly-owned subsidiaries of the Borrower that are incorporated in the State of Colorado (each a “Subsidiary” and collectively, the “Subsidiaries”) set forth in Schedule I attached to this letter (the “Schedule”) and the Transaction Documents (defined below), and providing the opinions set forth herein. We are providing this opinion in accordance with Section 4.01(d) of the Credit Agreement. Any term that is not otherwise defined in this letter will have the meaning ascribed to that term in the Credit Agreement. For purposes of the opinion letter, the following terms shall have the following meanings:


1.	“UCC” means the Colorado Uniform Commercial Code.


2.	“Filing Office” means the Secretary of State of the State of Colorado (the “Colorado Secretary of State”).

While certain members of this firm are admitted to practice in other states, we have not examined the laws of any state other than the laws of the State of Colorado, or consulted with members of this firm who are admitted in other jurisdictions with respect to the laws of such jurisdictions. Accordingly, the opinions contained herein apply only with respect to the present

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 2

laws of the State of Colorado or the federal laws of the United States of America (“Applicable Law”) and we express no opinion with respect to the laws of any other jurisdiction.


A.	Basis of Opinion and Documents Examined

In rendering the opinions contained in this letter we have relied, with your approval, as to factual matters that affect our opinions, solely on our examination of the Documents (as defined below), and have made no independent examination or investigation to verify the accuracy or completeness of facts or other matters asserted to be true and correct in such Documents.


1.	The Credit Agreement.


2.	The Guarantee Agreement.


3.	The Collateral Agreement.


4.	Unfiled copies of the UCC-1 financing statements attached to Schedule II hereto (individually, a “Financing Statement” and collectively, the “Financing Statements”) naming the Subsidiaries as debtors and the Collateral Agent as secured party.


5.	The Omnibus Unanimous Written Consents of the Board of Directors of each of the Subsidiaries, dated ____________, 201__ approving, by omnibus resolutions, among other things, the Credit Agreelliviii., we Guarantee Agreement, the Collateral Agreement and the filing of the Financing Statements.


6.	A good standing certificate dated __________, 201__ from the Colorado Secretary of State for each of the Subsidiaries regarding the good standing of each Subsidiary.


7.	An Officer's Certificate in Support of Legal Opinion issued by the President of each of the Subsidiaries (the “Certificate”).


8.	Such other documents, matters of law and fact as we have considered necessary or appropriate for the expression of the opinions contained herein.

For the purposes of this opinion, the Credit Agreement, the Collateral Agreement and the Guarantee Agreement shall be referred to as the “Transaction Documents” and collectively with the other documents and information referred to above are sometimes herein collectively referred to as the “Documents.”


B.	Assumptions

In rendering the opinions set forth in Section C below, we have assumed with your consent and without investigation: the genuineness of all signatures; the legal capacity of all

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 3

individuals who have executed any of the Documents reviewed by us; the authenticity of all Documents submitted to us as originals, the conformity to the originals of all Documents submitted to us as certified, photostatic, facsimile, reproduced or conformed copies, the authenticity of the latter documents and that the statements regarding matters of fact in the certificates, records, agreements, instruments and documents that we have examined are accurate and complete; the truthfulness of each statement as to all factual matters otherwise not known to us to be untruthful contained in any Document encompassed within the due diligence review undertaken by us; the payment of all required documentary stamps, taxes and fees imposed upon the execution, filing or recording of documents; there have been no undisclosed oral or written modifications of any provision of any Document reviewed by us in connection with the rendering of the opinions, all terms and conditions of, or relating to, the transactions contemplated by the Transaction Documents are correctly and completely embodied in the Transaction Documents; that all parties have complied with any requirement of good faith, fair dealing and conscionability; that each Subsidiary is solvent; that each Subsidiary has received adequate consideration for entering into the Transaction Documents; that (i) the Articles of Incorporation or Bylaws of each Subsidiary has not been amended and that no such amendment is pending or has been proposed, (ii) each Subsidiary is organized solely under the laws of the State of Colorado, (iii) there are no proceedings pending or contemplated for (A) the merger, consolidation, conversion, dissolution, liquidation or termination of any Subsidiary, or (B) any Subsidiary's transfer to or domestication in any other jurisdiction and (iv) each Subsidiary has not changed its name whether by amendment of its Articles of Incorporation, by reorganization or otherwise, within the last four (4) months.

Since we have not represented any of the Subsidiaries with regard to their respective corporate formalities, for purposes of the opinions rendered below, we rely on the presumption of regularity and continuity (a) for all stock issuances, and cancellations thereof where applicable, and (b) with the exception of the written consent referenced under Section A.S. and the Certificate referenced under Section A.7. above, for all of the minutes of the meetings and written consents of the Subsidiaries' Board of Directors and shareholders, and as to any such meetings or consents, that they were properly noticed or notice was properly waived.


C.	Opinions

Based on our examination and consideration of the Documents, and in reliance thereon, and subject to the comments, assumptions, exceptions, qualifications and limitations set forth in Sections B and D hereof, we are of the opinion, with respect to each of the Subsidiaries, that:

1.Each Subsidiary has been incorporated and organized under the Colorado Business Corporation Act or its predecessor, as applicable, is in good standing, and its status is active.

2.Each Subsidiary has the corporate power to: (a) own, lease and operate its property and conduct its business, (b) execute and deliver the Transaction Documents and to perform its obligations thereunder, and (c) grant the security interests to be granted by it pursuant to the Transaction Documents to which the Subsidiaries are a party.

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 4

3.Each Subsidiary has authorized by all necessary corporate action (a) the execution, delivery and performance of the Transaction Documents to which the Subsidiaries are a party, and (b) the filing of the Financing Statements being filed against it.

4.The Transaction Documents to which the Subsidiaries are a party have been executed and delivered by each Subsidiary.

5.The Financing Statements are in proper form for filing with the Filing Office, and upon the filing in such office of the Financing Statements, the Collateral Agent will have a perfected security interest in that portion of the Collateral described in the Collateral Agreement in which a security interest may be perfected under Article 9 of the UCC by the filing of a Financing Statement with the Filing Office. The filing of the Financing Statements in the Filing Office are the only filings necessary to perfect by filing the security interest in those items of the Collateral covered by Article 9 of the UCC where filing is the method of perfection as under Article 9 of the UCC as described in such Filing Statements, which is owned by the Subsidiary.

6.The execution and delivery by each Subsidiary of the Transaction Documents to which the Subsidiaries are a party, the performance of their payment and other obligations thereunder and the granting of the security interests to be granted pursuant to the Collateral Agreement do not violate: (a) any provisions of Colorado law, rule or regulation, which in our experience, are typically applicable to transactions of the nature contemplated by the Transaction Documents to which the Subsidiaries are a party; (b) the Articles of Incorporation or Bylaws, as either may have been amended, of each such Subsidiary, or (c) to our knowledge, any order, writ, injunction or decree of any court or governmental authority or any arbitral award.

7.No consent, approval, authorization, license or exemption by, or other order of, or registration, recording or filing with, any court or other governmental or regulatory authority or agency of the State of Colorado, which, in our experience, is typically applicable to transactions of the nature contemplated by the Transaction Documents to which the Subsidiaries are a party, is required for the execution and delivery by any Subsidiary of the Transaction Documents to which the Subsidiaries are a party, including the grant of security interests pursuant to the Collateral Agreement, except for the filing of the Financing Statements required for the perfection of security interests.

8.The Collateral Agreement creates in favor of the Collateral Agent a security interest under Article 9 of the UCC as in effect on the date hereof in all right, title and interest of each Subsidiary in the Collateral in which a security interest can be created under Article 9 of the UCC to secure the Obligations (as defined in the Collateral Agreement).

D.Comments, Assumptions, Limitations, Qualifications and Exceptions

The opinions expressed above are based upon and subject to, the further comments, assumptions, limitations, qualifications and exceptions as set forth below:

1.We express no opinion with respect to perfection of a security interest in any portion of the Collateral: (a) that is subject to federal statutes or treaty of the United States that provide for

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 5

national or international registration or filing of security interests (e.g., Intellectual Property and civil aircraft (including engines, propellers, appliances, and spare parts) under the Federal Aviation Act of 1958)), (b) that is subject to a certificate of title; (c) farm products, fixtures, timber to be cut or as-extracted collateral; (d) consumer goods or manufactured homes; (e) commercial tort claims; (f) Deposit Accounts, money, cash or cash equivalents; (g) non-negotiable Documents or Goods covered by non-negotiable Documents; (h) Letter-of Credit Rights; or (i) property excluded from coverage under Article 9 of the UCC.

2.We express no opinion with respect to the effect of any provision of the Transaction Documents which is intended to establish any standard other than a standard set forth in the UCC as the measure of the performance by any party thereto of such party's obligations of good faith, diligence, reasonableness or care or of the fulfillment of the duties imposed on any secured party with respect to the maintenance, disposition or redemption of collateral, accounting for surplus proceeds of collateral or accepting collateral in discharge of liabilities. We have also assumed that the Collateral Agent will enforce the respective Transaction Documents in compliance with the provisions of the UCC and any other provision of applicable law,

3.We have not made any investigation of and express no opinion as to the title of any party to property described in the Collateral Agreement, whether real or personal, tangible or intangible, or mixed, the accuracy or inadequacy of the description of any of the property described in the Collateral Agreement, whether real or personal, tangible or intangible, or mixed.

4.We express no opinion as to the effectiveness of the Lender's security as to any rights (including rights of payment) under any right, account or other obligation for which the United States government or any other government or agency, department or subdivision thereof is an obligor.

5.We note that perfection of a security interest in the Collateral also perfects a security interest in a supporting obligation for such Collateral and that a security interest in a right to payment or performance also perfects a security interest in a security, mortgage or other lien in personal or real property securing that right. We render no opinion regarding the validity or enforceability of any such supporting obligation or such supporting lien.

6.We express no opinion as to priority of perfection of the security interests of the Collateral Agent filed on behalf of the Lender, nor do we express an opinion on the validity, binding effect or the enforceability of the Transaction Documents. We have not made any investigation of, and do not express any opinion as to priority of any liens created by the Transaction Documents.

7.Our security interest opinions in Sections C.S. and C.6. of this opinion letter are limited to Title 4, Article 9 of the UCC. We express no opinion with respect to (i) the effect of section 4-9-315 of the UCC with respect to any proceeds of any Collateral that are not identifiable, or (ii) any Article 9 Collateral of a type that is or may become fixtures (as defined in section 4-9-102(a)(41) and (44) of the UCC). We express no opinion with respect to transactions excluded from Article 9 of the UCC by section 4-9-109 thereof. Except as expressly set forth in Sections C.5., C.6. and C.B. of this opinion letter, we express no opinion as to the perfection, the effect of perfection or non-perfection and the priority of any security interest that is perfected by any means other than

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 6

filing a financing statement under the UCC. Our security interest opinions in Sections C,5. and C.6. of this opinion letter are also subject to the following exceptions: that with respect to (i) federal tax liens accorded priority under law, and liens created under Title IV of the Employee Retirement Income Security Act of 1974, which are properly filed after the date hereof, we express no opinion as to the relative priority of such liens and the security interests created by the Collateral Agreement or as to whether such liens may be adverse claims; and (ii) any claim (including for taxes) in favor of any state or any of its respective agencies, authorities, municipalities or political subdivisions which claim is given lien status and/or priority under any law of such state, we express no opinion as to the relative priority of such liens and the security interests created by the Collateral Agreement or as to whether such liens may be adverse claims.

8.We express no opinion herein with respect to Healthcare Laws. “Healthcare Laws” means laws or regulations relating to the regulation of the health care industry or to payment for services rendered by healthcare providers, including, without limitation, (i) any provision of federal or state laws governing Medicare or any state Medicaid programs, (ii) Sections 1877, 1128, 1128A or 1128B of the Social Security Act, (iii) any prohibition on the making of any false statement or misrepresentations of material facts to any governmental agency that administers a Federal or State Health Care Program (including, but not limited to Medicare and Medicaid), (iv) the licensure, certification or registration requirements of health care facilities, services or equipment, (v) any state certificate of need or similar law governing the establishment of health care facilities or services or the making of health care capital expenditures, (vi) any state law relating to fee-splitting or the corporate practice of medicine, (vii) any physician self-referral prohibition or state anti-kickback law, (viii) any criminal offense relating to the delivery of, or claim for payment for, a healthcare item or service under any Federal or State Health Care Program, (ix) any federal or state law relating to the interference with or obstruction of any investigation into any criminal offense, (x) any criminal offense under federal or state law relating to the unlawful manufacture, distribution, prescription or dispensing of a controlled substance, and (xi) any laws relating to health or medical insurance.

9.We assume that the Transaction Documents and Financing Statements fall within the scope of the provisions of Section 7-108-501(1)(b) of Colorado Business Corporation Act and, as a result thereof, the remaining provisions of Section ▇-▇▇▇-▇▇▇ of the Colorado Business Corporation Act and any similar provisions of the Articles of Incorporation or Bylaws of the Subsidiaries relating to interested transactions do not apply to the Transaction Documents or the Financing Statements.

10.Our opinions are limited solely to laws of the State of Colorado, and the rules and regulations adopted thereunder, that, in our experience, are normally and directly applicable to transactions of the same nature as those contemplated by the Transaction Documents between unregulated parties, provided that, such laws do not include, and we express no opinion with regard to any state laws relating to: (i) pollution or protection of the environment; (ii) zoning, land use, building or construction; (iii) occupational safety and health or other similar matters; (iv) labor and employee rights and benefits; (v) the regulation of utilities; (vi) antitrust and trade regulation; (vii) tax; (viii) securities; (ix) copyrights, patents and trademarks; (x) banking and insurance; (xi) bankruptcy; (xii) health care and safety laws; (xiii) laws and policies concerning emergencies and criminal and civil forfeiture laws; (xiv) state statutes of general application to the extent they provide

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 7

for criminal prosecution (e.g., mail fraud and wire fraud statutes); (xv) any laws, rules, regulations or ordinances of any county, town, municipality or similar political subdivision or any agency or other instrumentality of the State of Colorado; and (xvi) in the case of each of the foregoing, all rules and regulations promulgated thereunder or administrative or judicial decisions with respect thereto.

11.We have assumed that the transactions contemplated by the Transaction Documents comply with any lending limitations and restrictions and securities laws applicable to the Lender or the Collateral Agent, that there are no other oral or written agreements to which the Subsidiaries are parties except the Transaction Documents, and that each of the Subsidiaries has “rights” in the Collateral within the meaning of the UCC consistent with and sufficient for purposes of the Transaction Documents. We express no opinion as to the effect of the Lender's or the Collateral Agent's compliance or non¬compliance with any federal or state laws or regulations applicable to any of them because of the Lender's or Collateral Agent's legal or regulatory status or the nature of their respective businesses. We also expressly disclaim any opinion relating to consents, approvals, authorizations, orders, registrations or filings as may be required to be made or obtained by the Lender or the Collateral Agent as a result of their respective involvement in the transactions contemplated by the Transaction Documents.

12.We caution you, and express no opinion, regarding the following: (i) to the extent any Collateral consists of contractual rights of any of the Subsidiaries or pursuant to certain governmental permits and licenses, the transfer of certain contractual rights of any of the Subsidiaries included within the Collateral might be subject to the consent or approval of the other parties to such contracts; and (ii) the transfer of certain governmental permits and licenses of any of the Subsidiaries included within the Collateral might require the approval of the applicable governmental authority or might require the purported transferee to apply to such authority for a license or permit in the transferee's own name.

13.Our opinions are limited solely to the Transaction as contemplated by the Transaction Documents.

14.The opinions expressed herein are as of the date hereof, and we assume no obligation to update or supplement such opinions to reflect any facts or circumstances that may hereafter come to our attention or any changes in law that may hereafter occur, Further the opinions expressed herein are based on the Transaction Documents as of the date hereof and we express no opinion with respect to such Transaction Documents as they may be corrected, amended, modified or restated even if such correction, amendment, modification or restatement relates back to the date of this letter.

15.Our opinions herein regarding the execution and delivery of the Transaction Documents to which the Subsidiaries are a party are based upon our review of copies of executed signature pages for such documents provided to us by others; we did not witness the execution or delivery of any of the Transaction Documents.

16.For purposes of this opinion letter we further advise you that the term “knowledge” means the current actual knowledge of the lawyers who are participating in drafting this opinion

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 8

letter and in handling the transaction described herein, but does not include, except as specifically provided hereafter, constructive knowledge or inquiry knowledge.

17.The opinions are furnished to the Administrative Agent and the Lender by us as counsel for the Borrower and are solely for the benefit of the Borrower, the Administrative Agent and Lender, and are rendered solely in connection with the Transaction Documents to which the opinions relate; provided however, that ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇ LLP may refer to this opinion letter for the purposes of fulfilling the condition precedent under Section 4.01(d) of the Credit Agreement. No opinions may be implied or inferred beyond the matters expressly stated herein. The opinions may be relied upon by the Administrative Agent and Lender only in connection with the Transaction Documents and may not be relied upon by any other person or for any other purpose without our prior express written consent in each such instance; provided that a copy of this opinion letter may be delivered by you to such financial institution that may become a Lender under the Credit Agreement, and such persons may rely on this opinion to the same extent as the addressees. Copies of this opinion letter may not be made available, and this opinion letter may not be quoted or referred to in any other document made available, to any other person or entity, except to any accountant or attorney for any person or entity entitled hereunder to rely hereon or to whom or which this opinion letter may be disclosed as provided herein, or as otherwise required by law.

Very truly yours,

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 9

Schedule I

Silver Point Finance, LLC, as Administrative Agent

SPCP Group, LLC, as Lender

20__

Page 10

Schedule II

Financing Statements

Copies of the Financing Statements follow this Schedule II

EXECUTION VERSION

EXHIBIT F-3

Form of Local Counsel Opinion (Florida)

[______], 201[_]

Silver Point Finance, LLC

Re: Rotech Healthcare Inc.

Ladies and Gentlemen:

We have acted as special Florida counsel to Rotech Healthcare Inc., a Delaware corporation (the “Borrower”) for the limited purpose of: (i) reviewing the corporate records of the 50 wholly-owned subsidiaries of the Borrower that are incorporated in the State of Florida (each a “Subsidiary and collectively, the “Subsidiaries”), as set forth in Schedule 1 attached hereto; (ii) reviewing the Documents (as defined in Exhibit “A”); and (iii) providing the opinions set forth herein. This opinion is being furnished to you pursuant to Section 4.01(d) of the Term Loan Credit Agreement, dated as of [______], 201[_] (the “Credit Agreement”), between Silver Point Finance, LLC, as lender and administrative agent, and the Borrower. Unless otherwise defined herein, capitalized terms used herein have the meanings set forth in the Credit Agreement. This opinion letter is furnished to you at your request, and is given with the consent of the Subsidiaries.

We have examined the UCC financing statements (collectively, the “Financing Statements”) attached hereto as Schedule 2 naming the respective Subsidiaries as debtor and ___________ (the “Collateral Agent”), as secured party, filed or to be filed with the Florida Secured Transaction Registry (the “Recording Office”).

In rendering the opinions expressed below, we have examined the originals or copies, certified or otherwise identified to our satisfaction, of such company records, agreements and instruments of the Subsidiaries, certificates of public officials and of officers of the Subsidiaries, and such other documents and records, and such matters of law, as we have deemed appropriate as a basis for the opinions hereinafter expressed.

In rendering the opinions set forth below, we have relied, with your approval, as to factual and other matters that affect our opinions, solely on our examination of the Documents and of the Certificate of the Subsidiaries (the “Certificate”), attached hereto as Exhibit “B”, and have made no independent verification of the facts or other matters asserted to be true or correct therein. Nothing has come to our attention, however, to cause us to question any of such facts or matters.

We have not made any investigation of and do not express any opinion as to, any matters of title or as to priority of any liens created by the Documents.

Silver Point Finance, LLC

[ ], 201[ ]

Page 2

For purposes of this opinion letter, we are licensed to practice law only in the State of Florida and express no opinion with respect to the effect of any law other than the law of the State of Florida, and the federal law of the United States (collectively, “Applicable Law”). As used in this letter, the “Florida UCC” shall mean the Uniform Commercial Code as now in effect in the State of Florida.

This opinion letter has been prepared and is to be construed in accordance with the Report on Third-Party Legal Opinion Customary Practice in Florida, dated December 3, 2011, issued by the Legal Opinion Standards Committee of the Florida Bar Business Law Section and the Legal Opinions Committee of the Real Property, Probate and Trust Law Section of the Florida Bar, as amended and supplemented (the “Report”). The Report is incorporated by reference into this opinion letter.

Based upon the foregoing, and subject to the assumptions, qualifications and limitations stated in this letter and in the Report, we are of the opinion that:

1.Each Subsidiary is a corporation, duly organized, validly existing under the Florida Corporation Act and their status is active with full corporate power to own, lease and operate its property, if any, and transact its business in the State of Florida.

2. Each Subsidiary has all requisite corporate power and authority to execute and deliver the Documents to which they are a party and all documents and instruments required in connection therewith, and to perform their obligations thereunder.

3. The execution and delivery of the Documents to which each Subsidiary is a party, and the performance of their obligations thereunder, have been duly authorized by all necessary corporate action.

4. The Documents have been duly executed and delivered by each Subsidiary.

5. The execution, delivery and performance by each Subsidiary of the Documents to which they are, respectively, a party, and the consummation by each Subsidiary of the transactions contemplated thereby, do not: (a) (i) violate their respective Articles of Incorporation or Bylaws; or (ii) violate any statute, rule or regulation of the State of Florida which, in our experience, is typically applicable to transactions of the nature contemplated by the Documents; or (b) to our knowledge, violate any order, writ, injunction or decree of any court or governmental authority or any arbitral award in the State of Florida.

6. No approval, order, authorization, consent, license, exemption by, or other action by, or filing, declaration, registration or recording with the State of Florida is required to authorize, or is required in connection with the execution, delivery or consummation by the Subsidiaries of any Documents under the statutes, rules or regulations of the State of Florida, which, in our experience, is typically applicable to transactions of the nature contemplated by the Documents.

7. Pursuant to the Collateral Agreement (as defined in Exhibit “A”), the Subsidiaries have each granted a security interest in favor of the Collateral Agent in the Collateral described in the Collateral Agreement securing the performance of the obligations purported to be secured thereby (the “Security Interest”) to the extent a security interest in the Collateral can be created therein under Article 9 of the Florida UCC.

8. The Financing Statements attached hereto as Schedule 2 are in proper form for filing in the Recording Office. Upon the filing of the Financing Statements in the Recording Office, describing the applicable collateral in which the Collateral Agent has a security interest, the Security Interest in the Collateral will be perfected to the extent security interests therein can be perfected by the filing of a UCC-1 financing

Silver Point Finance, LLC

[ ], 201[ ]

Page 3

statements under the Florida UCC in the Recording Office. The filing of the Financing Statements in the Recording Office are the only filings necessary to perfect, by filing, the Security Interest in those items of the Collateral covered by Article 9 of the Florida UCC, to the extent security interests therein can be perfected by the filing of a UCC-1 financing statements under the Florida UCC.

The foregoing opinions are subject to the following comments and qualifications:

a.We express no opinion as to the title of any party to property described in the Collateral Agreement, whether real or personal, the accuracy or inadequacy of the description of any of the property described in the Collateral Agreement, whether real or personal.

b.We express no opinion with respect to the effect of any provision of the Documents which is intended to establish any standard other than a standard set forth in the Florida UCC as the measure of the performance by any party thereto of such party's obligations of good faith, diligence, reasonableness or care or of the fulfillment of the duties imposed on any secured party with respect to the maintenance, disposition or redemption of collateral, accounting for surplus proceeds of collateral or accepting collateral in discharge of liabilities. We have also assumed that the Collateral Agent will enforce the respective Documents in compliance with the provisions of the Florida UCC and any other provision of applicable law.

c.Our security interest opinions in paragraphs 7 and 8 are limited to Article 9 of the Florida UCC. We express no opinion with respect to (A) the effect of section 9-315 of the Florida UCC with respect to any proceeds of any Collateral that are not identifiable or (ii) any Article 9 Collateral of a type that is or may become fixtures (as defined in section 102(a)(44) of the Florida UCC). We express no opinion with respect to transactions excluded from Article 9 of the Florida UCC by section 9‑109 thereof. Except as expressly set forth in paragraphs 7 and 8, we express no opinion as to the perfection, the effect of perfection or non-perfection and the priority of any security interest that is perfected by any means other than filing a financing statement under the Florida UCC. Our security interest opinions in paragraphs 7 and 8 are also subject to the following exceptions: that with respect to (i) federal tax liens accorded priority under law and (ii) liens created under Title IV of the Employee Retirement Income Security Act of 1974 which are properly filed after the date hereof, we express no opinion as to the relative priority of such liens and the security interests created by the Collateral Agreement or as to whether such liens may be adverse claims; and (B) any claim (including for taxes) in favor of any state or any of its respective agencies, authorities, municipalities or political subdivisions which claim is given lien status and/or priority under any law of such state, we express no opinion as to the relative priority of such liens and the security interests created by the Collateral Agreement or as to whether such liens may be adverse claims.

For purposes of the opinions expressed herein, we have assumed with your consent that:

i.The factual statements and information contained in each of the Documents and other documents executed by each Subsidiary in connection with the Documents are accurate and complete.

i.All signatures by parties to the Documents other than those by or on behalf of each Subsidiary are genuine; all documents that have been submitted to us as originals are authentic; and all documents submitted to us as certified, conformed or photostatic copies conform to authentic, original documents.

ii.All terms and conditions of, or relating to, the transactions contemplated by the Documents are correctly and completely embodied in the Documents.

Silver Point Finance, LLC

[ ], 201[ ]

Page 4

iii.The Documents, and the transactions evidenced thereby, are valid, binding and enforceable against each Subsidiary to the extent that such validity, binding effect and enforceability affect the opinions herein expressed.

iv.Each individual executing the Documents had sufficient legal capacity to execute such documents and perform their obligations thereunder (provided, however, we have no actual knowledge that any such individual lacks legal capacity to do so).

v.All parties have complied with any requirement of good faith, fair dealing and conscionability.

vi.Each Subsidiary is solvent.

vii.Each Subsidiary has received adequate consideration for entering into the Documents.

i.The execution and delivery by each Subsidiary of, and the performance by each Subsidiary of their obligations under, the Documents to which they are, respectively, a party do not and will not violate, breach or constitute a default under, or require any consent under: (i) any statute, rule, law or regulation to which each Subsidiary is subject (other than statutes, rules and regulations as to which we express our opinion in clause (a) of paragraph 5 above); or (ii) any order, writ, injunction or decree of any governmental authority or any arbitral award (other than those as to which we express our opinion in clause (b) of paragraph 5 above).

ii.That (i) the Articles of Incorporation or Bylaws of each Subsidiary has not been amended and that no such amendment is pending or has been proposed, (ii) each Subsidiary is organized solely under the laws of the State of Florida, (iii) there are no proceedings pending or contemplated for (A) the merger, consolidation, conversion, dissolution, liquidation or termination of any Subsidiary, or (B) any Subsidiary's transfer to or domestication in any other jurisdiction and (iv) each Subsidiary has not changed its name whether by amendment of its Articles of Incorporation, by reorganization or otherwise, within the last four months.

iii.The Collateral does not include “as-extracted collateral” and “timber to be cut” as used in the Florida UCC.

This opinion letter is subject to the following limitations:

a. We express no opinion with respect to the priority of the lien and security interest created by the Documents

b. We undertake no obligation to advise you of facts or changes in law occurring after the date of this opinion letter which might affect the opinions expressed herein.

c. For purposes of this opinion letter we further advise you that the term “knowledge” means the current actual knowledge, without any independent verification, of the lawyers who are participating in drafting this opinion letter and in handling the transaction described herein, but does not include, except as specifically provided hereafter, constructive knowledge or inquiry knowledge.

Silver Point Finance, LLC

[ ], 201[ ]

Page 5

This opinion is rendered solely for the benefit of the addressees, their successors and assigns, any applicable rating agency, the Collateral Agent and each parties' respective counsel and only as to the matters specifically set forth herein and may not be relied upon by any other person or entity without our prior written consent.

Very truly yours,

By: ______________________________

EXHIBIT “A”

DOCUMENTS

EXHIBIT “B”

CERTIFICATE OF THE SUBSIDIARIES

Schedule 1

Subsidiaries

Schedule 2

Financing Statements

EXECUTION VERSION

EXHIBIT G

[FORM OF]

COMPLIANCE CERTIFICATE

Reference is made to the Term Loan Credit Agreement dated as of [________], 2012, among Rotech Healthcare Inc. (the “Borrower”), the Lenders party thereto, and Silver Point Finance, LLC, as administrative agent for the Lenders (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement. Pursuant to Section 5.04(d) of the Credit Agreement, the undersigned, in his/her capacity as a Financial Officer of the Borrower, certifies as follows:

[Attached hereto as Exhibit [A] are (a) the consolidated balance sheet and related statements of income, stockholders' equity and cash flows as of [_______], 20[__] showing the financial condition of the Borrower and its consolidated Restricted Subsidiaries as of the close of such fiscal year and the results of its operations and the operations of such Restricted Subsidiaries during such year, together with comparative figures for the immediately preceding fiscal year, all audited by Deloitte & Touche LLP or other independent public accountants of recognized national standing and (b) an opinion of such accountants (which opinion may include a “going concern” qualification, but shall be without other qualifications or exceptions as to the scope of such audit or otherwise) to the effect that the consolidated financial statements attached hereto fairly present the financial condition and results of operations of the Borrower and its consolidated Restricted Subsidiaries on a consolidated basis in accordance with GAAP consistently applied.]¹

[Attached hereto as Exhibit [B] are the consolidated balance sheet and related statements of income, stockholders' equity and cash flows as of [______], 20[__] showing the financial condition of the Borrower and its consolidated Restricted Subsidiaries as of the close of such fiscal quarter and the results of its operations and the operations of such Restricted Subsidiaries during such fiscal quarter and the then elapsed portion of the fiscal year, and comparative figures for the same periods in the immediately preceding fiscal year.]²

[These fairly present the financial condition and results of operations of the Borrower and its consolidated Restricted Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments.] Include this sentence if the Borrower has not delivered a Form 10-Q within 45 days after the end of such fiscal quarter.


3.	To the knowledge of the undersigned, at no time during such fiscal period did a Default or Event of Default occur. [If unable to provide the foregoing

¹ Use this paragraph for fiscal year end financials.

² Use this paragraph for fiscal quarter end financials.

certification, fully describe the reasons therefor and circumstances thereof and any action taken or proposed to be taken with respect thereto (including the delivery of a “Notice of Intent to Cure” concurrently with delivery of this Compliance Certificate) on Annex A attached hereto.]


4.	The following represent true and accurate calculations in all material respects, as of the last day of the period then ended, to be used to determine whether the Borrower is in compliance with the financial covenants set forth in Section 6.03 of the Credit Agreement:

Maximum Total Leverage Ratio

Total Debt = [•]

EBITDA = [•]

Total Leverage Ratio = [•] to 1.00

Minimum Fixed Charge Ratio

EBITDA = [•]

Fixed Charges = [•]

Fixed Charge Ratio = [•] to 1.00

Minimum EBITDA

EBITDA = [•]

Supporting detail showing the calculation of Total Debt is attached hereto as Schedule 1. Supporting detail showing the calculation of Fixed Charges is attached hereto as Schedule 2. Supporting detail showing the calculation of EBITDA is attached hereto as Schedule 3.

³ Include this sentence if the Borrower has not delivered a Form 10-Q within 45 days after the end of such fiscal quarter.

IN WITNESS WHEREOF, the undersigned, in his/her capacity as a Financial Officer of the Borrower, has executed this certificate for and on behalf of the Borrower and has caused this certificate to be delivered this ________ day of __________.



ROTECH HEALTHCARE INC.,
by

	Name:
	Title:

[ANNEX A]

[Information Relating to Default or Event of Default]

⁴Annex A to be attached only if required pursuant to paragraph 3.

Schedule 1

Calculation of Total Debt

Schedule 2

Calculation of Fixed Charges

Schedule 3

Calculation of EBITDA

EXECUTION VERSION

EXHIBIT H

Proposed Amendment to Senior Secured Notes Indenture

*** Certain information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

TERM LOAN CREDIT AGREEMENT dated as of December 21, 2012 among ROTECH HEALTHCARE INC., THE LENDERS PARTY HERETO and SILVER POINT FINANCE, LLCas Administrative Agent

Document Metadata

Document Metadata

Table of Contents